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ABSTRACT
Phosphoinositide 3-kinase (PI3K) plays an important role in cellular signalling by 
generating phospholipid second messengers at the plasma membrane. A large 
repertoire of signalling and actin-binding proteins, which consistently regulate the 
dynamic assembly and spatial organisation of actin filaments, binds phospholipid 
second messengers, through their pleckstrin homology (PH) domains, and regulates 
changes in actin cytoskeleton dynamics and organisation in response to external 
stimuli. Thus, the actin cytoskeleton, which functions in the generation and 
maintenance of cell morphology and polarity, regulation of endocytosis and 
intracellular trafficking, contractility, motility and cell division, is considered as an 
integral part of the cell signal transduction system. PI3K-dependent actin cytoskeleton 
reorganisation has been the subject of intensive studies, as alteration in the 
cytoskeleton and thus in cell morphology and migration appear to be common 
signatures of malignancy where PI3K activation is significantly involved. PI3K- 
dependent regulation of actin cytoskeleton dynamics is proposed to be achieved by 
cross-talk with the Rho-family small GTPases, major regulators of actin cytoskeleton 
organisation. However, the molecular mechanisms behind PI3K-dependent actin 
reorganisation and their interaction with small GTPases in not yet clearly defined. The 
aim of this project was to investigate the role of the PI3K signalling in controlling 
actin cytoskeleton, and to explore possible common targets of PI3K and Rho-family 
small GTPase signalling pathways, as well as to search for new targets downstream of 
PI3K. Initially, the role of PI3K in the regulation of the actin cytoskeleton in 
Drosophila cells was defined. Furthermore, a “loss-of-fimction approach” based on 
RNA interference for genes involved in PI3K and small GTPase signalling was 
combined with quantitative differential protein expression analysis and mass 
spectrometry. The differentially expressed proteins, many of which were cytoskeleton 
proteins, metabolic and redox enzymes, were linked to signalling pathways and 
associated with the morphological phenotype of each knockdown. Finally, the 
research was focused on studying the regulation of phosphorylation of cofilin, an 
actin depolymerising protein. It has been established that cofilin phosphorylation and 
activity is not directly regulated by upstream signalling events, but by changes in the 
levels of filamentous actin itself, with slingshot, the cofilin phosphatase, being a key 
regulator in sensing the dynamic changes in F-actin levels. Thus, cofilin 
phosphorylation is a homeostatic sensor of actin polymerisation, which self-limits 
protrusive response to external stimuli.
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Chapter 1
Chapter 1: Introduction
1.1. Cellular signalling pathways
The ability of cells to respond to stimuli derived from the environment is essential 
to their survival and normal physiological function. In order to communicate with 
each other and with their environment, cells express cell surface receptor proteins. 
Binding of a ligand to its membrane receptor results in changes in their biochemical or 
physical states that typically initiates a cascade of signalling events within the cell 
(Pawson, 1995; Rosales et al., 1995). Intracellular signal transduction might involve 
physical processes (such as diffusion), chemical changes (such as phosphorylation) of 
signalling intermediates, or both. For most characterised signal transduction pathways, 
the initial signalling event and the final effectors are known, but intermediate events 
that transmit the signal are either partially or completely unknown. In order to 
understand fully intracellular signal transduction and complex signalling networks, it 
is essential to identify the intermediate signalling molecules and to understand how 
information flows from one to the next. Even though every signalling network is 
organised such that cell surface receptor proteins, recognising specific stimuli, 
transmit information to downstream components of individual signal transduction 
pathways, which terminate with effectors that elicit a specific cellular response (e.g., 
proliferation, differentiation, survival, secretion and morphogenesis), individual 
signalling pathways differ in their complexity. The simplest signalling pathway is the 
linear signalling cascade, involving a specific receptor and a single effector (Figure 
1.1a). Over time, this linear cascade evolved, becoming divergent with multiple steps 
between arms of the signalling pathways and using mechanisms involving cross-talk 
between signalling pathways (Figure 1.1b and c).
16
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Figure 1.1 Diagram of signalling pathways. The binding of a ligand to its receptor triggers 
the activation of signalling pathways through effector (E) proteins that transduce signals to 
several intracellular second-messenger systems, which eventually lead to biological actions. 
The proposed concepts of signalling pathways have evolved from simple linear cascades (a) 
to complex networks (b  and c), and currently networks with critical nodes that participate in 
the cross-talk between signalling networks (d , represented by the shaded/coloured boxes). In 
panel d, network 1 is represented by the green arrows, network 2 by the red arrows, and 
network 3 by the black arrows. Plain arrows represent an activation process, dashed arrows 
represent an activation process with less intensity, and blocked arrows represent an inhibition 
process. The numbers beside every component of the network (I, II, III for receptors and 1 to 
13 for effectors) represent distinct proteins, whereas the small letters indicate different 
isoforms of the same protein. Adapted from Taniguchi et al. 2006.
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A major challenge in signal transduction research is the identification of 
components, or nodes, within a network that are essential for the biological response 
to a ligand-receptor interaction, but which also allow divergence of the signal and 
facilitate cross-talk between systems and/or which fine-tune the response to stimuli 
(Figure l.ld). It has been proposed that “critical nodes” could constitute a group of 
related proteins (for example, gene isoforms) that are essential for the receptor- 
mediated signal, and in which two or more of these related proteins might have 
unique biological roles within a signalling network and therefore serve as a source of 
divergence within the signalling system. The nodes are highly regulated, both 
positively and negatively and they serve as a junction for potential cross-talk with 
other signalling systems (Taniguchi et al., 2006). This suggests of complexity of cell 
signalling network and the existence of complex interactions between molecules on 
different levels. Importantly, alterations in the ability of cells to respond appropriately 
to both internal and external stimuli, due to either molecular damage or genetic 
mutations of cellular components leads, to cellular pathophysiology associated with 
disease (e.g., cancer, autoimmune diseases, neuromuscular disorders, cardiovascular 
dysfunction etc).
Transduction of signals through cell signalling pathways is largely regulated by 
enzyme activity, protein-protein interaction, conformational changes and 
posttranslational modifications (PTMs) of proteins such as phosphorylation, acylation, 
glycosylation, nitration, and ubiquitination (Mann and Jensen, 2003). The most 
studied PTM is protein phosphorylation. Phosphorylation is a mechanism that can 
turn proteins “on” and “off’ by altering their activation state (Hunter, 1995). In 
addition, phosphorylation can change the binding properties of a particular protein or 
drive its translocation to a different cellular compartment. Protein phosphorylation is 
mediated by protein kinases and is negatively regulated by phosphatases. Thus, 
protein kinases and phosphatases play a key role in signal transduction and virtually 
all the major regulatory processes in normal and disease state cells are controlled 
directly or indirectly by phosphorylation. In addition to protein kinases, lipid kinases 
also play a major role in intracellular signal transduction. One of the intensively 
studied signalling pathways in which lipid kinases are involved is the 
phosphatidylinositol-3-OH kinases (PI3K) signalling pathway. This chapter focuses
18
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on the classification and structure of this family of lipid kinases, and provides a brief 
overview of our current knowledge of PI3K signalling, cellular processes it regulates 
and a special overview of the cross-talk that exist between PI3K and the small Rho 
GTPases in controlling the actin cytoskeleton.
1.2 Phosphatidylinositol-3-OH kinase signalling pathway
1.2.1 The structure of PI3K family
PI3Ks belong to a large family of PI3K-related kinases or PIKK. Other members 
of this family include protein kinases: mTOR (mammalian target of rapamycin), ATM 
(ataxia telangiectasia mutated), ATR (ATM and RAD3 related) and DNA-PK (DNA- 
dependent protein kinase). All possess the characteristic PI3K-homologous kinase 
domain and a highly conserved carboxyl-terminal tail (Kuruvilla and Schreiber,
1999). Importantly, all members of the PIKK family have been implicated in human 
cancer both as oncogenes in the case of class I PI3K, or as tumour suppressor genes in 
the case of ATM and ATR.
PI3Ks are members of a unique and conserved family of intracellular lipid kinases 
that phosphorylate the 3’-hydroxyl group of phosphatidylinositol (Ptdlns) (Figure 1.2 
A) and phosphoinositides. D3-phosphorylated phosphoinositides act as lipid second 
messengers and activate many intracellular signalling pathways that regulate various 
cellular functions including cell metabolism, survival, proliferation, polarity, actin 
reorganisation and vesicle trafficking (Vanhaesebroeck et al., 2001; Engelman et al., 
2006). Figure 1.2 B shows pathways that contribute to the biosynthesis of individual 
phosphorylated derivates of phosphatidylinositol and the enzymes that are involved in 
these processes.
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Figure 1.2 Pathways of phosphoinositide phosphorylation and dephosphorylation. A)
The molecular structure of phosphatidylinositol. Hydroxyl groups numbered in red can be 
phosphorylated B) Pathways of phosphoinositide phosphorylation and phosphatase-catalysed 
hydrolysis in mammalian cells. In red are phosphoinositides. Numbers in parentheses indicate 
the sites of phosphorylation on the inositol ring. Two known phosphoinositide phosphatases 
(PTEN and SHIP1) are indicated in green, and the kinases are indicated in blue.
The PI3Ks are divided in three classes (I-III) on the basis of their structural 
characteristics and substrate specificity (Vanhaesebroeck et al., 1997a) (Figure 1.3). 
Different classes of PI3K, as well as different isoforms within each class have distinct 
roles in cellular signal transduction.
Class I PI3Ks consists of heterodimeric enzymes composed of a catalytic subunit 
and an adaptor or regulatory subunit. This class is further divided into two classes, IA 
and Ib , based on the receptors to which they couple. Class IA PI3Ks are activated by 
growth factor receptors with intrinsic tyrosine kinase activity (RTKs) or non-receptor 
tyrosine kinases, such as src-family kinases or Janus type kinases (JAKs), whereas the
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class Ib PI3K is activated by G-protein-coupled receptors (GPCRs) (Vanhaesebroeck 
et al., 2001; Katso et al., 2001).
Class IA PI3K
Regulatory subunits: 
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- T S T U  . , , . 1^ ,  . - " s h T *1
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Figure 1.3 Classification of PI3K family members
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The class IA enzymes comprise three different isoforms derived from three separate 
genes: pi 10a (PIK3CA) and pi 1 Op (PIK3CB) that are expressed in many tissues, and 
pi 105 (PIK3CD), which is expressed predominantly in haematopoietic cells (Chantry 
et al., 1997). These catalytic subunits contain carboxy-terminal catalytic and 
phosphatidylinositol kinase (PIK) domains, a C2 domain (a calcium- and lipid- 
binding domain), and an amino-terminal Ras binding domain. Class IA enzymes also 
contain an amino-terminal regulatory-subunit binding domain. The regulatory 
subunits/adaptors of the class IA enzymes form a complex protein family, comprising 
at least seven members, which are generated by alternative spicing of three different 
genes namely p85a, p85p and p55y. These molecules contain two carboxy-terminal 
SH2-domains separated by an inter-SH2 region that serves as a docking site for the 
catalytic subunit. In addition, both p85a and p85p contain amino-terminal proline 
motif-binding SH3 and breakpoint cluster region (BCR) homology (BH) domains. BH 
domains are similar to the GTPase activating protein (GAP) domain of the BCR gene 
and although BH domains can bind the small GTPases Cdc42 and Racl, they do not 
show GAP activity. Differential splicing or differential transcriptional initiation of the 
gene encoding p85a gives rise to additional isoforms of the protein (p55a, 
p50a), which like p55y do not have the BH or SH3 domains. This truncated structure 
is characteristic of the Drosophila melanogaster and Caenorhabditis elegans 
regulatory subunits (Okkenhaug and Vanhaesebroeck, 2001). The biological 
significance of the multiple catalytic and regulatory subunits of class IA is currently 
unclear, but multiple isoforms probably evolved later to provide the mammalian 
PI3Ks with distinct functions. In contrast, Drosophila has only one catalytic subunit, 
Dpi 10, and one regulatory subunit, p60, both encoded by single genes Pi3K_92E and 
Pik57, respectively (Table 1.1). The activation of the class IA enzymes is driven by 
binding of SH2 domains of the regulatory subunits to the phosphorylated tyrosine 
residues (pY) within the sequence motif pY-X-X-M (where X is any amino-acid, M is 
methionine) which is found in many activated growth factor receptor tyrosine kinases 
and their adaptor molecules (Myers, Jr. et al., 1992).
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Class Type Mammals Drosophila melanogaster
Class IA Catalytic PIK3CA (p110a) 
PIK3CB (p110|3) 
PIK3CD (p1106)
Pi3K_92E (Dpi 10)
Regulatory PIK3R1 (p85a/p55a/p50a) 
PIK3R2 (p85P)
PIK3R3 (p55y)
Pik57 (p60)
Class IB Catalytic PIK3CG (p110v) None
Regulatory PIK3R5 (101) 
p84
PIK3R6 (p87PIKAP)
Class II Catalytic PIK3C2a
PIK3C2J3
P\K3C2y
Pi3K_68D
Class III Catalytic VPS34 Pi3K 59F (DVps34p)
Regulatory PIK3R4 (p150) Vps15-like
Table 1.1 Homology between mammalian and Drosophila PI3K family members.
Class Ib is represented by a single member, pi lOy, present only in mammals and is 
expressed mainly in leukocytes (Vanhaesebroeck et al., 1997b). The pllOy catalytic 
subunit binds p i01, a regulatory subunit that is unrelated to the regulatory subunits of 
the class IA enzymes. Binding of pi lOy to pi 01 renders it significantly more sensitive 
to activation by the p/y G protein complex. There is no class Ib PI3K in D. 
melanogaster or C. elegans, suggesting that the capacity of GPCRs to directly activate 
PI3K signalling is a trait that has evolved in mammals. However, under some 
circumstances pi 1 Op may also be activated by GPCRs, so it is possible that in lower 
organisms class IA PI3K mediates GPCR signals as well (Kurosu et al., 1997).
The class II PI3K family contains three members: PI3KC2a and PI3KC2p, 
expressed ubiquitously, and PI3KC2y expressed primarily in hepatocytes 
(Vanhaesebroeck et al., 2001). All three isoforms share significant sequence 
homology with the class I pi 10 subunits. In addition, class II PI3K has an extended 
divergent N-terminus and additional PX and C2 domains at the C-terminus (Figure 
1.3). These enzymes have no known regulatory subunits. In vitro, these enzymes 
preferentially phosphorylate Ptdlns and, to a lesser extent, PtdIns4P. However, 
PtdIns(4,5)P2 is a poor substrate for these enzymes (Engelman et al., 2006). Class II 
PI3Ks bind clathrin and localize to coated pits, indicating that they function in 
regulating membrane trafficking and receptor internalization (Gaidarov et al., 2001).
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Although this class has not been studied extensively, there is an evidence that class II 
PI3Ks can be activated downstream of growth factor receptors, integrins and 
chemokine receptors, although their role in signalling is not clear (Katso et al., 2001). 
A single Drosophila homologue Pi3K_68D exists (Table 1.1).
The single class III PI3K (VpS34) only phosphorylates Ptdlns to generate PtdIns3P 
(Koyasu, 2003). As it is the only class of PI3K enzyme present in yeast, it is thought 
to represent a primordial PI3K that gave rise to the other classes. The Vps34p 
(vacuolar protein-sorting defective) yeast catalytic subunit and its mammalian 
homologue, both contain carboxy-terminal catalytic and PIK domains, as well as a 
domain that binds a regulatory subunit. The regulatory subunit, VPS15p/pl50 
contains an amino-terminal myristylation signal, a serine/threonine kinase domain, a 
series of leucine-rich repeats, and a carboxy-terminal WD (tryptophan-aspartate 
repeat) motif. Studies, primarily in yeasts, have revealed that this class of PI3Ks plays 
an important role in vesicle trafficking, endocytosis and osmoregulation (Wendland et 
al., 1998). Recently, Vps34 was found to regulate mammalian target of rapamycin 
(mTOR) activity in response to amino-acid availability, suggesting that this enzyme is 
also crucial for controlling cell size (Byfield et al., 2005).
1.2.2 Negative regulation of PI3K signalling
Two types of lipid phosphatase negatively regulate lipid production through PI3K 
activity: PTEN (phosphatase and tensin homolog deleted on chromosome
10)/MMAC1 (mutated in multiple advanced cancers)/TEP-l(TGFp-regulated and 
epithelial cell enriched phosphatase) (hereafter referred as to PTEN) and SHIP 1/2 
(SH2-containing inositol phosphatase). Both phosphatases are responsible for 
dephosphorylating PtdIns(3,4,5)P3 (Figure 1.2).
PTEN was originally identified as a tumour suppressor gene that maps to human 
chromosome 10q23 and was found to be inactivated in breast cancer and 
glioblastomas during tumour progression (Li et al., 1997; Steck et al., 1997). The
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PTEN protein is both a protein and a lipid phosphatase (Cantley and Neel, 1999). 
PTEN hydrolyses the 3’-phosphate and plays a central role in limiting cellular levels 
of PtdIns(3,4,5)P3, thereby opposing PI3K-dependent proliferation and survival 
responses, and other downstream signalling cascades dependent on PtdIns(3,4,5)P3 
levels. Indeed, cells lacking PTEN function can exhibit a two fold increase in 
PtdIns(3,4,5)P3 levels (Stambolic et al., 1998). Early studies showed that 
overexpression of PTEN reduced insulin-induced PtdIns(3,4,5)P3 production in 
human 293 cells without affecting insulin-induced PI3K activation. Further, 
transfection of a catalytically inactive mutant of PTEN (C124S) causes 
PtdIns(3,4,5)P3 accumulation in the absence of insulin stimulation (Maehama and 
Dixon, 1998). In contrast to PTEN, the SHIP 1/2 removes the 5’ phosphate from 
PtdIns(3,4,5)P3 to generate PtdIns(3,4)P2. PtdIns(3,4)P2 can function as a second 
messenger to recruit pleckstrin homology (PH) domain containing proteins, such as 
Akt and PDK1. Thus, although both PTEN and SHIP1/2 reduce levels of 
PtdIns(3,4,5)P3 in cells, SHIP1/2 activity may alter the spectrum of PtdIns(3,4,5)P3. 
dependent signals rather than simply opposing all PI3K-mediated signalling, which 
appears to be the major function of PTEN (Luo et al., 2003).
1.2.3 PI3K signalling pathway
Much of our current understanding of PI3K-dependent signal transduction is based 
on studies of the class I PI3Ks. Products of their kinase activity, PtdIns3P, 
PtdIns(3,4)P2 (herafter PIP2) and PtdIns(3,4,5)P3 (hereafter PIP3), act as lipid second 
messengers, which primarily provide docking sites for recruitment of cellular proteins 
with unique lipid-binding motifs (such as pleckstrin homology (PH), Src Homology-2 
(SH2) or FYVE Ring Finger domains) to membranes. This results in changes 
activation status of the proteins. For instance, PH domains are found in a wide variety 
of proteins (dynamin, spectrin, pleckstrin, phospholipase D, Btk, Akt, PDK1 etc.), 
which, through their interaction with these lipids, undergo changes in their sub- 
cellular localization, conformation, activation state and interaction with other proteins 
(Chan et al., 1999). The function of PI3Ks in regulating protein translocation was 
shown to be conserved throughout eukaryotes (plants, yeast, fruit flies, mammals and
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other higher organisms) (Vanhaesebroeck et al., 1997a; Vanhaesebroeck et al., 2001), 
with the finding that signalling proteins accumulate at sites of PI3K activation by 
direct binding to PIP3. The most studied downstream targets of PI3K-dependent PIP3 
production are the serine/threonine kinases Akt/PKB and PDK1. Association of these 
two proteins with PIP3 brings them into proximity and facilitates the activation of 
PDK1 followed by phosphorylation of Akt by PDK1 at Thr308 in its activation loop 
(Vanhaesebroeck and Alessi, 2000). This subsequently leads to Akt activation. It has 
been reported that for full activation, Akt should be phosphorylated at Ser473 in the 
kinase tail, as well. The kinase responsible for this phosphorylation is still 
controversial, although several kinases are listed as potential candidates including 
PDK1 (Balendran et al., 1999), possible autophosphorylation (Toker and Newton,
2000), DNA-PK (Feng et al., 2004) or mTor/Rictor (Sarbassov et al., 2005). Active 
Akt phosphorylates many downstream target proteins, thereby regulating a range of 
cellular processes including cell proliferation, survival, response to nutritional status, 
growth, metabolism, cell cycle, motility, and vesicle sorting (Figure 1.4).
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Figure 1.4 Schematic representation of signalling through PI3K pathway.
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Many Akt targets become inhibited by the phosphorylation event induced by Akt. 
Such protein targets include Forkhead-related transcription factors (FKHRs) and the 
apoptosis-inducing protein Bad. Akt phosphorylation on both proteins creates a 
binding site for 14-3-3 proteins. The complex of FKHR and 14-3-3 is retained in the 
cytosol blocking nuclear translocation of FKHR and transcription of genes normally 
stimulated by FKHR (Brunet et al., 1999). Similarly, Akt phosphorylates BAD, which 
induces dissociation of BAD from Bcl-2 and B c1 -X l and formation of a Bad-14-3-3 
complex, leading to inhibition of the pro-apoptotic function. Another target negatively 
regulated by Akt phosphorylation is glycogen synthase kinase (GSK3) which is 
constitutively active in un-stimulated cells. Phosphorylation of GSK3-a and GSK3-p 
by Akt turns off the catalytic activity of these enzymes, leading to activation of 
pathways normally repressed by GSK3, which regulates gene transcription, cell cycle, 
cell proliferation and survival (Cohen and Frame, 2001; Vivanco and Sawyers, 2002). 
GSK3 phosphorylates several downstream proteins (glycogen synthase, c-Myc, cyclin 
D) to keep them inactive or to promote their degradation (Cohen et al., 2001). The 
tuberosclerosis complex (TSC1/2) is also inhibited after Akt mediated 
phosphorylation of TSC2 (Inoki et al., 2002), resulting in activation of mTOR 
(mammalian target of rapamycin). mTOR is a serine/threonine kinase that can exist in 
two complexes as mTORCl (mTOR/Raptor) and mTORC2 (mTOR/Rictor). 
mTOR/Raptor complex serves as a molecular sensor that regulates translation through 
the activation of S6K1 and 4E-BP1 (Hay and Sonenberg, 2004; Tee and Blenis, 
2005). S6K1 belongs to the AGC family of protein kinases and requires 
phosphorylation at two sites for its full activation; a site in a C-terminal hydrophobic 
motif and a site in the T loop of the kinase domain. mTORCl mediates 
phosphorylation of Thr389 within the hydrophobic motif, whereas PDK1 is 
responsible for phosphorylation of the T loop. Activated S6K1 phosphorylates the 
40S ribosomal protein S6, and which leads to the increased translation of a subset of 
mRNAs that contain a 5’ tract of oligopyrimidine (TOP). The 5’ mRNAs encode 
components of the translation apparatus, such as ribosomal proteins and elongation 
factors, and are predicted to account for 15-20% of total cellular mRNA. Thus, by 
causing increased translation of 5’ mRNAs, S6K1 would upregulate general 
translation capacity. However, this model has now lost favour due to the recent 
findings that translation of 5’ mRNAs does not depend on S6K (S6K1 and S6K2)
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activity nor on S6 phosphorylation (Pende et al., 2004; Ruvinsky et al., 2005). The 
mTORC2 complex (mTOR/Rictor) has been reported to phosphorylate Ser473 of Akt 
(Sarbassov et al., 2004) and also to play a role in actin cytoskeleton organisation 
(Jacinto et al., 2004; Sarbassov et al., 2005). The direct targets of mTORC2 that 
mediate signalling to the actin cytoskeleton are unknown, but may involve PKCa and 
the small GTPases Rho and Rac (Sarbassov et al., 2004).
Even though Akt is considered a crucial downstream target of PI3K and is likely to 
be responsible for many of the biological consequences of PI3K-dependent PIP3 
production, several studies have demonstrated that there are a number of PI3K- 
dependent, but Akt-independent cellular responses. For example, gain- or loss-of- 
function mutations in PI3K versus Akt gave non-overlapping phenotypes in several 
model systems, including transgenic and knockout mice, indicating that these genes 
are not purely epistatic. This Akt-independence seems to be involved in the regulation 
of the small Rho GTPases: Cdc42 and Rac, and potentially some of their GTP- 
exchange factors (GEFs), which have been shown to be regulated by PI3K, but not to 
be downstream of Akt (Welch et al., 1998; Han et al., 1998). Other PH domain- 
containing proteins that bind to PIP3 include some small GTPases and actin binding 
proteins. Through such interactions, it has been proposed that PI3K can regulate actin 
cytoskeleton organisation, and hence cell shape and motility. This will be discussed in 
more detail in the following sections.
1.2.4 Actin cytoskeleton and its regulation by Rho-GTPases
The cytoskeleton is a complex network of protein filaments that extends through 
the cytoplasm. It provides mechanical support for eukaryotic cells, allowing them to 
adopt a variety of shapes and to carry out coordinated and directed movements. As a 
highly dynamic structure, the cytoskeleton is reorganised continuously as the cell 
changes shape, divides, and/or responds to the environment. An essential component 
of the cytoskeleton in eukaryotic cells is actin, which is a structurally globular protein 
that polymerises in a helical fashion to form an actin filament. Actin filaments work
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in a complex network that is highly dynamic and functions with various actin binding 
proteins to control cell surface movements. The actin cytoskeleton functions in the 
generation and maintenance of cell morphology and polarity, in endocytosis and 
intracellular trafficking, in contractility, motility and cell division. Actin filaments 
lying just beneath the plasma membrane are cross linked into a network by various 
actin-binding proteins to form the cell cortex. The location and orientation of the 
cortical actin filaments is controlled by nucleation sites in the plasma membrane, and 
different regions of the membrane direct the formation of distinct actin-filament- 
based structures. A large repertoire of actin-binding proteins consistently regulates the 
dynamic assembly and spatial organisation of actin filaments, thus orchestring the 
motile behaviour of cells. Among these are proteins that
i) promote the branched nucleation of actin filaments, such as the Arp2/3 complex, or 
the linear nucleation of actin, such as the formins (Faix and Grosse, 2006);
ii) promote depolymerisation or severing of actin filaments, such as the actin- 
depolymerising factor (ADF/cofilin) family (Bamburg, 1999),
iii)associate with monomeric G-actin, such as profilin and p-thymosin to allow 
regulation of new filaments (Pollard et al., 2000),
iv)cap the ends of actin filaments to prevent extension, such as the capping proteins 
(Wear and Cooper, 2004) and
v) cross-link actin filaments to each other and to different cellular structures (Louvet- 
Vallee, 2000; Revenu et al., 2004).
Coordination and integration of the activities of this basic set of proteins is 
essential to control site-dependent actin polymerisation in vivo (Pantaloni et al., 2001; 
Pollard and Borisy, 2003). Furthermore, actin-binding proteins are also targets of 
various signalling pathways emanating from diverse extracellular stimuli, such as 
those from receptor tyrosine kinases (RTKs). These links allow rapid rearrangement 
of the cortical meshwork of actin filaments in response to extracellular signals. In this 
way, the actin cytoskeleton is considered an integral part of the cell signal 
transduction system, and its reorganisation is tightly controlled by cell signalling 
events. Within these signalling pathways, Rho-family GTPases play a key role acting 
as molecular switches at which signal inputs converge and are then transmitted as a 
coordinated array of output events regulating various location-specific cytoskeletal
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events (Figure 1.6). In addition, the Rho GTPases also regulate many other cellular 
processes including gene transcription, the cell cycle, vesicle transport and numerous 
enzymatic activities including PI3Kinase and NADP oxidase in mammalian cells and 
glucan synthase in yeast (Figure 1.5) (Hall, 1998; Hall, 2005). In this way, central 
nodes are created that can coordinate many cellular events.
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Figure 1.5 Cellular effects of Rho GTPases. (Hall, 2005)
Rho GTPases belong to the Ras superfamily of small GTPases and are highly 
conserved throughout eukaryotes. To date, 22 genes encoding different members of 
the Rho family have been identified in the human genome: RhoA, RhoB, RhoC, 
Racl, Rac2, Rac3, Cdc42, RhoD, Rndl, Rnd2, RhoE/Rnd3, RhoG, TC10, TCL, 
RhoH/TTF; Chp,Wrch-l; Rif, RhoBTBl, RhoBTB2; and Miro-1 and 2 (Jaffe and 
Hall, 2005). The yeast S. cerevisiae has five Rho proteins (Rho 1, 2, 3, 4 and Cdc42), 
whereas C. elegans and D. melanogaster are predicted to have 10 and 11, 
respectively. Rho, Rac, and Cdc42 were first recognized in the early 1990s for their 
unique ability to induce specific filamentous actin structures in fibroblasts; stress 
fibres, lamellipodia/membrane ruffles, and filopodia, respectively (Hall, 1998) and 
since then have been studied in great detail.
30
Chapter 1
Rho GTPases act as molecular switchers by cycling between a guanosine 
diphosphate (GDP) inactive and a guanosine triphosphate (GTP) active bound state. 
This cycle is regulated by guanine nucleotide exchange factors (GEFs) (Schmidt and 
Hall, 2002) and GTPase activating proteins (GAPs) (Bernards, 2003), which stimulate 
GTP loading and hydrolysis, respectively, and guanine nucleotide dissociation 
inhibitors (GDIs), whose role appears to be to block spontaneous activation 
(Olofsson, 1999) (Figure 1.6). There are over 60 GEFs and over 70 GAPs for the 
Rho-GTPase family in the human genome (Etienne-Manneville and Hall, 2002).
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Figure 1.6 The GTPase cycle. Rho GTPases cycle between an inactive GDP bound form and 
an active GTP-bound form. Their activity is regulated by GEFs, GAPs and GDIs. Active 
GTPases interact with effector proteins to mediate a response.
When bound to GTP, Rho GTPases interact with a variety of effectors. For Rac, 
Rho and Cdc42 over 60 targets (serine/threonine kinases, lipid kinases, lipidases, 
oxidases and scaffold proteins) have so far been identified using yeast two-hybrid and 
affinity chromatography techniques (Etienne-Manneville et al., 2002). Finally, Rho 
GTPases can be regulated through direct phosphorylation or ubiquitination (Lang et 
al., 1996; Wang et al., 2003), but the extent to which these covalent modifications 
play a role in normal physiology is unclear.
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To affect membrane dynamics and actin organisation, Rho GTPases need to act at 
membranes where they are usually activated by GEFs (Ridley, 2006). The activation 
of Rac and Cdc42 leads to the assembly of contractile actin:myosin filaments, 
protrusive actin-rich lamellipodia, and protrusive actin-rich filopodia, respectively 
(Etienne-Manneville et al., 2002). Lamellipodia are broad sheet-like protrusions 
containing a network of branching actin filaments and are found at the front of 
migratory cells. Both Rac and Cdc42 are active at the leading edge of cells and 
inhibition of each reduces lamellipodial extension (Nobes and Hall, 1995; Kurokawa 
et al., 2004). Target proteins for Cdc42 and Rac are Wiskot-Aldrich syndrome 
(WASP) proteins and WASP Verprolin-homologous (WAVE) proteins, respectively, 
which are also localised at the front of lamellipodia where they induce actin 
polymerisation and branching via recruitment of the Arp2/3 complex. In vitro Cdc42- 
GTP binds directly to N-WASP or the closely related haematopoietic WASP. This 
relieves an intra-molecular, auto-inhibitory interaction of N-WASP and exposes a C- 
terminal Arp2/3 binding/activation site (Ibarra et al., 2005; Stradal and Scita, 2006) 
(Figure 1.7 A). However, recent work has shown that WASP may be trans-inhibited 
through binding to a protein, WIP or CR16, which suppressed WASP activity (Ho et 
al., 2001; Martinez-Quiles et al., 2001). Ho et al. have also described biochemical 
purification of Toca-1 (transducer of Cdc42-dependent actin assembly) as an essential 
component of the Cdc42 pathway. They showed that Toca-1 binds both N-WASP and 
Cdc42 and promotes actin nucleation by activating the N-WASP-WIP/CR16 complex, 
the predominant form of N-WASP in cells. Thus, the cooperative actions of two 
distinct Cdc42 effectors, the N-WASP-WIP complex and Toca-1, are required for 
Cdc42-induced actin assembly (Ho et al., 2004). The proposed model is shown in 
Figure 1.7 B.
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Figure 1.7 Model for N-WASP regulation. A) Under resting conditions, N-WASP is 
maintained in an inactive state in the cytosol. Auto-inhibition is via interaction of the G- 
protein binding domain (GBD) and the C-domain of the VCA module. Alternatively, direct 
interaction with the basic-rich region could inhibit the activity o f a pre-bound Arp2/3 
complex. In response to extracellular stimuli, N-WASP autoinhibition is relieved by the 
binding of GTP-bound Cdc42 and PtdIns(4,5)P2 or SH3 containing proteins. In the open 
conformation, N-WASP can be imported into the nucleus, where it may be retained by FBP11 
and regulate gene expression. Alternatively, active N-WASP can stay in the cytosol. 
Phosphorylation by tyrosine kinases enhances the ability o f N-WASP to activate the Arp2/3 
complex in cooperation with F-actin and prevents its nuclear import. In certain models this 
may induce its degradation through the proteasome pathway. (Bompard and Caron, 2004). B) 
A model of N-WASP regulation by Toca-1 (transducer of Cdc42-dependent actin assembly) 
(Ho et al., 2004).
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Rac, on the other hand, has been reported to activate WAVE proteins indirectly 
through multi-protein WAVE complex (Figure 1.8). The WAVE complex includes 
WAVE1, Abi, Sral/PIR121, Napl/Kette and HSPC300 and exists in an inactive state 
(Ibarra et al., 2005). Rac can bind to Sral/PIR121 in the complex and this leads to its 
disassembly allowing WAVE proteins to interact directly with Arp2/3 and 
subsequently to activate Arp2/3-mediated actin nucleation. However, two recent 
studies reported independently that the WAVE-containing complexes remains stable 
in vivo, even after Rac activation (Innocenti et al., 2004; Steffen et al., 2004).
?.
i* m
Figure 1.8 Model for WAVE regulation. In this model, WAVE constitutively interacts with 
the Arp2/3 complex. However, in resting conditions Arp2/3 is not activated, either because 
binding of WAVE to the PIR121-Napl-Abi-HSPC300 complex prevents the interaction of  
WAVE-Arp2/3 with an essential co-activator (e.g. F-actin) or because it is mislocalised. 
Extracellular stimuli, through the activation o f Rac or the mobilization of Nek, recruit the 
pentameric complex to the plasma membrane. WAVE activation requires its proper 
localisation plus, in this model, the presence o f F-actin and/or the release o f the additional 
protein(s). Alternatively, a complex composed of WAVE, HSPC300, and Arp2/3 is released 
first, and then activation takes place in the presence o f F-actin and the signal is terminated by 
the degradation of free WAVE proteins. (Bompard et al., 2004)
The Arp2/3 complex is a stable complex of seven proteins, including two actin- 
related proteins Arp2 and Arp3, and the subunits p40, p34, p20 and p i6. Electron 
microscopy analysis of the branched filament array in lamellipodia has shown that the 
Arp2/3 complex sits at the branch junctions of filaments in the actin network
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(Svitkina and Borisy, 1999). Accordingly, biochemical and microscopic experiments 
have established that the Arp2/3 com plex causes branching o f  new actin filaments 
(daughter filaments) at 70° angles from pre-existing filaments (mother filaments) 
(Amann and Pollard, 2001; Millard et al., 2004). Branching can also occur from the 
barbed ends o f  growing filaments (Pantaloni et al., 2001) (Figure 1.9). Notably, 
Arp2/3 alone displays no activity on actin polymerisation in vitro and only its 
association with “nucleation promoting factors” such as W AVE or WASP leads to 
initiation o f  filament branching.
D a u g h te r  
fila m en t J
Barbed,
M oth er
filam ent
M oth er < 
filam en t
A R P 2/3
complex
P o in ted P o in ted
Figure 1.9 Cartoon of Arp2/3 complex binding to the side of the mother filament and the 
pointed end of the daughter filament in the y-branch. The two filaments are oriented at a 
70° angle. Two models on the right show the orientation of the ARP2/3 complex at a y-branch 
junction. Light blue and yellow subunits represent Arp2 and Arp3 respectively, and associate 
with the pointed end o f the daughter filament. The other subunits mediate contacts with the 
mother filament. (Goley and Welch, 2006)
Rho proteins, as members o f  Rho family small GTPases, have an important role in 
regulating actin organisation, especially in motile cells. Microinjection o f  
constitutively active Rho or extracellular signals, such as lysophosphatidic acid (LPA) 
and bombesin, which lead to the activation o f  Rho, induced formation o f  actin stress 
fibres and focal adhesions in fibroblasts (Ridley et al., 1992). In addition, Rho 
proteins have been known to act at the rear o f  the migratory cells and to be 
responsible for stress fibre formation and adhesion dynamics (Amano et al., 1997). 
Active Rho generates contractile forces through ROCK activation. ROCK is a 
serine/threonine kinase that mediates m yosin light chain (MLC) phosphorylation 
leading to formation o f  stress fibres and focal adhesions. However, recent studies
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have shown that RhoA can also accumulate at membrane protrusions during cell 
migration in randomly migrating cells and also sporadically in retracting tails, but is 
present in lower levels in the cell body. In contrast to randomly migratory cells, 
PDGF stimulation can induce membrane protrusions even though RhoA activity is 
low, perhaps because PDGF strongly activates Rac, which has previously been shown 
to antagonise RhoA activity (Pertz et al., 2006). These and other data show that 
different extracellular cues induce distinct patterns of RhoA signalling during 
membrane protrusion. Cell migration studies in tumour cells, using three-dimensional 
matrices, have revealed that some tumour cells generate leading edge protrusive 
structures that do not require Rho or ROCK, while other cells move in a rounded 
morphology and that Rho and ROCK are essential for the movement. In both cases it 
has been shown that Rac is required for migration (Sahai and Marshall, 2003). Rho 
can also stimulate new actin polymerisation at barbed ends through formin family of 
proteins, which includes diaphanous-related formins (DRF), mDIAl and mDIA2. 
mDLAl is a direct target of Rho-GTP and its binding to the GTPases relieves an 
autoinhibitory interaction, exposing an FH2 domain that then binds to the barbed end 
of an actin filament. mDLAl also contains an essential FH1 domain, which interacts 
with the profilin/actin complex and hence delivers it to the filament end. The main 
characteristic of mDIA is that once it has added an actin monomer to the existing 
actin filament, it remains bound to the barbed end and is ready to add another actin 
monomer. This progressive mechanism is known as a “leaky cap” mechanism (Figure
1.10).
Formin
(active)
Formin
(inactive)
Figure 1.10 Rho-dependent activation of formins. Rho activates formins to promote linear 
elongation of filaments at barbed ends. (Jaffe et al., 2005)
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In addition to the control of site-directed de novo actin nucleation, Rac, Cdc42 and 
Rho have also been shown to mediate a signalling cascade leading to the regulation of 
actin depolymerising proteins (ADF/Cofilin). ADF/cofilin severs actin filaments 
leading to an increase in uncapped barbed ends that serves as sites for actin 
polymerisation and filament elongation (Ghosh et al., 2004) and promotes actin 
monomer dissociation (depolymerisation) from the pointed ends (Pollard et al., 
2003). These two processes are important for progressive membrane protrusions and 
actin turnover. Cofilin activity is tightly regulated by upstream signalling events and 
is affected by phosphorylation, phosphoinisitol-lipid binding, changes in intracellular 
pH and through protein-protein interactions. Phosphorylation at Ser-3 site in cofilin 
blocks its ability to bind to actin and therefore its severing and depolymerisation 
activity. Cofilin phosphorylation is promoted by LIMK, which in turn is activated by 
PAK-family of Rac and Cdc42-dependent kinases (Yang et al., 1998) (Figure 1.11). 
LIMK-dependent phosphorylation of cofilin can also been induced by Rho acting 
through its target Rho kinase (ROCK) in an event in the stabilisation the actinimyosin 
filaments (Ohashi et al., 2000). Slingshot (SSH) is the Ser-3 cofilin phosphatase and 
can re-activate cofilin (Niwa et al., 2002). Signalling events upstream of SSH are not 
well defined, although there are reports linking SSH to PI3K (Nishita et al., 2004) and 
Rho (Tanaka et al., 2005) signalling.
1.2.5 Actin organisation regulated through cross-talk between PI3K 
and small Rho-GTPases
Several studies have shown that signals induced by growth factors such as EGF, 
PDGF and insulin, which result in membrane ruffling, are mainly dependent upon 
Racl (Ridley et al., 1992; Hawkins et al., 1995; Nobes et al., 1995). The initial step of 
growth factor binding to RTKs leads to receptor dimerisation and subsequently 
activation of its cytoplasmic kinase domain. The ensuing auto-phosphorylation of 
tyrosine residues of the receptor C-terminal tail and adaptor proteins enables binding 
of a variety of SH2 and PTB (phosphotyrosine binding) domain-containing effector 
proteins, thus leading to the generation of signalling platforms composed of
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multiprotein complexes. One such complex is a heterodimeric PI3K. Importantly, the 
activation of PI3K is shown to link insulin-dependent stimulation to Rho family small 
GTPases activation, primarily Rac and actin cytoskeleton rearrangements (Figure
1. 11).
P160ROCK
Fit la podia Lamallipodia Strata fibars
Figure 1.11 Signalling pathways downstream of PI3K affecting actin cytoskeleton 
organisation.
The actin cytoskeleton facilitates propagation of the morphological, metabolic, and 
nuclear effects of growth factors such as insulin by regulating proper subcellular 
distribution of signalling molecules that participate in the insulin signalling pathway 
(Tsakiridis et al., 1999). Studies on the involvement of the actin cytoskeleton in the 
initiation and regulation of insulin signals showed in muscle cells in vitro that insulin 
induces a rapid actin filament reorganization that coincides with plasma membrane 
ruffling and intense accumulation of pinocytotic vesicles. Initiation of these effects of 
insulin requires an intact actin cytoskeleton and activation of PI3K. The recruitment 
of PI3K subunits and glucose transporter proteins to regions of reorganized actin have 
been observed. In both muscle and adipose cells, actin disassembly inhibits early 
insulin-induced events such as recruitment of glucose transporters to the cell surface 
and enhanced glucose transport. Additionally, actin disassembly inhibits more
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prolonged effects of insulin, including DNA synthesis and expression of immediate 
early genes such as c-fos. Intact actin filaments appear to be essential for mediation of 
early events such as association of She with Grb2 in response to insulin, which leads 
to stimulation of gene expression.
It was shown using PI3K inhibitors (wortmannin) or dominant negative PI3K 
constructs that PIP3 synthesis was required for growth factor-stimulated membrane 
ruffling in endothelial cells, suggesting that synthesis of this lipid may be part of a 
signalling pathway leading to direct or indirect activation of Rac (Wennstrom et al., 
1994). Another study showed that PDGF stimulated Rac activation through increased 
guanine nucleotide exchange and was dependent upon PDGR-stimulated synthesis of 
PIP3 (Hawkins et al., 1995). In addition, Rac and Cdc42 have been reported to 
associate with p85/pl 10 in a GTP-dependent manner (Tolias et al., 1995). The in vitro 
binding of PIP3 to Racl has also been reported and was shown to strongly stimulate 
GDP dissociation from Racl (Missy et al., 1998). However, PIP3 preferably bound 
and stabilised the nucleotide-free form of Rac and did not promote GTP loading. 
Thus, the significance of this interaction for the regulation of Rac in vivo is still 
unclear. The availability of in vivo assays capable of measuring the levels of GTP- 
loaded Rac has helped to reinforce the functional link between PI3K and Rac 
activation, providing the biochemical evidence of a PI3K-Rac signalling pathway.
It is also important to note that Rac is not involved in all aspects of PI3K 
signalling. For example, PI3K does not use Rac to couple the insulin receptor to 
glucose uptake in adipocytes, but Rac is required for insulin stimulated membrane 
ruffling (Marcusohn et al., 1995). Cdc42 activity has also been linked to the PI3K 
signalling. Jimenez et al. have shown that PDGF stimulates Cdc42 activity by a 
pathway that involves N-WASP and the p85 subunit of the PI3K, but is independent 
of the catalytic activity of PI3K (Jimenez et al., 2000).
The important functional link of PI3Ks to the actin cytoskeleton is the observed 
role for these enzymes in the regulation of cell migration, towards chemical gradients 
(Servant et al., 2000; Jin et al., 2000), since PIP3 has been found to mediate the effect 
of the growth factors on the formation of the peripheral ruffles implicated in cell
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migration (Merlot and Firtel, 2003). It has been proposed that a PIP3/PIP2 gradient 
exists in migratory cells upon growth-factor stimulation, with PIP3 at the leading 
edge, PIP2 at the rear, and mainly Cdc42 recruited at the leading edge as a major 
regulator of cell polarity. Also in the moving cells that respond to chemotactic 
gradients, such as in neutrophils and D. discoideum, PIP3 is produced locally and 
transiently at the leading edge of these cells (Van Haastert and Devreotes, 2004). The 
potential to trigger Arp2/3-dependent actin assembly at the membrane sites, by the 
production of PIP2 or PIP3, depends on which membrane receptors are stimulated and 
which cell system is used (Insall and Weiner, 2001).
The missing molecular links in PI3K signalling to small GTPases appear to be 
GEFs and GAPs, as it seems that some of them have PH-domains (Di Paolo and De 
Camilli, 2006). In the past few years, several GEFs (e.g. Vavl, DOCK180, Sosl, 
TLAM1) have been implicated as PI3K-dependent, linking Rac downstream of the 
PI3K signalling pathway in vivo (Han et al., 1998; Kobayashi et al., 2001; Innocenti 
et al., 2003). For example, son of sevenless (Sos) is a dual-specificity GEF, with one 
Ras-specific catalytic domain and another domain for Rac. In vitro, PIP3 has been 
shown to bind to the PH domain of Sos and weakly activate Rac-GEF activity in 
immunoprecipitates from COS cells (Innocenti et al., 2003). The Sosl Rac-GEF 
activity downstream of receptor tyrosine kinase appears to require a complex with 
Eps8 and Abil (Scita et al., 1999; Scita et al., 2001). Localisation of Sosl to actin 
structures is mediated by Eps8, while its Rac-GEF activity appears to depend on the 
interaction of the p85 regulatory subunit of class la PI3K with Abil (Innocenti et al., 
2003). The upstream signal for recruitment of p85 to this complex is unclear, and it 
may be constitutively associated. Recently, it has been reported that class II 
phosphoinositide 3-kinase C2p (PI3KC2p) associates with the Eps8/Abil/Sosl 
complex and is recruited to the EGF receptor as a part of a multiprotein signalling 
complex that also involves She and Grb2 (Katso et al., 2006). Increased expression of 
PI3KC2P in A-431 epidermoid carcinoma cells resulted in stimulated Rac activity and 
enhanced membrane ruffling, and increased migration speed of the cells. Tiaml (T- 
cell lymphoma invasion and metastasis) comprises a DH domain, consensus 
sequences for phosphorylation by several protein kinases, a PEST domain, a Discs- 
large homology region and two PH domains, one located on each side of the DH
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domain. N-terminal PH domain can interact with PIP3, bringing Tiaml to the plasma 
membrane. When cellular PI3K activity is stimulated, GTP-Rac increases in 
agreement with the idea that PIP3 stimulates the GEF activity of Tiaml (Fleming et 
al., 2004). Vav is probably the most studied Rac-GEF. Crespo et al. showed that upon 
stimulation with antigens or mitogens, Vavl is tyrosine phosphorylated and this is 
sufficient to activate Vav Rac-GEF activity in vitro and in vivo (Crespo et al., 1997). 
PI3K is thought to modulate the activation of Vavl by influencing its degree of 
tyrosine phosphorylation, but this was found to be dependent entirely on the system 
used.
Finally, phosphoinositides may regulate actin polymerisation through direct 
binding with small Rho-GTPases. PIP2 governs actin polymerisation through its 
binding to N-WASP and cooperation with Cdc42. It is thought that PIP2 triggers a 
conformational change in N-WASP that allows its binding to and activation of the 
Arp2/3 complex (Miki et al., 1996). Binding to PIP2 also appears critical for the 
function of proteins such as the ezrin/radixin/moesin family that act as adaptors 
linking the plasma membrane to the actin cytoskeleton. Thus, any changes in the actin 
cytoskeleton organisation are mirrored by changes in cell membrane dynamics. 
Several other actin binding proteins also appeared to have PIP2 binding domains, 
suggesting these are important for maintaining actin organisation and cell shape. PIP3 
may also be important for directly controlling actin assembly, as it appears that 
WAVE can bind preferentially to PIP3 (Oikawa et al., 2004). In addition, given the 
relative low abundance of agonist stimulated PI3K lipid products in comparison with 
PIP2 or other Pis, it is generally believed that PI3K phosphoinisitides (i.e. PIP3) play 
a regulatory rather than a direct mechanistic role in the organisation of the actin 
cytoskeleton.
In conclusion, cross-talk between small Rho GTPases and PI3K signalling has 
been intensively studied and it has been firmly established that changes in cell 
morphology, polarity and motility are dependent upon PI3K activity mediated by Rho 
family GTPases or through direct binding to phosphoinositides. Numerous 
downstream targets of small Rho GTPases have also been extensively investigated for 
their ability to contribute to actin dynamics. Currently there are three major models,
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through which small Rho GTPases, particularly Rac, could regulate actin dynamics, 
all contributing to enhance protrusions at the cell cortex:
• De novo nucleation of actin filaments (F-actin) from monomers (G-actin) and 
filament elongation, resulting in the formation of a branched array of filaments 
by proteins of the profilin, WASP, WAVE and Arp2/3 complexes.
• Acceleration of actin turnover by proteins such as ADF/cofilin.
• Regulated exposure of existing barbed ends after dissociation of high affinity 
filament capping proteins, such as gelsolin.
Figure 1.12 is a hypothetical model that integrates all three models for regulation of 
actin dynamics in response to external stimuli (Pollard et al., 2001).
Extracellular stimuli Extracellular stimuli
S. Growing filaments push membrane forward
2. WASP/Scar activation
8. ADF/cofilin seven
& de polymerizes
4  1. Profilin-bound ATP-actin
10. ADP ATP exchange
Figure 1.12 Hypothetical cartoon of dendritic nucleation model for actin polymerisation,
capping, and network formation at the leading edge of a motile cell (Pollard et al., 2001). 
The model proposes that, in the absence of free barbed ends, cytoskeletal components are held 
in a metastable state, poised for assembly (step 1). Activation of WASP family proteins (step 
2) activates the Arp2/3 complex to create new barbed ends at a constant rate (step 3). These 
filaments grow rapidly (step 4) and push the membrane forward (step 5). After a short time, 
growth of barbed ends is terminated by capping (step 6). Constitutive ATP hydrolysis within 
actin filaments and dissociation of phosphate (step 7) triggers severing and depolymerisation 
of older filaments by ADF/cofilins (step 8) at a rate that is controlled by some of the same 
signals that stimulate assembly (step 4). Nucleotide exchange catalysed by profilin recycles 
ADP-actin subunits back to the ATP-actin monomer pool (step 10). In a continuously moving 
cell, assembly and disassembly are balanced.(Pollard et al., 2001)
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Arp2/3, cofilin and other actin binding proteins involved in Rac-dependent changes 
in actin organisation have domains that bind to phosphatidylinositols, mainly PIP2 or 
PIP3 (M achesky and Insall, 1999; Condeelis et al., 2001; Xian and Janmey, 2002; 
Pollard e t al., 2003), thus providing an additional link between PI3K and Rac in the 
regulation o f  actin cytoskeleton organisation. Figure 1.13 is a simplified schematic 
representation o f  this cross-talk. The signalling cascades are likely to be more 
complicated as the various inputs from other signalling pathways activated by RTKs 
and negative feedback loops in the signalling network could feed into any o f  the 
downstream targets, contributing to regulated changes that drive the alterations in 
actin organisation.
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Figure 1.13 Phosphoinositides and actin filaments. Binding of phosphoinositides to these 
actin-binding proteins favours the growth o f actin filaments. (Revenu et al., 2004)
The focus o f  m y study in this thesis is on PI3K signalling-dependent change and 
the actin cytoskeleton in response to growth factor treatment, as well as in examining 
cross talk between PI3K and small Rho GTPases and actin-binding proteins, which I 
have carried out using a combination o f  proteomic, genomic and cell biology  
methods.
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1.2.6 PI3K signalling and cancer
The PI3K signalling pathway regulates many normal cellular processes including 
cell proliferation, survival, growth, and m otility (i.e. growth regulation is important 
during development and in adulthood, to ensure that an organism and its organs grow  
to appropriate and reproducible size). However, the PI3K signalling pathway is also 
targeted by genom ic aberrations including mutations, amplifications and 
rearrangements more frequently than any other pathway in human cancer, with the 
exception o f  the p53 and retinoblastoma (Rb) pathways, which also cross-talk at 
multiple levels and constitute a signalling network implicated in tumour initiation and 
progression (Vivanco et al., 2002) (Table 1.2).
M o lecu le A ltera tio n  in tu m o u r s F r e q u e n c y T u m ou r lin e a g e
PTEN M utations (som atic) >50% G lioma, m elanom a, prostate cancer, Endom etrie 
cancer, endom etrioid ovarian can cer  
Variable in sporadic breast can cers (2-30% )
PTEN D e c r e a se d  ex p ressio n
M ethylation
L o ss o f  heterozygosity
>50% Breast, m elanom a, prostate
M icrosatellite instability-high colorectal ca n cer
Endometrial can cer
Leukaem ia
PTEN G erm inal m utations 80%  C ow d en ’s  
d is e a s e
High risk of breast, thyroid and endom etrial 
carcinom as
p85 A ctivating m utations Rare Ovary, colon, glioma, lym phom a cell line (CO)
p85 Fusion V ery rare Lym phoma
P85y D eletion  m utations Unknown Lung ca n cer  cell line (HCC15)
PI3KCA Activating m utations >50%
>20%
Bowel
Breast
AKT1 Am plification Low G astric
AKT2 Am plification Low Ovary (12-25% ) P a n crea s (20% ), breast (rare)
AKT2 Mutation Low Colorectal
AKT 3 O verexp ression Low H orm one-resistant prostate and breast ca n cer
PDK1 Mutation Low Colorectal
970s6 k inase Amplification 30% B reast
T S C 1 /2 Mutation >50% T uberous sc lero sis
Forkhead T ranslocations >50% A lveolar rhabdom yosarcom a
family Low A cute leukaem ia
TCL1 R earrangem ent U nclear T-cell leukaem ia
Chronic lym phocytic leukaem ia
Table 1.2 Abnormalities in the PI3K/Akt signalling pathway in cancer. (Hennessy et al., 
2005)
The first link between PI3K and tumourgenesis was established in the 1980s, when  
PI3K was discovered due to its association with the oncoproteins (Sugimoto et al.,
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1984). In addition, mutants of polyoma middle T that failed to bind PI3K were 
compromised in their ability to transform fibroblasts and polyoma middle T- 
transformed cells had elevated levels of PIP3 (Whitman et al., 1985). In 1997, the 
pi 10a catalytic subunit of PI3K was identified as an avian retrovirus-encoded 
oncogene that could transform chick embryo fibroblasts in vitro (Chang et al., 1997).
PI3K generates cell survival signals that allow them to withstand apoptotic stimuli. 
Many tumour cells display elevated levels of PI3K products as a result of deletion of 
the phosphatase PTEN, activation of Ras or expression of autocrine growth factor and 
under these conditions cells are relatively resistant to apoptosis (Downward, 2004a). 
Several studies have supported the role of PI3K as an oncogene in tumourgenesis. For 
example, Samuels et al. reported that PIK3CA gene, which encodes the 
pi 10a catalytic subunit, was the only gene with somatic (i.e., tumour-specific) 
mutations after they have examined 117 exons that encode the predicted kinase 
domain of the PI3K and PI3K-like genes in 35 colorectal cancers. Subsequent 
sequence analysis of all coding exons of PIK3CA in 199 additional colorectal cancers 
revealed mutations in a total of 74 tumours (32%). Further analysis from this work 
also showed that PIK3CA mutations generally arise late in tumourgenesis, just before 
or coincident with invasion (Samuels et al., 2004). These data suggest that PIK3CA is 
likely to function as an oncogene in human cancer, and clustering of mutations within 
PIK3CA could make this gene an excellent marker for early detection of cancers or 
monitoring cancer progression.
As mention previously, PTEN is a negative regulator of PI3K. It was identified as 
a tumour suppressor when genetic studies revealed that a locus on chromosome 
10q23, in which the PTEN gene was found, was frequently mutated in advanced 
cancers. PTEN has been found to undergo inactivation in a number of additional 
neoplasia, most frequently endometrial and prostate carcinomas, melanomas and 
thyroid tumours (Vivanco et al., 2002). In addition, germinal mutation of PTEN has 
been linked to conditions with an increased predisposition to cancer (Cowden’s 
disease, Bannayan-Zonan, Riley-Ruvalcaba, and Lhermitte-Duclos syndromes) 
(Waite and Eng, 2002). Interestingly, inactivation of the PTEN gene by homologous
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recombination in mice gave rise to animals with increased predisposition to neoplasia 
(Stambolic et al., 2000).
Furthermore, Akt, which appears to be the main downstream target of PI3K, is 
involved in the development of tumours, since its amplification and aberrant 
upregulation were found to be a significant signature in various human malignancies 
(ovarian, pancreatic, breast, gastric, head and neck) (Testa and Bellacosa, 2001; 
Altomare and Testa, 2005). During tumourgenesis, active Akt can turn off cell 
apoptosis by phosphorylation and inactivation of FOXO family of forkhead 
transcription factors (AFX, FKHR and FKHRL1) and pro-apoptotic Bcl-2 family 
member Bad. In addition, Akt promotes cell survival by indirectly activating the pro­
survival transcription factor nuclear factor-icB (NF-kB) through phosphorylation and 
inhibition of I-kB kinase (IKK). Furthermore, Akt blocks apoptosis by inactivating 
the tumour-suppressor p53, a nuclear transcription factor that affects cellular 
functions such as transcription, DNA synthesis and repair, cell cycle arrest, 
senescence and apoptosis. This indirect inactivation of p53 is mediated by Akt- 
induced phosphorylation of the oncoprotein Mdm2 (murine double minute), which in 
the phosphorylated state cannot enter into the nucleus and activate p53. The PI3K/Akt 
signalling pathway also regulates cell proliferation by controlling cell cycle 
progression and growth. Cell growth is controlled mainly by regulation of protein 
synthesis, thus the deregulation of proteins synthesis can contribute to the abnormal 
growth seen in tumour cells. Protein synthesis and cell growth mainly depend on 
nutrition and growth factors and they are regulated by the target of rapamycin (TOR) 
and S6K signalling pathways, downstream of PI3K/Akt. PI3K may contribute to other 
aspects of tumourgenesis in Akt-independent manner as well. As mention previously, 
PIP3 regulates small GTPase by activating a subset of GTP-GDP exchange factors 
(Bar-Sagi and Hall, 2000). Since Rac controls the actin cytoskeleton and cell motility 
and is important for Ras-mediated transformation, PI3K might activate both Rac and 
Ras-dependent invasion events that contribute to metastasis (Rodriguez-Viciana et al., 
1997). Furthermore, the mTOR/Rictor complex, which is downstream of Akt, was 
found to modulate the phosphorylation of protein kinase C a  (PKCa) and alters the 
actin cytoskeleton (Sarbassov et al., 2004). Akt can also phosphorylate and activate 
endothelial nitric oxide synthase (eNOS) and the production of nitric oxide (NO), an
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important regulator o f  endothelial cells. Overexpression o f  eNOS has been associated 
with tumours, thus the PI3K/Akt pathway may also contribute to tumour 
angiogenesis. Given the importance o f  the PI3K signalling pathway in cancer and 
knowing that PI3K pathway is activated during tumourgenesis, makes PI3K an 
optimal target for drug development in cancer therapy. More than 20 companies and 
academic centres have declared active programs in this area (Table 1.3).
E ffect on  
path w ay
Direct
Indirect
T arget E xam p le C o m p a n y /ce n tre S ta tu s
PI3K LY 294002 Lilly Poor pharm acology
W ortmannin an a lo g u es PROLX Preclinical
PX -866 Lilly Preclinical lea d s
S F 1 1 2 4 S em afore Preclinical lea d s
P1106
P l1 0 a
Pan-inhibitor
PEG Wortmannin 
KN309
Echelon
W yeth
Baxter
ICOS
Plram ed
Plram ed
Cerylid
Cerylid/Kinacia
Preclinical
Preclinical
Preclinical
Preclinical
PDK1 Berlex
Lilly
ICOS
Vertex
All are preclinical
ILK
AKT k in ase  dom ain
QLT
QLT
Abbott
Novartis
Lilly
Vertex
R oche
C elgen e
Kinacia/Cerylid
Preclinical
PX 316 B iolm age
PROLX
S creening
Preclinical
PH dom ain M ilefosine Zentaris
Keryx
NIH
Schering
C elgen e
Approved in Europe 
for breast cancer  
In clinical trails for 
leishm aniasis  
Preclinical
mTOR Rapam ycin W yeth
CCI779 W yeth/NCI/CTEP Approved
Rad 001 Novartis P h a se  II
A P 23573 Ariad P h a se  II
A P23841 Ariad P h a se  II
p7 0 S6 kinase
A P 23573 Ariad
Lilly
Preclinical
Forkhead family Calmodulin inhibitors Harvard
B iolm age
Clinical trails 
Preclinical
Growth factor EGFR Multiple Preclinical to
receptors HER2
Insulin
Integrins
approved
Intracellular k inases Src
Abl
Multiple
Table 1.3 List of drugs in development that target the PI3K or related pathways.
(Hennessy et al., 2005)
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1.3 Background to methodology
1.3.1 RNA interference
RNA interference (RNAi) or post-transcriptional gene silencing is an ancient 
natural antiviral mechanism that can be used to turn off gene expression in a sequence 
specific-manner (Downward, 2004b). In the early 1990s, attempts to manipulate gene 
expression by scientists working in three different fields resulted in unanticipated 
gene silencing effects. Rather than ignoring such results, these researchers went on to 
document and further investigate the nature of such silencing, which was named “co­
suppression” in plants, “quelling” in fungi and “RNA interference” in nematodes 
(Hammond et al., 2001). It all started in 1989, with the unexpected outcome of 
experiments performed by plant scientists at Advanced Genetic Sciences in Oakland, 
California (Napoli et al., 1990). The goal was to produce petunia plants with 
improved flower colours. To achieve this goal, they introduced additional copies of a 
gene encoding a key enzyme for flower pigmentation into petunia plants. 
Surprisingly, many of the petunia plants carrying additional copies of this gene did 
not show the expected deep purple or deep red flowers, but carried fully white or 
partially white flowers. When the scientists had a closer look, they discovered that 
both types of genes, the endogenous and the newly introduced transgenes had been 
turned off, and because of this observation, the phenomenon was first named "co­
suppression of gene expression". However, the molecular mechanism behind this 
event remained unknown. Plant virologists made similar observations. At that time, it 
was known that plants expressing virus-specific proteins showed enhanced tolerance 
or even resistance against viral infection. They concluded that short viral RNA 
sequences could attack incoming viruses and stop them from multiplying and 
spreading throughout the plant. They performed reverse experiments and placing 
short pieces of plant gene sequences into plant viruses. After the infection of plants 
with these modified viruses, the expression of the targeted plant gene was suppressed. 
They named this phenomenon “virus-induced gene silencing” (VIGS). The two 
phenomenona, co-suppression and virus-induced gene silencing were later named 
post-transcriptional gene silencing (PTGS). PTGS was later detected in fungi and was
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termed “quelling” (Romano and Macino, 1992). The wild type strains of the fungus 
Neurospora crassa were transformed with albino (al-1, al-2 and al-3) transgenes that 
are required for carotenoid biosynthesis. It was observed that the transformed strains 
frequently displayed a white (albino) phenotype, indicating that both endogenous 
albino genes and the introduced albino transgenes were inactivated. Later, the 
phenomenon of quelling was found to be a general silencing phenomenon, and has not 
being restricted only to the albino genes. In 1998, a Nature paper by Craig C. Mello 
and Andrew Z. Fire reported a potent gene silencing effect after the injection of 
double stranded RNAs (dsRNAs) into C. elegans (Fire et al., 1998,). In investigating 
the regulation of muscle protein production, they observed that neither mRNA nor 
antisense RNA injections had effects on protein production, but dsRNA successfully 
silenced the targeted gene. Because of this work, they coined the term RNA 
interference (RNAi). Eight years after this discovery, which over the years has proven 
to be an important research tool for studying different biological questions, Craig C. 
Mello and Andrew Z. Fire were awarded the Nobel Prize for medicine and 
physiology.
In nature, RNAi is considered an ancient evolutionary mechanism for protecting 
organisms from viral infections. Many viruses have RNA as a genetic material rather 
than DNA and go through at least one stage of their life cycle when they make double 
stranded RNA. When exposed to foreign genetic material (RNA or DNA), many 
organisms activate a highly specific immune response in order to silence the invading 
nucleic-acid sequences before these sequences can integrate into the host genome or 
subvert cellular processes. At the centre of these immune responses is a conserved 
enzyme machinery that integrates with dsRNAs and complementary mRNA (Mello 
and Conte, Jr., 2004). The general mechanism of RNAi has two main steps: initiation 
and effector steps (illustrated in Figure 1.14). In the first initiation step, dsRNAs, 
taken up by cells from the medium, are recognised by enzymatic machinery that 
converts the silencing trigger to ~21-25 nucleotide base pair RNAs called short 
interfering RNAs (siRNAs) (Figure 1.14 A). This ATP-dependent cleavage of dsRNA 
into siRNA is conducted by RNase III enzymes, known as Dicer enzymes. These 
enzymes are evolutionarily conserved from Drosophila, Arabidopsis, Caenorhabditis 
and Neurospora. The next effector step is enforced by the RNA Inducing Silencing
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Complex (RISC), which uses siRNAs to recognise and cleave target mRNAs (Figure 
1.14 B1-B4), which is then followed by degradation by exonucleases (Figure 1.14 
B5).
Figure 1.14 Mechanism of RNA interference. A) Initiation step: dsRNA is digested into 21- 
23 nt siRNAs by Dicer; B) Effector steps: Bl) siRNA assembles into RISC; B2) Unwinding 
of siRNA by RISC in an ATP-dependent reaction; B3) siRNA guide the RISC to 
complementary mRNA; B4) RISC causes cleavage of mRNA; B5) Exonucleases degrade 
cleaved mRNA resulting in gene silencing.
Interestingly, RNAi does more than help to defend cells against foreign nucleic 
acids. It also guides endogenous developmental gene regulation, and can even control 
the modification of cellular DNA and associated chromatin. In some organisms, the 
RNAi signal is transmitted horizontally among cells, and in certain cases, vertically 
through the germ line from one generation to the next (Mello et al., 2004). The early 
useful application of RNAi technology in human cells proved difficult since the 
introduction of dsRNA into cells induces antiviral responses, which includes 
interferon production. This leads to altered gene expression and often cell death, 
limiting the ability of viruses (or alien dsRNA) to replicate and spread through the 
organism. The theory behind this is that the Dicer machinery had been lost during 
evolution of mammals and replaced with more sophisticated and complex defence
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mechanisms which include the interferon system that is not present in invertebrates 
(Downward, 2004b). However, nowadays RNAi can be applied in mammalian 
systems by directly introducing siRNA molecules of less than 30 nucleotide base 
pairs, which do not induce the interferon response, but can trigger cleavage of the 
complementary mRNA sequences and silence genes. This is proof that evolution has 
kept the RNAi as a back-up system even after the development of the interferon 
system.
The emergence of RNAi as a technique to suppress gene expression has 
revolutionised molecular biology and is facilitating the elucidation of gene function 
on a genome-wide scale through large scale screening of phenotypic changes induced 
by RNAi-mediated gene silencing (Kiger et al., 2003; Dasgupta and Perrimon, 2004; 
Friedman and Perrimon, 2006). C. elegans and D. melanogaster are probably the most 
exploited species used in these types of studies, due to the fact, that in vitro RNAi 
treatments are highly efficient in gene expression knockdown. For example, siRNA 
libraries have been generated to target genes of the PI3K signalling pathway in HEK 
293T cells (Hsieh et al., 2004), searching for genes that affected phosphorylation of 
Akt. To obtain a global view of RTK/ERK signalling, Friedman et al. performed an 
unbiased, RNAi genome-wide, high-throughput screen in Drosophila cells using a 
novel, quantitative, cellular assay monitoring ERK activation, and this revealed a list 
of effectors which can be targeted for drug therapy (Friedman et al., 2006). RNAi has 
also been used in parallel with drug inhibitor treatment in studying signalling 
pathways (O'Grady et al., 2005). Since the RNAi-mediated gene-silencing machinery 
is also intact in cancer cells, multiple in vitro siRNA studies have been carried out to 
evaluate the knockdown phenotype of oncogenes. For example, the effect of targeting 
the Bcr-Abl kinase oncogene in chronic myelogenous leukaemia (CML) cells was 
tested by Wilda et al. (Wilda et al., 2002). Silencing the Bcr-Abl fusion protein by 
siRNA induced a strong apoptotic response in CML cells, which was comparable with 
the cell death caused by treatment with Abl kinase inhibitor Gleevec (imatinib 
mesylate). Despite the proliferation of promising in vitro and in vivo studies for 
RNAi-based drugs, some concern has been raised regarding the safety of RNAi, 
especially the potential for "off-target" effects in which a gene with a coincidentally 
similar sequence to the targeted gene is also repressed (Bartz and Jackson, 2005). A
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computational genomic study estimated that the error rate of off-target interactions is 
about 10%. One major study of liver disease in mice led to high death rates in the 
experimental animals, suggested by researchers to be the result of "over-saturation" of 
the dsRNA pathway (Grimm et al., 2006). Additionally, delivery of siRNA into 
mammalian cells remains a major hurdle for RNAi therapy. The two approaches to 
deliver siRNA in vivo: i) stably expressed siRNA precursor, such as short-hairpins 
RNAs, from viral vectors using gene therapy, and ii) delivery of synthetic siRNA by 
covalently linking the duplex RNA with lipids and/or delivery proteins, are often 
inefficient. Thus, if siRNAs are to be used as therapeutics further studies and 
optimisation are required. However, the advantage of RNAi therapy is that unlike 
resistance to other small molecules, which leads to an expensive and time-consuming 
search for new therapeutic agents, resistance to RNAi may be overcome by 
introducing a new siRNAs that targets a different site on the same mRNA. Moreover, 
siRNAs that target conserved sequences or multiple sequences at once may provide a 
solution to this problem (Dykxhoom and Lieberman, 2005).
1.3.2 Proteomics and 2D gel-based protein separation
Proteomics is the large-scale study of proteins, their structure, function and 
expression, in a cell, organism or biological fluid. All of the proteins in an organism 
throughout its life cycle are considered to be its proteome. Compared to the genome, 
which is constant, the proteome is dynamic and changes throughout its biochemical 
interactions with both the genome and the environment. In an organism, there can be 
different proteome activities in various parts of the body, in different environmental 
conditions and at different life stages. Depending on which aspect of proteins is 
studied, proteomics can be divided into proteomic profiling, functional and structural 
proteomics based and can involve a broad range of combined technologies (Figure 
1.15). Protein expression proteomics or profiling proteomics is the quantitative study 
of protein expression between samples that differ by some treatment variable. In this 
approach, protein expression of the entire proteome or of sub-proteomes between 
samples require the use of protein or peptide separation methods that are linked to
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quantitation and protein identification methods (e.g. immunodetection or mass 
spectrometry-based identification). Information obtained by this approach can lead to 
discovery of proteins expressed differentially between samples, and the identification 
of novel proteins in signal transduction or disease-specific proteins. Functional 
proteomics is the study of the role of proteins, based on the presence of specific 
functional groups or based on their involvement in protein-ligand interactions and 
protein complexes. Many proteins need to interact with other molecules in order to 
perform their role. Therefore, knowing the interactions and the partners of a protein 
could help to discover and define its role in a cell. Functional proteomics also 
involves the study of protein post-translational modifications, such as 
phosphorylation, which could help define the activity, localization, and degradation of 
proteins and are often the key to understanding the function of proteins. Signalling 
pathways, which are considered as cascades of specific interacting protein required to 
activate cellular functions, can often be deciphered by functional proteomics. 
Structural proteomics attempts to determine the tertiary structure of proteins, the 
structure of protein complexes and small molecule-protein complexes. X-ray 
crystallography and prediction of protein structures by computational biology are its 
main tools. The information obtained from profiling, functional and structural 
proteomics will help piece together the overall architecture of cells and explain how 
expression of certain proteins gives a cell its unique characteristics.
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Initial protein expression profiling studies began in 1975 with the introduction of 
two-dimensional gel electrophoresis by O’Farrell, who began mapping proteins from 
Escherichia coli (O'Farrell, 1975). Although many proteins could be separated and 
visualized, they could not be identified. Despite these limitations, shortly thereafter a 
large-scale analysis of all human proteins was proposed. The goal of this project, 
termed “the human protein index”, was to use two-dimensional protein 
electrophoresis (2-DE) and other methods to catalogue all human proteins. However, 
lack of funding and technical limitations, such as the unavailability of robust tools for 
high-throughput identification of the proteins displayed by 2-DE, prevented this 
project from continuing. An important step in the 2-DE strategy was an introduction 
of protein labelling and detection methods, which were needed to define quantitative 
and qualitative differences between complex protein samples. The sensitivity of 
protein stains has always been a factor influencing the amount of information that can 
be extracted from 2D gels. In addition, the most significant breakthrough in 
proteomics has been the application of mass spectrometric methods for identification 
of gel-separated proteins, which has extended analyses beyond the mere display of 
proteins.
1.3.3 2-Dimensional gel electrophoresis and 2D-DIGE
2-DE is a powerful and widely used method for the analysis of complex protein 
mixtures derived from various biological sources. In general, the 2-DE separates 
proteins according to two independent parameters i.e. isoelectric point (pi) and 
molecular mass (Mr). In the first dimension, proteins are separated by iso- 
electrofocusing (IEF) in a pH gradient environment, where proteins become focused 
at their isoelectric points (pi) when they reach a net charge of zero. In the second 
dimension, proteins are separated according to their relative molecular weight by 
conventional SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE). The 
electrophoretic separation of a protein is highly specific to its chemical properties and 
allows accurate comparison of proteins analysed on gels. 2-DE can allow separation 
of thousands of different proteins at a time as well as providing information about 
protein pi, Mr, post-translational modifications (which affect pi and MW) and the
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relative amount of each protein, when a suitable protein staining or labelling method 
is used in combination. Usually each spot on the resolving two-dimensional gel 
corresponds to a single protein species within the sample, although in certain cases 
more than one protein can be found to co-migrate on a 2D gel. At present, there are no 
other techniques that are capable of simultaneously resolving thousands proteins from 
complex biological samples in one separation procedure. However, there are some 
drawbacks of 2-DE (i.e. poor resolution of high and low molecular weight proteins 
and hydrophobic and basic proteins, low gel-to-gel reproducibility in different 
experimental runs, it is also a labour intensive and expensive technique) that has 
limited its application in some proteomic studies.
Several reviews have outlined the different methods of choice for detection of gel 
separated proteins (Patton, 2000; Rabilloud, 2000; Patton and Beechem, 2002). Most 
strategies for protein detection in 2D gels use post-electrophoretic protein staining and 
a multitude of different methods have been described which differ in their sensitivity, 
specificity, linear dynamic range and compatibility with downstream identification 
mainly by mass spectrometry. Common strategies include:
i) Colloidal Coomassie blue G-250 staining, that has a detection range of 8-50 
ng of protein/spot. It is simple to use and compatible with downstream MS 
(Neuhoff et al., 1988).
ii) Silver staining methods are employed normally with analytical gels due to 
their high sensitivity (typically 2-4 ng of protein/spot). However, classical 
silver-staining methods can be complex and are often incompatible with MS 
because of the aldehyde-based cross-linkers used in the sensitisation steps, and 
because silver ions can interfere with MS analysis. The non-linearity of the 
dynamic range in silver staining and the tendency of the dye to stain 
differently, based on protein amino acid composition, makes silver staining a 
poor choice for quantitation of protein expression.
iii) Fluorescent stains. There are numbers of these stains including SYPRO Ruby, 
SYPRO Orange, Deep purple etc. SYPRO Ruby is a transition metal organic 
complex that binds directly to proteins by electrostatic interactions, providing 
sensitivity similar to that of classical silver staining (1-2 ng of protein/spot) 
with a broad linear dynamic range, and is compatible with downstream mass
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spectrometry-based protein identification. However, fluorescent dyes are 
usually expensive and require fluorescence scanners for analysis. Fluorescent 
stains have also been developed for the detection of specific sub-groups pf 
proteins, e.g. Pro-Q Diamond and Pro-Q Emerald have been reported for the 
detection of phosphorylated and glycolysated proteins, respectively. However, 
these stains have not been widely used. In addition, there are fluorescent stains 
(e.g. fluorescamine, fluorescein isocyanate, N-(7-di-methylamino-4- 
methylcoumarinyl) maleimide and dansyl chloride) that bind covalently to 
proteins. However, this type of labelling was reported to have low sensitivity 
and poor resolution on 2D gels.
Proteins can also be labelled prior to the electrophoretic separation using:
i) Radioactive labelling - perhaps the most sensitive covalent labelling method is 
in vivo (with 32P/34S/131‘135I isotopes incorporation) and in vitro (32P-ATP 
kinase assay) radioactive labelling, which provides the widest linear dynamic 
range of detection. Radioactive labelled proteins are detected in-gel by 
exposing a film (autoradiography) or using a phosphorimager, which has a 
wider dynamic range than autoradiography, thus enabling better quantitative 
analysis. Although this detection method is powerful, it has some limitations. 
Radioactivity causes DNA damage and increased levels of p53 followed by 
cell cycle arrest and apoptosis. Moreover, radioactive compounds have a 
hazardous nature and are expensive.
ii) Fluorescent tags have been used for covalent labelling of proteins prior the 
separation (e.g. 5-(4,6-dichlorotriazine) aminofluorescein, 2-methoxy-2,4- 
diphenyl-3(2H)-furanone (MDPF) and dansyl chloride). Most of such dyes 
possess a charge that affects the electrophoretic properties of proteins and can 
cause artificial protein modification that can dramatically affect the ability to 
subsequent identifiy proteins by mass spectrometry. Importantly, advanced 
fluorescent covalent labelling of proteins was developed with the introduction 
of monobromobimane (MMBr)- and cyanine (Cy)- based dyes that react with 
cysteine and lysine residue, respectively.
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Fluorescence two-dimensional difference gel electrophoresis (2D-DIGE) is a 
recently developed 2D gel-based proteomics technique that provides a sensitive, rapid 
and quantitative analysis of differential protein expression between two or more 
biological samples. Developed by Unlu et al. (Unlu et al 1997), the technique utilizes 
charge- and mass- matched chemical derivatives of spectrally distinct fluorescent 
cyanine dyes (Cy3 and Cy5) which are used to covalently label protein lysine residues 
in different samples prior to mixing and separating the proteins on the same 2D gel. 
These cyanine fluorophors were modified to create the N-hydroxysuccinimidyl 
(NHS)-ester derivatives NHS-propyl-Cy3 and NHS-methyl-Cy5. A third cyanine dye, 
NHS-Cy2, was introduced, and these labels are commercially available from GE 
Healthcare (Figure 1.16).
Initially, NHS Cy3 and Cy5 dyes were used to label two different protein samples 
prior to running them on the same 2D gel electrophoresis (Unlu et al., 1997). This 
allows running two samples under identical electrophoretic conditions in a type of 
differential display format. Theoretically, to compare proteins derived from two 
differently-labelled samples, the dyes should be mass and charge matched and the dye 
modifications should not perturb the electrophoretic mobility of labelled proteins. For 
this reason, the size of the aliphatic chain (Figure 1.16 A) in the Cy dyes was 
originally modified to maintain a similar molecular weight between each dye and the 
dyes possess a positive charge which matches the positively charged amino groups 
they modify. The advantage of using lysine labelling is that almost all proteins contain 
at least one lysine residue, so most proteins in a complex sample can be labelled. The 
dyes are used under conditions of minimal stoichiometrical labelling, and ideally, just 
a single lysine residue in a protein molecule is labelled with estimated 3-5% of the 
total pool of the protein labelled. This minimal labelling is to keep proteins soluble, 
prevent large mass shift between labelled and unlabelled populations of proteins and 
reduce sample heterogeneity (Chan et al., 2005), while maintaining the sensitivity of 
detection (~1 ng of a protein per spot) and secure linearity over a wide dynamic range.
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Figure 1.16 Characteristics of the NHS-Cy-dyes. A) Structure of the NHS-Cyanine dyes. 
Cy2, 3-(4-carboxymethyl)phenylmethyl)-3’-ethyloxacarbocyanine halide A-hydroxy- 
succinimidyl ester; Cy3, l-(5-carboxypentyl)-r-propylindocarbocyanine halide N- 
hydroxysuccinimidyl ester; and Cy5, l-(5-carboxypentyl)-r-methylindodicarbocyanine 
halide N-hydroxysuccinimidyl. Each dye has a similar molecular weight and single positive 
charge matching the charge of the modified primary amino group. B) Each dye displays 
distinct emission spectra enabling the individual detection of differentially labelled proteins at 
the appropriate wavelength without overlap of signals. C) The dyes have an N- 
hydroxysuccinimidyl ester reactive group triggering covalent interaction with the primary 
amine groups of lysine residues or the N-terminus.
The method o f  using the three Cy dyes was originally evaluated and applied by  
Tonge et al. and Gharbi et al. (Tonge et al., 2001; Gharbi et al., 2002). The general
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protocol o f  using three Cy-dyes for protein labelling relies on labelling the proteins 
from different samples with either Cy3 or Cy5, while the third Cy2 dye is used to 
label a pooled consisting o f  equal amount o f  all samples in the experiment (Figure 
1.17).
1. Lysis and 
minimal labelling 
with NHS-Cy dyes
▼ f
A/Cy3 Standard B/Cy5 
A+B/Cy2
I pH
2. Mix samples and 
resolve by 2-DE
3. Fluorescence 
imaging I v : -K.JT.
r  •*. , • • • . • • • .
#  ♦ .  * • •  •  •  '
A/Cy3 
Ex 5 4 0  
Em 5 9 0  m m
A*B/Cy2 
Ex 480 mm  
Em 5 3 0  m m
B/Cy5 
Ex 620  mm  
Em 660  mm
4. Image analysis 
(DeCyder software) V # .. • •<
5. Post-stain gels with SYPRO Ruby
6. Scan and match with dye labeled images
7. Excise spots of interest
8. Digest with trypsin
9. ID peptides by mass spectrometry
Figure 1.17 Schematic representation of 2D-DIGE protocol for minimal lysine labelling 
and using an internal standard for normalization.
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Samples are then mixed appropriately and run in 2-D gel electrophoresis. The Cy2- 
labelled pool is run on all gels and acts as an internal standard for every protein spot 
on each of the gels, thereby improving spot matching across gels and increasing the 
accuracy of quantitation and statistical confidence of protein expression difference 
studies. Differential labelling and mixing means that samples are subjected to the 
same handling procedures and micro-environments during 2D separation, and raises 
the confidence with which protein changes can be compared and quantified. Since 
fluorescence detection also provides a superior linear dynamic range of detection and 
sensitivity to many methods (Patton 2000), this technology is suited to the analysis of 
biological samples with their large dynamic ranges of protein abundance. Importantly, 
this labelling strategy is compatible with downstream identification of gel spots by 
mass spectrometry (MS).
For protein expression profiling, gels are converted to digital images using 
scanning devices and these are processed to detect the protein features, spot volumes 
quantified and spot patterns matched across different gels. Statistical methods are then 
employed to detect protein spots with statistically significant changes in expression. 
This kind of image analysis is usually performed with dedicated software 
programmes.
1.3.4 Mass Spectrometry
Mass spectrometry (MS) is a powerful analytical technique used for the accurate 
measurement of the mass-to-charge ratio (m/z) of molecules. Traditionally, MS was 
developed for the analysis of small inorganic and organic molecules, but as the 
technology evolved, it has become suitable for analysis of various biomolecules, such 
as proteins, peptides, carbohydrates and nucleic acids. Biological mass spectrometry 
is developing at a rapid pace since the introduction of the soft ionisation techniques 
Matrix Assisted Laser Desorption Ionisation (MALDI) and Electrospray Ionisation 
(ESI). MALDI was developed by Karas and Hillenkamp (Karas and Hillenkamp, 
1988; Hillenkamp et al., 1991) and Tanaka. ESI was developed by Fenn (Fenn et al.,
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1989). In recognition o f  the development o f  ESI and for the development o f  soft laser 
desorption (SLD) Fenn and Tanaka received the N obel Prize for Chemistry in 2002.
B y definition, a mass spectrometer is composed of: i) an ion source; ii) a mass 
analyser; and iii) an ion detector. The function o f  the ion source is to convert an 
analyte into gas phase ions in a vacuum. The ions are then accelerated in an electric 
field into the analyser, which separates ions according to their m/z ratios. The function 
o f  the detector is to record the impact o f  individual ions and measure their intensity. 
Typical workflow o f  proteomic analysis involving mass spectrometry-based protein 
identification is shown on Figure 1.18
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Figure 1.18 Typical workflow of a proteomics/mass spectrometry experiment. A protein 
sample obtained from different biological sources, (for e.g. cell culture) can be separated into 
simpler fractions or even single protein spots using 1-D or 2-D gel electrophoresis. Proteins 
are then in-gel digested using proteases (usually trypsin). The generated peptide mixture can 
be further separated using peptide separation techniques. Peptides are then ionized by 
electrospray ionisation (ESI) or matrix-assisted laser desorption ionisation (MALDI) and 
analysed by mass spectrometry (time-of-flight or quadropole instruments). Finally, peptide- 
mass data is searched against databases using a search engine (e.g. Mascot). Adapted from 
(Aebersold and Mann, 2003).
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In proteomics, an analyte is usually a collection of peptides derived from a protein 
sample digested with trypsin or a similar enzyme. Two types of analysis are typically 
performed:
i) The analysis of intact peptide ions allows the masses of individual peptides to be 
calculated, and then proteins identified by correlative database searching.
ii) The fragmentation of peptide ions and determination of parent and daughter ion 
masses. These masses are then used in database searching to derive peptide 
sequences.
MALDI is an ideal first pass analysis method as it has a relatively high-throughput 
and generates predominantly singly charged ions [M+H]+ and the mass spectra are 
easier to interpret in terms of their peptide mass profiles. MALDI is used 
predominantly for the analysis of simple peptide mixtures, such as peptides derived 
from a single spot from a 2D gel. In MALDI MS analysis, the peptide mixture from 
an enzymatically digested protein sample is mixed and crystallised with an excess of 
an ultraviolet absorbing matrix, which is usually a low-molecular weight aromatic 
acid. The most commonly used matrices for protein/peptide analysis are 2,5- 
dihydroxybenzoic acid (DHB) and a-cyano-4-hydroxycinnamic acid (CHCA). The 
matrices facilitate ion formation by absorption of photon energy from a nitrogen UV 
laser beam used with the mass spectrometer (Karas et al., 1988). The matrix and the 
analyte are dissolved in an organic solvent and placed on a metallic multiple-sample 
target. The solvent evaporates leaving the matrix crystals in which the analyte is 
embedded. The target is placed in a vacuum chamber of the mass spectrometer and a 
high voltage is applied. At the same time, the crystals are targeted with a short laser 
pulse. The laser energy is absorbed by the crystals and emitted as heat, resulting in 
rapid sublimation that converts the analyte into gas phase ions. These ions accelerate 
away from the target through the analyser towards the detector with different speeds 
depending of their m/z ratios. It is reported that protein digests can be analysed by 
MALDI MS with detection limits in the low femtomole range. In addition, 
compatibility of protein stains with MALDI MS has been demonstrated for a variety 
of staining methods including colloidal Coomassie blue, silver staining and SYPRO 
Ruby, which makes this ionisation applicable for protein analysis from gel pieces.
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In contrast to MALDI, ESI ionises analytes from a solution. The analyte is 
dissolved in an organic solvent mixture and is forced through a narrow capillary held 
at a high voltage. A fine spray of charged droplets emerges from the capillary and is 
directed into the vacuum chamber of the mass spectrometer through a small orifice. 
An electrostatic field is formed between the capillary and the walls of the mass 
spectrometer, and as the droplets travel, they evaporate resulting in the formation of 
gas-phase ions that are accelerated through the analyser towards the detector. As ESI 
produces gas-phase ions from solution, it is readily integrated with upstream protein 
separation carried out by capillary liquid-chromatography (LC). The sensitivity of ESI 
MS, like MALDI MS, is in low femtomole range. However, an integrated liquid 
chromatography ESI MS system (LC-ESI MS) can be used for the analysis of more 
complex samples, since it provides on-line separation of peptides.
The core of each mass spectrometer is the mass analyser. There are three basic 
types of analyser: time-of-flight (TOF), quadrupole and ion traps. They differ in 
design and performance and can stand independently or can be put together in tandem 
to generate different types of data (e.g. Q-TOF, Q-TRAP). The key parameters of 
mass analysers are mass accuracy, sensitivity and resolution. The MALDI ion source 
is usually coupled to a time-of-flight (TOF) analyser for analysis of intact peptide ions 
(MALDI-TOF MS). TOF analysers exploit the fact that in any mixture of ions 
carrying the same charge, as in the case of MALDI, heavy ions will take longer to 
travel down an electric field-free flight tube than lighter ones. Thus, the time of flight 
of any ion is inversely proportional to the square root of its molecular mass. The final 
product of this kind of analysis is a list of m/z ratios that represents a peptide mass 
map, also called a peptide mass fingerprint (Mann et al., 1993; Yates, III et al., 1993; 
Henzel et al., 1993; James et al., 1993). The tryptic peptide masses in the mass 
spectrum are then matched to calculate theoretical tryptic peptide masses for each 
protein in the database. ESI sources have been coupled mostly to ion traps and triple 
quadropole analysers. The quadrupole consists of four parallel metal rods. Each 
opposing rod pair is connected together and a radio frequency (RF) voltage is applied 
between each pair. A direct current voltage is then superimposed on the RF voltage. 
Ions travel down the quadrupole in between the rods. Only ions of a certain m/z will 
reach the detector for a given ratio of voltages, while other ions have unstable
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trajectories and will collide with the rods. This allows selection of a particular ion, or 
scanning by varying the voltages. A triple quadrupole mass spectrometer has a linear 
series of three quadrupoles. The first (Ql) and third (Q3) quadrupoles act as mass 
filters, and the middle (Q2) quadrupole is employed as a collision cell. The collision 
cell is an RF only quadrupole (non-mass filtering) using Ar or He gas to induce 
collisional dissociation of selected parent ions from Ql. Subsequent fragments 
(daughter ions) are passed through to Q3 where they may be filtered or scanned fully, 
generating a collision-induced dissociation (CID) spectrum. Peptide fragmentation 
caused by collision mainly occurs at the lowest energy amide bonds of peptides. 
When the charge is retained by the amino terminal fragment, b-ions are formed, while 
y-ions are formed when the charge is retained by the carboxy-terminal fragment. The 
mass difference between sequential b- and y- ions thus corresponds to the mass of the 
amino acids in the sequence. A schematic representation of this peptide sequencing is 
shown in Figure 1.19.
1/3 V2 Vi
p . p . p . p . 1L p _
I1
0
II I2
0
II I3
0
| |
R4 0
1 II
H2N —  O
II
-c - - N -
|
1
- C -
II
- c - - N -
|
1
- c -
1
II
- C  - - N -
|
l ll
- C —  C —  OH
1
H
1
H
1
H
1
H
1
H
1
H
1
H
a i
bi
C1 a2
b2
c2 a3
b3
c3
Figure 1.19 Schematic representation of peptide fragment nomenclature. A schematic 
overview of the possible fragmentation on the peptide backbone and the nomenclature o f 
resulting fragment ions are shown. Different amino acids are distinguished by the side groups 
displayed in red (R1-R4). When the charge is retained on the C-terminal side of the peptide, 
fragments are named x, y and z, whiles they are named a, b and c ions when the charge is 
retained on the N-terminal side. The resulting fragments are dependent on many factors, such 
as the type o f fragmentation method, analyser principle and primary sequence dependency. 
The mass difference between sequential b- and y- ions thus correspond to the mass o f the 
amino acids in the sequence. Also fragmentations on the side chains are possible. These ions 
are known as v and w ions (not shown in this figure).
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The generated lists of peptide (or fragment ion) masses are searched against the 
theoretical masses for all proteins stored in a database (SwissProt, NCBI, IPI etc). 
Several search engines are available (Mascot, Prospector, Spectrum Mill etc.). They 
allow searching according to the proteolytic enzyme of choice, and can deal with 
missed cleavages, possible post-translational modifications and known chemical 
modifications. They generate a list of potential matches ranked according to a scoring 
system depending on best probability of a match being real at define mass tolerance 
(e.g. 50-100 ppm). Confidence in the identification process depends on the species of 
the sequence identified versus that studied, the mass and pi of the protein observed on 
a gel versus that predicted, the number of peptides matching the protein sequence of a 
particular protein, the mass accuracy of detection, the protein sequence coverage, the 
number of missed cleavages during the proteolysis process and the type of 
modifications observed, which reflects the process of sample handling.
Tremendous progress has been made in recent years in the development of 
optimised instrumentation for increased mass accuracy, sensitivity and automation. In 
the last decade, the sensitivity and accuracy of analysis for protein identification by 
MS has increased by several orders of magnitude, and nowadays it is estimated that 
proteins in the femtomolar range can be identified from gels. The size of instruments 
has also decreased and several mass analysers have been combined, providing 
elaborate and compact analytical instruments for high sensitivity and high-resolution 
biological mass spectrometry. In addition, high-throughput automation is constantly 
being improved to push the detection and identification limits further, allowing a 
promising future for proteomic analyses. In recent years, several tandem mass 
spectrometry-based quantitative proteomic techniques have been developed and 
optimized for wide use in proteomic studies. These technique include i) in vivo 
metabolic stable-isotope labelling and SILAC (stable isotope labelling with amino 
acids in cell culture), ii) in vitro chemical methods of stable isotope incorporation 
such as ICAT (isotope coded affinity tag) and iTRAQ (isobaric tags for relative and 
absolute quantification) or iii) adding an internal standard (a peptide with defined m/z) 
in samples prior to MS analysis. However, there are still other major challenges in 
proteomics, such as improvement of sample preparation protocols for reduction of
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sample complexity and increasing delectability of low-abundance proteins and 
proteomic coverage, which scientists need to tackle on a daily basis studying the 
proteomes.
1.3 Aims of the study
In the last two decades, research on PI3Ks has shown that they have a critical role 
in tumourgenesis, although the precise mechanisms are still not fully clear. Indeed, 
the elucidation of the role of PI3K and its downstream effectors in controlling cellular 
functions such as growth, proliferation, survival and morphogenesis is important to 
discover how aberrant PI3K signalling contributes to tumour development and 
progression. Perhaps the biggest challenge of all is to define the interaction and cross­
talk of the PI3K signalling pathway with other signalling pathways (Ras/MAPK, Rho- 
family GTPases etc.) in order to define how systematic molecular mechanisms are 
orchestrated in a cell to allow it to function normally, and to respond to external 
stimuli in an appropriate way. The main aim of my study was to examine the role of 
PI3K signalling pathway with particular focus on its role in actin cytoskeleton 
organisation and determination of cell shape.
Thus, the specific aims of my project were:
• To identify new protein targets of PI3K signalling and to understand their function 
and regulation. My initial aim was to establish a model cell system for studying 
PI3K-dependent signalling and to monitor acute changes of the cellular 
complement of proteins and their phosphorylation status following PI3K 
activation and inhibition. A model of breast luminal epithelial cells, HB4a, was 
chosen in which to examine PI3K signalling in response to growth factor 
stimulation. A combination of 2D-DIGE, mass spectrometry and immunoblotting 
was employed.
• To develop an alternative cell model in which to study PI3K-dependent regulation 
of the actin cytoskeleton in Drosophila haemocytes. Cell lines were selected and
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insulin stimulation was used to trigger acute PI3K signalling, and common PI3K 
inhibitors were used to block PI3K activity. The effects on the actin cytoskeleton 
were monitored by fluorescence and time-lapse microscopy.
• To understand the biochemical mechanisms that link PI3K to downstream 
pathways, which regulate changes in the actin cytoskeleton. The real challenge 
here is to delineate each signalling cascade and to identify nodes where pathways 
cross-talk. Thus, my objective was to try to understand how molecular 
mechanisms are governed in a coordinated ways that allow a cell to respond in an 
appropriate way to external stimuli. Previous studies had reported the existence of 
cross-talk between PI3K and small GTPase signalling pathways during cell shape 
changes and movement. My aim in this thesis was to try to understand signalling 
cross-talk and to try to identify common downstream targets by using genomic 
and proteomic techniques in parallel. A “loss-of-function” approach based on 
RNA interference was used with quantitative two-dimensional difference gel 
electrophoresis (2D-DIGE), to carry out a screen of differential protein expression 
of knockdown cells. The RNAi-strategy was used for disruption of translation of 
selected target genes involved in PI3K, Ras and small Rho-GTPase mediated 
signalling. Mass spectrometry was employed for the identification of the 
differentially expressed proteins between control and RNAi treatments. 
Alterations in protein expression were validated by western blotting. A list of 
proteins linked to the signal pathways was generated and the proteomic profiles 
were correlated with the observed morphological changes in the actin cytoskeleton 
in each knockdown.
• Finally, my study was extended to functionally characterise targets of interest 
identified from the proteomic screen. Cofilin, an actin depolymerising protein, 
was selected as an interesting target to follow up on its regulation, since its 
phosphorylation, which determines its activation status, was found to be perturbed 
by RNAi-induced silencing of PI3K, Rho-family small GTPases and actin 
modulators.
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Chapter 2: MATERIALS AND METHODS
2.1. Cell culture
2.1.1 Drosophila cell lines
In this study, four cell lines derived from Drosophila melanogaster embryos were 
used. S2R+, Kcl67 and S2 cells are haemocyte cells, while Clone 8 cells originate 
from the wing disc. Cells were maintained at 24°C in Schneider’s Drosophila medium 
(Invitrogen) or Shields and Sang M3 insect medium (Sigma Aldrich) supplemented 
with 10% (v/v) foetal calf serum (FCS) (Helena Biosciences; heat-inactivated at 60°C 
for 5 minutes), and antibiotics (50 IU/mL penicillin and 50 pg/mL streptomycin; both 
from Sigma). Cells were split (1:2 or 1:3) every 3-4 days depending on their 
confluence. For splitting, S2R+ cells were removed from culture flasks using trypsin- 
EDTA (Invitrogen). Trypsin treatment was not required for semi-adherent Kcl67, S2 
and Clone 8 cell lines.
2.1.2. Human mammary luminal epithelial cells (HMLECs)
The immortalised human mammary luminal epithelial cell line HB4a was obtained 
from Dr. M. O’Hare (Ludwig Institute) and was derived as described (Harris et al. 
1999). Cells were maintained in RPMI-1640 medium containing 10% (v/v) FCS, 2 
mM L-glutamine, 100 pg/mL streptomycin, 100 IU/ml penicillin (all from Gibco- 
Invitrogen Corp., UK), 5 pg/mL insulin and 5 pg/mL hydrocortisone (both from
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Sigma) in tissue culture dishes at 37°C in a 10% CO2 humidified incubator. Cells 
were passaged when they reached 80 to 90% confluence by trypsinisation according 
to standard procedures. Stocks of human mammary luminal epithelial cells (HMLEC) 
and fly cells were stored in liquid nitrogen and new batches of low passage number 
cells were used for experiments. Prolonged passaging of cells was avoided to prevent 
potential genetic drift. For freezing, trypsinised cells (fly and human cell lines) were 
pelleted and resuspended in 10% (v/v) DMSO and 90% (v/v) FCS. Cells were slowly 
taken to -80°C in a propanol container and then transferred to liquid nitrogen for 
long-term storage. Rapid thawing was carried out in a 37°C water bath and DMSO 
was removed by centrifugation prior to plating. Cells were allowed to recover for two 
to three passages prior to sampling.
2.2 Growth factor and inhibitor treatments
Prior to growth factor treatment, fly cell lines S2R+, Kcl67 and S2 were grown in 
serum-free insect medium supplemented with antibiotics for 16 to 24 hours. Cells 
were then treated for various times with 10 pg/mL bovine insulin (Sigma). Other 
growth factors used in this study were human epidermal growth factor (EGF) (200 
ng/mL) (R&D Systems), murine VEGF (50 ng/mL) and human PDGF-BB (125 
ng/mL) (both from PeproTech Inc.). For PI3K inhibitor treatment, fly cells were 
treated with wortmannin (100 nM) or LY294002 (10, 50 or 100 pM) (both from 
Calbiochem) diluted in DMSO. DMSO served as a vehicle-alone control. In some 
experiments, the PI3K inhibitors were added to the cells prior to insulin treatment. 
Actin-modulating drugs used were latranculin B (1 pg/mL) (Calbiochem), 
cytochalasin D (2 pg/mL) (Sigma) and jasplakinolide (1 pg/mL) (Invitrogen).
HMLECs were treated for various times with 1 nM EGF (R&D systems), a ligand 
specific for ErbB family members. Prior to treatment, cells were first serum-starved 
for 48 hours in 0.1% (v/v) FCS in RPMI-1640 media supplemented with L-glutamine 
(2 mM), hydrocortisone (5 pg/ml) and antibiotics. Specific PI3K inhibitors (10 pM 
LY294002, 100 nM wortmannin or 2 pM D000) were also used to study PI3K- 
dependent changes in the HMLEC proteome and were typically added 30 minutes
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prior to treatment with growth factor. Inhibition of the proteasome was achieved by 
treatment with 1 pM PS341 (gift from Peter Elliot, Millenium Pharmaceuticals, Inc.).
2.3 Sample preparation for ID and 2D SDS-PAGE
2.3.1 Cell lysis and protein extraction
Cells were washed with ice-cold phosphate-buffered saline (PBS) and lysed in the 
appropriate lysis buffer. For one dimensional sodium dodecyl sulphate- 
polyacrylamide gel electrophoresis (ID SDS-PAGE), cells were lysed in NP40 lysis 
buffer (50 mM HEPES; 150 mM NaCl; 1% NP40; 1 mM EDTA) supplemented with 
protease inhibitors (17 pg/mL aprotinin; 1 pg/mL pepstatin; 1 pg/mL leupeptin, 100 
pg/mL AEBSF) and phosphatase inhibitors (5 pg/mL BpVphen, 5 pM fenvalerate, 1 
pM okadaic acid, 2 mM sodium orthovanadate). Lysates were left for 15 minutes on 
ice, and then centrifuged at 13000 rpm for 10 min at 4°C to clear the insoluble cell 
debris. Protein concentrations were determined using a Bradford microtitre plate 
assay. Briefly, 2 pL of total cell lysate was mixed with 200 pL of Coomassie Protein 
Assay Reagent (Pierce-Perbio). The absorbance was read at 595 nm in a microtitre 
plate spectrophotometer (Spectra Max Plus, Molecular Devices). Standard curves 
were determined using bovine serum albumin (BSA) standards diluted in the same 
lysis buffer at the following concentrations: 0, 0.25, 0.5, 0.75, 1, 2.5, 5 and 10 pg/pL. 
Standards and samples were assayed in triplicate. The protein concentrations of the 
samples within an experiment were adjusted to the same concentration by adding lysis 
buffer and were denaturated in laemmli sample buffer (50 mM Tris pH 6.8, 10% (v/v) 
glycerol, 2% (w/v) SDS, 0.1% (w/v) bromophenol blue, 2% (v/v) P-mercaptoethanol; 
final concentrations) and heated at 100°C for 5 min. ID SDS-PAGE was performed 
following standard procedures using an appropriate % resolving gel for the proteins to 
be analysed.
For 2D-DIGE, cells were washed with ice cold PBS and lysed in 2D-DIGE lysis 
buffer (8 M urea, 2 M thiourea, 4% (w/v) CHAPS, 0.5% (w/v) NP40, 10 mM Tris-
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HC1 pH 8.3) supplemented with protease and phosphatase inhibitors (as above). The 
preferred pH of the buffer is 8.3 since the dye labelling is most efficient at pH 8-9. 
DTT was omitted from the buffer since high concentrations would interfere with dye 
labelling efficiency. Cell lysates were homogenised by passage (six times) through a 
25G needle. Insoluble material was removed by centrifugation (13,000 rpm/10 
min/4°C). Protein concentrations were determine by Bradford assay (as above), and 
aliquots of equal amounts of protein were covalently labelled with NHS-Cyanine dyes 
as described in the following section.
2.3.2 Protein labelling with NHS-cyanine dyes (DIGE-labelling)
The NHS-cyanine dye Cy2 was purchased from GE Healthcare, whilst NHS-Cy3 
and NHS-Cy5 were synthesised “in house” by Dr P. Gaffney (Imperial College 
London). Stocks were stored at a concentration of 1 mM in dimethyl formamide 
(DMF) at -20°C. Protein labelling and 2D-DIGE were performed according to Gharbi 
et al. (Gharbi et al., 2002). Prior to protein labelling, the Cy dyes were diluted in 
DMF and kept on ice, in the dark. Typically, 100 pg of total protein extract was 
labelled with NHS-Cy3 or NHS-Cy5 at 4 pmol dye/pg protein on ice in the dark for 
30 min. Equal amounts of protein extracts from each experimental condition were 
also pooled together and labelled with NHS-Cy2 to create an internal standard which 
was run on all gels against the Cy3- and Cy5-labelled samples to aid in spot matching 
and quantitation. Labelling reactions were quenched with a 20-fold molar excess of 
free L-lysine to dye on ice in the dark for 10 minutes: for 400 pmol CyDye, 0.8 pL of 
10 mM L-lysine solution was added. Equal amounts of proteins labelled with Cy3 and 
Cy5 were mixed appropriately and the same amount of Cy2-labelled pool was added 
to each mixture. Samples were reduced by adding 1.3 M dithiothreitol (DTT) to a 
final concentration of 65 mM for 15 minutes. Ampholine/Pharmalyte carriers (1:1) 
mix; pH 3 to 10 were added to a final concentration of 2% and bromophenol blue was 
added to each sample. The final volume of each sample was adjusted to 350 pL or 
450 pL with 2D-DIGE lysis buffer plus DTT to allow appropriate re-swelling of 18 
cm or 24 cm immobilised pH gradient (IPG) strips, respectively.
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2.4 Two- dimensional gel electrophoresis
For isoelectric focusing (IEF), 18 cm or 24 cm, non-linear pH 3-10 IPG strips (GE 
Healthcare) were rehydrated with Cy-dye labelled samples in a re-swelling tray 
overnight in the dark at RT, according to the manufacturer’s guidelines. The 
separation of the Cy-dye labelled proteins in the first dimension by IEF was carried 
out on a Multiphor II apparatus (GE Healthcare) for a total of 80 kVh at 18°C. For 
protein separation in the second dimension, 1.5 mm 12% SDS-PAGE gels were cast 
between 18 cm or 24 cm low-fluorescence glass plates. The inner surface of one plate 
of each set was covered with Bind Silane solution (PlusOne, GE Healthcare) to bond 
the gels. This allowed easier handling of gels during scanning and protein post- 
staining, storage and spot excision. Fluorescent reference markers were placed at the 
edges of these bonded plates to facilitate the generation of coordinates of each protein 
feature in the pick list. The inner surface of the other plate was treated with Repel 
Silane (PlusOne, GE Healthcare) to ensure easy separation of plates after running. 
After IEF, IPG strips were equilibrated in equilibration buffer (6 M urea, 30% (v/v) 
glycerol, 50 mM Tris-HCl pH 6.8, and 2% (w/v) SDS) in two steps for 15 minutes 
each with gentle rocking. In the first step, the equilibration buffer was supplemented 
with 65 mM DTT to reduce disulphide bonds, while in the second step 240 mM 
iodoacetamide (IAM) was added to the equilibration buffer to alkylate reduced thiol 
groups. IPG strips were then rinsed with Tris-HCl/SDS electrophoresis buffer and 
transferred onto the second dimension gels. Strips were overlaid with 0.5% (w/v) low- 
melting point agarose in Tris-Glycine-SDS electrophoresis buffer (Severn Biotech) 
with bromphenol blue. Gels were run in Protean II tanks (BioRad) at 10 mA per gel or 
in an Ettan 12 apparatus (GE Healthcare) at 2 W per gel at 8°C until the dye front had 
run off completely, thereby avoiding fluorescence signals from bromophenol blue and 
free dye. All steps were carried out in a dedicated clean room.
2.5 Detection of Cy-dye labelled proteins
Gel images were obtained by scanning the gels between plates on a Typhoon™ 
9400 mutliwavelength fluorescence scanner using ImageQuant software (both from
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GE Healthcare). Excitation and emission wavelengths of each dye used in this study 
are shown in Table 2.1. The photomultiplier tube voltage of the Typhoon scanner was 
adjusted for each channel (Cy2, Cy3 and Cy5) in preliminary low-resolution scans 
(1000 pm) to give maximum pixel values within 10% for each Cy-dye image, but 
below the saturation level. These settings were then used for high-resolution (100 pm) 
scanning. Images were generated as .gel files (same as Tagged Image File Format 
(TIFF)) and exported to image analysis software for further analysis.
SYPRO Ruby 400 632
Table 2.1 Excitation and emission wavelengths used to detect each of Cy-dyes and dyes 
used in gel post-staining.
2.6 Image analysis
Gel images were analysed using DeCyder™ image analysis software ver.4.0 (GE 
Healthcare). Firstly, images were analysed using the Differential In-Gel analysis 
(DIA) module. DeCyder DIA processes the three images derived from the three 
wavelengths (Cy2, Cy3 and Cy5) representing profiles of each of three labelling 
conditions run on a single gel, and performs automatic spot detection, filtering, 
background subtraction and normalisation. DIA also quantifies spot protein 
abundance on each image and expresses these values as ratios, indicating changes in 
expression levels by direct comparison of corresponding spots. This ratio can be used 
to directly evaluate changes between two labelled protein samples run on a single gel. 
Alternatively, the ratio can be used for protein spot quantitation against the same spot 
in the internal standard to allow accurate inter-gel protein spot comparisons. Features 
resulting from non-protein sources (e.g. dust particles and scratches on glass plates)
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were filtered out. Subsequently, the Biological Variance Analysis (BVA) module of 
DeCyder was used for matching protein spots from different conditions across gels by 
matching to a user selected master gel image, thus identifying common protein spots 
across the gels. User intervention was required at this stage to set landmarks on gels 
for accurate cross-gel matching. Comparison of test spot volumes with the 
corresponding standard spot volumes gave a standardised abundance for each 
matched spot and values were averaged across triplicates for each experimental 
condition and data plotted graphically within BVA. Statistical analysis was performed 
and spots displaying a > 1.5 average-fold increase or < -1.5 average-fold decrease in 
abundance with p  values < 0.05 from a Student’s T-Test were selected for spot 
picking and MS-based identification.
2.7 Protein post-staining and spot excision
Bonded 2D gels were post-electrophoretically stained using several staining 
methods to visualise proteins for accurate spot picking and to detect phosphorylated 
proteins.
2.7.1 Colloidal Coomassie Blue
Gels were post-stained with colloidal Coomassie blue G-250 (CCB) according to a 
modified protocol by (Neuhoff et al., 1988). Bonded gels were fixed in 35% (v/v) 
ethanol with 2% (v/v) phosphoric acid for more than three hours on a shaking 
platform and then washed three times for 30 min each in ddfUO. Gels were then 
incubated in 34% (v/v) methanol, 17% (w/v) ammonium sulphate and 3% (v/v) 
phosphoric acid for one hour prior to the addition of 0.5 g/L Coomassie G-250 
(Merck Biosciences) and left to stain for two to three days. De-staining was not 
required. Post-stained gels were scanned on the Typhoon™ 9400 scanner using the 
red laser with no emission filter. Post-stained scanned images were imported into the 
BVA module of DeCyder and matched with the Cy dye images. Using the reference 
markers fixed onto the glass plates at casting, a pick list of coordinates (.txt file) for
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protein features that were differentially expressed was created for automated spot 
picking. An Ettan automated spot picker (GE Healthcare) was used with a 2 mm 
picking head, which excised protein features from gels submerged under 1-2 mm of 
ddH20. Spots were collected in 96-well plates, drained and stored at -20°C prior to 
MS analysis. In some cases protein spots were picked manually by cutting the stained 
protein spots using a scalpel.
2.7.2 SYPRO Ruby fluorescent staining
In some experiments, bonded gels with separated cyanine Cy-dye labelled proteins 
were post-stained with SYPRO Ruby fluorescent protein stain (Molecular Probes, 
USA). Following electrophoresis, gels were fixed for at least 3 hours in fixing 
solution (30% (v/v) methanol, 7.5% (v/v) acetic acid, in ddHiO). Lower 
concentrations of methanol and acetic acid were used in order to avoid shrinkage and 
cracking of bonded gels. Gels were washed twice in water and then incubated in 
SYPRO Ruby staining solution for a minimum of 3 hours in the dark. Gels were then 
washed briefly in water to remove excess dye. Gels were then scanned on the 
Typhoon™ 9400 scanner (Table 2.1).
2.7.3 Pro-Q Diamond phosphoprotein gel staining
In some experiments gels were stained with Pro-Q diamond to detect 
phosphoproteins. Bonded gels were fixed in 10% trichloroacetic acid and 35% 
methanol with gentle agitation overnight at RT. Gels were washed in ddH20 for 5 x 
15 minutes to remove methanol and trichloracetic acid. Gels were stained with Pro-Q 
Diamond gel stain (Molecular Probes) with gentle agitation in the dark for ~3-4 hours. 
Gels were then incubated in destaining solution (4% acteonitrile, 50 mM sodium 
acetate, pH 4.0) in the dark at RT, with four changes of the destaining solution. The 
final destaining step was done overnight. Gels were scanned on the Typhoon™ 9400 
(Table 2.1).
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2.8 Protein in-gel digestion
For further analysis by mass spectrometry, gel pieces were washed three times with 
50% (v/v) acetonitrile, dried in a Speed Vac for 10 minutes, reduced with 10 mM DTT 
in 5 mM ammonium bicarbonate pH 8.0 (AmBic) for 45 minutes at 50°C and then 
alkylated with 50 mM iodoacetamide (IAM) in 5 mM AmBic for one hour in the dark 
at RT. Gel pieces were then washed three times in 50% (v/v) acetonitrile and vacuum- 
dried prior to re-swelling with 50 ng of modified trypsin (Promega) in 5 mM AmBic 
pH 8.0. The gel pieces were then overlaid with 10 pL of 5 mM AmBic and digested 
for 16 hours at 37°C. Supernatants were collected and tryptic digests were further 
extracted by washing the gel pieces twice with 5% (v/v) trifluoroacetic acid in 50% 
acetonitrile. Peptide extracts from each gel piece were pooled, vacuum-dried and 
resuspended in 5 pL of 0.1% formic acid and stored at -20°C prior to MS analysis.
2.9 Protein identification
Protein identification was carried out using matrix-assisted laser desorption/ 
ionisation time-of-flight (MALDI-TOF) MS by peptide mass fingerprinting. For this, 
0.5 pL of the trypsin digest was mixed with 1 pL of matrix solution (saturated 
aqueous 2,5-dihydroxybenzoic acid, DHB), and applied to a sample target plate and 
air dried. MALDI-TOF mass spectra were acquired using an externally calibrated 
Ultraflex mass spectrometer (Bruker Daltonics) in the reflector, positive ion mode. 
The mass spectrometer was calibrated using a standard mixture of peptides 
(calibration mixture 2 from the Sequazyme kit, Applied Biosystems). Internal 
calibration of each mass spectrum was performed using reference trypsin autolysis 
peaks: m/z 842.51 and m/z 2211.10. Prominent peaks in the mass range m/z 500-5000 
were then used to generate a peptide mass fingerprint, which was searched against 
NCBI database using the Mascot search engine, version 2.0.02 (Matrix Sciences Ltd.). 
For the search criteria, carbamidomethylation of cysteines was selected as a fixed 
modification, while oxidation on methionine, N-acetylation and pyro-glutamate were 
selected as variable modifications. A positive identification was accepted when a 
minimum of 6 peptide masses matched a particular protein (mass error of ± 50-100
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ppm, allowing 1 missed cleavage), sequence coverage was >25%, MOWSE scores 
were higher than a threshold value where p=0.05, the predicted protein mass agreed 
with the gel-based mass and the correct species sequence was identified. When a 
protein ‘hit’ fulfilled the specified thresholds of validation for protein identification, 
unmatched peptides were systematically re-submitted to the database in a search for 
possible multiple proteins per gel piece and potential sites of post-translational 
modification (e.g. phosphorylation).
Some identifications were made using nano-HPLC-electrospray ionization 
collision-induced dissociation tandem MS (nano-LC-MS/MS). This was performed on 
an Ultimate HPLC (Dionex) with a PepMap C l8 75-pm inner diameter column (LC 
Packings) at a flow rate of 300 nL/min, coupled to a Quadrupole Time-Of-Flight 1 
(QTOF1) mass spectrometer (Waters/Micromass, Manchester, UK). Spectra were 
processed using MassLynx software (Waters) and submitted to Mascot database 
search routines including +2 and +3 peptide charge, and a mass tolerance of ±100 
ppm. Positive identifications were accepted when at least two peptide sequences 
matched an entry with MOWSE scores above the p=0.05 threshold value.
2.10 Phosphopeptide analysis using titanium dioxide micro-columns 
and LC-MS/MS
Enrichment of phosphorylated peptides from peptides generated by in-gel digestion 
of selected protein spots (Cofilin) was performed using titanium dioxide essentially as 
described (Larsen et al., 2005). Briefly, titanium dioxide (Ti02) micro-columns with a 
length of ~3 mm were packed in GELoader tips with a small C8 3M Empore plug. 
The trypsin digest from the two Cofilin protein spots were diluted into 5% TFA, 80% 
acetonitrile (with inclusion of phthalic acid) and loaded onto the Ti0 2  micro-columns. 
The columns were washed with 5% TFA, 80% acetonitrile and bound phosphorylated 
peptides were eluted with 15 pL ammonia solution (10 pL ammonia (25% solution) in 
490 pL water). Eluates were acidified and analyzed by MALDI-TOF MS and nano- 
LC-MS/MS. MALDI-TOF MS was performed on a Voyager STR mass spectrometer 
(PerSeptive Biosystems, Framingham, MA). All spectra were obtained in the positive
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reflector mode and DHB (20 g/L) in 50% acetonitrile, 1 % phosphoric acid was used 
as the matrix. Data analysis was performed using MoverZ software 
(www.proteometrics.com) and peptide assignment was accomplished using GPMAW 
software (welcome.to/gpmaw). Nano-LC-MS/MS was performed on a Proxeon 
Biosystem Easy-nLC nanoflow system (Proxeon Biosystem A/S, Odense, Denmark) 
coupled to a QTOF Ultima mass spectrometer (Waters/Micromass, Manchester, UK). 
Peptides were loaded onto a 75 pm inner diameter fused silica pre-column (ReproSil- 
Pur, Ammerbuch-Entringen, Germany) and eluted with a 1.5% gradient (A buffer: 
0.5% acetic acid; B buffer: 0.5% acetic acid in 80% acetonitrile) onto a 50 pm inner 
diameter fused silica analytical column (ReproSil-Pur) and into the mass 
spectrometer. The mass spectrometer was operated in data dependent acquisition 
mode and two of the most intense ions were selected for collision induced 
dissociation per MS scan. The data were processed using MassLynx software and pkl 
files were searched using Mascot.
2.11 Double-stranded RNA production and RNAi treatment
RNA interference (RNAi) was performed on fly cells, by transfection with gene 
specific dsRNAs. Pairs of gene-specific primers were taken from existing primer 
libraries or designed de novo using the E-RNAi primer design tool (http://e- 
mai.dkfz.de/). Primer sequences of ~21 bp length (Table 2.2) flanked with T7 sites 
were chosen for PCR amplification of approximately 600 bp of exonic sequences of 
the genes to be silenced. PCR reactions were prepared with the forward and reverse 
primer set, fly genomic DNA, PCR buffer with Mg2+, DNA nucleotides (ATP, TTP, 
GTP and CTP) and “HotStart” DNA polymerase. The reagents for the PCR were 
supplied by Qiagen. The initial step for each PCR was a “hotstart” step at 95°C for 15 
minutes followed by 30 cycles of denaturation at 94°C for 30 seconds, annealing at 
50-60°C for 30 seconds and an extension step at 72°C for 1 minute. PCRs were 
terminated with a final extension at 72°C for 30 minute. PCR amplification was 
confirmed by 1% (w/v) agarose gel electrophoresis using GeneRuler 1 kb marker to 
assess the size of PCR products. DsRNAs were generated from PCR products by in 
vitro transcription using the MEGAscript™ High Yield Transcription Kit (Ambion)
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containing RNA nucleotides (ATP, UTP, GTP and CTP), lOx reaction buffer and T7 
RNA polymerase. Reactions were conducted at 37°C overnight and dsRNAs were 
purified using Multiscreen PCR96 purification plates (Millipore) attached to a vacuum 
pump. Purified dsRNAs were re-suspended in TE buffer (10 mM Tris-HCl pH 8.0, 1 
mM EDTA) and annealed at 95°C for 15 minutes followed by slow cooling to room 
temperature (RT). The dsRNA concentration was estimated on 1% (w/v) agarose gels 
using 500 ng GeneRuler 1 kb ladder. dsRNAs were stored at -20°C prior to use.
FBgn0020510 Abi Abi CAT GCCAATGT GACTCT GCT CCATCAAGTATGTGCGCAAG
FBgn0000042 Actin CG4027 ATTGCGGCTGATAAGGTTTT GTTGGGAAGGGGAAAGCTAC
FBgn0010379 Akt CG4006 GCTACTTCGTGCTCCACTCC TTTTGATCGCGTACAGCTTG
FBgn0033504 CAP CG18408 TACAACTTCCAGGCCCAGTC GATCGATCTCCTCTAGGCCC
FBfln0011744 Arp66B CG7558 CCATACTCCTCGTAGGCAGC CACTGCTACATCTGTCCCGA
FBflnOO10341 Cdc2 CG12530 CCAGTGTAATCCGGCAAACT TTTTCTTTGTGGGCTCTGGT
FBgn0011771 Hem Hem 2 TCTATGCACTGCGAAACCTG GGCTGTTCGAAGAAACTTGC
FBgn0041203 LIMK CG1848 TCCTTGGGTATCTCGACCAG CCAAGGCACAAAAACATTCC
FBgnOO15279 PI3K92E CG4141 CGATGTGAAAAAGCTGCAAA GCAGTGGTGTAACTCCCGAT
FBgn0000308 Profilin CG9553 TCCGTCCATTAGTCCATTCC CTTTCTCCACCTCTCGTTGC
FBgn0026379 PTEN CG5671 CGGTCCTTTGTACGCTTCTC GAAGACAAGCACTGGTTCCC
FBgn0010333 Rac1 CG2248 T CGAACACGGT GGGTATGTA AAATTTGAACAGTCCAGCCG
FBgnO014011 Rac2 CG8556 CCAGTGGCTCAACTGGTTTT CTGCCACAGAAAATCAGCAA
FBgn0003205 Ras85D CG9375 ATTCGGCTTGTTCATTTTGC GCACAGTCACCCACACAAAC
FBgn0029157 SSH CG6238 GGGCAATAGCAAAGGAAACGA GCATGCCCGAGGTATTCTTGT
FBgnOO11726 TSR CG4254 TGGCTTCTGGTGTAACTGTG AGTTTCTCCTCGACGGCTTC
Table 2.2 Forward and reverse primers sequences used to generate dsRNAs.
For RNAi experiments, fly cells were typically suspended in Schneider’s serum- 
free medium and plated at 2xl06cells/mL in tissue culture dishes (Falcon, BD 
Biosciences). DsRNA was added directly to the medium to a final concentration of 
0.3 pM, followed by gentle agitation. Cells were incubated for 30 minutes at room 
temperature, followed by addition of Schneider’s medium supplemented with 10% 
FCS. For 2D-DIGE experiments, each RNAi treatment was conducted as biological 
triplicates. For immunofluorescence staining analysis, RNAi treatment was usually 
performed in 384-well plates or 8 -well chamber slides. Cells were incubated for 4-5 
days to allow turnover of target proteins, prior to harvesting or fixing for analysis.
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2.12 Immunoblotting
Immunoblotting was used to validate protein expression differences and protein 
identities. Briefly, cell extracts were separated by ID or 2D SDS-PAGE and electro­
blotted onto polyvinylidene fluoride membrane (Immobilon P, Millipore) in a transfer 
tank using transfer buffer (195 mM glycine, 25 mM Tris, 20% (v/v) methanol). 
Membranes were blocked for one hour with 5% (w/v) low fat milk or 5% (w/v) 
bovine serum albumin (BSA, Sigma) in Tris-buffered saline (50 mM Tris pH 8.0, 150 
mM NaCl) with 0.1% (v/v) Tween-20 (TBS-T). Membranes were incubated with 
primary antibodies in TBS-T for one and a half hour at room temperature or overnight 
at 4°C. The list of primary antibodies used in this study is shown in Table 2.3. 
Membranes were washed with TBS-T three times for 10 minutes, and then probed 
with the appropriate horseradish peroxidase-coupled secondary antibody (GE 
Healthcare) for about 50 minutes. Membranes were washed three times for 10 
minutes in TBS-T and immuno-probed proteins were visualised using enhanced 
chemiluminescence (PerkinElmer, Life Sciences Inc.). Developed films were scanned 
on a BioRad GS-800 densitometer generating .tif files. Tiff images from 2D-westem 
blotting were aligned to 2D gel images using Adobe Photoshop. For membrane re­
probing, membranes were first stripped (by incubating with 0.2 M glycine pH 2, 2x 
30 minutes, and then washed with TBS-T, 3x 10 minutes) and then blocked with 5% 
BSA.
2.13 Immunofluorescence staining
Randomly growing cells or RNAi-treated cells were re-seeded onto serum-coated 
cover slips or left in 384-well plates depending on the experiment. For 
immunostaining, cells were washed with PBS and fixed with 3.7% (v/v) 
formaldehyde in PBS for 10 min. After washing with PBS, cells were permeabilised 
with 0.1% (v/v) Triton X-100 in PBS for 5 min, washed again and blocked with 5% 
(w/v) BSA in PBS for 1 h.
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Antibody Supplier/
Donation
Monoclonal/
Policlonal
Working 
concn. for WB
4E-BP1anti-phospho (Ser65) CST rabbit pAb 1 1000
Actin Sigma mouse mAb 1 2000
Akt CST rabbit pAb 1 2000
Akt (anti-phospho Ser473) CST rabbit pAb 1 1000
Akt (anti-phospho Ser505) S. Leevers rabbit pAb 1 1000
Cofilin (anti phospho Ser3) Eurogentec rabbit pAb 1 1000
cyclin D1 (DCS6) PharMlngen mouse mAb 1 500
ERK1/2 Promega rabbit pAb 1 5000
ERK1/2 (anti phosphoThr198/Tyr200) Sigma mouse mAb 1 1000
GSK3 alpha/beta anti-phospho (Ser21/9) CST rabbit pAb 1 1000
GSK3 clone 4G-1E (a and b) UBI mouse mAb 1 1000
Kip1/p27 (clone 57) Trans labs mouse mAb 1 3000
p90 RSK (anti-phosphoT359/S363) CST rabbit pAb 1 4000
Phospho-(Ser) PKC substrate CST rabbit pAb 1 1000
Phospho-(Ser/Thr) Akt substrate CST rabbit mAb 1 1000
Phospho-(Thr) PDK1 CST rabbit pAb 1 1000
Phospho-tyrosine, clone 4G10 UBI mouse mAb 1 1000
Phospho-tyrosine, pY99 Santa Cruz mouse mAb 1 5000
S6 ribosomal protein (anti phospho Ser235) I. Gout rabbit pAb 1 1000
S6K (anti phospho Thr398) CST rabbit pAb 1 1000
Stat3 CST rabbit pAb 1 1000
Stat3 (anti-phospho Ser727) CST rabbit pAb 1 1000
Table 23 List of antibodies used for validation of differentially expressed proteins in 
immunoblotting analyses including antibodies used for immunofluorescence staining.
(CST stands for Cell Signalling Technology)
For pSer505-Akt staining, cells were incubated with primary antibody (1:300 in 
PBS) overnight at 4°C, followed by incubation with secondary anti-rabbit antibody 
(1:300) conjugated to Cy5 for 1 h at RT. For pY20 staining, cells were incubated with 
the primary mouse antibody (1:300 in PBS) overnight at 4°C, followed by incubation 
with anti-mouse secondary antibody conjugated with FITC (1:300 in PBS). For F- 
actin, tubulin and DNA staining, cells were incubated for 1 h at RT with rhodamine- 
phalloidin (Sigma) (1:1000), FITC-conjugated anti-tubulin (1:1000) (Molecular 
Probes) and 4',6-diamidino-2-phenylindole (DAPI) (1:2000), respectively, all diluted 
in PBS. Cover slips were sealed, while PBS supplemented with 10% NaN3 was added 
to the 384-well plates to keep fixed cells wet and to prevent contamination. Cells were 
analysed by fluorescence and confocal microscopy. Fluorescent images were acquired 
using a Nikon 2000E microscope with 20x and 40x objectives and fitted with a cooled 
CCD camera (Cool Snap; Roper) and using MetaMorph software (Universal Imaging
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Inc.). Confocal images were acquired using an LSM 510 camera (Zeiss, Welwyn 
Garden City, UK) mounted over an Axioplan microscope (Zeiss) using a 40x/1.30 
Plan Neofluar oil immersion objective.
2.14 Time- lapse microscopy
For time-lapse microscopy, cells were plated onto optical quality glass-bottomed 
culture dishes made with optical quality glass to provide high-resolution images (Mat 
Tek Corporation, USA). Phase-contrast and fluorescence time-lapse movies were 
taken on a Nikon 2000E microscope with a Hamamatus DCAM digital camera, using 
Andor iQ 1.4 software, with a 100 x oil-immersion lens at 20 seconds intervals. Actin 
dynamics were analysed in live RNAi-treated cells by time-lapse fluorescence 
microscopy using GFP-moesin to visualise F-actin. For this, cells were treated for five 
days with dsRNAs and then plated onto uncoated glass dishes. Baculovirus 
harbouring DNA for the expression of the actin-binding region of moesin fused to 
GFP was then added to the cells and incubated overnight (Kunda et al., 2003). Cells 
were then imaged on a Nikon 2000E microscope with a Hamamatsu DCAM digital 
camera, using Andor iQ 1.4 software. Typically, actin re-organisation in the cells was 
filmed using the FITC channel with a lOOx oil-immersion lens at 20 sec intervals for 
3 minutes before and for 10 minutes after addition of 10 pg/mL insulin. Membrane 
dynamics were filmed by phase-contrast microscopy, with a lOOx oil-immersion lens. 
Kymographs of actin and membrane dynamics at the cell edge were generated from 
time-lapse movie images with MetaMorph software using a one pixel wide line drawn 
across the cell membrane at random points. Pixel data taken for each line from all 
images of each movie was combined to generate the kymographs.
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Chapter 3: Proteomic analysis of PI3K signalling in human 
mammary luminal epithelial cells
3.1 Introduction
Many critical events involved in the cellular response to external stimuli are 
mediated by changes in post-translational protein modifications (PTM) rather than by 
transcriptional changes. PTMs are processes modifying the primary structure of 
proteins in a sequence-specific way that includes the reversible addition or removal of 
functional groups by phosphorylation, acylation, glycosylation, nitration, and 
ubiquitination (Mann and Jensen, 2003; Seo and Lee, 2004). These modifications 
induce structural changes in proteins and modulate their activities, subcellular 
localisation, stability and interactions with other proteins and molecules. The 
complexity of the proteome is increased significantly by post-translational 
modification, particularly in eukaryotes where many proteins exist as a heterogeneous 
mixture of alternatively modified forms. To date, at least 300 different types of PTMs 
have been identified (Jensen, 2004). One of the most studied PTM is protein 
phosphorylation, because it is vital for a large number of protein functions that are 
important to cellular processes such as signal transduction, cell differentiation, 
development, cell cycle control and metabolism. A primary role of phosphorylation is 
to act as a switch to turn "on” or "off' a protein activity or a cellular pathway in an 
acute and reversible manner (Hunter, 1995). Furthermore, it is estimated that up to 
one third of all proteins in eukaryotic cells are phosphorylated at some point in their 
life cycle and many possess more than one phosphorylation site and thus exist as a 
mixture of alternative phospho-forms (Zolnierowicz and Bollen, 2000). Today, it is 
accepted that almost all processes regulated by protein phosphorylation are reversible 
and controlled by the combined actions of two different classes of enzymes, namely 
protein kinases and phosphatases. These kinases and phosphatases constitute about
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2% of the human genome (there are about 500 kinase and 100 phosphatase genes in 
the humane genome) (Venter et al., 2001; Manning et al., 2002; Alonso et al., 2004). 
The discovery of phosphorylation as a key regulatory mechanism of cell life, and the 
finding that perturbation in the protein phosphorylation status often leads to 
disturbance in cell biochemical and signalling pathways leading to abnormal 
information processing and development of various malfunctions that range from 
developmental defects to cancer, chronic inflammatory syndromes and diabetes 
(Yarden and Sliwkowski, 2001; Gray et al., 2003), has made protein phosphorylation 
an important study subject for many years.
Cell signalling through receptor tyrosine kinases (RTKs) plays a highly conserved 
role in metazoans, controlling fate determination, differentiation, proliferation, 
survival, migration and growth (Hunter, 2000). Autophosphorylation events on the 
tyrosine-kinase receptor following ligand binding and induced conformational change 
creates docking sites for many downstream adaptor and effector proteins, which then 
promote further activation of downstream signalling cascades. RTKs activate multiple 
downstream pathways, and one particularly well studied and evolutionary conserved 
component of these pathways is the lipid kinase PI3K family of enzymes, which have 
been implicated in the regulation of many important cellular functions (see Chapter 
1). Akt takes a central place in PI3K-dependent signalling and it controls the activity 
of numerous proteins involved in important cellular processes such as cell survival, 
proliferation, size control and metabolism. Interestingly, it has been reported that 
there are a large number of potential Akt substrates (over 5700) identified by database 
searching (EBI Database-International Protein Index) using the Akt phosphorylation 
consensus motif (Zhang et al., 2002), so it is likely that many of these substrates 
remain to be characterised. In addition, Akt is an extremely important signalling node 
and has been proposed as a therapeutic target for the treatment of inflammatory 
diseases, diabetes and cancer (Vivanco and Sawyers, 2002; Altomare and Testa, 2005; 
Cheng et al., 2005). However, although the PI3K/Akt signalling pathway is well 
studied, there are still gaps in our understanding of the complexity of this pathway, its 
cross-talk with other signalling pathways and the existence of other downstream 
targets regulated by the PI3K/Akt cascade.
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The work described in this chapter was designed to establish a model cell system 
for studying PI3K-dependent signalling and to monitor acute changes of the cellular 
complement of proteins and their phosphorylation status, which follow the PI3K- 
dependent activation. These aims were targeted using proteomic analysis consisting of 
ID and 2D immunoblotting in combination with 2D gel-based proteomics. This was 
combined with immunoblotting analysis, which employed specific phospho-kinase 
substrate antibodies, such as a phospho-Akt substrate antibody, to monitor changes in 
protein expression and phosphorylation of Akt-specific substrates. In addition, the 
immunoblotting analysis was reinforced by employing 2D-DIGE analysis, which 
makes use of three charge- and size-matched, but spectrally distinct fluorescent tags 
(NHS-Cy2, -Cy3 and -Cy5), used for covalent labelling different samples prior 
mixing and separation on the same 2D gels. This system allows accurate and sensitive 
quantitation of protein expression across multiple biological samples (Chapter 1). 
Currently, 2D gel electrophoresis is the only method capable of simultaneously 
resolving several thousands of proteins (Kawada et al., 2001), including protein 
variants produced by post-translational processing such as phosphorylation, 
glycosylation, and sulfation (Guy et al., 1994) in one run. The phosphorylation of a 
protein often leads to a decrease in its pi and consequently in its coordinates in a 2D 
gel. Thus, 2D gel electrophoresis has been used to discriminate phosphoproteins from 
nonphosphorylated proteins and post-electrophoretical gel staining techniques have 
been used to detect phosphoproteins to distinguish them from total proteome. 
Furthermore, combining 2D gel electrophoresis with mass spectrometry allows 
identification of proteins with differential expression or phosphorylation.
To investigate the role of PI3K signalling in response to EGF, a cellular model of 
breast epithelial cells, the HB4a cell line, was chosen. This immortalised luminal 
epithelial cell line was derived from reduction mammoplasty tissue of a normal 
subject (Stamps et al., 1994). These cells are conditionally immortal cells derived by 
infection of human breast epithelial cells with an amphotropic retrovirus, which 
transduced a ts mutant of SV40 large T-antigen. This process of immortalisation 
involves the sequestration and inactivation of the tumour suppressor proteins p53 and 
pRb by the SV40 large-T antigen. These proteins normally downregulate the cell 
cycle, but also act as sensors of cell damage to induce cell cycle arrest and apoptosis,
85
Chapter 3
given the appropriate stimuli. HB4a cells display several markers of the luminal 
epithelial cell type and have a characteristic luminal epithelial cellular morphology in 
culture. This cell line also responds to EGF stimulation as the cells express the EGF 
receptor, and are able to activate PI3K signalling pathway in response to various 
growth factor treatments or stress-inducing treatments, e.g. H2O2, as shown from 
previous work in our laboratory (Timms et al., 2002; White et al., 2004; Chan et al., 
2005).
3.2 Examination of PI3K signalling in luminal epithelial cells in 
response to EGF
For preliminary examination of EGF-dependent PI3K signalling in HB4a cells, an 
experiment was carried out where HB4a cells were pre-incubated with LY294002, a 
synthetically produced and widely used PI3K inhibitor (Vlahos et al., 1994), prior to 
EGF stimulation. For this purpose serum-starved HB4a cells, at 80% confluence, were 
pre-treated with 10 pM LY294002 for 30 min, followed by treatment with 1 nM EGF 
over a time course. DMSO served as a vehicle control to the LY294002 treatment. 
Cells were lysed, protein concentration was measured and equal amounts of proteins 
from different samples were separated by ID SDS-PAGE and transferred onto 
membranes for western blot analysis. The membranes were probed with 
phosphospecific antibodies, and then reprobed with the respective pan antibodies. The 
use of the phosphospecific antibodies allowed detection of the fraction of a protein 
that is phosphorylated, whereas the pan antibodies detected the total amount of the 
respective kinase and/or its substrate.
PI3K signalling was monitored by measuring the phosphorylation of Akt, GSK-3 
and 4E-BP1 over time following stimulation with EGF. Akt, a direct downstream 
target of PI3K signalling pathway, is activated in response to PIP3 production that 
drives Akt-membrane recruitment through binding to its pleckstrin homology (PH) 
domain, followed by phosphorylation of Akt at Thr308 and Ser473 sites. In this 
experiment, EGF stimulation induced Akt phosphorylation at the Ser473 site in 
control cells, but EGF-dependent Ser473-Akt phosphorylation was largely blocked by
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LY294002 treatment, confirming the findings of many reports that Akt is downstream 
of PI3K (Figure 3.1). In addition, the phosphorylation of 4E-BP1 was tested. 4E-BP1 
is a downstream target of the Akt/mTOR signalling branch, and it binds cap- 
dependent eukaryotic initiation factor (eIF4E) to inhibit translation (Beretta et al., 
1996; Gingras et al., 1998). Hyperphosphorylation of 4E-BP1 disrupts this binding 
and activates cap-dependent translation. In this experiment, phosphorylation at Ser65 
site of 4E-BP1 was tested, which revealed that PI3K inhibition by LY294002 
prevented EGF-induced 4E-BP1 phosphorylation. Glycogen synthase kinase 3 
(GSK3) can phosphorylate and inactivate glycogen synthase, cyclin D1 and other 
targets, and is an important element of PI3K/Akt cell survival signalling branch 
(Cohen and Frame, 2001). Mammals harbour two distinct genes for GSK3 encoding 
related protein kinases, GSK3-a and P, with similar catalytic properties. The activity 
of GSK3 can be inhibited by PI3K/Akt-mediated phosphorylation of GSK3-a at 
Ser21 and GSK3-p at Ser9 (Cross et al., 1995). In this experiment EGF induced the 
phosphorylation of GSK3-P on Ser9, and while LY294002 blocked basal 
phosphorylation of GSK3-P on Ser9, it did not noticeably block EGF-induced 
phosphorylation, although it has been reported that LY294002 prevents PI3K/Akt- 
mediated phosphorylation on GSK3-p (Cross et al., 1995).
DMSO LY29400J (10 pM)
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Figure 3.1 Effect of EGF stimulation and LY294002 treatment on PI3K pathway activity 
in HB4a cells. HB4a cells were maintained in serum free medium for 48 h. Cells were then 
pre-treated with DMSO or LY294002 (10 pM) for 30 minutes, followed by 1 nM EGF 
treatment over the indicated time course. Antibodies specific for phosphorylated Akt, GSK3- 
P and 4E-BP1 were used to test for the EGF-dependent phosphorylation of these downstream 
PI3K targets. Pan specific antibodies against Akt and GSK3 were also used to monitor 
loading and changes in the expression levels of the proteins.
87
Chapter 3
In parallel to PI3K signalling, MAPK signalling was also monitored by blotting the 
same samples with antibodies against phosphorylated ERK1/2 and p90RSK (Figure 
3.2). The ERK (MAPK) signalling cascade is activated downstream of many tyrosine 
kinase receptors in response to ligand binding and regulates many cellular processes 
(Schaeffer and Weber, 1999). In this study, EGF treatment induced phosphorylation 
of ERK at the Thr202/Tyr204 sites in the first minutes of the treatment and this 
phosphorylation was sustained for the following 8 hours, after which it declined to 
background levels by 24 hours. The EGF-dependent phosphorylation of Erkl/2 was 
not blocked by LY294002, confirming that the EGFR/Ras/MAPK signalling cascade 
acts independently of the EGFR/PI3K signalling cascade in HB4a cells. p90RSK 
(MAPK-activated protein kinase-1), a downstream target of ERK1/2, is a member of 
the RSK family of widely expressed serine/threonine kinases activated by MAPKs in 
response to many growth factors. p90RSK regulates a number of cellular functions 
through phosphorylation and regulation of multiple transcriptional factors (Frodin and 
Gammeltoft, 1999). In this work, phosphorylation of p90RSK at Thr359 and Ser363 
sites, which are necessary for its activation (Dalby et al., 1998), was also found to be 
EGF-dependent. Controversially, LY294002 partially blocked this phosphorylation of 
p90RSK, suggesting that PI3K may contribute to p90RSK activation.
Stat3 is a member of the Janus kinase/signal transducers and activators of 
transcription (JAK/STAT) signal transduction pathway and is a key signalling 
molecule for many cytokines and growth factor receptors (Heim, 1999; Aaronson and 
Horvath, 2002). Activation of this pathway stimulates cell proliferation, 
differentiation, cell migration and apoptosis (Rawlings et al., 2004). Stat3 is activated 
by phosphorylation at tyrosine 705, which induces dimerisation and nuclear 
translocation. The transcriptional activity of Stat3 is further regulated by Ser727 
phosphorylation, apparently via MAPK and/or mTOR. PI3K-dependent JAK/STAT 
signalling was monitored in HB4a cells by following the phosphorylation of Stat3 at 
the Ser727 site (Figure 3.2). Here, EGF treatment resulted in the stimulation of 
Ser727 phosphorylation, which reached a maximum at 1 hour after the stimulation. In 
the cells pre-treated with LY294002 there was a diminished response, suggesting a 
modulatory role for PI3K activity in Stat3 signalling.
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Mitogen-dependent changes in the expression of two critical cell cycle regulatory 
proteins (p27Kipl and cyclin Dl) were also monitored to assess the role of PI3K 
signalling in cell cycle control (Figure 3.2). p27Kipl is a member of the cyclin- 
dependent kinase inhibitor proteins. These inhibitors form heterotrimeric complexes 
with cyclins and cyclin dependent kinases (CDKs), inhibiting kinase activity and 
blocking progression through Gl/S phase (Pestell et al., 1999). Levels of p27ICipl are 
upregulated in quiescent cells and in cells treated with negative regulators of the cell 
cycle. In this experiment, there were no significant changes in the levels of p27Kipl 
over time with EGF stimulation in both cells pre-treated with DMSO and LY294002, 
suggesting that EGF stimulation, as well as PI3K inhibition do not overtly perturb the 
total level of this protein in these cells.
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Figure 3.2 Effect of EGF stimulation and LY294002 treatment on MAPK and STAT 
pathway activation in HB4a cells. HB4a cells were maintained in serum free medium for 
48h. Cells were then pre-treated with DMSO or LY294002 (10 pM) for 30 minutes followed 
by 1 nM EGF treatment over the indicated time course. Antibodies specific for 
phosphorylated p90RSK, ERK and Stat3 were used to test the EGF-dependent stimulation of  
these EGFR downstream targets. In addition, pan-antibodies against p90RSK, ERK and Stat3 
were also used to reprobe membranes to monitor total expression and loading o f the protein 
samples. Antibodies against cyclin D l and p27ICipl were also used to test effects on cell cycle 
proteins.
Cyclin Dl regulates the transition from G1 to S phase of the cell cycle. Its 
expression is induced by mitogens and it peaks during G1 phase when it binds to and 
activates cyclin-dependent kinases (Cdks), such as Cdk4 and Cdk6 (Harbour et al.,
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1999). In this experiment, cyclin Dl expression was induced maximally at a late time 
point (8 hours) and was then reduced to background levels after 24 h (Figure 3.2), in 
accordance with its known ubiquitin-dependent proteosomal degradation (Diehl et al., 
1997). There was a minimal effect of the LY294002 treatment on this response, 
indicating that PI3K signalling does not play a major role in regulating cell cycle 
progression in these cells.
Having established that HB4a cells can respond to EGF by activating PI3K- 
dependent signalling, the next goal was to look globally at specific kinase-dependent 
phosphorylation events. In order to detect PI3K-dependent phosphorylation changes 
in Akt- or PKC-substrates in response to EGF treatment, protein samples were 
immunoblotted with anti phospho-(Ser/Thr) Akt substrate and anti phospho-(Ser) 
PKC-substrate antibodies. Protein kinase C (PKC), a calcium and phospholipid- 
dependent protein kinase, is a major target of diacylglycerol (DAG), which together 
with inositol phosphate are direct products of receptor-activated PLCy-mediated 
hydrolysis of PIP2. Importantly, the PI3K and PLCy have been shown to be 
interdependent because PIP3 binds to the PH domains of certain Tec family tyrosine 
kinases, such as Btk, Itk and Tec, localising them to the plasma membrane, where 
they activate PLCy and DAG production. In addition, activation of some PKCs is 
supported directly by PI3K-independent PDK1 activity. PDK1 is active even in 
resting cells, and it can bind and phosphorylate PKC in the activation loop in a PI3K 
and PH-domain independent manner.
The phospho-(Ser/Thr) Akt substrate antibody used recognises preferentially 
peptides and proteins containing phospho-(Ser/Thr) preceded by Lys or Arg at 
positions -5 and -3, in a manner largely independent of other surrounding amino acids 
in the sequence. The phospho-(Ser) PKC substrate antibody detects endogenous levels 
of many cellular proteins only when phosphorylated at serine residues surrounded by 
Lys or Arg at the -2 and +2 positions with a hydrophobic residue at the +1 position. In 
both western blot analyses, the most obvious difference found was an increase of a 
signal at around ~30 kDa in response to EGF stimulation, which was blocked (pAkt- 
substrates) or reduced in (pPKC-substrates) samples pre-treated with LY294002 
(Figure 3.3). Other differences were also evident, but were poorly resolved. Thus, the
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observed change in phosphorylation of a protein at ~30 kDa was an interesting target 
for further investigation. In addition, in order to monitor PI3K-dependent tyrosine 
phosphorylation events, a membrane was probed with the anti-phosphotyrosine (pY) 
antibody clone 4G10 (Figure 3.3). EGF treatment was found to increase a 
phosphotyrosine signal in the first few minutes and hours of the stimulation, which 
weakened in the later time points. A similar phosphorylation pattern was observed in 
the cells pre-treated with LY294002, showing that “bulk” tyrosine phosphorylation 
events induced by EGF are not dependent upon PI3K.
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Figure 3.3 PI3K-dependent phosphorylation of Akt- and PKC- substrates and 
phosphotyrosine in response to EGF stimulation. HB4a cells were maintained in serum 
free medium for 48h. Cells were then pre-treated with DMSO or LY294002 (10 pM) for 30 
minutes followed by 1 nM EGF treatment for the indicated times. Phospho-Akt (A) and 
phospho-PKC (B) substrate antibodies that recognise specific phosphorylation of Ser/Thr in 
the Akt motif and phosphorylation of Ser in the PKC motif, as well as an anti-pY antibody 
(C), were used for immunoblotting.
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3.3. Examination of PI3K inhibitor-specific effects in HB4a cells in 
response to EGF
To examine PI3K inhibitor-specific effects on the basal phosphorylation level of 
downstream targets of PI3K, randomly growing cells were treated with three different 
PI3K inhibitors. The inhibitors LY294002, wortmannin and D000 were used. 
Wortmannin is a fungal metabolite potent at inhibiting PI3K activity (Arcaro and 
Wymann, 1993), and like LY294002, is widely active across the PI3K family, while 
D000 is a pi 105-specific inhibitor (Sawyer et al., 2003). Samples of inhibitor-treated 
cells were subjected to western blotting analysis, as described previously. This 
analysis showed that LY294002 and wortmannin, but not D000, could block basal 
phosphorylation of Akt at Ser473, GSK3-a at Ser21 and 4E-BP1 at Ser65 sites 
(Figure 3.4).
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Figure 3.4 PI3K inhibitor-specific effects on PI3K/Akt. HB4a cells were maintained in 
serum-supplemented medium prior to drug treatment. Cells were treated with (10 pM) 
LY294002, wortmannin (lOOnM) or D000 (2pM) for the times shown. The phosphorylation 
of Akt, GSK3, and 4E-BP1 were analysed by western blotting.
EGF-dependent PI3K signalling in HB4a cells was next analysed by pre-treating 
randomly growing cells with the three PI3K inhibitors followed by EGF for 1 hour. 
Samples were immunoblotted with antibodies against specific phosphorylation sites 
of Akt and GSK3 (Figure 3.5). The analysis revealed that wortmannin and LY294002 
blocked EGF-induced phosphorylation of Ser473-Akt and had a slight effect on Ser9-
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GSK3-P. DOOO failed to block EGF-induced phosphorylation of the two targets 
analysed.
C LY 'C  I Y DOOOWorf
pSer473 Akt 
pSer9  GSK3-P
Figure 3.5 Effect of different PI3K inhibitors on EGF-activated PI3K/Akt signalling.
Serum-starved HB4a cells were treated with PI3K inhibitors (10 pM LY294002, 100 nM 
wortmannin or 2 pM DOOO) for 30 min., prior to 1 nM EGF stimulation for 1 h. Western blot 
analysis was carried out using anti-phospho Ser473-Akt and Ser9-GSK3-p antibodies. C 
stands for control pre-treated with DMSO.
This study was taken further by examining global PI3K-dependent phosphorylation 
changes in response to inhibitor treatment and EGF stimulation. HB4a cells were pre­
treated with the PI3K inhibitors for 30 minutes, followed by EGF stimulation for 1 h, 
or were treated with vehicle (DMSO), LY294002 or EGF alone. Cells were subjected 
to western blotting analysis using anti-Akt, anti-PDKl and anti-PKC phospho-specific 
substrate antibodies (Figure 3.6). This analysis confirmed the previously observed 
LY294002-mediated blockade of phosphorylation events and an apparent mass shift 
of a putative Akt and PDK1 substrate of -30 kDa whose phosphorylation was induced 
by EGF. The appearance of the lower mass form may represent a dephosphorylation- 
induced shift in apparent molecular weight, although it would appear that this form is 
still phosphorylated perhaps on another site or sites. Other altered bands were also 
apparent in the gels. The same phenomena were observed in wortmannin, but not in 
DOOO pre-treated cells, suggesting that observed phosphorylation events are probably 
pi 10a- and pilOp-dependent and not dependent on pi 105. This is likely to be true 
because pi 105 expression is low in these cells and displays a more haematopoietic 
pattern of expression (Sawyer et al., 2003). The inhibitors had little effect on the 
phosphorylation of putative PKC substrates, although the 30 kDa protein was just 
detectable.
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Figure 3.6 Effect o f PI3K inhibitors on phosphorylation of Akt-, PDK1- and PKC- 
substrates in response to EGF stimulation. HB4a cells were maintained in serum free 
medium for 48h. Cells were then pre-treated with LY294002 (10 pM), wortmannin (100 nM) 
and DOOO (2 pM) for30 minutes, followed by 1 nM EGF treatment for lh. Anti phospho-Akt 
(A), phospho-PDKl (B) and phospho-PKC (C) substrate antibodies recognising specific 
phosphorylation site motifs for these kinases were used for western blotting. Arrows indicate 
altered band intensities. (C, D, LY and Wort stand for DMSO treated control, D000-, 
LY294002-, and wortmannin treated cells, respectively).
Taken together, it can be concluded that LY294002 and wortmannin both block the 
phosphorylation events induced by EGF stimulation. In contrast, it was expected that 
DOOO would not have an inhibitory effect on the EGF-induced stimulation of 
downstream targets of PI3K signalling in the mammary luminal epithelial cells, since 
the pi 106 is most likely not expressed in these cells. In my work here, I have found 
that despite the ability to identify differentially expressed or phosphorylated kinase 
substrates that depended upon PI3K activity this kind of ID blotting-based analysis 
method is limited. Further experimentation using more advanced proteomic 
techniques such as fluorescence protein labelling in combination with 2D gel 
electrophoresis and protein identification by mass spectrometry were used to facilitate 
quantitative protein expression profiling of PI3K-dependent signalling events and 
help to identify new targets of PI3K activity.
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3.4 Functional phosphoproteomic analysis of PI3K signalling events 
using 2D gel-based proteomics
Immunoblotting analysis can be a very sensitive and highly specific approach for 
detection of changes in protein levels as well as of altered post-translational 
modifications. In the previous sections, it was shown that although differences in the 
phosphorylation dynamics of putative kinase substrates can be detected by 
immunoblotting, these protein substrates could not be easily identified, because the 
number of potential theoretical substrates with phosphorylation motifs for a particular 
kinase is often high. In addition, quantitation of observed differences in total protein 
level and phosphorylation status is not trivial to carry out. Thus, in order to quantify 
and identify PI3K-dependent changes in the total proteome and in phosphorylated 
proteins in response to EGF, a functional proteomics approach combining 
immunoblotting and 2D-DIGE was carried out.
In a preliminary 2D-DIGE experiment, HB4a cells were pre-treated with 
LY294002 (LY) or vehicle (DMSO) alone for 30 minutes followed by EGF treatment 
for 1 hour. Cells were lysed in a urea-CHAPS based 2D-lysis buffer and subjected to 
2D-DIGE analysis, as described in the methods in Chapter 2. Briefly, equal amount of 
protein lysate from the two conditions were labelled with Cy3 and Cy5, respectively. 
The samples were mixed and run on an 18 cm pH 3-10 non-linear IPG strip in the first 
dimension, followed by 10% SDS-PAGE in the second dimension (Figure 3.7 A). The 
gel was scanned at two different excitation/emission wavelength combinations 
generating two fluorescent images of proteins labelled with Cy3 and Cy5. Images 
were imported into DeCyder software for image analysis. Paired fluorescent images 
were automatically matched using the DIA module of the software, as the images are 
directly superimposable (Figure 3.7 A). Gel images were then normalised and 
processed to calculate spot abundances and fold ratios of abundance between the two 
samples. This quantitative analysis showed 15 differentially expressed protein 
features (>1.5 fold changes in abundance) between EGF and EGF+LY treated 
samples out of 1986 detected features. Of these, 12 protein spots were upregulated in 
the EGF-treated sample versus the EGF+LY sample and 3 were downregulated 
(Figure 3.7 B).
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Figure 3.7 Example of DIA module analysis in DeCyder software. HB4a cells were treated 
with EFG (1 nM) alone for 1 hour and EGF following 30 minutes LY294002 (10 pM) 
pretreatment. Cell lysates from the two conditions were labelled with Cy3 and Cy5, 
respectively, mixed and run on the same 2-D electrophoresis gel. Gel images were curated 
using the DIA module of DeCyder software. A) Separate Cy3 and Cy5, as well merged Cy3 
and Cy5 gel images, edited in Photoshop for presentation purpose only, are shown. B) Scatter 
plot of spot volume and number versus volume ratio is shown with a threshold ratio set at 1.5 
(+/- 2SD) (vertical lines) and spot statistic information.
Following the image analysis, the gel was stained with SYPRO Ruby. SYPRO  
Ruby detects most proteins including those which are difficult to stain such as 
glycoproteins, calcium-binding proteins, lipoproteins and fibrillar proteins, without 
staining nucleic acids (Berggren et al., 2000). It can detect as little as 1-2 ng o f  
protein, similar to the detection limit o f  silver staining, but having greater sensitivity  
than Coom assie Brilliant Blue, both o f  which are used for protein staining o f  2D gels 
(Berggren et al., 2000; Gorg et al., 2000). In contrast to non-saturating Cy-dye
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labelling, which labels only ~5% of the protein, SYPRO Ruby labels total protein. 
Thus, the aim of using SYPRO Ruby staining was to allow accurate matching of Cy- 
dye labelled proteins with the total protein pool to facilitate automated protein spot 
picking. The Cy-labelled fluorescent images were matched with the SYPRO Ruby- 
stained gel image and showed an almost perfect match (Figure 3.8), although a shift 
between the Cy-labelled and total pool has been previously observed in the low 
molecular weight region of the 2D-DIGE gels (Gharbi et al., 2002).
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Figure 3.8 Post-staining of 2D-DIGE gel with SYPRO Ruby. Differently treated HB4a 
cells were lysed and labelled with Cy3 and Cy5and proteins were separate by 2-DE. The same 
2D gel was used for post-staining with SYPRO Ruby stain. The Cy3 image (red) was merged 
with SYPRO Ruby image (blue) to match total protein with the Cy-dye labelled proteins and 
possibly to detect any shift in the protein migration caused by Cy-dye labelling. Cy3, SYPRO 
Ruby and the merged image were edited in Photoshop for presentation purposes only.
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The specific staining of phosphoproteins was also attempted using the fluorescent 
Pro-Q Diamond phosphoprotein stain (Schulenberg et al., 2003). Pro-Q Diamond 
phosphoprotein stain has been reported to detect phosphate groups attached to 
tyrosine, serine and threonine residues, and it is advertised as an ideal stain for 
detection of kinase targets in signal transduction pathways and for phosphoproteomic 
studies, with the signal intensity correlating with the number of protein phosphates. 
Thus, in parallel to the 2D-DIGE analysis, two pairs of 2D gels were run. In each set, 
EGF and LY294002+EGF samples were run separately. One gel from each set was 
stained with Pro-Q Diamond phosphoprotein gel stain followed by SYPRO Ruby 
staining, whilst the second set was subjected for 2D western blotting analysis. The 
purpose of Pro-Q Diamond phosphoprotein gel staining, followed by SYPRO Ruby 
staining, was to distinguish potentially phosphorylated protein features from the total 
protein expression profile in each condition. However, I found in my experiments that 
Pro-Q Diamond phosphoprotein staining could not be distinguished from the SYPRO 
Ruby staining for total protein, suggesting that Pro-Q Diamond phosphoprotein stain 
is either non-specific or all proteins are phosphorylated to an extent which is 
dependent upon their abundance, which seems unlikely (Figure 3.9). In addition, I 
found that the staining was uneven, giving a high background in different regions of 
the gel. Similar problems with Pro-Q Diamond phosphoprotein staining have been 
encountered by other members of my laboratory, indicating that it cannot be used 
effectively for phosphoprotein detection.
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Figure 3.9 Pro Q-Diamond and SYPRO Ruby staining of 2D gels. 2D gels were subjected 
to phosphoprotein staining with Pro Q-Diamond, scanned and then destained for re-staining 
for total protein with SYPRO Ruby. Scanning was performed on a Typhoon multi-wavelength 
fluorescence scanner.
2D immunoblotting analysis of phosphorylated Akt substrates in the two 
treatments (EGF and LY294002+EGF) once more detected a phosphorylation event at 
~30 kDa in EGF treated cells, which was blocked in cells pre-treated with LY294002 
(Figure 3.10). There were also several other phosphorylation events, which were 
absent or altered in LY294002 treated cells, suggesting that phosphorylation of these 
Akt substrates in response to EGF was blocked by LY294002. Immunoblotting with
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the phospho-PKC substrate-specific antibody also revealed several putative PI3K- 
dependent PKC substrates, some of which appeared to be cross-reactive with the Akt-
specific substrate antibody (Figure 3.10).
pPKC sub stra tespAkt su b stra te s
Figure 3.10 Detection of PI3K-dependent phosphorylation of Akt- and PKC- substrates 
in response to EGF by 2D immunoblotting. Serum starved HB4a cells were pre-treated 
with LY294002 for 30 min, followed by EGF stimulation for 1 h. Protein lysates were 
subjected to 2D immunoblotting using antibodies against phosphorylated Akt (A) and PKC 
(B) substrates that recognise specific phosphorylated motifs. Circled futures in red represent 
prominent differential pAkt substrates in EGF treated cells versus the same protein feature 
(blue circle) in cells pre-treated by LY294002. Circled futures in green represent differential 
pPKC substrates in EGF treated cells versus the same protein feature (yellow circle) in cells 
pre-treated by LY294002.
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Although NHS-Cy labelling is quite sensitive, the observed differences in 
phosphosubstrate signals could not be aligned with Cy-dye images from the 
preliminary DIGE analysis. Moreover, none of the 15 altered protein spots appeared 
to give rise to a phosphosubstrate signal. In conclusion, it appears that these kinases 
substrates are low abundance proteins, which cannot be detected on 2D gels loaded 
with 300 pg of protein lysate.
An earlier study using the same phosphospecific Akt substrate antibody also 
detected a change in a 30 kDa protein in ES cells in response to EGF, which was 
dependent upon PDK1 (Zhang et al ., 2002). In this study immunoreactivity of PDK1- 
/- ES cell extracts with wild type ES extracts were compared by combining one- and 
two-dimensional immunoblotting analysis using Akt- and PKC- substrate antibodies 
together with protein database searching using epitope specificity matrices. These 
scientists predicted and subsequently identified phosphorylation in the 30 kDa S6 
ribosomal protein in wild type, but not PDK1-/- ES cells in response to EGF 
treatment. This information was used in the present study, and membranes were 
reprobed with a phosphospecific antibody against S6. This western blot analysis 
identified EGF-induced S6 phosphorylation as a PI3K-dependent event and S6 protein 
as a putative Akt substrate as well as S6 as the highly likely 30 kDa candidate protein. 
This phosphorylation event appeared to be associated with a large shift in pi of the 30 
kDa protein and suggested that the two altered features could be isoforms of the same 
protein (Figure 3.11).
Although this approach appeared to be a sensitive method for detecting kinase 
specific substrates, it has limited potential for the identification of these protein 
substrates. Firstly, I found that it is hard to predict which of the protein substrates 
change even when using database information, so that targets can be validated using 
specific antibodies against them. Secondly, it is hard to match 2D immunoblotting 
images with 2D fluorescence gel images, most likely due to the low abundance of 
these putative signalling molecules; matching would facilitate detection of the right 
protein spot from a 2D gel for subsequent picking and identification by mass 
spectrometry.
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Figure 3.11 Identification of S6 protein as an Akt substrate. Serum starved HB4a cells 
were pre-treated with LY294002 for 30 min, followed by EGF stimulation for 1 h. Protein 
lysates were subjected to 2D immunoblotting for phosphorylated Akt-substrates (A) and pS6 
(Ser235/236) (B) using the corresponding antibodies. The red circled feature represents the 
~30 kDa Akt-substrate whose phosphorylation was inhibited by the LY294002. The green 
circled feature represents protein isoforms recognised by a specific anti-phospho-Ser235/236 
S6 antibody.
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3.5 The effect of PI3K inhibitors on global protein expression 
examined by 2D-DIGE
Despite not being able to match phosphorylated substrates detected by 
immunoblotting with Cy-dye labelled spots, it appears that other targets of PI3K 
signalling can be detected by 2D-DIGE expression profiling as suggested by 
preliminary experiments. Thus, a more detailed analysis was performed using 
replicate samples and an internal standard to increase the accuracy of quantitation. 
Serum-starved HB4a cells were pre-treated with LY294002 (10 pM), wortmannin 
(100 nM) or D000 (2 nM) for 30 min, followed by EGF (1 nM) stimulation for 1 
hour. The proteosome inhibitor PS341 (1 pM) was also included with the aim of 
examining if any of the detected changes induced by EGF-dependent PI3K activation 
or inhibition are the result of proteasomal degradation. An un-stimulated control 
treated just with a vehicle (DMSO) was also included in the experiment. Cells were 
lysed in NHS-lysis buffer and processed as described in Chapter 2. Equal amounts of 
each protein sample (100 pg) were labelled with Cy3 or Cy5. Also, equal amounts of 
all samples were mixed and labelled with Cy2 to provide a standard pool to be run on 
each gel. Triplicate samples were prepared for each of the six conditions. Cy3 and 
Cy5 labelled protein samples (100 pg) were then mixed appropriately with an equal 
amount (100 pg) of Cy2 labelled pool and subjected to IEF on 24 cm, 3-10 non-linear 
IPG strips in the first dimension. Strips were then transferred to 12% SDS-PAGE gels 
and subjected to molecular weight separation in the second dimension. The Cy-dye 
labelling combinations for the six different conditions (control, EGF-treated cells and 
four different drug treatments: LY294002, wortmannin, D000 or PS 134 prior to EGF 
stimulation) run in triplicate resulted in the running of nine 2D gels. Gels were 
scanned at the corresponding wavelengths for Cy2, Cy3 and Cy5 detection (Chapter 
2) and 27 protein spot maps were generated. Fluorescence images were imported into 
DeCyder software for image analysis. Experimental design and Cy3 and Cy5 images 
generated for each gel, as well as, merged Cy3 and Cy5 images, are shown in Figure 
3.12.
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Figure 3.12 Representation of the experimental design in the study of PI3K-dependent 
changes in response to EGF treatment. HB4a cells were pre-treated with the following 
inhibitors: LY294002 (10 pM), wortmannin (100 nM), D000 (2 nM) or PS 341 (1 pM), 
including pre-treatment with DMSO (a vehicle) for 30 min, followed by EGF (1 nM) 
stimulation for 1 hour. Un-stimulated control and EGF-alone treated cells were also prepared. 
Cells were lysed in NHS-lysis buffer and processed as described Chapter 2. Equal amount of 
protein lysates were labelled with Cy3 or Cy5 dyes. A mixture of equal amounts o f each 
sample labelled with Cy2 was also prepared as an internal standard. Triplicate Cy3 and Cy5 
labelled samples were then mixed appropriately as shown in the figure, together with an equal 
amount o f the Cy2 labelled pool and run on 9 large format 2D gels. Respective gel images of 
samples labelled with Cy3 (red) and Cy5 (blue), including merged Cy3 and Cy5 gel images 
(purple) are shown.
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Image analysis was then performed using the BVA module of DeCyder software 
where matching of protein spots across different gels as well as quantitative 
comparison of changes in abundance between multiple samples was performed. This 
was facilitated by the use of the internal standard pool, which was run on all gels. A 
statistical analysis of the matched protein features was then performed revealing 11 
protein features differentially expressed (>1.5 or <-1.5 fold difference in abundance, 
p<0.05, n=3) in the five different treatments compared to the control un-treated cells 
(Table 3.1, Appendix 1). These protein spots were assigned for picking. Selected gels 
were post-electrophoretically stained with SYPRO Ruby and images were matched to 
Cy-dye fluorescence images in order to align spots and to generate a list of picking 
coordinates for automatic spot picking. Picked protein spots were trypsin digested, 
and the peptide mixtures obtained from each tryptic digest were subjected for peptide 
mass fingerprinting by MALDI-TOF MS.
EGF LY Wortmannin D000 PS341
Master Name NCBI Acc Seq. Score No. Predicted Predicted Av. T-test Av. T-test Av. T-test Av. T-test Av. ; T-test
No. No. Cov. peptide Pi MW Ratio Ratio Ratio Ratio Ratio
261 -1.32: 0.1 -1.111 0.51 -1.02 0.93 -1.43 0.024 -2.33 0.0015
417 Exrin 119717 24 86 15 5.94 69470 1.51 0.025 1.59 0.014 1.43 0.015 1.34 0.028 1.8 0.038
478 Moezin 4505357 26 100 12 6.02 67892 1.5 0.015 1.59 0.018 1.32 0.022 1.21 0.063 1.61 0.039
877 Keratin 7 67782365 35 109 16 5.4 51412 1.54 0.0072 1.24, 0.38 1.37 0.015 1.41 ‘ 0.012 1.28 0.29
898 Cytokeratin 8 181573 53 216 31 5.52 53529 1.51 0.022 1.28; 0.19 1.4 0.037 L 1.33 0.059 1.21 0.26
1352 -1.61 0.047 -2.01 0.069 -1.72 0.015 -1.69 0.0022 -1.43 0.11
1485 1.91 0.0018 2.04 0.0035 1.77 0.0035 1.97 0.0017 1.92 0.0023
1918 13H 0.36 -1.75 0.041 ""-1.23 0.37 -1.11' 0.62 -1.3j 0.35
1926 1.4 0.064 1.14 0.79 1.51 0.016 1.16! 0.074 1.26 0.5
1957 2.37 0.0004 1.93 0.032 2.32 0.0013 2.28 0.0007 1.93 0.078
1964 -2.09 0.0039 -2.05 0.021 -1.67 0.017 -2.37 0.0018 -2.4 0.0091
Table 3.1 2D-DIGE differential protein expression analysis of EGF and PI3K inhibitor- 
induced changes in HB4a cells. Protein features displaying differential expression in HB4a 
cells treated with inhibitors LY294002 (10 pM), wortmannin (100 nM), D000 (2 pM) and 
PS 134 (1 pM) prior to EGF treatment, and EGF treatment alone. Values are average ratios of  
abundance from different treatments applied versus control cells, where each condition was 
prepared in triplicate. Values for protein isoforms shaded in light and dark grey were 
significantly up- or down regulated (1.5 fold; p< 0.05; n=3), respectively. Proteins were 
identified by MALDI-TOF peptide mass fingerprinting. Protein name, NCBI accession 
number from database searches, sequence coverage (%), Mowse score and number of  
matched peptides are given for each o f the identified proteins.
Among the differentially expressed protein species, two cytokeratins, cytokeratin 7 
and cytokeratin 8 were significantly upregulated following EGF treatment, but only 
moderately suppressed by the inhibitor treatments (Figure 3.13, Table 3.1). 
Cytokeratins (CKs) form intermediate filaments and are part of the cytoskeleton. They 
are epithelial cells and differentiation markers, which are dynamically regulated, and
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interact with a range of cellular proteins. In general, CKs are organised in a complex 
network between the cell membrane and the nuclear surface and are involved in the 
organisation of the cytoplasm and cellular communication mechanisms. They are also 
involved in cell movement, cell-cell adhesion and connecting cells to the underlying 
connective tissue (Coulombe and Wong, 2004).
Cytokeratin 8 Cytokeratin7
Control EGF LY DOOO WORT PS 341 Control EGF LY DOOO WORT PS 341
Figure 3.13 Examples of proteins displaying EGF-dependent changes. Cytokeratin 7 and 
Cytokeratin 8 were induced by EGF. Graphs were derived from DeCyder image analysis 
where the standardised abundance was the ratio o f the volume o f a gel feature for each 
condition replicate versus the volume o f the corresponding standard gel feature. Triplicate 
data points are shown for spots from the untreated and treated samples with lines joining the 
average values. Examples o f gel migration and 3D images o f these to spots are shown for 
untreated and EGF-treated samples.
Ezrin and moesin (Figure 3.14) were two actin binding proteins upregulated in the 
EGF, LY294002+EGF and PS341+EGF treatments (Table 3.1), suggesting that whilst 
their abundance is affected by EGF signalling, this may not be subject to regulation 
by PI3K or proteosome degradation. Ezrin and moesin belong to a family of plasma
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membrane-localised actin binding proteins. They have been proposed to link the actin 
cytoskeleton to the plasma membrane and to be involved in signal transduction, 
growth control, cell-cell adhesion, and microvilli formation (Louvet-Vallee, 2000).
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Figure 3.14 Peptide mass fingerprinting of moesin, chain A. A differentially expressed 
protein was picked from a gel and digested with trypsin (Chapter 2). The peptide mixture was 
then analysed by MALDI-TOF MS giving the spectrum. The list o f peaks was searched 
against the NCBI database, giving a significant hit for moezin, chain A.
Protein species with master spot numbers 1485, 1957 and 1964 had the same 
pattern of regulation across the five treatments compared to the control cells, 
suggesting that these changes are only EGF-dependent, and independent of the drug 
treatments applied. Master spots 1918 and 1926 were only differentially regulated in 
LY294002+EGF treated cells (-1.75) and wortmannin+EGF treated cells (1.5 fold), 
respectively, compared to the control sample, suggesting that basal effects of these 
inhibitors might occur. One protein species (master spot 261) was differentially
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expressed only in cells subjected to proteasome inhibition. Unfortunately, MALDI- 
TOF MS analysis and database searching did not return any significant “hits” for 
these proteins. Thus, the peptide mixtures were additionally analysed by LC-ESI 
MS/MS, and the spectra obtained were searched against NCBI database. However, 
again no significant hits were obtained in this attempt.
When ratios were compared between inhibitors plus and minus EGF treatments, 
seven protein species were found to be differentially regulated (Table 3.2, Figure 
3.15). Master spot number 1823 was found to be downregulated in LY294002+EGF 
treatment, whereas spot 745 and 1918 were observed upregulated and downregulated, 
respectively, after both LY294002+EGF and PS341+EGF treatments. Spots 606 and 
741 were differentially expressed in response to wortmannin and DOOO treatment. In 
addition, spots 261 and 1317 were detected as protein species whose expression was 
downregulated in only +EGF treatment versus EGF treatment. From all seven protein 
species only spot 1317 was identified with confidence by MALDI-TOF MS peptide 
mass fingerprinting as the metabolic enzyme glyceraldehyde-3-phosphate 
dehydrogenase.
LY294002 Wortmannin DOOO PS 341
Master
No. Name
NCBI Acc 
No.
Seq.Cov.
(%>
Score No.Peptides
Predicted
Pi
Predicted
MW Av. Ratio T-test Av. Ratio T-test Av. Ratk>| T-test Av. Ratio T-test
261
606
741
745
1317
1823
1918
Glyceraldehyde-3-phosphate
dehydrogenase 31654 32 64 9 8.58 36070
1.19
1.34
-1.35
1.6
-12
0.3
0.1
0.074
0.16
0.36
0.046
0.017
1.29
1.93
-1.53
0.1
0.0066
0.0037
022
0.098
0.4
0.14
_ _
-1.71
0.0009
0.019
0.028
0.092
0.15
0.26
0.43
-1.77
2.13
1.14
I 0.0045 
I 0.045 
I 0.42 
0.011 
0.0009 
0.048 
0.18
1.15
-M
-1.21
-1.48
1.12 I
-123 
-1.32 
-1.09 |
1.85
-1.57
-1.79
-2.09
-1.48
-1.56
Table 3.2 2D-DIGE differential protein expression analysis of EGF-treated HB4a cells 
versus cells pre-treated with inhibitors. Protein features displaying differential expression 
in HB4a cells treated with inhibitors LY294002 (10 pM), wortmannin (100 nM), DOOO (2 
pM) or PS 134 (1 pM), compared to their counterparts in EGF treatment. Values are average 
ratios o f abundance from inhibitor pre-treated cells versus EGF-only treated cells, where each 
condition was prepared as a triplicate. Values for protein isoforms shaded in light and dark 
grey were significantly up- or down regulated (1.5 fold; p< 0.05; n=3), respectively. Proteins 
were identified by MALDI-TOF peptide mass fingerprinting. Protein name, NCBI accession 
number, sequence coverage (%), Mowse score and number o f matched peptides are given for 
each of the identified proteins.
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Wort+E
Figure 3.15 Examples of proteins displaying PI3K-dependent changes in response to 
EGF stimulation. Protein spots 606 and 1823 displayed PI3K-dependent differential 
expression. The peptide mixtures o f the trypsin digestion from each of these protein spots 
were analysed by MALDI-TOF MS and the list o f peptide masses generated were searched 
using Mascot. Graphs were derived from DeCyder image analysis where the standardised 
abundance is the ratio o f the volume of a gel feature from PI3K inhibitor with EGF-treated 
test samples versus the volume of the corresponding gel feature in the EGF-treated sample. 
Data points are shown for triplicate measurements with lines joining the average values. 3D 
images of spots are shown for EGF treated and PI3K inhibitors (LY294002, wortmannin) plus 
EGF treated samples.
In summary, the work carried out in this section showed that only a few abundant 
protein species could be detected, which displayed altered expression following EGF 
and/or inhibitor treatments. In addition, only a third of differentially expressed 
proteins could be identified using MALDI-TOF MS and LC-MS/MS.
3.6 Conclusions
Since the discovery of phosphorylation as a key regulatory mechanism in almost 
all cellular processes, the analysis of the phosphoproteome has been an attractive area 
of study. However, despite a growing knowledge of many phosphorylation consensus 
sequences, this posttranslational modification cannot usually be predicted accurately 
from translation of the gene sequence alone. In addition, analysis of phosphorylation
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events is not straightforward for five main reasons. First, the stoichiometry of 
phosphorylation is generally relatively low, with only a small fraction of the available 
intracellular pool of a protein being phosphorylated at any given time in response to a 
stimulus. Second, there are often multiple phosphorylation sites on proteins, implying 
that any given phosphoprotein can exist in several different phosphorylated forms. 
Third, many targets of phosphorylation such as signalling molecules (Yoon and 
Seger, 2006), are present at low abundance within cells and enrichment is a 
prerequisite for successful analysis. Fourth, most analytical techniques used for 
studying protein phosphorylation have a limited dynamic range, which means that 
although major phosphorylation sites might be located easily, minor sites might be 
difficult to identify. Finally, phosphatases are often highly active and can 
dephosphorylate residues unless precautions are taken to inhibit their activity during 
preparation and purification steps of cell lysates.
The aim of my work in this chapter was to establish a model cell system for 
studying PI3K-dependent signalling and to monitor changes in global protein 
expression and phosphorylation events, which happened in response to activation of 
PI3K signalling. The aim was tackled using proteomic analysis consisting of ID and 
2D immunoblotting in combination with 2D gel-based proteomics. Immunoblotting 
analysis employing kinase-specific substrate antibodies, such as Akt, PKC and PDK1 
substrate antibodies, were used to monitor changes in protein expression and 
phosphorylation of kinase-specific substrates. In parallel, I employed 2D-DIGE 
analysis for the accurate and sensitive quantitation of protein expression across 
multiple biological samples and combined with mass spectrometry to allow me to 
identify differentially expressed proteins. An additional aim of mine was to try to 
correlate 2D immunoblotting data with the data obtained from 2D-DIGE analysis. 
Post-electrophoretic gel staining for the detection of phosphoproteins was also applied 
to try to distinguish phosphoproteins from the total proteome.
In an initial experiment to assess PI3K activation in a cell model of breast luminal 
epithelial cells (HB4a cells), PI3K inhibitors (LY294002, wortmannin and DOOO) 
were combined with EGF treatment to show whether the PI3K signalling pathway is 
responsive to EGF treatment. In the first instance, selected antibodies that recognise
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phosphorylation of target proteins of PI3K/Akt and Ras/ MAPK signalling were used 
and showed that both pathways were activated upon EGFR stimulation by EGF. In 
addition, this immunoblotting analysis revealed that PI3K inhibitors could block 
successfully Akt phosphorylation on Ser473, suggesting that the kinase responsible 
for this phosphorylation is PIP3-dependent as it was inhibited by both LY294002 and 
wortmannin treatments. In contrast, the pi 108 specific inhibitor, DOOO, did not have 
an inhibitory effect on this and other PI3K-dependent phosphorylation events, 
showing that pi 108 is not expressed in these cells, as suggested previously. Although 
it is well established that Akt phosphorylation on Ser473 is PI3K-dependent, there is 
controversy about the kinase that phosphorylates this site. Proposed kinases 
responsible for this phosphorylation event are PDK1 (Balendran et al., 1999), DNA- 
PK (Feng et al., 2004) and most recently the mTOR/Rictor complex (Sarbassov et al., 
2005), or perhaps it could be mediated by auto-phosphorylation event (Toker and 
Newton, 2000). One approach to identify the kinase responsible for phosphorylation 
of Ser473 in Akt could be to apply a specific RNA interference screen to silence the 
expression of all kinases and to use anti-phospho Ser473 Akt antibody for detection in 
a high-throughput manner. In addition to the later work, the application of new 
generation, highly specific PI3K and protein kinase inhibitors could be applied.
PI3K-dependent signalling induced by EGF was further assessed in this cell model 
by monitoring the phosphorylation of downstream targets of Akt. EGF-induced 
phosphorylation on 4E-BP1 was blocked by PI3K inhibitor treatment, showing how 
PI3K/Akt signalling functions normally to prevent 4E-BP1 from blocking translation 
through binding of cap-dependent eukaryotic factor eIF4E. It was also observed that 
the phosphorylation of GSK3-a, and to lesser extent GSK3-p, appeared to be PI3K- 
dependent. This was surprising since in most studies GSK3-p is described as a direct 
downstream target of Akt and its phosphorylation and inactivation are prevented by 
LY294002 treatment. However, GSK3-p can be also be phosphorylated by the MAPK 
signalling cascade (Shaw and Cohen, 1999). As I observed here that MAPK signalling 
was activated by EGF in HB4a cells, and that LY294002 had no effect on EGF- 
induced phosphorylation of ERK or p90RSK, this could suggest that GSK3-p 
phosphorylation is more dependent upon MAPK signalling in HB4a cells. Further 
work is required to establish the details of GSK3-p regulation in HB4a cells, indeed
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the possibility of cross-talk between the PI3K and MAPK signalling branches cannot 
be excluded, and this will also require more detailed analysis to resolve it. Monitoring 
the expression and phosphorylation of cell cycle regulatory proteins, such as p2 7 ^  
and cyclin D1 showed that the expression of these proteins was not perturbed after 
blocking the PI3K signalling suggesting that PI3K does not play a major role in 
regulating cell cycle progression in these cells. Furthermore, the phosphorylation of 
Stat3 at Ser727 was not perturbed by inhibition of PI3K indicating that Stat-dependent 
transcription in HB4a cells is not dependent on the PI3K signalling cascade.
ID and 2D immunoblotting using substrate-specific antibodies that recognise the 
phosphorylation consensus motifs of Akt, PDK1 and PKC revealed several putative 
protein targets of these kinases, which were EGF-dependent and PI3K-dependent. In 
particular, the ~30 kDa phosphorylation event induced by EGF stimulation, but 
blocked by LY294002 was validated as the phosphorylation of ribosomal protein S6 
on Ser235/236. S6 is a downstream target of S6K whose activation and 
phosphorylation is stimulated downstream of PI3K/Akt and the mTor/Raptor complex 
following RTK activation (Miron et al., 2003; Lizcano et al., 2003). Whilst the 
identity of this protein was predicted from a previous study (Zhang et al., 2002) and 
validated here by using immunoblotting, the same EGF- and/or PI3K-dependent 
phosphorylation event could not be matched to any of the changes observed in the 
2D-DIGE analysis. The work from the 2D-DIGE experiments showed that only a few 
abundant protein species had altered expression after the treatments applied. For 
example, the expression of ezrin and moesin, as well as cytokeratin 7 and 8, appeared 
to be differentially regulated in response to EGF treatment. Ezrin and moesin belong 
to a group of closely related membrane-cytoskeleton linkers (ERM proteins) that 
regulate cell adhesion and cortical morphogenesis. They have been proposed to link 
the actin cytoskeleton to the plasma membrane and to be involved in signal 
transduction, growth control, cell-cell adhesion, and microvilli formation (Louvet- 
Vallee, 2000). ERM proteins can be phosphorylated on different sites and this may 
regulate their activities. The observed differential expression of ezrin and moesin in 
response to EGF treatment could be due to their post-translation modification, such as 
phosphorylation, as EGF-induced phosphorylation on ezrin and moesin has been 
observed in other cell types (Krieg and Hunter, 1992). This however needs to be
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further validated in HB4a cells. Cytokeratin 7 and 8 belong to the epithelial keratins 
or cytokeratins (CKs) that are part of an intermediate system of fibrous filaments 
contributing to the cytoskeleton (Lazarides, 1980). The CK family members are 
expressed in different epithelial cells and constitute useful markers of epithelial sub- 
type and differentiation. The EGF-induced upregulation of cytokeratin 7 and 8 
expression could also be linked to PTM of these proteins in response to EGF and be 
dependent upon PI3K activity. This interesting observation requires further analysis. 
The major disadvantage of the 2D-DIGE approach was that only a third of the 
differentially expressed proteins could be identified with confidence using MALDI- 
TOF MS and LC-MS/MS. Although some of these changes may represent altered 
phosphorylation, rather than altered protein expression, post-staining with Pro-Q 
Diamond phospho-stain failed to show any phospho-specific staining. The reason for 
this observation remains unclear and further optimisation of the protocol may be 
required.
Finally, the comparison of immunoblotting and 2D-DIGE showed no correlation of 
the differences observed in the two methods, most likely because of the low 
abundance of downstream targets of Akt, PDK1 and PKC, which cannot be detected 
by the staining or labelling methods used in 2D gel electrophoresis. Thus, it can be 
concluded that this approach for functional cell signalling studies of protein 
phosphorylation on a global scale is rather limited. Firstly, although 2D gel 
electrophoresis and protein staining/labelling can provide valuable information, it 
suffers from several limitations, such as an inability to detect low-copy number 
proteins, as well as very small or large proteins and hydrophobic proteins such as 
membrane proteins due to their aggregation during IEF. Phosphoprotein gel staining 
was shown to be non-specific approach and so limited the analysis. In addition, 
although western blotting allows the detection of very low abundance 
phosphoproteins, I found that this method is not very suitable for quantitative analysis 
due to the variability of the amount of proteins transferred to the membrane and low- 
linear dynamic range of enhanced chemiluminescence (ECL) detection. In addition, 
the selectivity and affinity characteristics of the antibodies are of major importance 
since "false positive" interactions may be detected, thus reducing the applicability of 
this approach.
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In recent years, several other methods have been proposed as highly specific and 
selective for large scale quantitative and qualitative analysis of the phosphoproteome. 
Ptacek Qt al. reported the use of proteome chip technology where synthetic peptides 
served as kinase substrates to allow extraction of consensus motifs (Ptacek et al., 
2005), which were then be incorporated into in silico prediction programs for 
generation of phosphorylation maps. However, this approach also appeared to have 
limitations, as kinases are often less specific in vitro than they are in vivo. Thus, in the 
last few years mass spectrometry has proven to be powerful technology for 
proteomics and a method of choice for unbiased (i.e hypothesis-free) analysis of in 
vivo phosphorylation. Olsen et al. reported a general mass spectrometry technology 
for identification and quantitation of phosphorylation sites as a function of stimulus, 
time and subcellular location (Olsen et al., 2006). They combined “double-triple 
labelling” using SILAC (Stable isotope labelling with amino acids in cell culture; 
(Ong et al., 2002)) for quantitation, strong-cation exchange chromatorgraphy (SCX) 
and titanium dioxide (Ti02) chromatography for phosphopeptide enrichment (Larsen 
et al., 2005), and high accuracy multistage MS, to examine EGF-stimulated 
phosphorylation events in HeLa cells. They detected 6600 phosphorylation sites on 
2244 proteins and determined their temporal dynamics after stimulation with EGF and 
recorded these dynamic changes in the Phosida (phosphorylation site) database. In 
another study, an isotopically labelled internal standard (IS) was employed to provide 
a quantitative measure of kinase activation status in absolute units. Cutillas P.R. et al. 
used MS for the quantification of PI3K-dependent protein kinase activity toward a 
substrate (Akt) that is highly selective for this pathway. They applied the analytical 
strategy of using IS to the PI3K/Akt pathway and show that it is possible to quantify 
signal transduction pathway activation with great precision, with high sensitivity and 
in a specific manner (Cutillas et al., 2006). This kind of approaches for studying 
dynamics of signalling networks, although complex, have been proposed to provide a 
missing link for cellular regulation and dynamics in signal transduction, and they 
could be employed in a future research project as a platform to study PI3K-dependent 
phosphorylation events in HB4a cells.
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Chapter 4: Characterisation of insulin- and PI3K-dependent 
actin cytoskeleton organisation
4.1 Introduction
The actin cytoskeleton forms a complex dynamic network of filaments that 
maintain cell shape, enable certain cell movements and play important roles in both 
intracellular transport (for e.g. the movement of vesicles and organelles) and cellular 
division. To perform all these biological functions, the organisation of the actin 
cytoskeleton must be tightly regulated both temporally and spatially. Many proteins 
associated with the actin cytoskeleton are thus likely targets of signalling pathways 
that control actin assembly and reorganisation. A large number of actin-binding 
proteins regulate cytoskeleton organisation by controlling filament formation and 
contraction and also cross-linking of the actin network (Pollard and Cooper, 1986; 
Stossel, 1993; Welch et al., 1994; Schafer and Cooper, 1995). The activities of these 
proteins are often modulated by signalling molecules such as kinases and 
phosphorylated phosphoinositides (Janmey, 1994) as a part of complex signalling 
pathways.
In this chapter, the possible role of growth factor/PI3K mediated actin cytoskeleton 
organisation in fly haemocyte cell lines will be investigated. Most of the current 
knowledge about PI3K signalling-dependent actin reorganisation comes from studies 
of initiation of motility induced by growth factors (PDGF, EGF, IGF and insulin) in 
migratory cells (see Introduction). In 1994, Kotani et al. showed that insulin and IGF- 
1 can both induce membrane ruffling in a PI3K-dependent manner (Kotani et al., 
1994). They showed that by microinjecting phosphorylated peptides, containing Y-M- 
X-M motifs or a mutant p85 regulatory subunit, which lacks a binding site for the
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catalytic pi 10 subunit of PI3K, into the cytoplasm of human epidermoid carcinoma 
KB cells, the association of insulin receptor substrate-1 (IRS-1) with PI3K was 
blocked. Importantly, this inhibited insulin- or IGF-1-induced, but not EGF-induced, 
membrane ruffling in KB cells. In addition, wortmannin inhibited insulin- or IGF-1- 
induced membrane ruffling. It has been also reported that a mutation in the PDGF 
receptor can eliminate binding to and activation of PI3K, which then leads to a failure 
of porcine aortic endothelial cells to ruffle and chemotax in response to PDGF 
(Kundra et al., 1994; Wennstrom et al., 1994a; Wennstrom et al., 1994b). 
Furthermore, constitutively active PI3K mutants or the addition of exogenous PIP3 
can initiate cell motility and membrane ruffling, and the use of PI3K inhibitors 
LY294002 and wortmannin in many studies has shown how PI3K activity is required 
in actin reorganisation (Arcaro and Wymann, 1993; Wymann and Arcaro, 1994).
However, in addition, with these findings, PI3K-independent growth factor 
mediated actin reorganisation and motility has also been reported. For example, 
Kovacsovics et al. showed that although thrombin receptor-activating peptide (TRAP) 
can activate PI3K signalling, neither wortmannin nor LY294002 altered the kinetics 
of actin assembly or the exposure of nucleation sites in TRAP-stimulated platelet 
cells. In contrast, PI3K inhibitors showed a specific inhibitory pattern of cell 
aggregation (Kovacsovics et al., 1995). Higaki et al. reported that in vascular smooth 
muscle cells, PDGF-induced chemotaxis is independent of PI3K activity, while 
PDGF-induced amino acid uptake, glucose incorporation, and cytoskeletal 
reorganisation are dependent on PI3K. They showed that wortmannin blocked PI3K 
activity induced by PDGF, but did not inhibit PDGF-induced chemotaxis in smooth 
muscle cells and Swiss 3T3 cells. They also reported that Chinese hamster 
ovary/Delta p85 cells overexpressing a dominant negative p85 subunit of PI3K 
showed a chemotactic response comparable to that of parental cells while showing a 
remarkable decrease in PI3K activity (Higaki et al., 1996). In addition, wortmannin 
and LY294002 inhibited PDGF-induced amino acid uptake and actin-stress fibre 
reorganization in Swiss 3T3 cells. In addition, although growth factor-mediated PI3K- 
dependent actin reorganisation has been proposed to occur through cross-talk between 
PI3K and the Rho-family small GTPases, a master regulator of the actin cytoskeleton 
(see Introduction), the molecular mechanisms involved are poorly understood.
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The main aim of the research presented in this chapter was to establish a role for 
PI3K signalling in modulating actin cytoskeletal reorganisation in fly haemocyte cell 
lines, and to establish a model cell system that could be further used to delineate the 
signalling pathways downstream of PI3K that feed into the actin cytoskeleton, thereby 
to define possible common targets in both PI3K and small Rho GTPase signalling 
cascades. For these purposes, a series of experiments were conducted to assess the 
activation of PI3K signalling and actin cytoskeleton reorganisation induced by growth 
factor (insulin) treatment in the presence or absence of commonly used PI3K 
inhibitors in fly cells. One of the reasons for choosing fly haemocyte cells for this 
study is that very little is known about growth factor- and PI3K-mediated actin 
reorganisation in fly haemocytes in this system. Also, decades of study have revealed 
that D. melanogaster, which bears little resemblance to humans, nevertheless shares 
much of our genetic heritage and possess strikingly similar versions of the genes that 
promote normal human development and, when altered, contribute to disease. 
Moreover, numerous studies have demonstrated homology in the signalling and 
biochemical pathways between flies and humans. Fly cells also have a simpler 
genome, for example expressing only one gene for each class of PI3K. Finally, 
available molecular biology tools such as RNAi interference for knockdown of the 
expression of targeted genes are more easily employed in fly cells, facilitating specific 
and high-throughput functional analyses.
4.2 Insulin-dependent PI3K signalling
In order to test if PI3K signalling is linked to actin cytoskeleton remodelling in 
cultured Drosophila haemocyte cell lines, the first goal was to select an appropriate 
cell line and growth factor stimulus that can activate PI3K signalling. Three different 
Drosophila cell lines including S2R+, Kcl67 and S2 were used. These cell lines have 
distinct cell shape, size and adhesion properties. The properties and culturing 
conditions for these haemocyte fly cell lines are presented in Table 4.1.
Although these cell lines are apparently derived from embryonic haemocytes 
(insect blood cells), S2 and Kcl67 cells are small and round (10 pm diameter)
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(Schneider, 1972), whereas S2R+ (S2 receptor plus) cells (Yanagawa et al., 1998) are 
large (averaging 50 pm), flat and strongly adherent to glass, plastic and extracellular 
matrix. Staining the three cell lines for filamentous actin with rhodamine-phalloidin 
showed prominent differences in their actin organisation (Figure 4.1). S2R+ cells 
display large wide lamellipodia and thick cortical actin, whereas in S2 and Kcl67 
cells the actin is accumulated in the rounded cell body, and in a thinner cortical ring, 
with the S2 cells displaying more heterogenouse staining. All three cell lines were 
used to test the growth factor-mediated activation of PI3K signalling and further to 
test PI3K-dependent actin cytoskeleton reorganisation. However, S2R+ cells were 
mostly used in further studies due to their morphological properties, and knowing that 
there are a large number of distinct actin-related phenotypes that can be readily 
distinguished when gene silencing strategy, such as RNAi, is employed to these cells 
(Kiger et al., 2003).
Cell line nam e: K c167 S 2 S 2R +
Origin: DM d issociated  em bryos. 8-12h
DM dissociated em bryos, near 
hatching
DM dissociated em bryos, near 
hatching
Characteristics:
H em ocyte-like g en e  expression , 
phagocytic, uniformly round, clam p in 
sh e e ts , e cd yson e, respon sive into 
adherent, bipolar sp indle-shaped cells
H em ocyte-like g en e  
expression , phagocytic, sem i­
adherent in colonies, round, 
ganular cytoplasm
Hem ocyte like gen e  
expression, phagocytic, flat 
cells; Fz+ and W g-responsive
Growth media: Schnieder's Schnieder's Schnieder's and M3
Doublinq tim e (~23"C): Approx 24hrs Approx 24hrs 3-4 days
R ecom m ended splitting 
freouencv:
2 -3  days 2-3  days 2-3 days
R ecom m ended splitting 
dilution:
Split 1:4 Split 1 :4 Split 1:2
RNAi treatable: +++ +++ +++
Transfectable: ++ ++ +++
Motility: - - -
Adherence: Sem i-adherent Sem i-adherent Adherent
Table 4.1 Drosophila haemocyte cell line characteristics
S2R+ Kc167
Figure 4.1 F-actin staining of Drosophila haemocyte cell lines. Cells were fixed and stained 
for F-actin and nuclei with rhodamine phalloidin (red) and DAPI (green), respectively. 
Images were acquired on a fluorescence microscope using a 40x objective. Scale bar = 50 pm.
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Initially, to identify a suitable growth factor that can activate PI3K signalling, 
serum-starved S2R+ cells were stimulated with different purified or recombinant 
growth factors (10% foetal calf serum, bovine insulin, human EGF, mouse VEGF and 
human PDGF). These were chosen since they have been reported to activate PI3K 
signalling and to promote actin remodelling in different cell systems. Conditioned 
medium from cells grown for two days in serum-supplemented Schneider’s medium 
was also used to test whether there were any cell secreted (autocrine) factors that 
could promote activation of PI3K. The activation of PI3K signalling was assessed by 
immunoblotting for phosphorylation of Ser505 of Drosophila Akt, a homologous site 
to Ser473 in the C-terminal hydrophobic kinase tail of mammalian Akt, which is 
required for its activation (see Introduction). The immunoblotting revealed increased 
phosphorylation of Akt and indicated that activation of PI3K took place in response to 
bovine insulin alone (Figure 4.2). Insulin also stimulated the phosphorylation of 
Thr398 of Drosophila S6K, a homologous site to Thr389 of mammalian S6K, which 
is critical for release of the auto-inhibitory state of S6K, and allows phosphorylation 
of Thr229 at the catalytic domain of S6K and kinase activation (Pullen et al., 1998). 
The phosphorylation of Drosophila S6K at Thr398 and its activation is known to 
occur downstream of PI3K/Akt in response to insulin (Lizcano et al., 2003). A 
moderate increase in the phosphorylation of Drosophila ERK was also detected only 
under insulin treatment, suggesting activation of MAPK signalling. It was notable that 
the other growth factors (EGF, VEGF and PDGF) and FCS treatment did not promote 
phosphorylation of Akt or ERK, suggesting that these growth factors of non-fly origin 
cannot activate the respective Drosophila membrane tyrosine kinase receptors 
upstream of Akt, S6K or ERK in fly haemocytes, or possibly that homologous 
receptors are not expressed in these cells. There was no effect of conditioned medium 
on the phosphorylation of Akt, S6K and ERK suggesting that there are no factors 
secreted from the cells that have potency to activate PI3K or MAPK signalling.
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Figure 4.2 Investigation of mitogen-activated signalling in S2R+ cells treated with 
different growth factors. S2R+ cells were maintained in serum-free Schneider’s medium 
overnight (Ctrl), followed by stimulation with 10% foetal calf serum (FCS), condition 
medium (CM), bovine insulin (10 pg/mL), human EGF (200 ng/mL), human PDGF (125 
ng/mL) or mouse VEGF (50 ng/mL) for 30 min. After treatment, cells were washed with ice 
cold PBS and lysed in NP40 lysis buffer. Using immunoblotting, equal amounts o f protein 
lysates were probed for pSer505-Akt, pThr398-S6K and pThrl98/pTyr200-Erk. Membranes 
were stripped with 0.2 M glycine (pH 2) and re-probed for total Akt and p-actin as loading 
controls.
Insulin binds to the insulin receptor (InR), which possesses tyrosine kinase activity. 
This triggers auto-phosphorylation of the receptor on multiple tyrosine sites and 
downstream substrates with subsequent recruitment and activation of downstream 
targets such as PI3K. After establishing bovine insulin as an activator of signalling 
events in fly haemocytes, the induction of tyrosine phosphorylation by insulin was 
examined in S2R+ cells by immunostaining of fixed cells with anti-phosphotyrosine 
antibody (anti-pY20 Ab) (Figure 4.3). This staining revealed a signal that was 
heterogeneously dispersed throughout the cells before insulin treatment. Following 
insulin stimulation, the phosphotyrosine signal became rapidly localised to the 
membrane and is likely to correspond to the phosphorylation and activation of the InR 
and its immediate downstream targets. The staining was sustained at the membrane 
for around 30 minutes. After one hour of insulin stimulation, membrane staining had 
decreased dramatically with punctuate staining around the nucleus, suggesting that the 
signal of tyrosine phosphorylated proteins was internalised.
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Figure 4.3 Distribution of cellular phosphotyrosine in S2R+ cells following insulin 
treatment. Cells were plated into a 384-well plate and maintained in Schneider’s medium 
supplemented with 10% FCS, overnight. 10 pg/mL insulin was used to stimulate cells for 
different times. Cells were then fixed, permeabilised and blocked with 5% BSA in PBS for 
lh, followed by overnight incubation with mouse anti-pY20 antibody. Cells were then 
incubated with a secondary anti-mouse antibody conjugated with FITC (1:300). Images were 
acquired on a Nikon 2000E fluorescent microscope using a 40x objective.
To investigate in more detail the kinetics of insulin-induced PI3K activation in 
S2R+ cells, a time course of insulin stimulation was performed and Ser505 
phosphorylation of Akt was examined by immunoblotting. Insulin induced a rapid 
(within 2 minutes) phosphorylation of Akt that was sustained for the following 10 to 
15 minutes, before gradually declining (Figure 4.4). Phosphorylation of the 
downstream kinase S6K on Thr389 was also examined and displayed a delayed 
response compared to Akt. S6K phosphorylation increased gradually and remained 
elevated for up to two hours. This data confirmed that insulin is able to activate 
PI3K/Akt signalling and its downstream target S6K in S2R+ cells, although the 
kinetics of their activation is different.
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Figure 4.4 Time course of Akt and S6K phosphorylation in Drosophila S2R+ cells. S2R+ 
cells were maintained in serum-free medium overnight, followed by stimulation with 10 
pg/mL bovine insulin for the time points indicated. Cell lysates were immunoblotted with 
antibodies that recognise pSer505-Akt and pThr389-S6K. Membranes were then stripped and 
reprobed for total Akt and S6K.
Insulin-induced signalling was also examined in S2 cells. One set of S2 cells were 
maintained in serum-supplemented medium and another set were maintained in 
serum-free medium overnight, prior to insulin stimulation. Cell lysates from each time 
point were then subjected to immunoblotting for pAkt, pS6K and total Akt and S6K 
(Figure 4.5 A and B). In both cases, the phosphorylation of Akt was not detectable 
prior to insulin treatment. As seen previously in S2R+ cells, addition of insulin 
induced the rapid intense phosphorylation of Ser505-Akt in S2 cells. In both cases, 
phosphorylation of Akt was sustained at the later time points of stimulation when 
compared to insulin treatment in S2R+ cells, although the response appeared to be 
biphasic in the serum-starved cells. In both conditions there was a detectable 
phosphorylation of Thr389-S6K before insulin treatment, with the cells that were 
maintained in serum-free medium displaying a more delayed response to insulin 
stimulation. This may suggest that factors present in bovine serum, although not able 
to activate PI3K signalling on there own, can augment the insulin-induced activation.
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Figure 4.5 Kinetics of Akt and S6K phosphorylation in S2 cells stimulated with insulin.
A) S2 cells were maintained in serum-supplemented Schneider’s medium overnight, prior to 
treatment with 10 pg/mL insulin over a time course. B) S2 cells were maintained in serum- 
free Schneider’s medium for ~16 h prior to treatment with 10 pg/mL insulin over a time 
course. In both cases, cells were lysed in NP40 lysis buffer and lysates were analysed for 
pSer505-Akt and pThr389-S6K by immunoblotting. Membranes were reprobed for total Akt 
and S6K.
To exclude the constant triggering of Drosophila InR/PI3K signalling by insulin, 
which was present in the medium during the treatment, an experiment was performed 
where serum-starved S2 cells were treated with insulin for only one minute. The 
medium was then replaced with serum-free medium for the rest of the time course. In 
this experiment, the result from the immunblotting suggested that S6K and ERK were 
phosphorylated before the insulin treatment and prior to phosphorylation of Akt 
(Figure 4.6). This suggests that pThr398-S6K might not be directly dependent on Akt 
activation, and could be related to ERK signalling or be directly regulated through 
InR/PI3K/PDKl cascade as previously reported (Radimerski et al., 2002). A transient 
decrease of Akt phosphorylation was also observed as previously shown.
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Figure 4.6 Time course of phosphorylation of Akt, S6K and ERK in transiently 
stimulated S2 cells. S2 cells were maintained in serum-free medium overnight. Cells were 
treated with 10 pg/mL bovine insulin for one minute, followed by replacement of the medium 
with fresh serum-free medium and incubation of the cells for the time points indicated. Cell 
lysates were immunoblotted for pAkt, pS6K and pERK. Zero minute corresponded to the 
time before insulin treatment. Other time points indicate the time of incubation of the 
cells in serum-free medium after the insulin-containing medium had been replaced.
Analysis of insulin-dependent activation of PI3K signalling in fly cells was further 
extended by examining the localisation of pSer505-Akt in S2R+ by 
immunofluorescence staining (Figure 4.7). There was no detectable signal of 
pSer505-Akt in serum-starved cells prior to insulin addition. Adding insulin promoted 
membrane and cytoplasmic localisation of pSer505-Akt, with the most intense 
membrane staining detected after 10 minutes of treatment. This process most likely 
represents recruitment of Akt to sites on the membrane where PIP3 is generated and it 
follows observed insulin-induced phosphotyrosine staining of the membrane (Figure 
4.3). Interestingly, the signal of pSer505-Akt was also detectable in nuclei over the 
entire time course with insulin, but peaked at 10 minutes. Cells were stained in 
parallel for DAPI, to serve as a staining control and to detect nuclei.
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Figure 4.7 Immunostaining of pSer505-Akt in S2R+ cells stimulated with insulin. S2R+ 
cells were plated into a 384-well plate and maintained in serum-free Schneider’s medium 
overnight. Schneider’s medium supplemented with 10 pg/mL insulin was then added to the 
cells for the time points indicated. Cells were then fixed, permeabilised and blocked prior to 
incubation with anti pSer505-Akt antibody overnight at 4°C. For immunofluorescence 
detection o f pSer505-Akt, a secondary anti-rabbit antibody conjugated to FITC was used. 
Cells were also stained with DAPI to detect nuclei. Images were acquired on a Nikon 2000E 
fluorescent microscope using a 20x objective.
Localisation of pSer505-Akt following insulin stimulation was also examined in 
the less-adherent rounded Kcl67 cells. Serum-starved cells treated with insulin were 
subjected to immunofluorescence analysis using anti-pSer505-Akt and pY99 
antibodies. As with the S2R+ cells, the same phenomenon of membrane localisation 
of pSer505-Akt in response to insulin stimulation was observed (Figure 4.8). 
Membrane localisation of pSer505-Akt was detected after two minutes of insulin 
stimulation and remained for up to 40 minutes. Phosphotyrosine staining was more
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punctuated in the serum-starved cells, but displayed membrane localisation following 
insulin treatment, which remained for at least 40 minutes. DAPI staining was 
unaffected and served as a staining control for nuclei.
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Figure 4.8 Insulin-dependent Akt activation and tyrosine phosphorylation in Kcl67 
cells. Kcl67 cells were plated into a 384-well plate and maintained in serum-free Schneider’s 
medium overnight. Cells were stimulated with 10 pg/mL insulin over a time course. Cells 
were then fixed, permeabilised and blocked prior to incubation with anti pSer505-Akt and anti 
pY99 antibodies overnight at 4°C. For immunofluorescence detection of pSer505-Akt, a 
secondary anti-rabbit antibody conjugated to Cy5 was used, and for detection of pY99 a 
secondary anti-mouse antibody conjugated to FITC was used. Cells were also stained with 
DAPI to detect nuclei. Images were acquired on a Nikon 2000E fluorescent microscope using 
a 40x objective.
Taken together, these data show that insulin can promote membrane associated 
tyrosine phosphorylation in different Drosophila haemocyte cell lines and a parallel 
membrane associated activation of PI3K/Akt signalling with a delayed activation of 
the downstream target S6K.
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4.3 Insulin-dependent actin reorganisation
Following on from the finding, that insulin activates PI3K signalling in this 
system, the next step was to test if insulin would have an effect on the actin 
cytoskeleton in the Drosophila haemocyte cell lines. Most experiments were 
performed with S2R+ cells as they display morphological properties that could 
facilitate the examination of changes in the actin cytoskeleton induced by growth 
factor-mediated PI3K activation. For this purpose, serum-starved S2R+ cells were 
treated with bovine insulin over a time course and cells were fixed and stained for 
filamentous actin (F-actin) using rhodamine-phalloidin. Cells were also stained with 
anti-tubulin antibody, to assess any changes in the microtubule network, and with 
DAPI to stain nuclei. Images were acquired automatically and captured from eight 
replicates, with four different fields for each replicate. Thus, a total of 32 images were 
collected for each time point and each staining condition. This experiment revealed 
actin reorganisation following insulin stimulation. The most obvious change was an 
increase in F-actin staining at the cell cortex at the early time points (2-30 minutes) of 
the stimulation. By 60 minutes the cortical actin staining was lost and appeared as 
intense punctuated staining within the cell (Figure 4.9). Tubulin staining was 
relatively unaffected by insulin treatment up to 30 minutes, although at later time 
points there were some indications of reorganisation of microtubule network revealed 
by more condensed staining patterns.
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Figure 4.9 Insulin-dependent actin cytoskeleton reorganisation in S2R+ cells. S2R+ cells 
were plated into a 384-well plate in serum-free Schneider’s medium overnight. Cells were 
then treated with 10 pg/mL bovine insulin over a time course. Cells were then fixed, 
permeabilised and stained with rhodamine-phalloidin (1:1000), FITC-conjugated anti-tubulin 
antibody (1:300) and DAPI (1:2000) for 1 h. Images were collected automatically on a Nikon 
2000E fluorescence microscope, using a 20x objective.
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A statistical analysis of total pixel intensity for each time point on each channel 
(rhodamine-phalloidin, FITC and DAPI) was carried out using MetaMorph software. 
The pixel intensities at each time point (Figure 4.10) were used to calculate the ratios 
of F-actin/tubulin (TRITC/FITC) and F-actin/nuclear staining (TRITC/DAPI), which 
were then plotted against time of insulin stimulation (Figure 4.11). This analysis 
showed that there was no significant change in the level of total F-actin with insulin 
stimulation, suggesting that insulin only promotes F-actin reorganisation and re­
localisation, rather than altering the F-actin expression level.
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Figure 4.10 Graphical representation of the total pixel intensity for actin, tubulin and
nuclear staining in S2R+ cells stimulated with insulin. Total pixel intensities of 32 images 
for each time point and each staining condition were calculated using MetaMorph software 
and average values with standard deviation (SD) bars for each time point were plotted.
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Figure 4.11 Graphical representation of the ratio of F-actin/tubulin and F-actin/nuclear 
staining intensities in S2R+ cells stimulated with insulin.
129
Chapter 4
In addition to the S2R+ cells, Kcl67 cells were also used as a second cell model to 
test the effect of insulin on actin cytoskeleton reorganisation. Kcl67 cells, in general, 
have a different morphology than S2R+ cells, being more rounded with no cortical 
lamella. Kcl67 were starved overnight and then stimulated with insulin over a time 
course, followed by fixing and staining for F-actin (Figure 4.12). This experiment 
showed that even in rounded cells insulin promoted actin reorganisation, characterised 
by a transient increase in F-actin staining at the cell cortex, similar to that observed in 
S2R+ cells.
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Figure 4.12 F-actin staining of Kcl67 cells stimulated with insulin. Kcl67 cells were 
maintained in serum-free Schneider’s medium overnight and then stimulated with 10 pg/mL 
bovine insulin. Cells were fixed, permeabilised and then stained with rhodamine phalloidin 
(1:1000 in PBS, lh) for detection of F-actin. Scale bar = 50 pm.
To study time-dependent membrane dynamics related to insulin-mediated cortical 
actin reorganisation, S2R+ cells were also filmed by time-lapse microscopy before 
and after insulin stimulation. Snap-shots of the movie and a kymograph are presented 
in Figure 4.13, and are representative images from three independent experiments.
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Figure 4.13 Insulin induces intense membrane ruffling in S2R+ cells. S2R+ cells were 
plated onto uncovered glass-bottomed culture dishes and phase-contrast images were captured 
every 20 seconds before and after insulin stimulation using a time-lapse microscopy system, 
with a lOOx oil-immersion objective. Cell images are shown from the movie at the indicated 
time points with zero minute representing the time point of insulin addition. On the right is a 
kymograph showing the pixel intensities across a section of the cell membrane over the time 
course (indicated in black line in the first image). The kymograph was generated in 
MetaMorph software. The scale bar = 50 pm. (The figure is a representative from four 
independent experiments).
This time-lapse approach revealed that quiescent S2R+ cells display a low level of 
membrane ruffling characterised by dynamic protrusions and retraction of the cell 
edge which was increased in response to insulin treatment. This intense membrane 
ruffling is likely to be driven by insulin-dependent reorganisation of cortical actin.
4.4 PI3K-dependent actin reorganisation
Data from the previous sections showed that insulin activates PI3K signalling in 
Drosophila cell lines and results in actin cytoskeleton reorganisation in cells with 
different morphologies. In order to test if this insulin-induced actin cytoskeleton 
reorganisation is PI3K-dependent, several experiments were performed using the 
commercially available and widely used PI3K inhibitors LY294002 and wortmannin.
Firstly, the PI3K inhibitors were tested to see if they could block insulin-dependent 
activation of PI3K. This was monitored by immunoblotting for pSer505-Akt in S2R+
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cells. Concentrations of LY294002 (100 pM) and wortmannin (100 nM) were chosen 
based on previous published work in Drosophila cells, which showed that these 
concentrations could block PI3K activity in Kcl67 and S2 cells (Lizcano et al., 2003). 
Both LY294002 and wortmannin were able to block the insulin-dependent 
phosphorylation of Akt at Ser505 confirming previous observations (Figure 4.14).
Insulin
LY294002
Wortmannin
pSer505 Akt 
total Akt
+ + + 
+
+
m
Figure 4.14 PI3K inhibitors block insulin-dependent phosphorylation of Akt. S2R+ cells 
were plated at 80% confluence in Schneider’s medium supplemented with 10% FCS. After 
~16 hours, cells were pre-treated with 100 pM LY294002 or 100 nM wortmannin for 20 min, 
followed by 20 minutes treatment with 10 pg/mL bovine insulin. Cells were lysed in NP40 
lysis buffer, and lysates were subjected to immunoblotting for pSer505-Akt, followed by 
stripping blots and re-probing for total Akt.
To test whether actin cytoskeleton organisation is dependent upon PI3K in 
Drosophila haemocytes, S2R+ and Kcl67 cells were treated with LY294002 and 
wortmannin, before fixing and staining for F-actin with rhodamine-phalloidin (Figure 
4.15). It was evident that PI3K inhibition disrupted the normal actin structure of S2R+ 
cells as shown by a loss of cortical F-actin staining and with retraction of the cell 
edges leaving a few processes attached to the substrate. This was more evident in 
LY294002 versus wortmannin treated cells.
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Figure 4.15 F-actin staining of S2R+ cells treated with PI3K inhibitors. S2R+ cells were 
maintained in Schneider’s medium supplemented with 10% FCS before treatment with 100 
pM LY294002 or 100 nM wortmannin for 20 min. Cells were washed with PBS, fixed, 
permeabilised and stained for F-actin with rhodamine-phalloidin (1:1000 in PBS) for lh. 
Pictures were captured on a fluorescence microscope, using a 40x objective. Arrows indicate 
the spiked structures left at the cell edges following inhibitor-induced retraction. Scale bar = 
50 pm.
In K cl6 7  cells, the w ell-defined cortical actin ring was also disrupted in response 
to PI3K inhibition. Cells also displayed spiked structures at the cell edge in response 
to LY294002 (Figure 4 .16), but not in response to wortmannin.
LY294002 W ortmannin
Figure 4.16 F-actin staining of Kcl67 cells treated with PI3K inhibitors. Kcl67 cells were 
maintained in Schneider’s medium supplemented with 10% FCS before treatment with 
LY294002 (100 pM) or wortmannin (100 nM) for 20 min. Cells were fixed and permeabilised 
prior to F-actin staining with rhodamine-phalloidin. Pictures were captured on a fluorescence 
microscope using a 40 x objective. Scale bar = 50 pm.
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To test if insulin-dependent membrane ruffling was regulated by PI3K signalling, 
S2R+ cells were treated with PI3K inhibitors or DMSO vehicle prior to insulin 
stimulation and filmed using phase-contrast time-lapse microscopy (Figure 4.17). 
From the movies themselves and snap-shots taken at various time points, it was 
obvious that both inhibitors could block membrane ruffling in the cells. Generated 
kymographs confirmed that these inhibitors blocked virtually all dynamic protrusion 
of the membranes suggesting a role for PIP3 in the regulation of actin dynamics in 
cells at steady state. In addition, both induced a retraction of the cell edge, leaving 
processes attached to the substrate. The insulin-induced increased in membrane 
ruffling was also blocked by both inhibitors. There were, however, differences in the 
kinetics of the effects produced by the two inhibitors. Whereas both caused immediate 
inhibition of membrane ruffling; the cellular retraction, loss of cortical lamella and 
formation of spiked structures was delayed in LY294002-treated cells versus 
wortmannin-treated cells and did not occur until after insulin treatment.
Distance
Figure 4.17 Phase-contrast time-lapse movies of S2R+ cells treated with DMSO and 
PI3K inhibitors, LY294002 and wortmannin prior to insulin stimulation. S2R+ cells 
were plated onto uncoated glass-bottomed dishes in Schneider’s medium supplemented with 
10% FCS, overnight. Images for a movie were then captured every 10 seconds using a phase 
contrast time-lapse microscope with a lOOx oil-immersion lens. Cells were filmed for 5 
minutes prior to treatment with DMSO, LY294002 (100 pM) or wortmannin (100 nM) 
(labelled on the figure as -10’), followed by insulin (10 pg/mL) addition after a further 10 
minutes (labelled as O’). On the right are kymographs showing the pixel intensities across a 
section o f the cells (indicated by white lines in left-hand image). Kymographs were generated 
in MethaMorph software, and are representative from three independent experiments.
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Lower concentrations of LY294002 (10 and 50 pM) were also tested and showed 
that these concentrations of LY294002 could also block basal ruffling and cause 
cellular contraction. However, at these concentrations insulin-induced membrane 
spreading and ruffling was not prevented (Figure 4.18).
Figure 4.18 Time-lapse movies of S2R+ cells treated with LY294002 prior to insulin 
stimulation. S2R+ cells were plated onto uncoated-glass bottomed dishes in Schneider’s 
medium supplemented with 10% FCS, overnight. Images were captured every 10 seconds on 
a phase contrast time-lapse microscope using a lOOx oil-immersion lens. Cells were filmed 
for 15 min. prior to treatment with 10 pM LY294002 or 50 pM LY294002 and 10 minutes 
after this treatment insulin (10 pg/mL) was added for an additional 20 min. Kymographs were 
created in Metamorph software by drawing lines perpendicular to the cell membrane and 
pixel intensities along these lines combined across the time course.
Taken together, these data show that PI3K activity is required for actin 
cytoskeleton remodelling in response to insulin in fly haemocyte cell lines. This 
remodelling was characterised by increased filamentous actin staining and cell 
spreading at the cell cortex and an increase in the rate of membrane ruffling, although 
no directional cell movement was observed.
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4.5 Conclusions
The actin cytoskeleton participates in many cellular processes, including the 
maintenance of cell shape, coordinated cell movement and intracellular trafficking. To 
coordinate such a vast array of cellular functions, the actin cytoskeleton must be 
dynamic and adaptable, i.e. it must be able to adapt to rapidly changing conditions 
and external stimuli, such as exposure to mitogenic factors and hormones.
In an attempt to define a role for PI3K in regulating the actin cytoskeleton, 
Drosophila haemocyte cell lines were used as a model system to explore growth 
factor-dependent activation and kinetics of PI3K signalling and growth factor/PI3K- 
dependent actin cytoskeleton reorganisation in vitro. Several growth factors (insulin, 
EGF, PDGF, VEGF and calf serum) were tested in order to establish the best one to 
use to study PI3K-dependent actin cytoskeletal reorganisation. Western blotting for 
pSer505-Akt, an established downstream target of active PI3K, showed that EGF, 
PDGF, VEGF and calf serum did not promote the phosphorylation of Akt in S2R+ 
cells, suggesting that Drosophila EGFR and PVR, the fly homologues of mammalian 
VEGFR and PDGFR (Duchek et al., 2001; Cho et al., 2002), do not bind and respond 
to these non-fly growth factors. In addition, incubation of cells in conditioned medium 
did not result in Akt phosphorylation, suggesting that there were no autocrine growth 
factors secreted from cells, which were then able to activate tyrosine kinase receptor 
signalling and subsequently PI3K activation. Only insulin treatment was able to 
induce phosphorylation Akt at Ser505 site, suggesting that bovine and fly insulin are 
similar enough to trigger the Drosophila receptor, and confirming previous findings 
that the main activator of PI3K signalling in Drosophila haemocytes occurs through 
activation of the insulin receptor (InR).
InR is a tyrosine kinase that requires ligand binding for its activation and to 
promote autophosphorylation on tyrosines, which triggers activation of downstream 
signalling pathways that regulate glucose uptake, mitogenesis, growth etc. Activated 
InR is known to be internalised and then subjected to degradation or recycling that 
brings the receptors back to the plasma membrane (Di Guglielmo et al., 1998). In the 
study here, the activation of the receptor was indirectly followed by phosphotyrosine
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immunostaining in both S2R+ and Kcl67 cell lines. It was observed that prior to 
insulin stimulation the phosphotyrosine signal was distributed heterogeneously inside 
cells. In the early minutes of insulin stimulation this phosphotyrosine signal was 
dramatically increased at the cell membrane, suggesting phosphorylation and 
activation of the InR and its substrates were taken place. The phosphotyrosine signal 
was found to be sustained on the membrane for around 30 minutes, after which the 
staining became perinuclear, suggesting that translocation of the receptor to 
intracellular compartments has happening, and that it could be degraded or recycled, 
possibly through endosomes, to the cell surface as previously reported in other cell 
lines (Fehlmann et al., 1982; Carpentier et al., 1985).
PI3K is known to be a downstream target of activated receptor tyrosine kinase and 
is recruited into a signalling complex through interaction of the two SH2 domains of 
the regulatory subunit (p85) via the sequence motif pY-X-X-M (where X is any 
amino acid), which exist in receptor tyrosine kinases (i.e. InR) or their adaptor 
molecules (i.e. insulin receptor substrate, IRS). This reaction brings PI3K to the inner 
side of the plasma membrane where it can interact with its substrates, the 
phosphoinositides, leading to their phosphorylation on position 3’ of the inositol ring 
and the production of lipid second messengers such as PIP3. This is followed by 
recruitment of PH-domain containing molecules (such as Akt) to the membrane, 
which is a crucial step for their phosphorylation and activation (Chan et al., 1999). 
The kinetics of PI3K activation in S2R+ and Kcl67 cell was examined by following 
the phosphorylation of Akt and its cellular localisation. It was observed that the 
phosphorylated Akt signal was very low in either serum-starved or serum- 
supplemented randomly growing cells, but was rapidly induced upon insulin 
stimulation and became localised to the plasma membrane, presumably due to the 
generation of PIP3 by PI3K. My data reported here thus supports the previous 
findings in other cell systems.
The pAkt signal was also found to be increased in the nucleus in response to 
insulin, suggesting that nuclear translocation of phosphorylated Akt has taken place 
(Webster, 2004). This may be required for the phosphorylation of some Akt targets 
(e.g. forkhead transcription factors (FOXO), the transcriptional regulator Bcl-6 and
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the cell cycle regulators p27ICipl and p21Cipl/WAF1, which are nuclear. Recent reports 
showed that the role of pAkt in the nucleus could be to phosphorylate and inactivate 
its targets by promoting their translocation out of the nucleus and their accumulation 
in the cytoplasm (Webster, 2004). For example, when F0X03a is phosphorylated by 
Akt in the nucleus, it is expelled from the nucleus and sequestered in an inactive 
complex with 14-3-3, thus preventing transcription of pro-apoptotic genes such as 
Bim- and p27Kipl, and that promotes cell survival (Webster, 2004; Trotman et al., 
2006). In addition, Zhou et al. showed that a dominant negative Akt mutant (DN-Akt) 
inhibits cell growth due to nuclear localisation of p2iClpl/WAF1 (Zhou et al., 2001). 
They demonstrated that Akt normally associates with p2 iCipl/WAF1 and phosphorylates 
a consensus threonine residue (Thrl45) in its nuclear-localisation signal, leading to 
the cytoplasmic localisation of p2 iCipl/WAF1 and preventing it from inhibiting cell 
cycle progression and promoting cell proliferation. The analysis of PI3K/Akt 
activation in response to insulin stimulation in S2R+ cells showed that 
phosphorylation of Ser505-Akt peaked at the very early time points of the insulin 
stimulation and then gradually declined. Interestingly, a biphasic regulation of pAkt (a 
transient decrease followed by sustained increase) was induced by insulin in S2 cells, 
and was shown to be more prominent in serum-starved cells (Figure 4.5). This 
appears to be a novel observation in fly haemocyte cells, although a biphasic 
phosphorylation of Akt has been reported previously in other cell types (Nagano et 
al., 2001). However, it is unclear whether this represents a real cellular response that 
is relevant to signalling output, or a consequence of different extraction due to the re­
localisation of pAkt following growth factor triggering.
The activation of pS6K was also examined since it is known to be a downstream 
target of PI3K signalling through PDK1 (Williams et al., 2000), Akt (Lizcano et al., 
2003) and the mTOR/Raptor complex (Sarbassov et al., 2005). An antibody that 
recognises phosphorylated Thr389 (which is located in a hydrophobic sequence 
outside the catalytic domain) was chosen because phosphorylation of this site is 
known to lead to activation of S6K and phosphorylation of ribosomal protein S6 with 
concomitant up-regulation of translational capacity of cells including increased 
ribosome biosynthesis (Pearson et al., 1995). In the study here, only insulin induced 
the phosphorylation at this site of S6K, and this phosphorylation followed Akt and
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MAPK activation. The regulation of pS6K by PI3K/Akt and/or Ras/MAPK signalling 
is still unclear, but several studies have suggested possible cross-talk between these 
two signalling pathways. It was shown that PI3K can be activated through direct 
association with active GTP-bound Ras (Rodriguez-Viciana et al., 1997), perhaps 
through the Ras-binding domain of the catalytic subunit p i 10. Ras can activate 
PI3K in vitro, but its relevance for normal PI3K function in vivo has not been 
defined. Humans express two forms of S6K. Although it has been shown that S6K1 
can be phosphorylated in vitro by Ras/MAPK signalling (Mukhopadhyay et al., 
1992), it appears that S6K1 residues are distinctly recognised from the Ras/MAPK- 
dependent phosphorylation motifs (Ballou et al., 1991). On the other hand, S6K2, 
which is also regulated by PI3K and mTOR (Lee-Fruman et al., 1999), can be 
activated in vivo by MAPK (Wang et al., 2001). Both human S6K1 and S6K2 are 
more similar to each other than to the single S6K gene present in Drosophila. 
However, DS6K, like S6K2, contains a C-terminal proline-rich domain which may be 
involved in SH3 domain-mediated protein-protein interaction important in S6K 
signalling (Ballou et al., 1991). Here, I showed that DS6K can be activated by insulin, 
though the kinetics of activation compared with Akt (and ERK) activation varied 
depending on the conditions in which the cells were maintained. S6K activation was 
delayed in the absence of serum, suggesting serum factors may prime the activation in 
response to insulin. As both ERK and Akt were activated by insulin, the relative 
contribution of MAPK and PI3K signalling to S6K activity is unknown, and further 
studies will be required to address this signalling event.
After I established the process of insulin-dependent activation of PI3K signalling 
in the Drosophila haemocyte cell models, I then examined the effect of the InR/PI3K 
signalling cascade on the actin cytoskeleton. One of the early events in the insulin 
response is the reorganisation of actin filaments and two types of insulin-dependent 
morphological changes in actin filaments have been described, depending on the cell 
type studied: an increase in actin stress fibre formation, dynamic polymerisation and 
depolymerisation of actin below the plasma membrane, more commonly referred to as 
‘membrane ruffling’ (Goshima et al., 1984b; Ridley and Hall, 1992a). It is well 
established that insulin rapidly induces actin remodelling in a variety of cell types 
including HeLa cells (Goshima et al., 1984a), Rat-1 fibroblasts and CHO cells
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overexpressing the insulin receptor (Knight et al., 1995; Clodi et al., 1998) and Swiss 
3T3 fibroblasts (Ridley et al., 1992a; Ridley et al., 1992b). However, no such reports 
exist for fly haemocytes, widely used in studying the role of the insulin/PI3K 
signalling, particularly in regulating proliferation, cell size, survival and metabolism 
(Leevers et al., 1996; Weinkove et al., 1999; Franke et al., 2003). Only recently, a 
study on fly migratory haemocytes in vivo showed that PI3K is an essential mediator 
for cell polarisation and directed cell migration (Wood et al., 2006). This study 
showed although haemocyte cells can sense a chemotactic gradient from 
PDGF/VEGF ligands Pvf2 and Pvf3, these directed migrations occur independently of 
PI3K signalling. Confocal analysis of embryos expressing a dominant-negative kinase 
dead form of the D. melanogaster PI3K catalytic subunit (Dpi 10D954A), specifically 
in haemocytes, showed normal haemocyte distribution at all stages of development, 
and these cells appeared morphologically indistinguishable from their wild-type 
counterparts exhibiting dynamic lamellipodia and filapodia formation. However, 
PI3K was required for haemocytes to polarise and chemotax toward a laser-ablated 
wound site and in the mutant-expressing embryos, wounds remained largely 
undetected by the haemocytes. In addition, implantation of DMSO- or LY294002- 
presoaked beads into the embryos showed that DMSO beads became surrounded by 
haemocytes, whereas no cells chemotaxed toward the beads soaked in the PI3K 
inhibitor.
Herein, I showed that PI3K signalling can contribute to actin organisation in fly 
haemocytes in vitro and that this occurs both basally and in response to growth factor 
(insulin) stimulation. I used a time course of insulin stimulation and statistical 
analysis of filamentous actin staining to reveal that whilst the total level of F-actin 
staining did not change dramatically with the treatment, there was a rapid increase in 
F-actin staining at the cell cortex that remained for 30 minutes. This was followed by 
a dramatic reorganisation of cytoskeletal structures, both of F-actin and microtubules, 
observed as a loss of cortical actin lamellipodia and microtubule condensation. Since 
F-actin reorganisation followed the kinetics of insulin-dependent Akt activation, this 
suggested to me that cytoskeletal reorganisation might be PI3K-dependent in this cell 
model. To test this, I used LY294002 and wortmannin to examine the effects of PI3K 
inhibition on actin reorganisation in response to insulin. Treatment with both
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inhibitors resulted in disruption of cortical actin and efficiently blocked basal- and 
insulin-induced membrane ruffling. This was accompanied by apparent retraction of 
the cell edges resulting in loss of cortical lamellipodia and in generation of spiked 
structures that were relatively devoid of F-actin. There were, however, differences in 
the kinetics of the cell retraction caused by LY294002 and wortmannin. The observed 
difference in inhibitor efficiency could have been due to the different solubility of the 
drugs, the time taken for the drugs to enter cells and reach their targets, the half-life of 
the inhibitors and their target specificity. Moreover, for LY294002 at least, there was 
a dose-dependent response for blockade of insulin-dependent membrane ruffling; 
high concentration of LY294002 (100 pM) blocked both basal and insulin-dependent 
membrane ruffling, whereas only basal ruffling was blocked when cells were pre­
treated with lower doses of LY294002 (10 or 50 pM). Although wortmannin and 
LY294002 have served as powerful tools for implicating PI3Ks in a wide range of 
physiological processes, and much of our understanding of PI3K action in cells 
derives from the use of these two reagents, they are broadly active against the whole 
PI3K family showing little specificity among members. In addition, they also appear 
to target other kinases such as GSK-3, CK II, and non-kinases (Gharbi et al., 2007). 
Consequently, little is known about the specific signalling functions of individual 
PI3Ks and further work could include the use of class specific PI3K inhibitors. 
Indeed, Knight et al. used a set of new generation PI3K class-specific inhibitors to 
define the PI3K isoforms required for insulin signalling (Knight et al., 2006). They 
identified pi 10a as the critical lipid kinase required for insulin signalling in 
adipocytes and myotubes, whereas pllOP and pi 108 played a secondary role in 
insulin signalling in these cells. They also showed that compounds targeting pi 10a 
blocked the acute effects of insulin treatment in vivo, whereas a pi 1 Op inhibitor had 
no effect. These results illustrate the use of a systematic target validation approach 
employing a panel of inhibitors that span a protein family. However, these inhibitors 
have not been tested in fly cells or their specificity towards Drosophila PI3K 
determined. This area could be the subject of future work. Another approach for 
examining the role of specific molecules in signalling is to employ RNAi-mediated 
gene silencing. I used this approach in the next chapter to further explore the role of 
PI3K and other signalling molecules in regulating the actin cytoskeleton.
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The physiological role of insulin-triggered cytoskeletal re-arrangements is not 
completely clear. Although it may be involved in stimulating glucose up-take by 
promoting GLUT-4 (glucose transporter) insertion at membrane ruffles in some cell 
types (Khayat et al., 2000), it is also possible that the actin reorganisation itself is 
permissive for other actions of insulin such as signalling, DNA synthesis and gene 
expression. In addition, PI3K-induced changes in the actin cytoskeleton can be related 
to some physiological roles of PI3K signalling in fly haemocyte cells such as 
phagocytosis. Fly haemocytes have been reported to be phagocytic (Ramet et al., 
2002). Phagocytosis is an essential component of the innate immune response that 
involves extensive cytoskeletal rearrangement and membrane remodelling (Aderem 
and Underhill, 1999). PI3K activity is known to be required for effective phagocytosis 
(Araki et al., 1996; Gillooly et al., 2001; Allen et al., 2005). For instance, Allen et al. 
showed that ulcerogenic (type I) strains o f Helicobacter pylori (Hp) strongly activated 
class Ia PI3K in macrophages, a process which can coincident with phagocytosis, and 
caused endogenous p85 and active Akt accumulation in forming phagosomes. In 
addition, they observed that wortmannin and LY294002 inhibited phagocytosis in a 
dose-dependent manner, and blockade of engulfment correlated directly with loss of 
PIP3 in the membrane adjacent to the attached bacteria. In this study, it was also 
shown that PIP3 regulated actin polymerization at sites of Hp uptake. Further 
examinations would be required to show if PI3K-mediated actin cytoskeleton 
organisation and membrane ruffling are required for phagocytosis in fly haemocytes 
in vitro.
In conclusion, the work I presented in this chapter of my thesis has shown that 
PI3K signalling in fly haemocyte cells in vitro can be triggered by insulin and the 
kinetics of activation of downstream targets depends on the existing growth 
conditions. Also, dual regulation of p70S6K by PI3K/Akt and Ras/MAPK as a 
mechanism was implicated, and these pathways are an area for further research. In 
addition, I established that activation of the insulin receptor signalling pathway can 
cause dynamic actin reorganisation, which is blocked by PI3K inhibitors and is 
therefore PI3K-dependent. So most importantly, I developed a cell model system for 
further examination of the mechanisms involved in PI3K-dependent actin regulation 
using RNAi and proteomics, the focus of the following chapter.
142
Chapter 5
Chapter 5: Functional proteomic analysis of PI3K signalling 
and actin regulation in D r o s o p h i l a  cells
5.1 Introduction
Work from the previous chapter, showed that PI3K signalling is involved in 
insulin-stimulated actin cytoskeleton remodelling and that this signal specifically 
initiates new cortical actin polymerisation in Drosophila haemocyte cell lines. The 
aim of the work I present in this chapter was to identify possible downstream targets 
of this PI3K activity and to study their molecular function. To study this I used a 
combination of technologies, RNAi-dependent gene silencing, 2D-DIGE global 
protein expression profiling and cellular phenotype analysis by fluorescence 
microscopy.
Initially, a 2D-DIGE analysis experiment was performed using Drosophila cell 
lines with different morphologies to establish culturing conditions, such as generating 
sufficient amounts of protein, needed for protein expression profiling. In addition, this 
experiment was also designed to examine the feasibility of matching protein changes 
with cellular phenotype, particular cellular morphology among cells with different 
morphologies.
The main aim was then to perform proteomic analysis of S2R+ cells following 
RNAi knockdown of specific genes involved in the PI3K signalling and actin 
cytoskeletal regulation (Kiger et al., 2003). The RNAi strategy was applied with the 
aim of overcoming some of the limitations of PI3K drug treatment, such as hidden 
target specificity (Brunn et al., 1996; Bain et al., 2003), but also to extend the
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functional analysis of putative downstream targets of PI3K. RNAi is a sequence- 
specific, post-transcriptional, gene silencing process mediated by short interfering 
RNA (siRNA) molecules (see Chapter 1). In this study, RNAi was applied to silence 
the expression of genes that are involved in PI3K signalling and cytoskeleton 
regulation, and it was carried out in a model Drosophila cell line. Several factors 
make RNAi in Drosophila cell lines an excellent approach for functional genomic 
studies. Firstly, the complete genome sequence of Drosophila melanogaster has been 
mapped (Adams et al., 2000), and the well-annotated Drosophila genomic sequences 
have simplified the design of gene-specific double-stranded RNAs (dsRNAs) for 
knockdown of expression of specific genes. Secondly, RNAi is extremely efficient in 
Drosophila cells, facilitating partial to complete knockdown in 98-100% of cells. 
Thirdly, RNAi in fly cells is a very simple technique, as it requires simple addition of 
the dsRNA to the culture medium without the need for expensive transfection 
reagents. Finally, Drosophila has been a favoured tool for genetic studies for over 100 
years and is an excellent model in which to identify genes involved in cellular and 
developmental processes. It is furthermore remarkable that the Drosophila genome 
encodes homologues of over 60% of human disease genes and also lacks much of the 
genetic redundancy observed in vertebrates (Rubin et al., 2000).
Quantitative proteomic analysis of selective RNAi knockdowns was carried out 
using 2D-DIGE to define protein profiles for each RNAi treatment. Mass 
spectrometry was used to identify differentially expressed proteins. In this way novel 
downstream targets of PI3K and regulators of actin could be identified. Overlapping 
sets of protein expression changes among the different RNAi treatments were then 
subject to further analysis, which will aim to carry out pathway mapping. 
Immunoblotting analyses were used to confirm the results of the 2D-DIGE and MS 
analyses. Finally, immunofluorescence microscopy was performed to study 
morphological changes and actin reorganisation in cells subjected to the different 
RNAi treatments, and to try to link these changes with the observed changes in the 
proteome.
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5.2 Evaluation of 2D-DIGE for comparative analysis of protein 
expression profiles in Drosophila cell lines displaying distinct 
morphological phenotypes
Initially, a pilot experiment was performed aimed at establishing culturing 
conditions for the Drosophila cells needed to generate sufficient amounts of protein 
for 2D-DIGE expression profiling. Four different fly cell lines (S2R+, Kcl67, S2 and 
Clone 8) were used and their protein expression profiles were generated by 2D-DIGE, 
followed by comparative protein abundance analysis. S2R+, S2 and Kcl67 cells have 
been reported to display haemocyte cellular properties (Schneider, 1972). As 
described previously, S2R+ cells are phagocytic, adherent and flat cells. S2 cells grow 
in semi-adherent colonies and display a rounded morphology with a granular 
cytoplasm. Kcl67 cells are also phagocytic and uniformly round. Clone 8 cells were 
derived from the wing disc, they are semi-adherent, elongated and can grow in 
multiple layers (Peel et al., 1990). Thus, this experiment was designed to examine the 
feasibility of matching protein changes with cellular phenotype, particular cellular 
morphology.
The four cell lines were plated at ~1.5x 106 cells/mL in 6-well culture dishes, and 
maintained in the appropriate fly medium supplemented with 10% FCS until they 
reached confluence. To test for method reproducibility, cells were grown as triplicate 
cultures, which were analysed separately (biological replicates). Cells were lysed and 
an equal amount of total protein lysate (100 pg) from each sample was labelled with 
Cy3 or Cy5 dyes. In parallel, a pool was prepared by mixing an equal amount of 
protein from each sample and was labelled with Cy2 (Figure 5.1). Protein lysates 
labelled with Cy3 and Cy5 from different cell lines were mixed appropriately on 
different gels to avoid biases (Figure 5.1). Cy2-labelled pool was run on each gel to 
serve as an internal standard to facilitate spot matching, as it is comprised of all 
proteins from the four different samples used in the analysis, data normalisation 
across gels in one run and quantitation across the gels (Figure 5.1). The six gels were 
scanned at three different wavelengths (Chapter 2, Table 2.2) to generate 18 protein 
spot maps.
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Figure 5.1 Experimental design of NHS-Cy dye labelling to compare protein expression 
profiles of four different Drosophila cell lines by 2D-DIGE. S2R+, S2, Kcl67 and Clone 8 
cells were grown in triplicate cultures until fully confluent and then lysed in NHS-lysis buffer. 
Equal amounts o f protein lysate (100 pg) were labelled with 400 pmol of Cy3 (red plates) or 
Cy5 (blue plates). A Cy2-labelled internal standard (yellow) was prepared by mixing equal 
amounts of each protein lysate. Cy3 and Cy5 labelled samples were then mixed appropriately, 
including the Cy2 internal standard in each mixture. Mixed samples were then run on six 
individual 2-D gels and fluorescent images captured. The figure shows the labelling strategy 
and superimposed images generated for the six gels (from Image Quant software). Changes in 
expression o f specific proteins are shown as green (up in Cy3 channel), red (up in Cy5 
channel) and blue (up in Cy2 channel).
Quantitative comparison o f  protein expression and differential analysis was carried 
out using DeCyder software. Triple images obtained from the same 2D gels were 
automatically curated and matched using the differential in-gel analysis (DIA) module
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of DeCyder, since the images are directly superimposable. DIA was used to estimate 
the protein spot number on each gel (Figure 5.2). The matched images were then 
imported into the biological variance analysis module (BVA), where protein spots 
from a selected master gel (Figure 5.3) were matched with the corresponding spots 
across the other gel images.
Log Volume Ratio
Figure 5.2 Differential image analysis using DeCyder software. A) A scatter plot of spot 
volumes and number versus volume ratio is shown with the threshold ratio set at +/-1.5 (+/- 2 
SD) (vertical lines). White spots represent matched protein features displaying no changes in 
abundance between two protein samples run on the same 2-D gel. Red spots represent 
features from one sample with an increased volume ratio compared to their counterparts from 
the other sample, while blue spots represent features with decreased volume ratios. B) 
Representative 2D-DIGE image extracted from DIA showing protein features with similar 
(white), increased (red), and decreased (blue) volume ratios between two samples run on the 
same gel. C) Cy3 and Cy5 separated gel images. Protein features displaying a fold-change in 
abundance >1.5 fold or < -1.5 are circled red (increased) and blue (decreased), respectively.
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Figure 5.3 Master gel image used in the biological variance analysis (BVA) module of 
DeCyder. Best resolved gel 1 was selected as the master gel for BVA analysis as it displayed 
the most protein features. This figure represents the overlaid fluorescent images derived from 
S2 and Kcl67 lysates labelled with Cy3 (red) and Cy5 (blue) respectively, prepared using 
Adobe Photoshop. Protein molecular weight markers were resolved on the right hand side of 
the gel.
A total of 1930 features were detected on the master gel. Image analysis and 
statistical evaluation of differences between the four cell lines revealed many protein 
features that displayed differential expression (> 1.5 or a < -1.5 average-fold change 
in abundance; p<0.05, n=3). This showed that the cell lines are very different in 
terms of their expressed proteomes. The number of common proteins differentially 
expressed between each of the three haemocyte cell lines is presented as a Venn 
diagram (Figure 5.4). A total of 54, 87 and 90 protein isoforms, of which 17, 17 and 
13 unique protein spots, were found differentially expressed when the ratios of the 
protein abundances were compared between S2R+ and S2, Kcl67 and S2, and S2R+ 
and Kcl67 cells, respectively. Thus it would appear that the S2R+ and S2 cells are
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similar, which is perhaps not surprising since the S2R+ cell line was cloned from the 
S2 cell line. The overlap between the comparisons on the Venn diagram represents the 
number of common protein species whose abundances were changing significantly 
between the corresponding comparisons. For instance, 9 common protein species 
were differentially expressed in S2R+ and Kcl67 cells, respectively, when compared 
to the their counterparts in S2 cells; 49 common protein species were differentially 
expressed in S2 and S2R+ cells, respectively, when compared to the their counterparts 
in Kcl67 cells; 16 protein species were differentially expressed in S2 and Kcl67 
cells, respectively, when compared to the their counterparts in S2R+ cells. 12 out of 
1930 protein features displayed significant differences in abundance among all three 
haemocyte cell lines.
S2/S2R+
49 Kc167/S2Kc167/S2R+
Figure 5.4 Venn diagram showing the number of differences expressed and overlapping
protein spots between three haemocyte cell lines. The ratio in abundance of each protein 
feature was calculated between each haemocyte cell line that displayed a >1.5 or a < -1.5 
average-fold changes in abundance (p<0.05). The overlap of the three comparisons in the 
ratios of protein abundances (Kcl67/S2R+, S2/S2R+ and Kcl67/S2) represents the common 
protein features differentially expressed in all three comparisons. The overlap between each 
two comparisons represents only protein species differentially expressed in one cell line 
compared to the other two cell lines.
Clone 8 cells were found to display an even greater number of differentially 
expressed proteins when compared with each haemocyte cell line (Figure 5.5). 59 
protein features were significantly differentially expressed in Clone 8 cells compared 
to all haemocyte cell lines. In addition, there were 14, 18 and 53 protein features 
differentially expressed in Clone 8 cells compared to S2, Kcl67 and S2R+ cells, 
respectively. The other overlaps in the sections represent the number of common
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protein species differentially expressed in Clone 8 when compared to the two 
corresponding haemocyte cell lines.
Kc167
Figure 5.5 Numbers of Clone 8-specific differentially expressed protein features 
compared to fly haemocyte cell lines. Number of protein spots in Clone 8 showing a > 1.5 
or a < -1.5 average-fold change, (p<0.05, n=3) versus haemocyte cell lines: S2, S2R+ and 
Kcl67.
The highly abundant differentially expressed protein spots were subjected to 
MALDI-TOF MS analysis. Gels were stained with CCB and protein spots were 
excised from gels and subjected to trypsin digestion and MALDI-TOF MS analysis. 
Since the number of protein features differentially expressed was so high it could be 
argued that these protein expression changes are unlikely only to reflect differences in 
the morphologies of the cells alone. Indeed the identification for some of the abundant 
proteins showed these to be mainly enzymes involved in redox homeostasis (slow 
superoxidase dismutase, cytosolic thioredoxin peroxidase variant 2, glutathione-S 
transferase E2) and co-factors involved in protein transcription and translation 
(EFlbeta, eIF-5A, CG5224, 40S ribosomal protein SI2, bicaudal-transcription factor) 
(Table 5.1). Two actin-binding proteins: cofilin and annexin B9a, were also 
differentially expressed between cell lines. Two isoforms of cofilin were identified, 
and both were found to be significantly downregulated in S2R+ flat adherent cell line, 
when compared to cell lines with rounded morphologies (S2 and Kcl67). In addition 
to this, in Clone 8 cells acidic and basic isoforms of cofilin were significantly 
downregulated and upregulated, respectively, when compared to their counterparts in 
the haemocyte cell lines S2R+ and S2 cells. Both cofilin isoforms were significantly 
downregulated in Clone 8 cells when compared to their counterparts in Kcl67 cells 
(Table 5.1, Appendix 2).
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S2R+/KC167 S2/S2R+ Kc167/S2 S2R+ S2 Kc167
Spot
No.
Name NCBI No. Pi
(pred)
MW
(pred)
Seq. Cov 
(%)
Score
p=0.05
No.
Peptides
Av.
Ratio
T-test Av. Ratio T-test Av. Ratio T-test Av. Ratio T-test Av. Ratio T-tesf Av. Ratio T-test
1610 AnnexinB9a 10121901 4.77 36302 24 165/59 17 1.77 0.00092 1.04 0.78 1.7 0.0064 *1.59 0.0089 -1.53 0.027 1.12 0.27
1632 CG31196, 14-3-3E 23171618 4.74 29326 65 169/59 18 -1.07 0.34 1.34 0.028 1.25 0.081 -1.11 0.11 •1.51 0.00075 -1.19 0.052
1768 CG1519, Proteasome a7 subunit 7303843 5.46 27772 65 162/59 17 1.35 0.00005 -1.08 0.45 1.51 0.018 -1.02 0.92 -1.1 0.53 1.32 0.038
1782
EF-1-beta and EF-1-delta stimulate the 
exchange of GDP bound to EF-1-alpha to GTP
3757564 4.4 24289 54 104/59 12 -1.63 0.00028 -1.37 0.00067 -1.19 0.021 1.32 0.00042 -1.01 0.89 -1.2 0.015
1811 CG5224, translational initiation 21428462 5.57 25363 38 74/59 7 1.16 0.067 -1.13 0.22 1.31 0.055 -2.86 0.00005 -3,22 0.00028 -2.45 0.00028
1824
CG1404,ran, GTPase activity, GTP binding, 
protein binding
28317119 7.66 24921 72
205/59 18 1.24 0.074 -1.47 0.025 1.83 0.0043 1.64 0.11 1.11 0.59 2.04 0.045
1832 CG17523, Glutathione S transferase E2 19922528 5.39 25440 33 80/59 9 1.27 0.035 -1.21 0.46 1.55 0.19 -1.53 0.042 -1.86 0.12 -1.2 0.24
1841 Cytosolic thioredoxin peroxidase variant 2 12744791 5.52 21952 44 101/59 10 1.79 0.092 1.36 0.29 1.32 0.38 -4.12 0.00083 -3.03 0.00012 -2.3 0.013
1857
similar to CG3644, bicaudal, regulation of 
transcription from RNA polymerase II promoter
21627285 6.85 17727 48 76/59 6 1.33 0.005 -1.44 0.00037 1.92 0.00038 -1.02 0.49 -1.47 0.00075 1.36 0.09
1874
CG4254, Cofilin, actin severing and 
depolymerisation 7291724 6.74 17428 82 96/75 18 -2.85 0.00003 2.48 0.00016 -7.07 0.00001 -2.07 0.00021 -1.2 0.079 •5.9 0.00001
1875 elF-5A, translational initiation 21626716 4.98 17922 49 64/57 8 -7.07 0.00001 1.41 0.0026 -2.36 0.0003 -1.15 0.055 1.62 0.0018 -1.46 0.0069
1882
CG4254, Cofilin, actin severing and 
depolymerisation 7291724 6.74 17428 68 78/59 19 -3.28 0.00002 1.36 0.0005 -4.45 0.00001 2.11 0.00005 2.86 0.00001 -1.56 0.0012
1885 Slow superoxide dismutase 4572573 5.68 15200 52 86/59 7 -2.03 0.00003 12 0.014 -2.03 0.00003 2.08 0.00005 2.5 0.00005 1.24 0.00001
1892 40S ribosomal protein S12 902622 7.1 16970 62 138/59 10 -1.03 0.56 -1.28 0.012 1.24 0.011 1.14 0.056 -1.47 0.29 -1.18 0.018
1894 Cyclophilin 1 33589296 8.43 18067 86 175/59 16 1.81 0.0086 1.62 0.0076 1.08 0.37 -1.76 0.00099 -1.09 0.29 -1.01 0.75
1902 RH27794p 21064703 7.82 17216 60 61/57 13 1.26 0.019 1.3 0.02 -1.03 0.69 -1 6 2 0.0027 -1.24 0.064 -1.29 0.032
Table 5.1 2D-DIGE protein expression analysis of Drosophila cell lines with different morphologies and MS-based protein identifications. Protein 
features displaying differential expression are shown. Values are average ratios of abundance between different cell lines (S2R+/Kcl67, S2R+/S2, 
Kcl67/S2, Clone 8/S2R+, Clone 8/S2 and Clone 8/Kcl67). T-test p  values are given as a measure of confidence for each ratio measured. Values for protein 
isoforms shaded in light and dark grey were significantly up- and down-regulated (>1.5 fold; p< 0.05; n=3), respectively. Proteins were identified by 
MALDI-TOF peptide mass fingerprinting. Protein name and/or Drosophila annotation ID, NCBI accession number from database searches, sequence 
coverage (%). database search score and number of matched nentides are given for each of the identified proteins.
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As this analysis represents only a snap shot of the protein expression that could 
occur in each cell line, it is hard to link the differentially expressed or cell line- 
specific proteins to certain biological functions and cell properties with greater 
assurance. There were no obvious patterns or links to indicate altered morphology or 
other cellular processes. For these reasons further protein identification by mass 
spectrometry of the differentially expressed proteins was not carried out. Most 
importantly, this experiment provided a baseline of the growth conditions and Cy-dye 
labelling conditions for further analysis of fly proteins by 2D-DIGE.
5.3 Functional genomic and proteomic analysis of PI3K signalling 
and actin regulation in S2R+ cells
One of the main aims of this work was to carry out a functional proteomic and 
genomic analysis of RNAi-treated S2R+ cells as a method to identify PI3K-dependent 
protein targets that act as morphology modifiers. Taking into account that PI3K 
signalling induces actin reorganisation in S2R+ cells and that this PI3K-dependent 
modification of the actin cytoskeleton could be achieved through interaction of 
selected genes with small GTPases of the Rho-family (see Chapter 1), selected genes 
of the PI3K and small GTPase signalling pathways were targeted for knockdown of 
their protein expression using RNAi strategy. Protein expression in these knockdowns 
was quantified and compared using the 2D-DIGE platform, in combination with mass 
spectrometry, for protein identification. An additional goal was to correlate protein 
expression changes resulting from perturbation of these signalling pathways with 
phenotypic changes (cell morphology, actin cytoskeleton organisation and cell size) 
resulting from RNAi knockdown. The identification of common targets was carried 
out as it could assist in mapping the signalling pathways involved, and possibly reveal 
nodes of signalling cross-talk. This study was performed on S2R+ cells, because of 
their morphological properties and their potential to reorganise actin cytoskeleton in 
response to acute activation of PI3K signalling, and also a large number of distinct 
actin-related phenotypes can be distinguish when RNAi strategy is used, as reported 
by Kiger et al. 2003.
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5.3.1 2D-DIGE experimental design
2D-DIGE analysis was used to compare protein expression profiles of total cell 
lysates from control untreated S2R+ cells and knockdowns treated with interfering 
dsRNAs for selected genes involved in PI3K and Rho-family small GTPase 
signalling. Two separate experiments were performed, due to the fact that there is a 
limitation in the number of 2D gels that can be run in a single experiment. In the first 
experiment Racl plus Rac2, Cdc42 and Arp3 were targeted for RNAi-mediated 
silencing (Table 5.2 A). These genes are known to be involved in actin polymerisation 
and formation of lamellipodia (Kunda et al., 2003). In the second experiment, pi 10 
(the catalytic subunit of PI3K), PTEN, Akt, Ras, Abi plus Hem, cofilin and GFP were 
targeted (Table 5.2 B). GFP would serve as a control to examine possible “off-target” 
effects of the RNAi treatment itself. Cofilin was actually chosen for the second 
experiment since it was identified as a differentially expressed protein in the first 
experiment, and it is known to regulate actin cytoskeleton organisation. Abi and Hem 
were selected based on their involvement in regulation of actin polymerisation 
(Bogdan and Klambt, 2003).
To assess reproducibility in both experiments, each RNAi condition was analysed 
as biological triplicates, meaning that cells were plated and treated with the 
corresponding dsRNAs in three separate cultures, which were grown and prepared 
independently. Cells were treated with dsRNAs and maintained in 10% serum- 
supplemented medium for five days to allow knockdown of expression before 
harvesting. Equal amounts of proteins from each RNAi condition were then labelled 
with Cy3 or Cy5. A standard pool was also prepared by mixing equal amount of 
proteins from each condition and labelled with Cy2. Labelled protein samples and 
standard pool were mixed appropriately (Table 5.2 A and B), and run on 24 cm, pH 3- 
10, non linear IPG strips in the first dimension, followed by separation of the proteins 
by 12% SDS-PAGE in the second dimension.
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A
Gel No Gel 01 Gel Gel 03 Gel 04 Gel 05 Gel 06
Cy dye 02
Cy3 Ctrl Ctrl Arp3 Rac1+Rac2 Cdc42 Cdc42
Cy5 Rac1+Rac2 Arp 3 Rac1+Rac2 Cdc42 Ctrl ArP3
°y?....
B
Gel No Gel 01 Gel Gel 03 Gel 04 Gel 05 Gel 06
Cy dye 02
Cy3 Ctrl Ctrl p110 p110 Abi+Hem Abi+Hem
Cy5 Ras PTEN PTEN Cofilin Cofilin p110
Gel No Gel 07 Gel Gel 09 Gel 10 Gel 11 Gel 12
Cy dye 08
Cy3 Ras Ras PTEN Cofilin Akt GFP
Cy5 Abi+Hem Akt Akt GFP GFP Ctrl
Table 5.2 Experimental design for 2D-DIGE analysis of RNAi-treated cells A) 2D-DIGE 
protein expression comparison o f RNAi treatments Racl plus Rac2, Cdc42 and Arp3 with 
untreated cells. The table shows labelling o f triplicates from each condition with Cy3 or Cy5, 
including the Cy2 labelled pool run on each gel. B) 2D-DIGE protein expression comparison 
of RNAi treatments pi 10, PTEN, Aktl, Ras85, Abi plus Hem, Cofilin and GFP with 
untreated cells. The table shows the combination o f Cy3 and Cy5 labelled sample triplicates 
run on each gel, including the Cy2 labelled pool.
In the first 2D-DIGE experiment three different RNAi treatments (Arp3, Racl plus 
Rac2 and Cdc42 RNAi knockdowns) prepared as triplicates were compared with 
untreated controls on 6 gels, thus generating 18 fluorescent spot maps (Table 5.2 A). 
In the second 2D-DIGE experiment, a combination of eight different conditions 
(seven RNAi conditions (pi 10, Akt, Ras85D, PTEN, Cofilin, Abi plus Hem and GFP) 
plus an untreated control, were prepared as triplicates and run on 12 gels, generating 
36 fluorescent images (Table 5.2 B). Examples of one gel set of three images derived 
from each fluorescence channel for Cy2, Cy3 and Cy5 are shown in Figure 5.6. Image 
analysis was carried out using DeCyder software. Briefly, triple fluorescent images 
from the same 2D gel were automatically curated and matched in the DIA module. 
Then, matching and comparison of protein features across different gels was
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performed using internal landmarks comprising abundant protein features present in 
all gel images using the BVA module.
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Figure 5.6 Representative Cy2, Cy3, Cy5 fluorescence gel images obtained from a single
2D gel in the 2D-DIGE experiment. Equal amounts o f Cy3 and Cy5 labelled protein 
samples, derived from pi 10 and cofilin RNAi-knockdown cells were mixed with an equal 
amount o f Cy2-labelled internal standard pool. Proteins were separated by 2D gel 
electrophoresis, and the gel was scanned at the appropriate excitation/emission wavelengths to 
generate the set of three images shown.
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Subsequently, statistical analysis was performed where the average abundances of 
protein features for each condition were compared with those of the untreated control. 
Protein features displaying a > 1.5 or < -1.5 average-fold change in abundance, 
displaying reproducible changes (p<0.05, n=3) and matching on all images were 
selected for MS-based identification. The two individual analyses and statistical 
evaluation of differences between untreated control sample and RNAi-treated samples 
revealed a total of 40 differentially expressed protein features. Gels were post- 
electrophoretically stained with CCB and gel images matched to the fluorescent 
images. A pick list of 39 proteins of interest was generated. Spots were excised 
robotically and subjected to MS-based protein identification.
5.3.2 Protein identification by mass spectrometry
Differentially expressed proteins from the two 2D-DIGE experiments were initially 
subjected to identification by MALDI-TOF MS peptide mass fingerprinting and 
MASCOT database searching (see Chapter 2). In cases were peptide mass fingerprints 
could not be matched to available predicted Drosophila protein sequences, the search 
was extended to all species available in the databases. Furthermore, LC-MS/MS was 
used in cases where a protein ID could not be obtained by MALDI-TOF MS analysis 
(see Chapter 2). In total, 27 of the 40 differentially expressed protein features were 
identified with high confidence (Table 5.3, Appendix 3). All protein features yielded 
single protein identifications, and two spots yielded the same protein identification 
suggesting isoforms of the same gene product. The 2D gel migration of most of the 
identified differentially expressed proteins in 2D gels is shown in Figure 5.7. Of the 
13 unidentified protein features, some were of low abundance and gave poor spectra, 
whiles the others stained well with CCB and gave spectra of good quality, but could 
not be identified from database searches. The identified proteins were grouped 
according to their known biological functions (Figure 5.8).
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Table 5.3 2D-DIGE differential protein expression analysis of RNAi-treated cells and MS-based protein identifications. Protein features displaying 
differential expression in S2R+ cells treated with dsRNA for the knockdown o f expression of Drosophila Arp3, Cdc42, Racl plus Rac2, PTEN, Ras, 
PI3K, Ras, Akt, cofilin, Abi plus Hem and GFP are shown. The table includes data combined from two separate experiments. Values are average ratios o f  
abundance from dsRNA treated cells versus untreated control cells from three separate cultures. T-test p  values are given as a measure of confidence for 
each ratio measured. Values for protein isoforms shaded in light and dark grey were significantly up- and down-regulated (>1.5 fold; p< 0.05; n=3), 
respectively. Proteins were identified by MALDI-TOF peptide mass fingerprinting and LC-MS/MS peptide sequencing (latter method denoted by * in 
‘Score’ column). Protein name and/or Drosophila annotation ID, NCBI accession number from database searches, sequence coverage (%), database 
search score (denominator is threshold score at p=0.05), number of matched peptides and molecular function are given for each o f the identified proteins.
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Figure 5.7 A representative gel displaying the position of differentially expressed proteins in the two experiments. Blue circle = 
proteins identified in the first experiment. Black circle proteins = identified in the second experiment. White circle = unidentified proteins 
from the first experiment. Red circle = a common protein differentially expressed in the two experiments.
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Figure 5.8 Percentage of differentially expressed proteins in RNAi knock-down cells 
grouped according to their biological functions.
5.3.3 Differentially expressed proteins identified by 2D-DIGE/MS
Metabolic enzymes. Two of the differentially expressed proteins are predicted to 
be involved in carbohydrate metabolism. CGI 0160 (Ecdysone-inducible gene L3, 
ImpL3), with L-lactate dehydrogenase activity, was found to be upregulated (1.75 
fold difference) in cells subjected to RNAi-mediated silencing of PTEN, whilst iso­
citrate dehydrogenase, a mitochondrial enzyme which participates in the citric acid 
cycle, was found to be downregulated by 1.75 and 1.6 fold in cells subjected to 
knockdown of cofilin and Abi plus Hem, respectively.
Redox enzymes. Five of the identified proteins are classified or predicted to be 
enzymes involved in redox regulation. Three of these enzymes (1-cys peroxiredoxin 
2540, GST D5 and GST E9) were differentially expressed only in cells subjected to 
RNAi treatment for the knockdown of PTEN (Figure 5.9). The two other enzymes 
were peroxiredoxin 6005 and oxidoreductase CG4199. Peroxiredoxin 6005 was 
upregulated in Abi plus Hem knockdown cells, which also displayed moderated 
downregulation of 1-cys peroxiredoxin 2540 (Figure 5.9). CG4199 was upregulated in 
the RNAi knockdowns for Arp3 and Racl+Rac2. An example of the mass spectrum 
and database search report for peroxiredoxin 6005 is shown in Figure 5.10.
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Figure 5.9 Examples of redox enzymes displaying RNAi-induced changes in protein 
expression. Proteins 1-cys-peroxiredoxin 2540, GST D5 and peroxiredoxin 6005 display 
differential expression in cells subjected to PTEN and Abi plus Hem RNAi-induced gene 
silencing. Proteins were identified from gels by MALDI-TOF MS. Examples of gel position 
and 3D-images o f protein spots, as well as graphs showing relative abundance were derived 
from DeCyder image analysis. Graphs show the standardised protein abundance (ratio o f the 
volume of a test gel feature versus the volume of the corresponding standard gel feature) for 
each RNAi condition. Triplicate data points are shown for spots from the untreated and 
treated samples with lines joining the average values.
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Figure 10. MS-based identification of peroxiredoxin 6005 protein by peptide mass 
fingerprinting. A) The peptide mixture generated from tryptic digest o f the protein spot 
number 1914 was analysed by matrix-assisted laser-desorption/ionisation time-of-flight MS 
(MALDI-TOF MS) to generate the mass spectrum shown. Circled masses show the two 
trypsin peaks (m/z 842.509 and 2211.104) used for internal calibration. B) The list o f peptide 
masses from the processed spectrum was searched against the NCBI theoretical peptide 
fragment database using Mascot and gave three ‘hits’ for peroxiredoxin with probability- 
based scores higher than the threshold value (59 in this case) where p=0.05 meaning the ‘hit’ 
is highly significant. C) Protein sequence coverage o f the matched peptides for the top ‘hit’ 
represents 56% o f the sequence of peroxiredoxin 6005. Sequences and masses of the matched 
peptides are shown at the bottom of the figure. D) Error distribution displays the mass error of 
each peptide in ppm compared to its counterpart in the database.
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Actin binding proteins. Five out o f  the 26 ’hits’ obtained from MS database 
searches were actin binding proteins predicted to be involved in cytoskeletal 
organisation. Two o f  these protein spots yielded the same identification meaning that 
this differentially expressed protein exists as two isoforms. This protein was identified 
with high confidence as cofilin (twinstar, CG 4254). Peptide mass fingerprints for both 
forms are shown in Figure 5.12. M ascot search results from one form are shown in 
Figure 5.13. The two isforms o f  cofilin, found to be differentially expressed in several 
knockdown conditions (Table 5.3) ran with similar molecular weights (~17 kDa), but 
different p is (acidic form p l=5.69, and basic form pl=6.74) (Figure 5.11). This initial 
peptide mass fingerprint did not reveal any m odification that could explain the shift in 
the pi o f  the two cofilin  spots.
Cofilin Cofilin
(acidic) (basic)
pl=5.69 pl=6.74
Figure 5.11 Representative 2D-DIGE gel image displaying the position of the acidic and 
basic cofilin isoforms identified by MS.
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Figure 5.12 Representative MALDI-TOF MS spectra of two cofilin isoforms. Mass spectra were acquired on an Ultraflex MALDI-TOF mass
spectrometer. The upper (red) panel shows the MS spectrum of master spot number 2237, corresponding to the acidic isofonn, and the lower (blue) panel
o> shows the spectrum of the basic spot (master spot number 2293). co
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Figure 5.13 Database searching for identification of basic cofilin by peptide mass 
fingerprinting. Proteins were picked and digested with trypsin and the peptide mixture 
generated was analysed by MALDI-TOF-MS. A). Score distribution of protein ‘hits’ 
identified in the database search. B) Peptide mass mapping against the theoretical peptide 
masses in the NCBI database using Mascot identified cofilin with a score of 139 and 95% 
sequence coverage. The list o f matched peptides and modifications (variable and fixed) are 
shown in bold red lettering. C) Error distribution displays the mass error of each peptide in 
ppm compared to its counterpart in the database.
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Perhaps the most interesting observation from the analysis was that the acidic 
cofilin spot displayed an opposite expression profile in the pi 10 and PTEN 
knockdown cells, as expected for a bona fide target of PI3K signalling (Figure 5.14)
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Figure 5.14 The acidic form of cofilin is regulated by both PI3K/PTEN and actin 
modulators. A) Representative 2D-DIGE gel images and 3-D fluorescence profiles of the 
acidic and basic cofilin protein isoforms in untreated S2R+ (Ctrl), cofilin, PTEN and pi 10 
knockdown samples, including gel images and 3-D fluorescence profiles o f the acidic and 
basic cofilin protein isoforms in untreated control and cells subjected to RNAi treatments. B) 
Relative abundances of the acidic and basic isoforms of cofilin in respective RNAi-treated 
cells. Values represent the average o f three measurements from biological replicates. Error 
bars represent the standard deviation.
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The acidic cofilin spot was downregulated in PTEN (-1.57 fold) and moderately 
upregulated in pi 10 (1.14 fold). Additionally, knockdown of Arp3, Cdc42 and Racl 
plus Rac2 resulted in an up-regulation of the acidic cofilin spot (Figure 5.14), whereas 
in the double knockdown of Abi plus Hem the expression of the acidic cofilin as 
differentially downregulated. Importantly, expression of the two cofilin isoforms was 
potently downregulated in the cells subjected to silencing of cofilin gene expression 
(Figure 5.14). This confirmed that the dsRNA treatment, over five days, resulted in 
loss of protein expression and is applicable even to relatively abundant proteins that 
can be detected by 2D-DIGE. It thus proves the efficiency of RNAi in this Drosophila 
cell system.
Actin related protein 66B (Arp3, CG7558), a component of the Arp2/3 complex 
required for de novo actin nucleation and actin polymerisation (Chapter 1), was also 
found to be significantly downregulated (-2.83 fold) in cells targeted for knockdown 
of expression of Arp3 (Figure 5.15). Again, this observation demonstrated that the 
RNAi strategy had been successful for silencing this target gene. MALDI-TOF MS- 
based identification of Arp3 is shown in Figure 5.16 A and B.
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Figure 5.15 Loss of Arp3 protein in cells subjected to RNAi-mediated knockdown of 
Arp3. A) Migration o f Arp3 protein in 2-D gels and its 3-D profile obtained from DeCyder 
and displaying loss o f the Arp3 protein in arp3 RNAi-treated cells. The pick arrow indicates 
on the missing protein spot in Arp3 RNAi-mediated knockdown sample. B) Histogram 
showing average standardised abundance o f Arp3 expression in untreated (Ctrl), Arp3, Racl 
plus Rac2 and Cdc42 RNAi-treated cells. Error bars show standard error of the mean from 
triplicate measurements.
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ail 17737543 Mass: 47459 Score: 160
CG7558-PA [Drosophila melanogaster] 
all 41618424 Mass: 12627 Scoro: 28
TPA: HDC11838 [Drosophila melanogaster]
Expect: 60 Queries matched: 3
all558S68 Mass: 47488 Score: 129 Expect: 4.4e-009 Queries matched: 14
actin related protein [Drosophila melanogaster]
Probability Based Mowse Score 
Fixed modifications: Carbamidomethyl (C)
Variable modifications: N-Acetyl (Protein),Oxidation (H),Pyro-glu (N-term Q) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Number of mass values searched: 38 
Number of mass values matched: 16 
Sequence Coverage: 50%
Hatched peptides shown in Bold Red
1 HAGRLPACVI DV9TGYSKLG FAGNKEPQFI IPSAIAIKES ARVGDTNTRR
51 ITKGIEDLDF FIGDEAFDAT GYSIKYPVRM GLVEDVDLME RFLEQCVPKY
101 LRAEPEDHYF LLTEPPLNTP ENREYTAEIH FETFNVPGLY IAVQAVLALA
151 1SHASRSAEE RTLTGIWDS GDGVTHVIPV AEGYVIGSCI KHIPIAGRNI
201 TSFIQSLLRE REVGIPPEQS LETAKAIKEK HCYICPDIAK EFAKYPTEPG
251 KWIRHFSGVM TVTKAPFNVD VGYERFLGPE IFFHPEFSNP DFTIPLSEIV
301 DNVICWCPID VRRPLYHNIV LSGGSTMFKD FGRRLQRDIK RSVDTRLRI3
351 ENLSEGRIKP KPIDVQVITH HHQRYAWFG GSHLASTPEF YQVCHTKAAY
401 EEYGPSICRH HPVFGTKT
Start - End Observed Mr(expt) Hr(calc) Delta Miss Sequence
5 - 1 8 1479.79 1478.78 1478.74 0.03 0 LPACVIDVGTGYSK
26 - 38 1426.86 1425.86 1425.82 0.03 0 EPQFIIPSALAIK
54 - 75 2423.12 2422.11 2422.12 -0.01 0 GIEDLDFFIGDEAFDATGYSIK
80 - 91 1515.74 1514.74 1514.68 0.05 0 HGLVEDWDLMER Oxidation (H)
92 - 99 1070.56 1069.55 1069.53 0.03 0 FLEQCVFK
100 - 123 2914.56 2913.55 2913.43 0.12 1 YLRAEPEDHYELLTEPPLHTPEHR
103 - 123 2482.17 2481.17 2481.18 -0.02 0 AEPEDHYTLLTEPPLHTPEHR
162 - 191 3056.53 3055.52 3055.59 -0.07 0 TLTGIWDSGDGVTKVIPVAEGYVIGSCIK
199 - 209 1291.77 1290.76 1290.73 0.03 0 HITSFIQSLLR
210 - 225 1782.94 1781.93 1781.92 0.02 1 EREVGIPPEQSLETAK
212 - 225 1497.80 1496.79 1496.77 0.02 0 EVG1PPEQSLETAK
255 - 264 1066.57 1065.56 1065.55 0.01 0 MFSGVNTVTK
265 - 275 1266.65 1265.64 1265.60 0.03 0 APFNVDVGYER
313 - 329 1913.00 1911.99 1911.99 0.00 0 RPLYNNTVLSGGSTKFK Oxidation (H)
398 - 409 1415.65 1414.64 1414.62 0.03 0 AAYEEYGPSICR
410 - 418 1019.49 1018.48 1018.45 0.03 0 hnpvfgtmt Oxidation (K)
Figure 5.16 MS-based identification of Arp3 protein by peptide mass fingerprinting. A)
Spot 781 was picked from a gel and digested with trypsin as described in Chapter 2. The 
peptide mixture generated was then analysed by MALDI-TOF MS to generate the mass 
spectrum shown. B) The list of peptide masses from the processed spectrum was searched 
against the NCBI database using Mascot and gave two ‘hits’ for Arp3 with probability-based 
scores higher than the threshold value (59 in this case) where p=0.05. Protein sequence 
coverage of the matched peptides for the top ‘hit’ represents 50% of the sequence of Arp3. 
Sequences and masses of the matched peptides are shown at the bottom of the figure.
Misato (C G I424), a putative component o f  the cytoskeleton, was another actin 
binding protein found to be upregulated in Arp3 knock-down cells.
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Annexin B ll (CG9968) has also been reported to be an actin-binding protein 
(Gerke et al., 2005) that was found to be downregulated in most of the RNAi 
treatments, including the GFP RNAi treatment (Table 5.3). This indicated that this 
change may be due to an off-target effect of dsRNA treatment.
Protein synthesis and processing. Three differentially expressed protein spots 
identified by MS were categorised as enzymes involved in protein synthesis and 
processing. CG5706, an enzyme with phenylalanine tRNA ligase activity, was found 
to be upregulated only in cells with reduced expression of Arp3. Cysteine proteinase- 
1 was downregulated in cells targeted for knockdown of PTEN, whilst fragile X- 
related protein was downregulated in cells subjected to PTEN, cofilin and Abi plus 
Hem RNAi-mediated gene silencing.
Heat shock proteins. Two heat shock proteins (Hsp), Hsp60 and Hsp68, were 
upregulated in cells with loss of expression of Arp3 and Racl plus Rac2, and in cells 
subjected to double RNAi treatment of Abi plus Hem, respectively.
Other Drosophila proteins. Among the other proteins identified as being 
differentially expressed was ubiquitin in the cells subjected to pi 10, Akt, Abi plus 
Hem and GFP RNAi-induced gene silencing (Table 5.3). However, the theoretical 
mass and pi of this ubiquitin did not correspond to the mass and pi of the protein 
feature on the 2D gel. This suggests that this differentially expressed protein might be 
ubiquitinated. However, other sequence information was not available to enable its 
identification. CGI 0424-PA was also identified. This protein has no known or 
predicted function and was significantly upregulated in the PTEN knockdown cells. 
Finally, upregulation of the capsid polypeptide derived from Drosophila C virus was 
observed in cells subjected to RNAi treatments for knockdown of Arp3, Cdc42 and 
Racl plus Rac2 expression.
Contaminant proteins. Six protein species were identified as contaminants 
derived from the bovine serum used in the growth medium. There were different 
isoforms of albumin and antitrypsin found to be significantly differentially expressed 
in the samples treated for silencing of expression of pi 10, Aktl, Arp3 and Racl plus
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Rac2 (Table 5.3). Since each condition was prepared as biological triplicates, and 
cells were washed thoroughly and analysed separately, the differential presence of 
these serum-derived proteins suggests that cells subjected to these RNAi treatments 
may have altered adhesive properties resulting in retention of these abundant “sticky” 
serum proteins.
5.3.4 Characterisation of cofilin phosphorylation
The presence of two cofilin isoforms, which had different electrophoretic 
migration properties, and the observed differential expression of the acidic isoform in 
pi 10, PTEN, Arp3, Racl plus Rac2, Cdc42 and Abi plus Hem RNAi knockdown 
cells, suggested that cofilin may be post-translationally modified. Based on previous 
2D studies (Hensbergen et al., 2005) and the fact that cofilin can be phosphorylated 
(Agnew et al., 1995), it was reasoned that the acidic isoform might be a 
phosphorylated form. To test whether phosphorylation was indeed present, a titanium 
dioxide (Ti02) enrichment strategy for phosphopeptides was employed (Larsen et al., 
2005) prior to repeat MS analysis. This method was carried out in collaboration with 
Dr M Larsen, Odense University, Denmark. Briefly, tryptic digests from the two 
cofilin gel features were loaded onto Ti02-coated beads packed into gel loading tips. 
These “microcolumns” were then washed and bound phosphorylated peptides were 
eluted in ammonia solution. Eluates were acidified and then analysed by MALDI- 
TOF MS. This approach clearly identified a peptide with mass corresponding to a 
phosphorylated form of the N-terminal tryptic peptide (Ac-ASGVTVSDVCK+P) 
(Figure 5.17). Moreover, comparison of spectra from the acidic and basic isofroms, 
showed that 80 Da sift between peaks corresponding to the phosphorylated and 
unphosphorylated forms of this peptides, including that the phosphorylation was 
specific for the acidic isoform (Figure 1.17)
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Figure 5.17 Proteomic analysis of cofilin phosphorylation. Enlarged regions of MALDI- 
TOF MS spectra showing the Ti02-enriched N-terminal phosphopeptide of Drosophila 
cofilin, and non-enriched tryptic digests from gel pieces containing the acidic and basic 
Cofilin isoforms. The 80 Da mass difference between the phosphorylated and un- 
phosphorylated peptides is indicated (Data for the figure were obtained from Dr M Larsen).
Furthermore, LC-MS/MS-based sequencing of the Ti02-enriched phosphopeptide 
pool confirmed that this peptide was phosphorylated at Ser3 (Figure 5.18). 
Significantly, this modification is known to inactivate cofilin, preventing it from 
binding to and severing actin filaments (Agnew et al., 1995; Bamburg, 1999).
171
Chapter 5
Basic isoform
Acidic isoform
3040 U40 9400 40.00 43 00 4400 40.Q0 40.00 00.00 0300 0400 0000
B
K
m.14 
147 12
44
Ac-ApSG -  H3 PO4  
Ac-AjdSGV -  H3 P 0 4
102 16, 
200.15
0011
iii
Ac-ApSGVTVSDVCK
022 23 
’ 406.24*
dfjLiowiiJul * oifL
V v
SO 100 150 200 250 300 350 400 450 500 5S0 600 650 700 750 600 850 800 650 1000 1050 1100
Figure 5.18 Analysis of enriched cofilin phosphopeptides by LC-MS/MS. Titanium 
dioxide-enriched phosphopeptides from the acidic and basic cofilin spots on the 2D gel were 
analyzed by LC-MS/MS. A) Single ion chromatograms of the doubly charged N-terminal 
phosphorylated peptide Ac-ApSGVTVSDVCK im/z 622.8). Upper panel shows the single ion 
chromatogram obtained from the basic cofilin spot and the lower panel shows the single ion 
chromatogram obtained from the acidic cofilin spot. The ion is only detected in the lower ion 
chromatogram. B) Tandem mass spectrum of the phosphorylated peptide Ac- 
ApSGVTVSPYCK (* indicates carbamidomethylation of cysteines). The y-ion series is 
illustrated together with a few b-ion fragments that localise the phosphorylation site to the N- 
terminal serine residue. (Data for the figure were obtained from Dr M Larsen)
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In addition, the MS/MS analysis suggested that cofilin might also be 
phosphorylated on Thr6 (Figure 5.19) or Ser8, at lower stoichiometry - a finding that 
needs further validation.
100- T6 -  could be partial phosphorylated  
(only a very sm all am ount)
808 *0 K C V D S V T
K C V D S V  +  p T  =  K C V D S V p T  
7 0 7 .3 8  +  1 8 1 .0 4  =  8 8 8 .4 3 8pS.44
* -
K C V D S V  to.
\ K C V D S V  +  T  =  K C V D S V T  
7 0 7 .3 8  +  1 0 1 .0 4  =  8 0 8 .4 3
K C V D S V p T -H 3P 0 4 = K C V D S V T  
8 8 8 .4 3 -9 8  = 7 9 0 .4 3
38
K C V D S V + (p T -H 3P O J  
= 7 0 7 .3 8 + ( 1 8 1 .0 4 -9 8 )  _ 
= 7 0 7 .3 8 + 8 3 .0 4 = 7 9 0 .4 3  L o s s  o f  P h o s P h a te  f r o m  PT
810.44
^700.37
1) w  . . . , JkL4_ ... 1. -  .  .  1. .
00 700 710 720 730 740 750 760 770 780 7» 800 110 820 830 840
Figure 5.19 Analysis of T i0 2-enriched cofilin phosphopeptides by LC-MS/MS reveals 
partial phosphorylation on Thr6 in the Ac-ApSGVTVSDVCK peptide. (Data for the 
figure is obtained from Dr M Larsen). It has been proposed that the y-ion KCVDSVT ([m/z
808.43) could be partially phosphorylated at threonine. Although KCVDSVpT with m/z 
888.43 was not seen in the spectra, possible due to the low stoichiometry (black arrow), the 
peak m/z 790.43 could indicate a loss o f a phosphate o f 98 Da from KCVDSVpT (m/z
888.43).
5.3.5 Validation of differences in protein expression observed by 
2D-DIGE
The main approach to validate the efficiency of RNAi-induced loss of protein 
expression relied on the specific detection of proteins by immunoblotting. However, it 
is important that using 2D-DIGE and MS reduced expression of both Arp3 and cofilin 
was detected in all the respective RNAi knockdowns. Since the systematic generation 
of new antibodies is time-consuming and costly, only proteins for which antibodies
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were available were further analysed and validated using immunoblotting. Firstly, 
phosphorylation of Akt at Ser505 and Akt levels in all samples subjected for RNAi 
were analysed by western blotting, since Drosophila specific anti-pSer505-Akt and 
anti-Akt antibodies were available (Figure 5.22). This immunoblotting revealed the 
RNAi-induced loss of Akt expression. Furthermore, the pAkt level was found 
significantly lower in pi 10 RNAi knockdown cells, showing that the expression of 
pi 10, the catalytic subunit of class I PI3K, was successfully reduced by RNAi, 
abrogating PIP3 production and the activation of downstream molecules. As expected, 
in contrast to the Akt and pi 10 knockdowns, PTEN RNAi-mediated knockdown gave 
significantly higher levels compared to the untreated control, the GFP control and 
other RNAi treatments (Figure 5.20). This data confirms that phosphorylation at the 
Ser505 site in Akt is dependent upon PIP3 levels. Interestingly, phosphorylation of 
Akt was not perturbed in the Ras knockdown cells, since Ras has been reported to be 
an upstream activator of PI3K (Rodriguez-Viciana et al., 1997; Vanhaesebroeck et al., 
2001). An unexpected observation was the increased phosphorylation of Akt in Racl 
plus Rac2 and Arp3 RNAi knockdown cells. This raises the possibility of a regulating 
a feed-back loop downstream of Rac.
RNAi trea tm en t RNAi treatm ent
Abi+ Rac1 +
CjjJ D ^ j O F ^ J  Akt C|j) 5 Qtrj Arp3Cdc42?ar.?
----------—  —  — -------------—
Figure 5.20 Validation of pAkt and Akt levels in the protein lysates derived from RNAi 
knockdowns. Protein lysates from the respective knockdowns were subjected to ID SDS- 
PAGE and western blotting for pSer505-Akt and total Akt. The upper blot showed that the 
level o f pAkt was downregulated in the Akt and pi 10 knockdowns, and upregulated in the 
PTEN, Arp3 and Racl plus Rac2 knockdowns. The lower blot shows the level o f Akt itself, 
revealing complete loss o f Akt in the Akt knockdown sample.
Since it was apparent that cofilin phosphorylation was responsive to changes in 
both PI3K and Rho-family small GTPase signalling pathway components, Drosophila 
pSer3-cofilin antibody was raised against the Drosophila protein, for further study of 
the signalling events involved. This Drosophila-specific antibody was also made
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since the available human anti-pSer3-cofilin antibody did not recognise Drosophila 
protein. Once available, the anti-pSer3-cofilin antibody was used to confirm the 
phosphorylation of Ser3 in the differentially expressed acidic cofilin spot. 2D- 
immunoblotting revealed that the antibody recognised only the acidic form of cofilin 
(Figure 5.21). Unfortunately, the lack of an anti-cofilin antibody precluded the 
validation of the non-phosphorylated cofilin isoform or comparison of the levels of 
the two cofilin isoforms by immunoblotting.
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Figure 5.21 Validation of Ser3 phosphorylation of cofilin by 2D immunoblotting.
Enlarged and aligned regions o f 2D-DIGE, CCB and anti-pSer3-cofilin 2D immunoblot 
images.
In addition, pSer3-cofilin levels were assessed by western blotting to confirm 
PI3K-dependent cofilin phosphorylation using the same samples from the 2D-DIGE 
experiment (Figure 5.24). The immunoblotting confirmed the observations that the 
level of cofilin phosphorylation was altered in PTEN (downregulated) and pi 10 
(upregulated) compared to the untreated control. As expected, phosphorylation of 
cofilin was barely detected in cofilin RNAi-treated samples.
pCofilin
103 115 4 4 104 100100
Figure 5.22 Immunoblotting analysis of pSer3-cofilin levels in control untreated and 
RNAi-treated S2R+ cells confirming PI3K/PTEN modulation of cofilin phosphorylation 
and cofilin knockdown. Protein lysates from the respective knockdowns were subjected for 
ID SDS-PAGE and western blotting for pSer3-cofilin. Relative abundance is shown below 
the blot as a % of the control, and is the average calculated from densitometry measurements 
o f blots from three independent experiments.
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5.3.6 Investigation of morphological changes and actin cytoskeleton 
organisation in S2R+ cells subjected to specific RNAi- 
mediated gene silencing
In parallel with the functional proteomic analysis, cell shape and actin organisation 
were examined in the RNAi knockdowns using fluorescence confocal microscopy. 
The aim of this analysis was i) to define the shape of each knockdown cell, ii) to try to 
group actin phenotypes and iii) to try to link the phenotypes to their proteomic 
profiles, which were obtained in the 2D-DIGE analysis for each knockdown. Aliquots 
of RNAi-treated S2R+ cells grown for the 2D-DIGE proteomic analysis were taken 
out of the culture dishes a day before harvesting, and were plated onto eight-well 
chamber slides, coated with serum. Cells were incubated overnight, then fixed and 
stained for F-actin using rhodamine-conjugated phalloidin. Images of cells were 
acquired by confocal microscopy (Chapter 2).
Actin staining of cells revealed the RNA-mediated reduction of expression of Racl 
plus Rac2, Cdc42, Arp3 and double knockdown of Abi plus Hem generated similar 
cell shapes characterised by the “starfish” morphology and actin phenotypes with 
reduced levels of cortical F-actin, thus compromising the ability to form lamellipodia 
(Figure 5.23). The same phenotypes for these knockdowns were previously observed 
in other functional genomics studies when S2R+ cells were used (Kiger et al., 2003; 
Kunda et al., 2003). In Kcl67 and S2 cells, these genes were also found to regulate 
cortical F-actin organisation in a similar fashion to experiments using S2R+ (Rogers 
et al., 2003; Kiger et al., 2003). In the RNAi knockdowns of components of the PI3K 
signalling pathway, only PTEN-deficient cells showed strong morphological changes 
and F-actin re-organisation (Figure 5.25). PTEN knockdown cells were seen to be 
larger than the untreated and GFP RNAi-treated cells, supporting results from 
previous data, which showed that the PI3K/Akt signalling cascade positively regulates 
cell size (Leevers et al., 1996; Kozma and Thomas, 2002). In addition, these cells had 
large lamellipodia (data shown in next chapter) and structures resembling stress 
fibres, but also showed weak adhesion as they were easily washed off the slides. This 
latter observation suggests that PTEN-deficient cells may exhibit defects in cell 
adhesion, as previously reported (Tamura et al., 1998). In addition, pi 10- and Akt-
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gene silenced cells had moderate F-actin reorganisation and defects in cell shape. The 
cells did not display a decrease in size as would be expected, given the PTEN 
phenotype, and were viable with no signs of apoptosis. A small cell phenotype was 
observed in the Ras knockdown cells, where actin was also found to be strongly 
perturbed. Cell subjected to knockdown of cofilin (twinstar) also showed perturbed F- 
actin organisation, with an increase in F-actin staining, which has been previously 
reported (Kiger et al., 2003). Cofilin knockdown cells were found also to be bi- and 
poly- nuclear (shown in the next chapter), suggesting that cofilin/twinstar protein is 
important in cell division (Kiger et al., 2003). Finally, the negative control for RNAi 
treatment (GFP knockdown cells) showed no alteration in morphology or actin 
cytoskeleton organisation, suggesting that RNAi-mediated silencing itself does not 
affect actin cytoskeleton organisation.
abi+hem cdc42 ra c l+2
pi3k92e twinstar
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Figure 5.23 F-actin organisation and cell morphology in cells subjected to RNAi- 
mediated knockdown of expression. S2R+ cells subjected to RNAi treatments were stained 
for F-actin with rhodamine-phalloidin and images o f the cells were captured by confocal 
microscopy. Scale bars o f 50 pm are shown on each image.
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5.4 Conclusions
5.4.1 Summary of differentially expressed proteins
A combination of RNAi-specific gene silencing and 2D-DIGE analysis revealed 
effects on a group of differentially expressed proteins, which are implicated in both 
PI3K and Rho-family of small GTPase regulated processes, particularly in regulation 
of actin cytoskeleton organisation and redox homeostasis. From a total of 40 protein 
isoforms displaying differential expression only 26 were successfully identified with 
high confidence by MS. Although some of the unidentified protein features were 
reasonably abundant (could be detected by CCB staining) and gave good quality 
spectra, 13 protein spots (~33 %) could not be identified from the database searching. 
Most probably the available databases for fly protein sequences are not fully complete 
or modifications present in these fly proteins make it difficult to assign protein 
identities with certainty. It should also be added that searches were repeated on a 
recently updated version of the NCBI database and using additional modifications 
without success.
Among the differentially expressed proteins identified, two were metabolic 
enzymes involved in glycolysis and the citric acid cycle. L-lactate dehydrogenase 
(LDH) was upregulated only in cells subjected to PTEN knockdown. LDH is an 
oxidoreductase that catalyses the final step in anaerobic glycolysis; the reduction of 
pyruvate by NADH to form lactate. It is well established that in the absence of PTEN, 
PI3K initiates the increased production of PIP3, which leads to constitutive activation 
of Akt and its downstream targets. The PI3K/Akt signalling pathway can induce 
increased glucose uptake and glycolysis in cells (Elstrom et al., 2004), which may 
play a role in Akt-induced cell survival and growth (Rathmell et al., 2003). However, 
the role of glycolysis under conditions of elevated PI3K/Akt signalling has been 
controversial, and different models have been proposed where Akt can promote 
aerobic (Elstrom et al., 2004) or anaerobic glycolysis (Ramanathan et al., 2005). In 
the absence of PTEN the level of LDH was increased, suggesting that PI3K/Akt 
activation may drive anaerobic glycolysis in S2R+ cells, although the opposite change 
was not observed in either the PI3K or Akt knockdowns. The second metabolic
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enzyme identified was iso-citrate dehydrogenase (IDH), a mitochondrial enzyme, 
which participates in the citric acid cycle, and was downregulated in cells treated with 
dsRNA for silencing of Ras, cofilin and Abi plus Hem. IDH catalyzes the third step of 
the cycle; the oxidative decarboxylation of iso-citrate, producing alpha-ketoglutarate 
and CO2 while converting NAD+ to NADH. Ras has been previously linked to the 
regulation of carbohydrate metabolism (Chiaradonna et al., 2006) and the Krebs cycle 
(Biaglow et al., 1997). In addition, alpha-ketoglutarate, the product of this reaction, is 
one of the most important nitrogen transporters and an intermediate in metabolic 
pathways and the urea cycle (Tretter and Adam-Vizi, 2000). Downregulation of a 
component of the Krebs cycle in the Ras knockdown could suggest that the rate of 
aerobic glycolysis may be lower, with cells gaining energy though alternative 
metabolic processes. It is worth mentioning here, that Ras knockdown cells were 
significantly smaller in size than the control RNAi-untreated cells, suggesting that the 
alteration in the Krebs cycle and subsequently in the urea cycle, which is important 
for normal protein metabolism, could be reflected in the cellular phenotype. The 
finding of reduced iso-citrate dehydrogenase expression, in cofilin and Abi plus Hem 
RNAi knockdown cells, is more difficult to explain, but could imply that disturbance 
in actin organisation and the stress that the cells probably go through might alter 
metabolic energy production pathways.
Five proteins, with known roles in regulating redox metabolism and oxidative 
stress, were found to be differentially expressed. Cellular oxidative stress arises from 
significant increase in the concentration of reactive oxygen species (ROS) and 
reactive nitrogen species (RNS), and/or a decrease in the levels of detoxification or 
antioxidants (Schrader and Fahimi, 2006). There are many natural sources of 
oxidative stress that can produce ROS, for example exposure to environmental 
oxidants, toxins like heavy metals, ionising or UV irradiation, heat shock and 
inflammation. Major ROS are hydrogen peroxide (H2O2), free radical species 
(containing unpaired electrons), such as the superoxide anion O2” and the highly 
reactive hydroxyl radical ( OH). High levels of ROS exert their toxic effects through 
oxidation of biomolecules such as DNA, proteins and lipids, thus leading to DNA 
damage and deregulation of redox sensitive metabolic and signalling pathways and to 
pathogenic conditions. Among ROS, only H2O2 has been implicated in the cell
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signalling. The enzymatic machinery that minimises potential macromolecular 
damage influenced by ROS includes peroxiredoxins, superoxide dismutase, catalase, 
glutathione peroxidise and glutathione transferase. In this study, two Drosophila 
glutathione S-transferases (GST), two peroxiredoxins (Prx) and a predicted 
oxidoreducatase were found to be differentially expressed in cells with reduced 
expression of PTEN and the actin cytoskeleton regulators Arp3, Racl plus Rac2 and 
Abi plus Hem.
The peroxiredoxins (Prx) are a major class of cellular reductants, which exhibit 
thiol-dependent peroxidase activity and are found in a variety of prokaryotes and all 
eukaryotes (Radyuk et al., 2001). The main function of these proteins is protection 
from oxidative stress and damage (Wood et al., 2003). Five peroxiredoxin genes have 
been identified in D. melanogaster on the basis of a genome-wide search (Radyuk et 
al., 2001). They are divided into two subgroups based on the presence of either one 
(1-Cys Prx) or two (2-Cys Prx) conserved cysteine residues. DPrx-2540 and DPrx- 
6005 belong to the 1-Cys subgroup, while DPrx-4156, DPrx-4783 and DPrx-5037 to 
the 2-Cys subgroup. Each of the five genes displays unique developmental expression 
profile and subcellular localisation, suggesting that these genes have diversified to 
perform distinct physiological functions. The two Cys-1 Prxs, DPrx-2540 and DPrx- 
6005, are cytosolic and possess distinctive temporal patterns of expression. DPrx- 
2540 is expressed at very high levels during embryogenesis and hardly at all 
thereafter. On the other hand, DPrx-6005 is expressed at all stages of the fly life cycle, 
with greater abundance in embryos and adult animals. DPrx-2540 was found to be 
downregulated in cells with reduced expression of PTEN and also moderately in Abi 
plus Hem knockdown cells. Thus, positive silencing of PTEN expression appears to 
cause cells to exhibit changes in the expression of their redox machinery. Despite this, 
DPrx-6005 was found to be upregulated in the double knockdown cells of Abi plus 
Hem, suggesting that disruption of the Wave/Scar complex could also alter the redox 
status of the cells. In addition, reducing the expression of Racl plus Rac2 or Arp3 
resulted in upregulation of CG4199-PA, a predicted disulphide oxidoreductase 
possibly involved in reactive oxygen species metabolism. Although Rac has been 
previously linked to the generation of ROS through recruitment of NADPH oxidase 
(Wemer, 2004) there are no reports that the molecules regulating the actin
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cytoskeleton downstream of Rac, such as Arp3, Abi, Hem could alter redox 
homeostasis. It has been proposed that Rac-induced activation of O2 " production 
through recruitment of NADH oxidase is permissive for RTK signalling through 
reversible oxidation and inhibition of protein tyrosine phosphatases Similarly, 
transient PIP3 production following RTK activation may be augmented by an ROS- 
dependent inhibition of PTEN (Leslie et al., 2003; Kwon et al., 2004).
GSTs are a family of enzymes that protect cellular molecules from irreversible 
damage caused by ROS, by catalysing the conjugation of a reduced form of 
glutathione (GSH), generally making the final products more water soluble and 
excretable (Enayati et a l . ,  2005). The biological consequences of failure to express 
GST proteins may result in rapid accumulation of aberrant protein modifications 
which could lead to the development of pathogenic conditions (McEligot et al., 2005). 
There are at least two ubiquitously distributed, distantly related groups of GSTs, 
classified according to their localisation within the cell: microsomal and cytosolic 
(Enayati et a l . ,  2005; Frova, 2006). A third class, Kappa class GSTs, are localised in 
mammalian mitochondria and peroxisomes, and are structurally distant from 
microsomal and cytosolic GSTs. In Drosophila there is a single microsomal GST 
gene, but two main classes (I and II) of cytosolic GSTs. Class II GST orthologues are 
found in a diverse range of species from nematode to mammals, and are relatively 
conserved suggesting that they play fundamental roles in conserved physiological 
processes. In contrast, the class I GSTs are unique to insects and comprise the Delta 
and Epsilon GSTs, which have evolved independently in various insect species, 
suggesting that these enzymes play important roles in the adaptation of these species 
to their environments. Two type of class I cytosolic GSTs, GST D5 and GST E9, were 
found to be upregulated only in cells with reduced expression of PTEN, suggesting 
that increased levels of PIP3 can induce changes in redox homeostasis, requiring 
increased expression of these GSTs for cellular protection. This interpretation 
assumes that these GST are inducible under high levels of ROS (Kanai et al., 2006; 
Sharma et a l . ,  2006), although it is difficult to explain why DPrx-2005 expression 
would be decreased under such conditions. The effects of the studied knockdowns on 
redox homeostasis requires further examination, although this was beyond the scope 
of this study.
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Two heat shock proteins, Hsp60 and Hsp68, were found to be differentially 
expressed. Heat shock proteins play different roles in differentiation and development 
and in adaptation to cellular stress. They are cytoplasmic or ER proteins that bind to 
nascent or unfolded polypeptides and ensure correct folding and/or transport of 
proteins. The Hsp60 family are essential proteins that can be divided into two groups 
based on their sequence homology (Lund et al., 2003). Notably, the group II Hsp60 
proteins appear to play a major role in the folding of actin and tubulin, as well as, 
other substrates (Frankel and Mooseker, 1996). Here, Hsp60 was found to be 
upregulated in the cells with loss of expression of the actin regulatory proteins Arp3 
and Racl plus Rac2, whilst Hsp68, of which little is known, was also upregulated in 
the Abi plus Hem knockdown cells. It is known that the expression levels of Hsps are 
induced in response to cellular stress. Thus, it would appear that perturbation of the 
actin cytoskeleton in cells with loss of Abi plus Hem, Racl plus Rac2, or Arp3, which 
display similar morphological phenotypes (Figure 5.23) experience the same form of 
cellular stress, possibly resulting in the induction of these heat shock proteins. This 
notion is further supported by the fact that the expression of redox regulated proteins 
was also perturbed in these cells (see above), although the molecular determinants of 
this stress response are as yet unclear.
Fragile X mental retardation-related protein (FMR1P) is an RNA-binding protein 
that acts as a negative translational regulator and is a signature for individuals with 
fragile X mental retardation, a developmental neurological disorder in humans 
(O'Donnell and Warren, 2002). The Drosophila form of FMR1P was found to be 
differentially expressed in cells subjected to RNAi-induced knockdown of PTEN, Abi 
plus Hem and cofilin. FMR1P is present in many cell types and is particularly 
abundant in the cytoplasm of neurons and in distal dendrites (Caudy et al., 2002). 
FMRP contains two protein K (KH) homology domains and an RGG box, motifs that 
are known to be autonomously capable of binding RNA and it has been suggested that 
FMR1P plays a role in the regulation of local protein synthesis at the postsynaptic 
site, essential for normal dendritic spine maturation. Thus, abnormal dendritic spines 
have been observed in both fragile X patients and FMR1P knockdown mice. 
Drosophila contains a single, functionally conserved member of the finr family 
(Zhang et al., 2001), compared to the three related genes present in mammals, and has
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been found to associate with the RNAi-silencing machinery (Caudy et al., 2002). To 
elucidate the function of FMR1P, Schenck et al. initiated a search for interacting 
proteins by screening an embryonal mouse library using a yeast two-hybrid system 
(Schenck et al., 2001). They isolated two cytoplasmic proteins that interact with the 
FMR protein, CYFIP1 (pl40Sra-l, specifically Racl-associated protein) and CYFIP2 
(PIR121 or pop), which are 88% identical in their amino acid sequence. The 
Drosophila genome, on the other hand, contains a single ortholog of CYFIP1/2. Both, 
CYFIP1 and 2, and fly CYFIP have been shown to be specific targets for Racl, 
binding only to the GTP-bound form (Billuart and Chelly, 2003). Furthermore, 
CYFIP2 is a part of the inactive Scar/WAVE complex. Active Scar/WAVE is known 
to mediate Rac-dependent cytoskeleton remodelling by direct interaction with the 
Arp2/3 complex, which when activated promotes actin nucleation (Bompard and 
Caron, 2004). A model of competition between CYFIP/WAVE and CYFIP/FMR1P 
has been proposed, where Racl activation would result in a positive regulation of 
FMR1P function in regulating the translation of specific mRNAs (Figure 5.24), such 
as that of the Futsch protein, a Drosophila homologue of the microtubule-associated 
protein lb (MAPIB) (Zhang et al., 2001). In this model CYFIP binds to activated 
Rac-GTP, and then FMR IP and WAVE are released and activated so they can 
regulate the tubulin and actin cytoskeleton, through the control of specific mRNA 
translation of proteins such MAP IB and through the Arp2/3 complex, respectively 
(Billuart et al., 2003). Although this model suggests that FMR1P is inactive when 
bound to CYFIP, it does not provide further information about the importance of the 
complex for FMR1P stability. For instance, Hem and Abi are both components of the 
inactive Scar complex. It has been reported that Abi protects the Scar complex from 
proteosome degradation (Kunda et al., 2003). In the case of reduced levels of Abi, it is 
possible that CYFIP is degraded. Thus, the reduced level of FMR IP in Abi plus Hem 
knockdown cells suggests that maybe the FMR1P/CYFIP complex is important for 
stabilising FMR IP in the same manner as for the SCAR complex proteins. However 
to prove such a model further experiments are needed.
Lower levels of FMR IP were also detected in PTEN RNAi-treated cells. This 
suggests that increased PIP3 levels, which could keep Rac activated, would sequester 
CYFIP2, releasing FMR1P from the complex, leading to FMR1P degradation. The
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level of FMR IP was also reduced in cofilin RNAi-knockdown cells. There are no 
reports linking cofilin function with FMR1P; however, this seems an interesting 
observation and possibly suggests feedback from the actin cytoskeleton. However, it 
is important to note that the three knockdown conditions displaying decreased levels 
of FMR1P, all differed in cell shape and actin organisation.
RacGDP
RacGTP
CYFIP2
FMRP/CYFIP2 
Inactive ?
WAVE
inactive
RacGTP
FMRP/FMRPWAVE active
CYFIP
mRNA
polyribosomes
Arp2/3 complex 
Activation
Local regulation of translationActin nucleation
Local remodelling of actin
Figure 5.24 Rac-dependent regulation of protein translation by FMR1P and FMR1P 
indirect control of actin cytoskeleton organisation by FMR1P. Adapted from Billuart et 
al, 2003.
Four abundant actin binding proteins (Arp3, misato, annexin B ll and cofilin), 
were differentially expressed under the RNAi conditions applied in this study. Arp3 
(CG7558) was found to be downregulated in cells subjected to Arp3 RNAi-induced 
silencing, showing that the protein knockdown strategy had been successful. Arp3 is a 
part of the Arp2/3 complex, consisting of seven subunits, two of which are related to 
actin (Arp2 and Arp3) and five of which are unique. Arp2/3 is a nucleator of new 
actin filaments at the leading edges of cells and its activity is regulated by proteins of 
the WASP and WAVE family, which are in turn controlled by signals from receptor 
tyrosine kinases and the small GTPases Cdc42 and Rac. The active Arp2/3 complex 
promotes de novo actin nucleation and polymerisation supporting cortical actin
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formation in adherent cells. Thus, disrupting the Arp2/3 complex in S2R+ resulted in 
cells with reduced F-actin staining and loss of cortical actin lamellipodia gives rise to 
a starfish-like phenotype, similar to its upstream regulators Rac, Cdc42 and Abi plus 
Hem. Despite this, changes in expression of Arp3 did not appear in the other 
knockdown treatments, suggesting that expression of this protein itself is not 
regulated by the upstream targets in the signalling cascade.
Another putative component of the cytoskeleton which was differentially 
expressed only in Arp3 RNAi-treated cells was misato. Misato (beautiful dawn) is an 
“orphan” gene that encodes a descendant of an ancestral tubulin-like protein, and 
exhibits motifs with similarity to members of a GTPase family that include eukaryotic 
tubulins and myosin heavy chain (Miklos et al., 1997), but with no known role in 
actin cytoskeletal organisation. Misato is associated with several chromosomal 
aberrations in Drosophila and null mutations at the misato locus of D. melanogaster 
are associated with disorganisation of the spindle apparatus and irregular 
chromosomal segregation at cell division, leading to cell death (Miklos et al., 1997). 
Misato expression was increased in cells with a reduced level of Arp3 protein and 
may occur in response to disrupted actin organisation which may effect organisation 
of microtubules. However, deregulation of misato expression was not been observed 
in other knockdowns (e.g. Racl plus Rac2, Cdc42, cofilin, Abi plus Hem) that affect 
the actin cytoskeleton.
Annexin Bl l ,  an actin and lipid binding protein, was found to be differentially 
downregulated in the control for RNAi treatment (GFP RNAi) and in most of the 
RNAi experiments, suggesting that this change is an off-target effect of the RNAi 
mechanism. Drosophila annexin B ll is a member of the annexin family, which are 
calcium-dependent phospholipid-binding proteins (Gerke et al., 2005). They are 
abundant in the eukaryotic kingdom. Annexins are characterised by the unique 
architecture of their Ca binding sites, which enables them to peripherally dock onto 
negatively charged membrane surfaces (to acidic phospholipids) in their Ca bound 
conformation. These properties link annexins to many membrane-related events, such 
as the regulated organisation of membrane domains and/or membrane-cytoskeleton 
linkages, certain exocytic and endocytic transport steps and the regulation of ion
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fluxes across membranes. Most of the studies on annexins show that they often 
function as modulators of these processes, rather than as essential effectors. 
Importantly, annexins can participate as actin-binding proteins and serve directly as 
an F-actin interaction platform, especially in regions enriched with PIP2 or highly 
dynamic actin (Gerke et al., 2005). It has been reported that annexins are involved in 
endocytosis (Rescher and Gerke, 2004), so the finding of differentially expressed 
annexin B ll even in the RNAi negative control suggests that it could be involved in 
dsRNAs uptake, which in fly cells is mediated by endocytosis. Recently, the pathway 
for dsRNA uptake was identified in D. melanogaster S2 cells (Saleh et al., 2006), 
with dsRNA entering the RNAi pathway through an active and specific pathway that 
involves clathrin-mediated endocytosis and vesicle-mediated intracellular trafficking 
that depends upon lipid and cytoskeleton guidance. Considering the biochemical and 
physiological properties of annexins, the findings reported here could suggest the 
involvement of annexin B11 in dsRNA uptake. However, this needs to be examined 
further. Three other proteins were also differentially expressed in GFP RNAi-treated 
cells, but they could not be identified.
Cofilin (twinstar, CG4254) is another cytoskeletal regulatory protein, which was 
found to be differential expressed in Racl plus Rac2, Cdc42, Abi plus Hem, Arp3, 
PTEN, pi 10 and cofilin RNAi-knockdown cells. Cofilin is an actin binding protein 
potent in severing and depolymerising F-actin, and thus supports the actin recycling 
(Bamburg, 1999). Here, two isoforms of cofilin were identified. Using a TiC>2 
phosphopeptide-enrichment strategy (Larsen et al., 2005) the acidic cofilin isoform 
was found to be phosphorylated at Ser3. This post-translational modification of cofilin 
has been identified in systems and is known to inhibit the actin binding ability of 
cofilin (Agnew et al., 1995). In addition, LC-MS/MS analysis of the enriched 
phosphopeptides from the acidic cofilin isoform revealed that cofilin could be 
partially phosphorylated on Thr6 and Ser8, although this finding needs further 
examination. The basic cofilin isoform was not phosphorylated and represents the 
active form of cofilin in cells. The two isoforms were downregulated in cofilin 
knockdown cells, confirming the success of the RNAi strategy. pCofilin was 
differentially upregulated in cells subjected to the RNAi-mediated knockdown of 
expression of pi 10, double Racl plus Rac2, Arp3, Cdc42, and downregulated in
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PTEN, Abi plus Hem and cofilin RNAi-treated cells. The observation of opposing 
expression of pCofilin levels in pi 10 and PTEN RNAi-treated cells compared to the 
control cells, suggests that regulation of cofilin phosphorylation and activity occurs 
downstream of PI3K. However, pCofilin did not appear to be differentially expressed 
in Ras and Akt RNAi-treated cells, suggesting that PI3K probably regulates cofilin 
activity through interaction with another signal transduction pathway, possibly 
through regulation of Rho GTPases. Indeed pCofilin levels were increased Racl plus 
Rac2 and Cdc42 RNAi treatments. Surprisingly, pCofilin was also found to be 
upregulated in Arp3 knockdown cells. Since the Apr2/3 complex is directly linked to 
actin and regulates polymerisation and branching of the actin network, this suggests a 
possible negative feed-back mechanism in the regulation of cofilin severing activity 
on F-actin. Conversely, the double knockdown of Abi and Hem cells were found to 
express a lower level of phosphorylated cofilin. Both proteins regulate the stability of 
the WAVE protein in WAVE complex and thus are implicated in actin polymerisation 
through the Arp2/3 complex (Kunda et al., 2003). It would be expected that 
knockdown of Abi and Hem should give the same phenotype as Arp3 knockdown 
cells, which was the case in terms of their similar cell morphologies, but not in terms 
of cofilin phosphorylation. This difference is difficult to explain at this stage of the 
analysis and would require further examination. However, the finding of pCofilin as a 
common target for two major signalling pathways was a potentially exciting 
discovery. Thus, cofilin regulation by PI3K signalling and Rho-family of small 
GTPases was the subject of further study and it is presented in the following chapter.
Finally, albumin and antitrypsin were identified as differentially expressed proteins 
in the proteome of pi 10, Akt and Ras knockdown cells. Albumin and antitrypsin 
proteins were derived from the foetal calf serum used in the medium and were thus 
characterised as contaminates. However, the expression changes were statistically 
significant suggesting possible changes in adhesive properties of the RNAi targeted 
cells.
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5.4.2 Morphological changes observed and common protein 
expression patterns among the RNAi-treated cells
RNAi-induced loss-of-gene function analysis used for selected Rho GTPases and 
components of the WAVE/Scar and Arp2/3 complexes produced results that 
confirmed the importance of these genes in determining cellular morphology and 
actin organisation and supports previous observations in S2R+ cells (Kiger et al., 
2003; Kunda et al., 2003). Loss of these proteins has shown to result in common 
“starfish-like” phenotypes, which place these proteins in the same signalling cascade 
that regulates F-actin remodelling and cortical lamellipodia formation (Kunda et al., 
2003). These phenotypes were characterised by deregulation of some common 
proteins involved in cellular stress responses (Hsp60 and Hsp68, peroxiredoxin) 
which could suggest that the loss of actin structure induces cell stress and causes the 
observed upregulation in the expression of these proteins. Cofilin RNAi cells were 
distinguished by their high levels of F-actin staining, presumably due to the loss of 
cofilin’s ability to depolymerise F-actin. Cofilin knockdown cells showed similarities 
in their proteome profile with PTEN and Abi plus Hem knockdown cells, but differed 
in cell morphology. Furthermore PTEN knockdown cells were larger and showed 
signs of stress fibres structures. The cells also appeared to have an adhesion defect 
because they were only weakly attached to the culture dishes. In addition, the PTEN 
knockdown cells displayed a unique proteomic phenotype with a potential increase in 
anaerobic glycolysis, suggesting that there is misbalance in their redox homeostasis. 
This observation was further supported by the cells increased expression of GST 
proteins and decreased expression of a peroxiredoxin. Interestingly, cofilin, Abi plus 
Hem and PTEN knockdown cells, although displaying different morphologies, had 
some common differentially expressed proteins, which including downregulation of 
the same metabolic enzymes and downregulation of cofilin phosphorylation.
PI3K knockdown resulted in only a moderate degree of actin reorganisation 
phenotype compared to that of the PI3K inhibitors on the actin cytoskeleton reported 
in the previous chapter. This would suggest that the acute inhibition of the PI3K 
signalling has a more rapid and prominent effect on the actin cytoskeleton, while in 
the RNAi-mediated knockdown the perturbation of PIP3 levels may be less intensive,
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with any remaining PI3K permitting formation of normal cortical F-actin structures as 
well as allowing time for adaptive response that maintain the cell shape. Adaptive 
responses could be a general reason to explain differences between acute (inhibitor 
and insulin) responses and chronic responses (RNAi). However, it has to be 
mentioned that PI3K inhibitors may also produce off-target effects, as both LY294002 
and wortmannin may not be absolutely specific for Drosophila PI3K and could 
possibly inhibit other kinases. Thus, it was important to test/compare both strategies. 
Akt knockdown cells also remained relatively unaffected in terms of their actin 
organisation despite the fact that Akt was shown to be almost completely depleted in 
the knockdown. This could mean that signalling downstream of Akt may not feed into 
cytoskeleton regulation despite some recent reports where it does (Vandermoere et al., 
2007). This result was also in contrast to the loss of Akt phenotype that was observed 
in the genome wide screen by Kiger et al where cells were seen as flat, but displayed 
retracted F-actin (Kiger et al., 2003). These contradictory results required that the Akt 
knockdown be repeated several times, including targeting the same region of the 
mRNA sequence as was in Kiger study. However, this revealed the same phenotype, 
without obvious changes in the actin cytoskeleton. Furthermore, Ras knockdown cells 
displayed different morphology from PI3K and Akt knockdown cells, even though it 
has been reported that Ras can act upstream of PI3K. Ras knockdown cells were 
significantly smaller than the control cells, and appeared to have perturbed actin 
cytoskeleton organisation. However, their proteomic profile with changes only in 
metabolic enzyme did not reflect the morphological phenotype of the respective 
knockdown observed.
In summary, the work I carried out and described in this chapter has revealed the 
power of 2D-DIGE for quantitative analysis of differential protein expression in the 
fly proteome. Preliminary work on different cell lines helped to establish the 
application of 2D-DIGE method for the proteomic analysis of fly cell proteomes. 
Further analysis was not performed since the differences observed were too numerous 
and unlikely to reflect differences in cell morphology alone. Combining an RNAi 
approach for gene silencing with 2D-DIGE analysis proved a valuable strategy for 
defining the biochemical profiles of cells where crucial signalling molecules and actin 
modulators where absent due to RNAi-mediated gene silencing. Furthermore, some
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common protein targets, presumably acting downstream of the silenced genes were 
detected. One such protein was cofilin, whose phosphorylation, and hence activation, 
appeared to be regulated by both PI3K and the Rho-family of small GTPases, 
suggesting that PI3K and Rac signalling are positively regulated in the same 
signalling cascade for cofilin regulation. Thus, it can be proposed that in combination 
with RNAi, 2D-DIGE can be used for monitoring cell signalling events and the 
regulation of protein expression, although only for reasonably abundant proteins. 
Importantly, this study opened up the question of the possible negative regulation of 
cofilin activity by actin itself, as it appeared that perturbations of the Arp2/3 complex 
can also alter cofilin activity. Cofilin regulation was the subject of further 
experimentation and is presented in the following chapter.
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Chapter 6: Regulation of cofilin phosphorylation and 
activity
6.1 Cofilin - an actin severing and depolymerising protein
Actin is the most abundant protein in eukaryotic cells and its ability to assemble 
reversibly into long and flexible polymeric filaments and to form a three-dimensional 
meshwork provides the foundation upon which many essential cellular processes (e.g. 
cell division, motility, and determination of shape) rely. Performing these functions 
demands strict regulation of the spatial and temporal organisation of the actin 
cytoskeleton. This is facilitated on many levels by a myriad of accessory actin- 
binding proteins such as sequestering proteins (thymosin £4 and profilin), capping 
proteins (CapZ), proteins that stimulate polymerisation from the pool of actin 
monomers in a process known as nucleation (Arp2/3 complex and formins) and 
proteins that break or “sever” actin filaments and drive depolymerisation (actin 
depolymerising factor (ADF)/cofilin). In addition, numerous signalling pathways feed 
into this system, relaying extracellular stimuli to induce changes in the actin 
cytoskeleton. The primary structure of actin is highly conserved among eukaryotes. 
Monomeric G-actin is a 43 kDa globular protein with four subunits. ATP, together
04-with Mg binds to G-actin and can be hydrolysed to ADP+Pi. Actin polymerisation 
occurs in an organised manner, involving head-to-tail interactions, producing filament 
polarity where each filament has a pointed (-) end and a barbed (+) end. During 
filament growth, incorporation of actin monomers occurs from both ends, however 
this addition of actin monomers loaded with ATP is asymmetric, such that the barbed 
end elongates five- to ten-fold faster than the pointed end.
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Cofilin is a member of a group of small actin-binding proteins (15-22 kDa), 
collectively called the ADF/cofilin family that includes destrin, depactin, actophorin, 
and actin depolymerising factor (ADF), and promotes actin depolymerisation 
(Bamburg, 1999). The first member of this family, ADF, was identified in extracts of 
embryonic chick brain (Bamburg et al., 1980), whereas cofilin was purified from 
porcine brain four years later (Maekawa et al., 1984). Cofilin was characterised 
primarily as an F-actin binding protein (1:1 ratio with actin subunits) and hence was 
named for its ability to form cofilamentous structures with actin (Nishida et al., 1984).
The cofilin structure is characterised by the presence of two actin-binding sites; a 
G/F-site at the N-terminus and an F-site at the C-terminus, thus cofilin can interact 
with both actin monomers and actin-ADP filaments. The G/F site is responsible for 
both G- and F-binding and is sufficient for cofilin depolymerising activity. The F- 
binding site is required in addition to the G/F site for F-actin binding and severing 
activity. Studies on cofilin have shown that cofilin binds G-actin-ADP with greater 
affinity than G-actin-ATP at physiological ionic strength. Cofilin also binds F-actin- 
ADP with greater affinity than it binds to F-actin-ATP or F-actin-ADP+Pi (Carlier et 
al., 1997). Upon binding to actin filaments, cofilin increases filament twist (McGough 
et al., 1997) and promotes the turnover of the filaments by increasing the dissociation 
rate of the monomers at the pointed (-) end of actin filaments without capping the 
actin filament ends (Carlier et al., 1997), thereby increasing the number of free barbed 
ends where polymerisation and depolymerisation can occur. The mechanism of cofilin 
in enhancing actin filament turnover appears to be pH-dependent, as cofilin exhibits 
stronger depolymerising activity at pHs above 7.5 than at lower pHs. This pH 
dependence is due to an increase in the critical concentration for actin-cofilin complex 
formation at higher pHs.
Phosphorylation of cofilin at a conserved serine-3 residue at the N-terminus 
inhibits its actin binding activity (Agnew et al., 1995). Several studies have used 
recombinant mutants of cofilin containing an Asp or Glu substitution at Ser3 (or 
equivalent) to mimic the negative charge of the phosphorylation form. These proteins 
had a decreased affinity for actin of 10-20 fold when assayed in vitro (Agnew et al.,
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1995; Smertenko et al., 1998; Ressad et al., 1998). Four different kinases that appear 
to act downstream of the Rho-family GTPases can phosphorylate cofilin: LIMK1, 
LIMK2, TESK1 and TESK2 (Yang et al., 1998; Arber et al., 1998; Dan et al., 2001; 
Rosok et al., 1999; Toshima et al., 2001; Sumi et al., 1999). However, LIMK is the 
key factor in the cofilin phosphorylation across different eukaryota. LIMK is activated 
by phosphorylation of Thr508/505 (LIMK1/2) within a kinase loop, through divergent 
Rho GTPase pathways: Rac/Cdc42 acting through p21 -activated kinase 1 (PAK1) and 
PAK4 (Edwards et al., 1999; Dan et al., 2001), Cdc42 acting through MRCK 
(myotonic-dystrophy-related Cdc42 binding kinase) (Sumi et al., 2001) and Rho A 
through ROCK (Rho associated coiled-coil-containing kinase) (Ohashi et al., 2000). 
Thus, members of the Rho-family GTPases, which regulate the organisation of actin 
into lamellipodia, filapodia and stress fibres in animal cells, show a common 
mechanism in the ability to regulate actin dynamics through phosphorylation of 
cofilin. Functionally, LIMK promotes F-actin stability through cofilin 
phosphorylation and inactivation, as LIMK overexpression in cells promotes F-actin 
accumulation (Arber et al., 1998; Yang et al., 1998). Two selective cofilin 
phosphatases have also been identified; chronophin (CIN) (Gohla et al., 2005) and 
slingshot (SSH) (Niwa et al., 2002). SSH was identified from genetic studies in flies 
(Niwa et al., 2002), and is widely expressed in various organisms. SSH can 
dephosphorylate cofilin at Ser3, thereby suppressing the assembly of actin filaments 
induced by LIMK-dependent phosphorylation and inactivation of cofilin (Figure 6.1). 
In addition, it has been reported that endogenous LIMK1 and SSH-1L interact in vitro 
and co-localize in vivo, and this interaction results in SSH-lL-induced 
dephosphorylation and downregulation of LIMK1 activity (Soosairajah et al., 2005). 
Also the phosphatase activity of purified SSH-1L appears to be F-actin dependent and 
is negatively regulated via PAK4-mediated phosphorylation at Ser937 and Ser978 
sites (Yamamoto et al., 2006; Soosairajah et al., 2005). 14-3-3 zeta protein can also 
bind to phosphorylated SSH, thus decreasing the amount of SSH that binds to F-actin 
and its activity to dephosphorylate and activate cofilin (Nagata-Ohashi et al., 2004).
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Figure 6.1. The activity of ADF/cofilin is regulated by a balance of phosphorylation and 
dephosphorylation. Through filament severing and increasing the off-rate from the pointed 
(-) ends o f actin filaments, ADF/cofilin enhances filament turnover. If the pool o f assembly- 
competent actin is high where ADF/cofilin is active, net assembly can occur on the new 
barbed (+) ends. However, if  the actin monomer pool is low, net depolymerization will occur. 
Mammalian ADF and cofilin are inhibited in their activity towards actin binding and 
dynamics by kinases LIMK that phosphorylate the proteins on the conserved Ser-3 residue. 
Dephosphorylation by phosphatases such as slingshot, SSH, activates them.
In addition to this, other actin binding proteins including tropomyosin, profilin, 
actin-interacting protein (Aipl) and cyclase associated protein (CAP) can interfere 
with cofilin-dependent actin filament dissociation (reviewed in (Ono, 2003). In 
general, tropomyosin competes with cofilin for F-actin binding and inhibits 
depolymerisation. However, in different cell models the spatial organisation between 
cofilin and tropomyosin differs suggesting that both could regulate different types of 
actin reorganisation. Profilin, on the other hand, binds G-actin enhancing the 
exchange of actin-bound ADP with ATP, and promotes filament growth from barbed
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ends. However, when the barbed ends are capped, profilin sequesters actin monomers. 
Profilin also competes with cofilin for G-actin and enhances exchange of actin-bound 
nucleotide in the presence of cofilin, thereby increasing the rate of actin turnover 
synergistically with cofilin. Aipl specifically enhances cofilin activity for filament 
disassembly, as it caps barbed ends, and binds to the side of severed filaments (Okada 
et al., 2006). CAP binds and sequesters G-actin and it stimulates dissociation of 
cofilin-G-actin heterodimers, thus releasing cofilin from the complex to allow cofilin- 
dependent depolymerisation of F-actin filaments from pointed ends. CAP also 
supports barbed end elongation by enhancing the exchange of ADP- with ATP-actin. 
This ability of CAP to release cofilin from its inhibitory complex with G-actin makes 
CAP a candidate for regulating the dephosphorylated pool of cofilin in vivo in many 
cell types.
Another mechanism for regulation of cofilin function is through its binding to 
PIP2. This binding inhibits the actin-binding activity of cofilin (Ojala et al., 2001; 
Yonezawa et al., 1991; Yonezawa et al., 1990). This mechanism is thought to be 
important event in the spatial regulation of cofilin activity at the cell cortex or leading 
edge of migratory cells. PIP2 can undergo hydrolysis mediated by PLCyl leading to 
activation of cofilin and other actin binding proteins and thus actin remodelling. 
(Yonezawa et al., 1991; Yonezawa et al., 1990). PIP2 can also be phosphorylated by 
PI3K, and this could lead to the release of cofilin from the inhibitory complex with 
PIP2 and its activation. In some studies of growth factor-mediated stimulation of 
cells, dephosphorylation of cofilin has been observed in the early time points of the 
stimulation. For example, in resting cells cofilin was found to be mostly 
phosphorylated, and stimulation with EGF, which activates PLCy induced 
dephosphorylation and activation of cofilin, which matched with early transient 
barbed end formation during a biphasic actin polymerisation process (Mouneimne et 
al., 2004). In addition, Nishita et al. have reported that in cultured cells, insulin- 
induced activation of PI3K signalling stimulated cofilin dephosphorylation and its 
localisation to membrane protrusions through PI3K-dependent regulation of SSH 
activity (Nishita et al., 2004). However, the acute regulation of cofilin 
phosphorylation seems to vary by cell type, since in some cells stimulation induces 
changes in the net phospho-cofilin levels, while in other cells a significant increase in
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phospho-cofilin turnover is observed (Arai and Atomi, 2003), indicating the 
complexity of the regulatory mechanism. Thus, currently it is not clear whether a lack 
of kinase activity is sufficient to cause a decrease in cofilin phosphorylation that can 
results in cofilin activation, or whether phosphatase activity is also necessary. 
Differences between cell types can complicate the analysis because the level of G- 
actin or F-actin in vivo at the start of an experiment might also dictate the outcome.
The ability of eukaryotic cells to control and coordinate cortical actin filament- 
based protrusive activity suggests the existence of cellular machinery that monitors 
and regulates actin filament levels. In the previous chapter, I adopted an unbiased 
approach, using 2D-DIGE to search for protein isoforms that are sensitive to RNAi- 
induced changes in actin cytoskeleton regulators and mediators of lamellipodia 
formation such as Rac, Cdc42, Arp3 and Abi with Hem. Cofilin phosphorylation at 
Ser3 was identified as a common response to the loss of expression of these proteins. 
In addition, pSer3-cofilin levels were also altered in opposing directions by changes 
in the level of PIP3, induced following PI3K and PTEN RNAi treatments. This data 
suggested that the level of cofilin phosphorylation is responsive to changes in actin 
organisation and is probably regulated by actin signalling events downstream of PIP3. 
Thus, the main aim of my work in this chapter was to examine the signalling 
mechanism behind the control of cofilin phosphorylation and its regulation of actin 
cytoskeleton in fly haemocytes.
6.2 The kinetics of cofilin phosphorylation and actin remodelling 
following an acute stimulation
Since I had observed opposite changes in the expression of cofilin phosphorylation 
in cells that lacked PI3K and PTEN when grown at steady state, my next aim was to 
examine the dynamics of cofilin phosphorylation in cells that undergo acute changes 
in actin cytoskeleton organisation, induced by activation of PI3K signalling. In 
Chapter 4, I identified insulin as a potent stimulus that activates PI3K signalling and 
dynamic actin remodelling (Figure 4.2, 4.9 and 4.13). Thus, an immunoblotting 
strategy was employed to test if cofilin phosphorylation is responsive to the acute
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activation of PI3K signalling and to asses the dynamics of insulin-induced changes in 
cofilin phosphorylation. Firstly, serum-starved S2R+ cells were stimulated with 
insulin and cofilin phosphorylation was examined over a time course. Cofilin was 
phosphorylated transiently on Ser3 in response to insulin, gradually peaking at 30 
minutes, after which it started to decline (Figure 6.2).
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Figure 6.2 Time course of insulin-induced phosphorylation of cofilin. S2R+ cells were 
grown in serum-free medium overnight and stimulated with 10 pg/mL insulin for the 
indicated times. Protein lysates were subjected to western blotting with anti-phospho-Ser3 
cofilin antibody. Blots were analysed by densitometry. Values represent the mean phospho- 
cofilin signal from two experiments after normalising with respect to (3-actin levels.
Having observed that insulin can induce phosphorylation of cofilin, as well as the 
robust activation of the PI3K signalling, the next aim was to determine if this 
phosphorylation event was indeed PI3K-dependent. For this purpose, the PI3K 
inhibitor LY294002 was used to block insulin-dependent activation of PI3K. Pre­
incubation of S2R+ cells with LY294002 significantly reduced the ability of insulin to 
induce cofilin phosphorylation, suggesting that this cofilin phosphorylation is 
dependent upon PI3K activity (Figure 6.3).
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Figure 6.3 LY294002 blocks insulin-induced phosphorylation of cofllin. S2R+ cells were 
pre-treated for 20 minutes with LY294002 (100 pM) or DMSO vehicle prior to insulin 
treatment (10 pg/mL), or with neither 20 minutes. Lysates were prepared and subjected to 
western blotting analysis for pSer505-Akt, p-actin and pSer3-cofilin.
Since PIP3 production is required in S2R+ cells for the maintenance of an actin- 
rich cortex, the normal ruffling behaviour of resting cells, for insulin-induced actin 
polymerisation and for cofilin phosphorylation, my next task was to perform 
functional analysis of cofilin phosphorylation during acute actin signalling. LIMK and 
slingshot (SSH) have been previously identified in Drosophila and other systems as 
the major cofilin kinase and phosphatase, respectively. Thus, RNAi-induced 
knockdown of expression of both LIMK and SSH was first carried out and the levels 
of Ser3-cofilin phosphorylation were assessed in these cells. In addition, these cells 
and cofilin RNAi treated cells were stained with rhodamine phalloidin to examine the 
cytoskeleton organisation. It was observed that silencing of LIMK and SSH genes 
resulted in a decrease and increase in the basal phosphorylation of cofilin, 
respectively, confirming their known role in regulating cofilin phosphorylation 
(Figure 6.4). As expected, cells treated with dsRNA against cofilin displayed virtually 
no cofilin expression.
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Figure 6.4 LIMK and slingshot are major regulators of cofilin phosphorylation. S2R+ 
cells were left untreated (Ctrl) or treated with dsRNAs for knockdown o f expression of  
LIMK, SSH and cofilin for five days. Cells were lysed and pSer3-cofilin and p-actin levels 
were assessed by immunoblotting.
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Five days after the incubation with dsRNAs, cofilin knockdown cells displayed a 
more rounded morphology with an increase in the level of F-actin staining (Figure 
6.5). This suggests that in the absence of cofilin, new actin polymerisation continuous 
unregulated, because of the loss of F-actin severing and depolymerisation in these 
cells. In addition, most of the cells appeared to be multinuclear, suggesting a defect in 
cytokinesis, a role that has been previously assigned to cofilin (Nagaoka et al., 1995). 
On the other hand, SSH and LIMK knockdown cells did not display any major 
disturbance in F-actin organisation or gave any major distinguishable phenotype 
(Figure 6.5). They also did not display signs of altered cytokinesis as most of the cells 
were mononuclear.
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Figure 6.5 Actin organisation in cells lacking cofilin and its respective kinase and 
phosphatase. S2R+ cells were left untreated or treated with dsRNAs for knockdown of 
expression of LIMK, SSH and cofilin (TSR) for five days. On day five, cells were fixed and 
stained for filamentous actin with rhodamine phalloidin (1:1000) and nuclei with DAPI 
(1:5000). Images were acquired by a fluorescence microscopy at 20x magnification. Scale bar 
= 100 pm.
Phalloidin DAPI Merged
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Next, to study of actin dynamics and membrane ruffling over time stimulation with 
insulin LIMK, SSH and cofilin RNAi-knockdown S2R+ cells were stained for actin 
before and after insulin stimulation and filmed by fluorescence time-lapse microscopy 
(Figure 6.6 A and B). For the microscpy, cells were infected with baculovirus 
harbouring a GFP-moesin actin-binding domain fusion protein. This experiment 
confirmed the previously observed cortical actin reorganisation of cortical actin and 
increased membrane ruffling in response to insulin stimulation (Figure 6.6 B). Cofilin 
knockdown cells were unable to reorganise actin or to ruffle in response to insulin, 
suggesting a role for cofilin in insulin-induced actin polymerisation and 
reorganisation, as previously described (Ghosh et al., 2004). In addition to this, SSH 
silencing caused a significant reduction in the cell’s ability to mount a protrusive 
response to insulin stimulation (Figure 6.6 B). However, the overall morphology and 
actin distribution of SSH knockdown cells were maintained (Figure 6.6 A). 
Controversially, cells expressing reduced levels of LIMK had a well-defined cortical 
lamella and ruffled intensively before and after insulin stimulation. This suggested 
that active unphosphorylated cofilin is required for insulin-dependent membrane 
ruffling, rather than simply for depolymerisation. Genes known to be required for 
lamellipodia formation (Racl plus Rac2 and Arp3) were also silenced by RNAi to 
allow examination of their role in insulin-induced actin reorganisation. Both 
knockdowns displayed a common “starfish-like” phenotype, and both knockdowns 
appeared unable to mount a morphological response to insulin treatment. These data 
confirmed that the Rac-Arp2/3 signalling cascade is required for the generation of 
new F-actin-based protrusions downstream of acute PI3K signalling, as are active 
cofilin and SSH.
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Figure 6.6 Functional analysis of cofilin during acute actin-signalling. A) Actin staining 
of RNAi-treated cells stimulated with insulin. S2R+ cells were incubated with dsRNAs for 
LacZ, cofilin, LIMK, SSH, Racl+2 and Arp3 for five days. On day five, cells were treated 
with insulin (10 pg/mL) for 10 minutes. Cells were then fixed and stained for F-actin with 
rhodamine-palloidin. Scale bars = 50 pm. B) Visualisation o f actin dynamics in dsRNA- 
treated cells using moesin-GFP. Snapshots o f time-lapse movies just prior to insulin addition 
are shown on the left. Scale bars = 50 pm. The two lines used to generate the kymographs 
(right hand side) are indicated on the cell images. Actin reorganisation was filmed for 3 
minutes before and for 10 minutes after the addition of insulin (10 pg/mL), with the white line 
on each kymograph representing the point o f insulin addition (O’). Images are representative 
of two independent experiments.
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The proteom ic analysis presented in Chapter 5 showed that cells lacking 
lamellipodia (R acl plus Rac2, Cdc42 or Arp3 RNAi knockdown cells) express 
relatively high levels o f  inactive phosphorylated cofilin. This suggested that changes 
in cofilin phosphorylation m ight result directly from changes in the cellular levels o f  
actin filaments and not as a response to upstream signalling events. In support o f  this 
idea, cells lacking R acl and Rac2 maintained high levels o f  cofilin phosphorylated at 
Ser3 independent o f  insulin addition (Figure 6.7). Similarly, SSH RNAi treated cells, 
which showed an impaired ruffling response, also did not display dynamic changes in 
cofilin phosphorylation in response to insulin/PI3K signalling (Figure 6.7).
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Figure 6.7 Immunoblotting analysis of pSer3-cofilin and pSer505-Akt in Racl plus Rac2 
and SSH RNAi-treated cells stimulated with insulin. S2R+ cells were cultured in the 
presence of dsRNAs for knockdown of LacZ, Racl plus Rac2 and SSH for five days and then 
treated with 10 pg/mL insulin for the indicated times prior to lysis and immunoblotting. 
Samples were analysed for pSer3-cofilin, pSer505-Akt and P-actin. P-actin immunoblotting 
served as a loading control.
6.3 Regulation of cofilin phosphorylation by actin-targeting agents
To explore in more detail i f  changes in F-actin organisation are sufficient to 
directly alter Ser3-cofilin phosphorylation and activity, I used actin-targeting agents 
to induce acute changes in the relative levels o f  cellular F- and G-actin. Tw o different 
groups o f  actin-targeting agents were used, those that inhibit filament assem bly or 
destabilise filaments (latrunculin B and cytochalasin D), and those that stabilise actin 
filaments (jasplakinolide). Latrunculin cytotoxins are potent inhibitors o f  actin 
filament formation, which are isolated from the Red Sea sponge Negombata
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magnified (Spector et al., 1983). The effect o f  latrunculin B on actin is strictly limited 
to actin m onom er sequestering, which is due to the conformational changes caused in 
actin m onomers after latruncluin B binding that prevents formation o f  stable 
interactions betw een m onomers (Morton et al., 2000). Cytochalasin D is a cell 
permeable m ycotoxin, which is isolated from Zygosporium mansonii. Cytochalasin D 
disrupts actin filam ents and inhibits actin polymerisation by binding with high affinity 
to growing (barbed) ends o f  actin filaments, and preventing addition o f  monomers to 
these sites (Casella et al., 1981). Jasplakinolide is an actin filament stabiliser that is 
synthesised by the marine sponge Jaspis johnsonis. It is a potent inducer o f  actin 
polymerisation and decreases the amount o f  sequestered actin in the cytoplasm  (Bubb 
et al., 1994; Bubb et al., 2000).
I treated S2R + cells with latrunculin B, cytochalasin D or jasplakinolide over a 
time course, and then protein lysates were subjected to immunoblotting o f  pSer3- 
cofilin levels. Both the G-actin sequestering compound, latrunculin B, and the barbed 
end capping toxin, cytochalasin D (both previously found to eliminate the actin-rich 
cell cortex in fly  haem ocytes (Kiger et al., 2003)), induced a steady increase in the 
levels o f  cofilin  phosphorylation over a period o f  30-60 minutes (Figure 6.8). 
Conversely, in resting cells, where actin polymerisation is induced by jasplakinolide 
treatment, basal phosphorylation o f  cofilin at the Ser3 site was rapidly eliminated, 
within the first few  m inutes o f  the jasplakinolide treatment (Figure 6.8). Notably, total 
actin levels were unaffected by any o f  the treatments. These data further supported the 
idea o f  there being a direct correlation between the levels o f  actin filaments present in 
the cells and the level o f  phosphorylated cofilin.
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Figure 6.8 The effects of actin-targeting agents on cofilin phosphorylation. Resting S2R+ 
cells were treated with latmnculin B (1 pg/mL), cytochalasin D (2 pg/mL) or jasplakinolide 
(1 pg/mL) for the times indicated. Protein lysates were subjected for immunoblotting to 
pSer3-cofilin and p-actin.
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However, to exam ine i f  cofilin  phosphorylation is a process regulated downstream  
o f  PI3K signalling itse lf  or it is regulated only by changes in the actin cytoskeleton in 
response to upstream signalling events, the actin drugs were tested in S2R+ cells 
subjected to insulin stimulation. This experiment showed that in latrunculin B pre­
treated cells pSer3-cofilin levels stayed high in both insulin-treated and untreated 
cells. Importantly, the jasplakinolide treatment com pletely blocked pSer3-cofilin  
accumulation in response to insulin. Thus, dynamic changes in the cofilin  
phosphorylation downstream o f  PI3K signalling are likely to be entirely regulated 
through changes in cortical actin filaments present in the cells, even in the case o f  
PI3K-mediated actin dynamics.
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Figure 6.9 Cofilin phosphorylation is not directly regulated by insulin signalling, but is 
dependent upon insulin-induced actin reorganisation. S2R+ cells were pre-treated with 
latrunculin B (1 pg/mL) or jasplakinolide (1 pg/mL) followed by 20 minutes o f insulin 
treatment (10 pg/mL) or vehicle alone. Protein lysates were subjected to immunoblotting for 
pSer3-cofilin, pSer505-Akt and P-actin.
In support o f  the hypothesis that there is an actin-dependent feedback control 
mechanism involving cofilin  phosphorylation, I performed experiments aimed at 
addressing whether the cofilin  kinase (LIMK) or cofilin phosphatase (SSH ) are 
sensitive to changes in actin hom eostasis during protrusive activity. Thus, after five  
days o f  RNAi treatment, I treated RNAi knockdown cells for LIMK and SSH with 
latrunculin B and jasplakinolide, respectively. In addition, double LIMK plus SSH  
knockdown cells were also treated with latranculin B or jasplakinolide. This 
experiment showed that cells lacking SSH blocked jasplakinolide-induced loss o f  
cofilin phosphorylation (Figure 6.10 A). This loss o f  jasplakinolide response appeared 
not to be due to raised levels o f  pSer3 cofilin in SSH RNAi cells, as SSH appeared to
204
Chapter 6
block the jasplakinolide-induced decrease in pSer3-cofilin levels in cells also lacking 
LIMK (Figure 6.1 OB).
A
pCofilin 
p-Actin
B
Jasplakinolide 
pCofilin
P-Actin
C
Latrunculin B 
pCofilin 
P-Actin
LIMK LIMK/SSH
-  10' 30’ 60’ -  10’ 30’ 60’ -  10’ 30’ 60’
m • ** m  •
II
SSH SSH+LIMK
0‘ 3‘ 10’ 30’ 0‘ 3‘ 10’ 30’
Jasplakinolide Latranculin B
SSH LIMK
- 10’ 30' - 10' 30' - 10' 30’ - 10’ 30’
■ *•
________
Figure 6.10 Slingshot is the major regulator of actin-dependent cofilin phosphorylation.
(A) SSH RNAi blocks jasplakinolide-induced loss o f cofilin phosphorylation. Control S2R+ 
cells and cells treated with dsRNA for knockdown o f expression of SSH were treated with 
jasplakinolide (1 pg/mL) for the times indicated and pSer3-cofilin and p-actin levels assessed 
in the lysates by immunoblotting. (B) LIMK RNAi does not reverse SSH RNAi blockade of 
jasplakinolide-induced loss o f cofilin phosphorylation. SSH and SSH plus LEMK RNAi cells 
were treated with jasplakinolide (1 pg/mL) for the indicated times and pSer3-cofilin and p- 
actin levels were assessed in lysates by immunoblotting. (C) The effect of LIMK and SSH on 
latrunculin B-induced cofilin-phosphorylation. Control, LIMK and LIMK plus SSH RNAi- 
treated cells were treated with latrunculin B (1 pg/mL) for the indicated times and pSer3- 
cofilin and P-actin levels in lysates were determined by immunoblotting.
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B y contrast, although RNAi-induced silencing o f  LIMK significantly reduced the 
overall levels o f  pSer3-cofilin, it was unable to suppress completely the changes in 
pSer3-cofilin levels seen upon treatment o f  cells with latrunculin B (Figure 6.10 C). 
Significantly, how ever, cells with RNAi-m ediated loss o f  expression for both LIMK  
and SSH overrode this latrunculin-induced increase in pSer3-cofilin levels. These 
results suggested that downregulation o f  SSH phosphatase activity after latrunculin 
treatment plays an important role in the regulation o f  the pSer3-cofilin response, as 
does its upregulation in the presence o f  jasplakinolide. Thus, SSH is likely to be the 
key regulator in actin-mediated cofilin  phospho-regulation in this system.
Finally, in support o f  the hypothesis that cofilin phosphorylation and activity 
depends on F-actin organisation or the ratio o f  G to F actin in cells, S2R+ cells were 
targeted for RN Ai-m ediated knockdown o f  expression o f  actin, CAP, profilin, cofilin  
(as a positive control o f  the RNAi-treatment) and LacZ (as a negative control o f  the 
RNAi-treatment). Levels o f  cofilin  phosphorylation in each knockdown were assessed  
by immunoblotting (Figure 6.11). This analysis showed that loss o f  actin expression  
itself leads to a robust increase in cofilin phosphorylation. In addition, pSer3-cofilin  
levels appeared not to change significantly in CAP and profilin knockdown cells.
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Figure 6.11 Cofilin phosphorylation in cells with loss of actin, CAP and profilin 
expression. pSer3 cofilin and P-actin levels were determined by immunoblotting in lysates of 
control (untreated) cells and cells treated with dsRNA targeting actin, profiling, CAP, cofilin 
and LacZ.
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6.5 Conclusions
The work reported in this chapter was carried out to examine the signalling 
mechanisms by which cofilin phosphorylation is regulated. The results showed that 
cofilin phosphorylation is regulated directly by changes in actin cytoskeleton that are 
driven by the signalling events upstream of actin and other actin binding proteins. 
Cortical actin polymerisation that drives membrane ruffling requires active cofilin, 
which can sever actin filaments, to provide new growing sites on F-actin, and can 
depolymerise F-actin to restore the G-actin pool, thereby facilitating actin recycling 
during dynamic changes in actin reorganisation. With this in mind, and knowing that 
insulin-induced cortical actin polymerisation and membrane ruffling were PI3K- 
dependent events, cofilin phosphorylation was examined under conditions of acute 
PI3K stimulation. I observed that cofilin phosphorylation is transiently induced upon 
insulin stimulation and this event was found to be PI3K-dependent. This was a 
surprising result, as the processes of actin polymerisation and cofilin phosphorylation 
were separated in time. Since actin polymerisation and PI3K activity peaked in the 
early minutes of the stimulation, whilst cofilin phosphorylation peaked later at 30 
minutes, it would be expected that cofilin is unphosphorylated and active during actin 
polymerisation. Unfortunately, due to lack of means to study the spatial organisation 
of cofilin and phosphocofilin at this stage of the analysis in fly cells, it is hard to 
predict where active and inactive pools of cofilin are localised within a cell. Thus, the 
analysis of the molecular mechanism that governs cofilin phosphorylation after 
growth factor-induced actin polymerisation could be a subject for future studies.
Moreover, in my analysis I observed that active cofilin was required for cortical 
actin polymerisation and membrane protrusions, since LIMK knockdown cells, where 
expression of inactive phosphorylated cofilin was found to be suppressed, displayed 
high basal cortical actin polymerisation that was further increased in response to 
insulin treatment. On the other hand, SSH silenced cells, where levels of inactive 
phosphorylated cofilin were significantly higher, had limited ability to mount a 
protrusive response to insulin stimulation, even though gross cellular morphology and 
actin organisation were preserved. Cofilin knockdown cells, although they had high 
levels filamentous actin, were not able to mount protrusive response to insulin
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stimulation, due to the possibility that no free G-actin is available for insulin-induced 
actin polymerisation. Furthermore, Racl plus Rac2 knockdown cells, which displayed 
high cofilin phosphorylation, were also unable to mount a morphological response to 
insulin treatment. All these results suggested to me that cofilin activity depends on 
upstream events controlled by small GTPases that drive actin polymerisation. A big 
surprise came from analysis of Arp3 RNAi-silenced cells, which like the Racl plus 
Rac2 knockdown cells, displayed a “starfish-like” phenotype with high levels of 
phosphorylated cofilin, and did not ruffle in response to insulin. Current knowledge 
about actin cytoskeleton signalling suggests that Arp2/3 complex and cofilin are 
functionally distinct towards regulating actin cytoskeleton dynamics. However, no 
reports exist about direct feed-back regulation mechanism between these proteins. In 
addition, both SSH and Racl plus Rac2 knockdown cells did not change the level of 
phosphorylated cofilin with insulin, suggesting that SSH is sensitive to filamentous 
actin dynamics and changes in F-actin induced by upstream signalling event. Thus, 
the data here suggested that cofilin phosphorylation/ dephosphorylation is dependent 
directly upon the changes in the F-actin dynamics. This hypothesis is in contrast to 
that based on several other studies where cofilin phosphorylation was reported to be 
regulated as a direct result of activation of LIMK or inactivation of SSH induced by 
Rho-family GTPase activity (Yang et al., 1998; Agnew et al., 1995; Soosairajah et al., 
2005).
To address the role of actin-dependent changes in mediating cofilin 
phosphorylation, I examined the effects of actin toxins on the cofilin phosphorylation 
in resting S2R+ cells. As previously reported in several studies and detected in my 
own experiments reported here, cofilin phosphorylation was induced upon treatment 
with G-actin sequestering or F-actin depolymerisation. On the other hand, cofilin was 
dephosphorylated upon jasplakinolide-induced polymerisation of F-actin. However, I 
did observe that insulin did not increase cofilin phosphorylation in cells pre-treated 
with jasplakinolide, furthermore proving that cofilin phosphorylation is not directly 
regulated by the upstream signalling events that derived from activated PI3K 
signalling, but is directly regulated by F-actin reorganisation. Thus, I propose SSH, 
which can bind actin filaments (Tanaka et al., 2005), to be the key regulator of this 
dynamic cofilin phospho-regulation and the sensor of changes in filamentous actin
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levels in S2R+ cells. This conclusion came from examining the contribution of the 
kinase and the phosphatase in affecting the change in cofilin phosphorylation induced 
upon altering the levels of filamentous actin. LIMK and SSH dsRNA were applied to 
reduce the rate of both forward and backward reactions. This analysis revealed that 
SSH knockdown was able to block the jasplakinolide-induced decrease in pSer3- 
cofilin levels in cells, and this effect was also observed in the cells lacking both SSH 
and LIMK. On the other hand, although RNAi-induced silencing of LIMK reduced 
the overall levels of pSer3-cofilin, it was unable to fully suppress changes in pSer3- 
cofilin levels seen upon treatment of cells with latrunculin B. Furthermore, addition of 
SSH dsRNA to LIMK RNAi cells blocked this latrunculin B-induced increase in 
pSer3-cofilin levels. This result suggests that the downregulation of SSH phosphatase 
activity after latrunculin treatment plays an important role in the regulation of the 
pSer3-cofilin response, as does its upregulation in the presence of jasplakinolide.
Finally, RNAi-induced silencing of actin also induced a robust increase in cofilin 
phosphorylation. This confirms the link between actin filaments and pSer3-cofilin, 
and suggests that free cofilin could serve as a substrate for constantly active LIMK in 
cells. Importantly, it also demonstrates that G-actin is not required for a change in F/G 
actin levels to be translated into change in the extent of cofilin phosphorylation. In 
addition, CAP and profilin knockdown cells showed no change in the cofilin 
phosphorylation. Recently it has been reported that both profilin and CAP work 
synergistically to drive nucleotide exchange (Bertling et al., 2007). Thus, I propose 
that both CAP and profilin induce exchange of G-actin-ADP into G-actin-ATP to 
release cofilin from the inhibitory complex with ADP-actin monomers, thus 
promoting actin turnover in fly haemocytes. In the absence of profilin and CAP, 
nucleoide exchange on G-actin is possibly limited, further blocking dissociation of 
cofilin from G-actin-ADP complex and limiting cofilin phosphorylation by LIMK, as 
well limiting the actin polymerisation. Under these conditions, both the kinase and the 
phosphatase are limited in their action, as LIMK can phosphorylate only free cofilin, 
and SSH activity is also decreased due to blocked actin polymerisation. However, to 
define the exact role of CAP and profilin in the cofilin phosphorylation more work is 
required and that could be a goal for further examination.
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In summary, the work in this chapter suggests that although both LIMK and SSH 
contribute to the regulation of cofilin phosphorylation, in S2R+ cells, SSH can be 
assigned as a major regulator in the cofilin phosphorylation as changes in the 
filamentous actin found to be responsible for dynamic changes in cofilin 
phosphorylation are mediated through actin-dependent SSH activity.
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Chapter 7: DISCUSSION AND FUTURE DIRECTIONS
Soon after completion of the first maps of the human genome by the Human 
Genome Project and the private company Celera in June 2001, the scientific 
community found itself in the 'post-genomic era' - where proteomics had taken a 
prominent position. Proteomics involves not only the systematic separation and 
cataloguing of all proteins produced in an organism, but also the study of how 
proteins are regulated, change structure and interact with other proteins and 
molecules, how they regulate biological pathways and cell processes and perhaps 
most importantly how protein changes can give rise to disease. Studying proteomes in 
detail is a challenging task, as the proteome differs from cell to cell in an organism 
and constantly changes as a consequence of responses to internal regulation and the 
environment. Since it was proposed that proteomic studies are key to understanding 
disease, and also in linked drug target discovery, it came as no surprise that many 
academic institutions, and biotechnology, computer and software companies around 
the world rushed to pour knowledge, expertise, resources and capital into this new 
research field. While this was happening, the process and technology of RNA 
interference were discovered. RNAi is a powerful genomic technology that allows 
analysis of gene function by post-transcriptional silencing of specific target genes and 
looking at how cellular function is perturbed.
For the studies described in my thesis, I have used a combination of technologies 
which includes a proteomic strategy based on 2D-DIGE and MS, and RNAi-mediated 
gene silencing, to identify targets of PI3K and Rho-GTPases signalling. I then further 
combined this RNAi strategy with biochemical and cell biology analysis to follow up 
on the role of the identified targets in the regulation of actin cytoskeleton dynamics. 
PI3K signalling is involved in the regulation of several important cellular processes
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including cell survival, proliferation, growth and metabolism (Vanhaesebroeck et al., 
2001). Deregulation of this pathway can lead to alterations in this very important 
signalling pathway that have been implicated in the origin and progression of diseases 
such as cancer, auto-immune disorders and diabetes. The complexity of changes in the 
activity of the PI3K signalling pathway arises as a result of interactions with other 
signalling pathways such as those involving the Rho family small GTPases, 
Ras/MAPK and JAK/STAT, which are involved in a complex signalling network that 
allows a cell to respond appropriately to different stimuli. Identifying the components 
of these signalling networks and understanding the control mechanisms and cross-talk 
that occurs between interacting signalling pathways, is a major challenge in cell signal 
transduction study. In my research program I was interested in exploring cross-talk 
between the PI3K and small GTPases signalling pathways and how it regulates the 
actin cytoskeleton and alters cell biology that is dependent on this system.
Initially, I used 2D gel-based proteomic and immunoblotting techniques in a 
functional proteomic analysis to detect and identify putative targets of the PI3K 
signalling pathway. Application of PI3K inhibitors and the use of kinase specific 
substrate antibodies, which recognized phosphorylation motifs for Akt, PDK1 and 
PKC showed that phosphorylation of several kinase substrates depends upon EGF- 
induced activation of PI3K signalling in mammary luminal epithelial cells HB4a. 
However, it was difficult to predict which proteins were changing from this analysis. 
The combination of 2D-DIGE and 2D immunoblotting, aimed at determining the 
substrates whose phosphorylation was changing upon PI3K-specific activation, also 
appeared not to be ideal strategy for functional protein analysis since observed 
changes in protein expression in 2D-DIGE analysis could not be matched to kinase- 
specific substrate detection by the immunoblotting technique often related to lack of 
reagents. However, some revealing targets, such as intermediate cytoskeleton 
filaments (cytokeratin 7 and cytokeratin 8), and membrane-cytoskeleton linkers 
(moesin and ezrin) were found in my work, to be differentially expressed upon EGF 
stimulation in HB4a cells, which implies a reliance on alterations in the cytoskeletal 
organisation and cell-to-cell contact in these cells to effect physiological changes .
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Since this human cell model was not ideal for many functional studies to study 
PI3K-dependent actin cytoskeleton reorganisation, a fly cell model, which had many 
other advantages, was developed instead. In Chapter 4 ,1 showed that insulin was able 
to activate PI3K signalling in haemocytes, a process where I used PI3K inhibitors to 
define growth factor induced changes in cell shape and dynamics of the cytoskeleton 
of Drosophila haemocytes. I also monitored the insulin-mediated alterations in the 
actin cytoskeleton using time lapse microscopy, immunostaining and immunoblotting 
techniques. These experiments showed that insulin activates the PI3K signalling 
pathway, and subsequently mediates actin reorganisation producing increased 
membrane ruffling and protrusive activity at the cell edges. The PI3K inhibitors, 
LY294002 and wortmannin, were used to show that these effects on the actin 
cytoskeleton were dependent upon PI3K activity. It is important to mention that this 
Chemical Genetic approach, as some workers call it, has its limitations; because these 
inhibitors used may also target other kinases. As I proposed earlier, the study of PI3In­
dependent actin reorganisation could well be extended by using more specific small 
molecule inhibitors that have been developed in recent years or by employing specific 
RNAi-mediated gene targeting. Most importantly, work that I developed has 
established a model cell system in which to study PI3K dependent signalling events 
and was the first dissection of PI3K-actin signalling in Drosophila haemocytes. My 
study also follows closely a recent report by Wood et al. of a role for PI3K in cell 
motility during fly development (Wood et al., 2006)
Using this Drosophila cell system, my next goal was to examine the biochemical 
mechanisms that allow PI3K to regulate changes in the actin cytoskeleton, and to test 
if this process is mediated by cross-talk with small GTPases, as has been suggested to 
be take place in other cell models. In this work I applied genomic and proteomic 
techniques in parallel. I used an RNAi “loss-of-function” approach in combination 
with quantitative 2D-DIGE to carry out differential protein expression analysis of 
RNAi- targeted cells. dsRNAs were used for disruption of the translation of selective 
target genes involved in PI3K signalling, Rho family small GTPase-mediated 
signalling and actin-binding proteins. The proteomic technique appeared to be ideal 
for monitoring changes in cytoskeletal proteins that have high cellular copy numbers. 
Through fluorometric scanning of gels, run with mixtures of control and treated
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samples, and cell lysates differentially tagged with dye fluorphores, differential 
protein expression profiles were quantified. I used mass spectrometry for the 
identification of certain proteins differentially expressed between control and RNAi 
treatments, and the identity of these proteins, as well as changes in their expression 
was validated by immunoblotting, where antibodies were available. During the work I 
identified a number of proteins and tried to link their effects in these experiments to 
their putative role in signal pathways. Among these proteins most were abundant 
cytoskeletal proteins, metabolic and redox enzymes. In parallel, I examined changes 
in the cell morphology (actin cytoskeleton) using fluorescence microscopy. My data 
showed that the combination of 2D-DIGE and mass spectrometry can be a powerful 
platform for protein expression profiling, and I was even able to detect changes in the 
phosphorylation of one targeted protein. In addition, the changes in the proteome I 
found were reflected in changes in the cellular phenotype of the knockdowns. For 
example, in PTEN knockdown cells which appeared to have an increased cell size, 
and alterations in the filamentous actin, which are presumably related to defects in 
adhesion, profiling of the proteome showed that some proteins that are involved in the 
regulation of redox homeostasis, protein synthesis and actin cytoskeleton organisation 
were differentially expressed. Also I found that cells where there was a loss of 
expression of the actin depolymerising protein cofilin, appeared to have high levels of 
filamentous actin, while cells lacking a protein that drives actin nucleation and branch 
polymerisation had “the star-fish” actin phenotype. There were however several 
limitations to this proteomic approach, such as that imposed by the extent of protein 
separation, the low protein identification rate caused by several practical problems 
including sensitivity, the difficulty in matching differential protein expression 
between gel runs, all of which limited the depth of the analysis. During the course of 
this study, several other methods have been developed which use protein labelling and 
mass spectrometry for large scale quantitative and qualitative analysis of proteomes. 
Strategies such as iCAT (cysteine based labels) or iTRAQ (amino group labels) 
tagging of sample proteins or peptides in vitro; or SILAC - labelling of proteins with
i  o  i  ^
light and heavy amino acids (containing deuterium instead of H, C instead of C, or 
15N instead of 14N) in vivo, could be used as a step forward in continuing the type of 
proteomic profiling of RNAi-silenced cells that has been carried out here. For 
example, the power of RNAi technique to choose genes for studying, could easily
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allow the experiments to be extended to profiling and quantifying the proteomes of 
cells that lack the GEFs or GAPs, or even transcription/translation factors, the design 
would be varied depending on which aspect of cell signalling is to be addressed. In 
addition, new work which followed the dynamics of cell signalling events in time, 
after an acute stimulation (with insulin, for example) would increase the power of the 
analysis and could lead to identification of additional targets. These labelling 
strategies combined with sample purification and MS protein identification have 
proven to be more powerful, sensitive and specific ways to identify differences in 
protein expression profiles, and PTMs, when two or more conditions are compared 
(Mann, 2006). The availability on new highly sensitive mass spectrometers with 
modem LC front ends would also change dramatically the utility of the approach.
In the last part of this thesis, I focused my work on an exploration of the nature of 
the regulation of cellular cofilin activity which is known to be determined in part by 
its phosphorylation on Ser3. Significantly, phosphorylation of cofilin on this 
evolutionarily highly conserved residue prevents the binding of cofilin to actin 
filaments, completely inhibiting its ability to promote filament disassembly 
(Bamburg, 1999). Cofilin was selected as an interesting target for further functional 
analysis as it appeared to be a signalling node regulated by both PI3K and Rho-family 
small GTPases. Cofilin phosphorylation was identified as being differentially 
modulated in opposite ways in PI3K- and PTEN-silenced cells, but was unaffected by 
RNAi-induced silencing of Ras and Akt, suggesting that PI3K regulates cofilin 
phosphorylation through a signalling cascade independent of Akt. In addition, 
phospho-cofilin was also expressed more highly in cells where the expression of 
genes that promote actin nucleation/polymerisation and lamellipodia formation 
(Cdc42, Racl and Rac2) had been silenced. These results came as a surprise to me 
since previous studies have suggested that Rac activates LIMK to induce cofilin 
phosphorylation and inhibition. (Yang et al., 1998; Arber et al., 1998). Moreover, 
cofilin phosphorylation has been seen to be upregulated in Arp3 knockdown cells, 
where lamellipodia and the underlying cortical actin network are also lost (Biyasheva 
et al., 2004; Kunda et al., 2003), suggesting that cofilin phosphorylation is probably 
regulated by the dynamic changes in the actin cytoskeleton in response to signalling
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downstream of PIP3 generation (Firtel and Chung, 2000), rather than through a direct 
signalling pathway. In this model, LIMK would found to be constitutively active.
In addition, it has been reported that even though levels of pSer3-cofilin can 
respond to PI3K signalling as suggested by the analysis in steady state and observed 
in other systems (Mouneimne et al., 2004; Nishita et al., 2004), there was evidence in 
my work that indicated that the observed changes in cofilin phosphorylation status 
were unlikely to mediate PI3K-induced actin remodelling. First, I found that active 
dephosphorylated cofilin was required for mounting protrusive dynamics of the actin 
cytoskeleton. Second, I showed that the morphogenetic response to insulin was 
unaffected by the loss of LIMK, the kinase responsible for cofilin phosphorylation in 
this and other systems (Arber et al., 1998; Yang et al., 1998), suggesting that an 
increase in cofilin phosphorylation is not required for cytoskeletal remodelling during 
the initial protrusive response. Third, I found that PI3K signalling, cortical actin 
accumulation and membrane ruffling all occurred within the first few seconds or 
minutes of insulin addition, whilst an increase in cofilin phosphorylation was delayed. 
Fourthly, in SSH and Rac RNAi cells, which are unable to generate protrusions, I 
found that pSer3-cofilin levels remained at a constant and elevated level following 
insulin stimulation, as would be predicted by such a model. Lastly, it is clear from the 
literature that the relationship between PI3K-signalling and cofilin phosphorylation 
varies widely across the different systems in which it has been analysed (Mouneimne 
et al., 2004; Nishita et al., 2004; Song et al., 2006). Taken together these data 
suggested an alternative model in which changes in cofilin phosphorylation occur as a 
result of the downstream effect of PI3K-induced changes in actin filament formation, 
and favouring a molecular mechanism in which the cofilin phosphatase, SSH, is the 
key regulator of cofilin phosphorylation which responds to changes in filamentous 
actin. To examine this hypothesis, where I directly perturbed actin cytoskeleton 
dynamics and the ratio of G- and F-actin by using actin toxins on cells, I found that 
cofilin phosphorylation changed in response to changes in the F/G actin ratio induced 
by these toxins. For example, in cells treated with latrunculin B or cytochalasin D, 
which induce rapid loss of filamentous actin (Kiger et al., 2003), I found that pSer3- 
cofilin levels were increased. Conversely in cells treated with the jasplakinolide, 
which induces ectopic actin filament formation, I saw a relatively rapid and complete
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loss of the pSer3-cofilin signal. Moreover, I was able to show that jasplakinolide also 
could block the ability of insulin to induce cofilin phosphorylation in these cells. 
Taken together these data indicated to me that actin remodelling is required for 
dynamic changes in the level of Ser3-cofilin phosphorylation, and that acute changes 
in F-actin levels are sufficient to alter the cofilin phosphorylation status. Since the 
increase in cofilin phosphorylation is observed in cells with a paucity of cortical actin 
filaments, this would limit the rate of filament severing and depolymerisation. 
Conversely, cofilin is activated in cells with excess actin filaments, thereby 
maintaining the monomeric actin pool. This suggests to me that dynamic changes in 
cofilin phosphorylation are required for maintenance of actin filament homeostasis 
such that actin protrusive activity would be self-limiting. It also suggests there is a 
sensor that can measure changes in actin filament levels. Four recent studies have 
sought to implicate cofilin phosphatase SSH as mediating this role, by showing that 
SSH is activated through binding to actin filaments (Nagata-Ohashi et al., 2004; 
Soosairajah et al., 2005; Tanaka et al., 2005; Yamamoto et al., 2006).In support of 
this, my data shows that SSH is likely to be the key regulator of pSer3-cofilin levels 
in S2R+ cells, since it was required for dynamic changes in pSer3-cofilin levels in 
response to insulin, and because the kinetics of loss of cofilin phosphorylation 
following jasplakinolide treatment were more rapid than the effects of latrunculin B. 
Furthermore, I found that SSH RNAi suppressed both jasplakinolide and latrunculin 
induced changes in pSer3-cofilin, whereas on its own LIMK RNAi did not produce 
this effect. Also it is important that RNAi-mediated silencing of actin increased the 
level of cofilin phosphorylation, meaning that it is unlikely that G-actin levels play a 
significant role in driving the change in pSer3-cofilin levels that takes place following 
perturbation of the F/G actin ratio. Finally, limiting the potential for nucleotide 
exchange on actin monomers by RNAi-mediated silencing of profilin and CAP 
probably blocks both LIMK and SSH activities, as a limited pool of actin-ATP would 
be available for polymerisation required for SSH activity and no free cofilin would be 
available for phosphorylation by LIMK. Thus, in conclusion it appears to me that the 
binding of SSH to actin filaments acts as a sensor of relative F actin levels.
To reconcile the role of cofilin in the formation of actin-dependent protrusions in 
S2R+ cells with the observed changes in pSer3-cofilin I found following an acute
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PI3K response, I suggested the following scenario (Figure 7.1): Following insulin 
addition, PI3K is activated within the first few minutes, causing the conversion of 
PIP2 to PIP3 within the inner leaflet of the plasma membrane. This activates Rac, 
possibly through the association of an unidentified PH domain-containing Rac-GEF 
with PIP3, leading to the nucleation of Arp2/3-dependent actin filaments at the cell 
cortex with subsequent filament elongation and protrusion formation. In these cells, 
active non-phosphorylated cofilin, at the cell front edge, depolymerises existing ADP- 
actin filaments to replenish the actin monomer pool and to generate uncapped barbed 
actin filament ends for new elongation. Thus, the balance between G-actin and F-actin 
is quickly moved towards F-actin, and cofilin released from G-actin is quickly 
phosphorylated by constitutively active LIMK. Thus, at the early stages, before 
significant levels of new actin filaments have been formed, low level SSH activity 
will act, in opposition to the effects of LIMK, to maintain a limited pool of active 
cofilin that is sufficient to remodel the existing actin filament network. Later, as new 
actin filaments accumulate and the PI3K signal declines at ~30 minutes, SSH activity 
will come to dominate, through its association with actin filaments and, perhaps, 
through its inhibition of LIMK (Soosairajah et al., 2005). This effect will reduce 
cofilin phosphorylation and help to restore the F-actin/G-actin equilibrium. I would 
like to suggest that this dynamic regulation helps to generate the cell’s robust but self- 
limiting actin filament response to acute actin-signalling. In the context of a graded 
extracellular signal in the developing embryo (Wood et al., 2006), a similar system 
could act over spatially distinct regions of the cell to facilitate chemotaxis by 
coordinating the polymerisation of actin filaments at the cell front, with their 
disassembly at the cell rear. Thus, the next goal will be to examine the proposed 
model for cofilin regulation in vivo.
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Decrease in the ups ream signal after 30' induces deciain 
in the actin polymeirsation rate. Since F-actin levels 
are high, SSH activity peaks, leading to dephosphorylation 
and activation of cofilin (drop in phosphocofilin level), 
w leading to actin depotymerisation. to restore G-actin pool
Acute stimulation induces rapid actin polymerisation 
through active Rac/WAVE complex /Arp2/3 complex, 
mobilising most of the G-ectin, thus leaving free 
cofilin to be phosphorylated by LIMK
PTEN
Ml Ml — 1 SSH
HI UMK
Cofilin
pCofilin Cofilin
Figure 7.1 Dynamic changes in cofilin phosphorylation upon acute stimulation are 
dictated by F-actin-dependent changes in SSH activity.
Finally, I would like to conclude that the research work I have presented here 
shows that using a combination of techniques, genomic and proteomic, for studying 
cell signalling pathways, is a powerful approach to help address specific biological 
questions in Cell Biology. As the proteomic profile can be reflected by the cell 
phenotype, the combination of genomic and proteomic analysis provides more 
detailed information about the molecular mechanisms involved in cellular processes. 
Moreover, as in any proteomic profiling study where large databases are often 
generated, the real challenge arises when the data needs to be integrated in a 
meaningful way that could represent functional and biochemical properties of proteins 
involved in specific cell signalling pathways or networks.
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2 1 4 - 2 2 5 1 4 1 9 . 7 5 1 4 1 8 . 7 4 1 4 1 8 . 7 4 0 . 0 0 0 R .L E G L T D E IN F L R .Q
2 2 6 - 2 3 3 1 0 6 2 . 5 3 1 0 6 1 . 5 2 1 0 6 1 . 5 0 0 . 0 1 0 R . Q L Y E E E IR . E  P y r o - g l u  ( N - t e r a  Q)
2 2 6 - 2 3 3 1 0 7 9 . 5 3 1 0 7 8 . 5 2 1 0 7 8 . 5 3 - 0 . 0 0 0 R .Q L Y E E E IR .E
2 3 4 - 2 5 2 2 1 0 9 . 0 1 2 1 0 8 . 0 0 2 1 0 8 . 0 1 - 0 . 0 1 0 R . E L Q S Q IS D T S W L S M D N S R . S
2 3 4 - 2 5 2 2 1 2 4 . 9 7 2 1 2 3 . 9 6 2 1 2 4 . 0 0 - 0 . 0 4 0 R . E L Q S Q IS D T S W L S M D N S R . S  O x i d a t i o n  (M)
2 5 3 - 2 6 4 1 3 2 0 . 6 4 1 3 1 9 . 6 3 1 3 1 9 . 6 6 - 0 . 0 3 0 R . S L D M D S IIA E V R . A
2 7 6 - 2 8 5 1 1 6 9 . 5 7 1 1 6 8 . 5 6 1 1 6 8 . 5 4 0 . 0 2 0 R .A E A E S M Y Q IK .Y
2 8 6 - 2 9 5 1 1 3 7 . 5 5 1 1 3 6 . 5 4 1 1 3 6 . 5 7 - 0 . 0 3 0 R .Y E E L Q S L A G K .H
3 0 5 - 3 1 2 9 7 9 . 4 7 9 7 8 . 4 6 9 7 8 . 4 4 0 . 0 2 0 FT. T E IS E M N R . N
3 2 9 - 3 4 1 1 3 4 4 . 6 8 1 3 4 3 . 6 7 1 3 4 3 . 6 7 0 . 0 0 0 R . A S LEA A IA D A K Q R. G
3 5 3 - 3 6 2 1 1 2 9 . 6 3 1 1 2 8 . 6 2 1 1 2 8 . 6 1 0 . 0 1 0 K.  L S E L E A A L Q R . A
3 6 5 - 3 7 2 1 0 0 0 . 4 9 9 9 9 . 4 8 9 9 9 . 4 9 - 0 . 0 1 1 K . QDM ARQLR. E  P y r o - g l u  ( N - t e r m  Q)
3 7 3 - 3 8 1 1 1 5 3 . 5 5 1 1 5 2 . 5 4 1 1 5 2 . 5 5 - 0 . 0 1 0 R .EY Q EL M N V K . L
3 8 2 - 3 9 2 1 2 7 7 . 7 2 1 2 7 6 . 7 2 1 2 7 6 . 7 0 0 . 0 1 0 K.  L A L D IE IA T Y R .K
4 7 2 - 4 8 2 1 1 7 3 . 6 1 1 1 7 2 . 6 0 1 1 7 2 . 6 3 - 0 . 0 3 0 R .  L V S E S S D V L P R . -
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S p o t  No. 417 M oesin, Chain A
Probability Based Mowse Score
q i1 50513540 Mass: 35010 Score: 100 E xpect: 2e-005 Q ueries matched: 12
Chain A, Moesin Fern  Domain Bound To Ebp50 C-Term inal P ep tide
1  M P K T IS V K V T  T M D A E L E F A I  Q P N T T G K Q L F  D Q W K T I G L R  E V W F F G L Q Y Q
5 1  D T K G F S T W L K  L N K K V T A Q D V  R K E S P L L F K F  R A K F Y P E D V S  E E L I Q D I T Q R
1 0 1  L F F L Q V K E G I  L N D D IY C P P E  T A V L L A S Y A V  Q S K Y G D F N K E  V H K S G Y L A G D
1 5 1  K L L P Q R V L E Q  R K LN K D Q W E E R IQ V W H E E H R  G M L R E D A V L E  Y L K IA Q D L E M
2 0 1  Y G V N Y F S IK N  K K G S E L W L G V  D A L G L N IY E Q  N D R L T P K I G F  P W S E I R N I S F
2 5 1  N D K K F V I K P I  D K R A P D E V F Y  A P R L R I N K R I  L A L C M G N H E L  Y M R RRK P
S t a r t  - E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2  - 8 8 4 2 . 5 1 8 4 1 . 5 0 8 4 1 . 5 0 - 0 . 0 0 1 M .P K T I S V R .V  N - A c e t y l  ( P r o t e i n )
9  - 2 7 2 0 8 2 . 0 8 2 0 8 1 . 0 7 2 0 8 1 . 0 0 0 . 0 7 0 R .V T T H D A E L E F A IQ P N T T G R .Q  O x i d a t i o n  (M)
2 8  - 3 5 9 7 6 . 5 1 9 7 5 . 5 0 9 7 5 . 5 4 - 0 . 0 4 0 I t .  Q L F D Q W It. T
5 4  - 6 0 8 3 8 . 4 3 8 3 7 . 4 2 8 3 7 . 4 4 - 0 . 0 2 0 I t .  G F S T V U T . L
7 2  - 7 9 9 6 1 . 5 4 9 6 0 . 5 3 9 6 0 . 5 6 - 0 . 0 3 1 R .R E S P L L F I t .F
1 0 1  - 1 0 7 8 9 4 . 5 3 8 9 3 . 5 3 8 9 3 . 5 4 - 0 . 0 1 0 R .L F F L Q V T t.E
1 6 6  - 1 7 1 8 6 2 . 3 5 8 6 1 . 3 5 8 6 1 . 3 6 - 0 . 0 1 0 R .D Q W E E R .I
1 7 2  - 1 8 0 1 2 3 3 . 6 2 1 2 3 2 . 6 1 1 2 3 2 . 6 1 0 . 0 1 0 R .IQ V W H E E H R .G
2 3 8  - 2 4 6 1 1 0 4 . 6 1 1 1 0 3 . 6 0 1 1 0 3 . 5 8 0 . 0 3 0 I C .IG F P W S E IR .N
2 5 5  - 2 6 2 9 5 9 . 6 0 9 5 8 . 5 9 9 5 8 . 5 9 0 . 0 0 0 I t .  F V T ltP ID I t .  I t
2 6 3  - 2 7 3 1 3 1 0 . 7 5 1 3 0 9 . 7 4 1 3 0 9 . 6 8 0 . 0 6 1 I t .  K A PD F V F Y A P R . L
2 6 4  - 2 7 3 1 1 8 2 . 6 2 1 1 8 1 . 6 1 1 1 8 1 . 5 9 0 . 0 2 0 R .A P D F V F Y A P R .L
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S p o t  No. 1317 G ly c e ra ld eh y d e -3 -p h o sp h a te  d e h y d ro g e n a s e
Probability Based Mowse Score
j £ L y ^ . 6 6 9 j l 9 2 ;  M a s s :  3 6 2 0 4  S c o r e :  1 4  E x p e c t :  0 . 0 0 8 4  Q u e r i e s  m a t c h e d :  9
g l y c e r a l d e h y d e - 3 - p h o s p h a t e  d e h y d r o g e n a s e  [ H o m o  s a p i e n s ]
1  MGKVKVGVNG FGRIGRLVTR AAFNSGKVDI V AINDPFIDL NYMVYMFQYD
5 1  STHGKFHGTV KAENGKLVIN G N PITIFQ ER  DPSKIKWGDA GAEYW ESTG
1 0 1  VFTTMEKAGA HLQGGAKRVI ISAPSADAPM FVMGVNHEKY D N S L K IISNA
1 5 1  SCTTNCLAPL AKVIHDNFGI VEGLMTTVHA ITATQKTVDG PSGKLWRDGR
2 0 1  GALQNIIPAS TGAAKAVGKV I PELNGKLTG MAFRVPTANV SW DLTCRLE
2 5 1  KPAKYDDXKK W KQASEGPL KGILGYTEHQ W SSD FN SD T  HSSTFDAGAG
3 0 1  IALNDHFVKL ISWYDNEFGY SNRWDLMAH MASKE
S t a r t - E n d O b s e r v e d M r ( e x p t ) M r  ( c a l c ) D e l t a M i s s S e q u e n c e
6 - 1 3 8 0 5 . 3 9 8 0 4 . 3 8 8 0 4 . 4 2 - 0 .  0 4 0 K .V G V H G F G R .I
6 7 - 8 0 1 6 1 3 . 9 4 1 6 1 2 . 9 3 1 6 1 2 . 8 9 0  . 0 4 0 K . L V I N G N P I T I F Q E R . D
1 1 9 - 1 3 9 2 2 4 5 . 1 2 2 2 4 4 . 1 1 2 2 4 4 . 0 9 0 .  0 2 0 R . V I IS A P S A D A P M F V M G V N H E K . Y
1 4 0 - 1 4 5 7 3 9 . 3 3 7 3 8 . 3 3 7 3 8 . 3 5 - 0 . 0 3 0 K . Y D N S L K . I
1 6 3 - 1 8 6 2 6 1 1 . 2 3 2 6 1 0 . 2 2 2 6 1 0 . 3 5 - 0 . 1 2 0 K .  V I H D H F G IV E G L M T T V H A IT A T Q K
2 2 8 - 2 3 4 8 1 1 . 4 1 8 1 0 . 4 0 8 1 0 . 4 1 - 0 . 0 0 0 K . L T G M A F R . V O x i d a t i o n  (M )
2 5 5 - 2 6 0 7 8 1 . 3 8 7 8 0 . 3 8 7 8 0 . 4 0 - 0 .  0 3 1 K . Y D D I K K . V
2 6 4 - 2 7 1 8 2 9 . 3 8 8 2 8 . 3 8 8 2 8 . 4 3 - 0 . 0 6 0 K Q A S E G P L K . G
3 1 0 - 3 2 3 1 7 6 3 . 8 2 1 7 6 2  . 8 1 1 7 6 2 . 8 0 0 . 0 2 0 K . L IS W Y D N E F G Y S H R  V
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APPENDIX 2
MOWSE Score, matched peptides and sequence coverage of identified proteins 
(Table 5.1)
S p o t  No. 1610 A nnexin  B9a
z
%
30 100 150
P r o b a b i l i t y  B ased  riowse S co re
1 .  a i l  1 0 1 2 1 9 0 1  M a s s : 3 6 3 0 2  S c o r e :  1 6 5  E x p e c t :  1 . 3 e - 0 1 2  Q u e r i e s  m a t c h e d :  1 7
a n n e x i n  B 9 a  [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  M S S A E Y Y P F K  C T P T V Y P A D P  F D P V E D A A IL  RK A K K G FG TD  E K A I I E I L A R
5 1  R G IV Q R L E IA  E A FK T S Y G K D  L IS D L K S E L G  G K F E D V IL A L  H T P L P Q E Y A Q
1 0 1  E L H D A IS G L G  T D E E A I I E I L  C T L S N Y G IK T  IA Q F Y E Q S F G  K S L E S D L K G D
1 5 1  T S G H F K R L C V  S LV Q G H R D EN  Q G V D E A A A IA  DAQALHDAGE G Q V G T D E S T F
2 0 1  N S I L I T R S Y Q  Q L R Q IF L E Y E  N L S G H D IE K A  IK R E F S G S V E  K G F L A IV K C C
2 5 1  K S K ID Y F S E R  LH D SH A G L G T  K D K T L I R I I V  S R S E I D L G D I  KEAEQNKYGK
3 0 1  S L E S W IK E D A  E T D IG Y V L V T  LTA U
S t a r t - E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2 - 1 0 1 1 3 3 . 5 0 1 1 3 2 . 5 0 1 1 3 2 . 5 1 - 0 . 0 1 0 SSAEYYPFK N - A c e t y l  ( P r o t e i n )
1 1 - 3 1 2 3 4 7 . 1 8 2 3 4 6 . 1 7 2 3 4 6 . 1 2 0 . 0 5 0 CTPTVYPADPFDPVEDAAIl.R
3 6 - 4 2 7 5 3 . 3 7 7 5 2 . 3 7 7 5 2 . 3 3 0 . 0 3 0 GFGTDEK
4 3 - 5 0 8 9 8 . 5 7 8 9 7 . 5 7 8 9 7 . 5 6 0 . 0 0 0 A IIE IL A JR
5 7 - 6 4 9 2 0 . 5 0 9 1 9 . 4 9 9 1 9 . 5 0 - 0 . 0 1 0 LEIA E A FK
7 0 - 7 6 8 0 3 . 4 7 8 0 2 . 4 6 8 0 2 . 4 4 0 . 0 2 0 DL ISD LK
1 3 0 - 1 4 1 1 4 1 8 . 6 5 1 4 1 7 . 6 5 1 4 1 7 . 6 9 - 0 . 0 4 0 TIAQFYEQSFGK
1 4 2 - 1 4 8 7 9 1 . 3 4 7 9 0 . 3 4 7 9 0 . 4 1 - 0 . 0 7 0 SLESDLK
1 5 8 - 1 6 7 1 1 4 5 . 5 9 1 1 4 4 . 5 9 1 1 4 4 . 6 0 - 0 . 0 2 0 LCVSLVQGNR
2 0 8 - 2 1 3 7 9 4 . 4 4 7 9 3 . 4 3 7 9 3 . 4 1 0 . 0 2 0 SXQQLR
2 1 4 - 2 2 9 1 8 9 4 . 8 8 1 8 9 3 . 8 7 1 8 9 3 . 9 0 - 0 . 0 3 0 QIFLEYEW LSGHDIEK P y r o - g l u  (N-
2 1 4 - 2 2 9 1 9 1 1 . 9 0 1 9 1 0 . 9 0 1 9 1 0 . 9 3 - 0 . 0 3 0 QIFLEYEN L S GNDIEK
2 3 4 - 2 4 1 8 8 2 . 4 1 8 8 1 . 4 1 8 8 1 . 4 1 - 0 . 0 1 0 EFSGSVEK
2 4 2 - 2 4 8 7 4 7 . 4 8 7 4 6 . 4 7 7 4 6 . 4 7 0 . 0 0 0 GFLAXVK
2 5 2 - 2 6 0 1 1 4 4 . 5 6 1 1 4 3 . 5 6 1 1 4 3 . 5 6 - 0 . 0 0 1 SK ID Y FSER
2 5 4 - 2 6 0 9 2 9 . 4 3 9 2 8 . 4 3 9 2 8 . 4 3 - 0 . 0 0 0 ID Y FSER
3 0 1 - 3 0 7 8 6 2 . 4 8 8 6 1 . 4 7 8 6 1 . 4 6 0 . 0 1 0 S L E S V IK
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S p o t No. 1632 CG31196, 14-3-3e
P r o b a b i l i t y  B ased  dow se S c o re
1 .  q i 1 2 3 1 7 1 6 1 8  M a s s :  2 9 3 2 6  S c o r e :  1 6 9  E x p e c t :  5 . 4 e - 0 1 3  Q u e r i e s  m a t c h e d :  1 8
C G 3 1 1 9 6 - P C ,  i s o f o n o  C [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  M TE R EN H V Y K  A K L A E Q A E R Y  DEMVEAMKKV A S M D V E L T V E  E R N L L S V A Y K
5 1  N V IG A R R A S G  R I I T S I E Q K E  E H K G A E E K L E  H IK T Y R G Q V E  K E L R D IC S D I
1 0 1  L N V L E K H L IP  C A T S G E S K V F  YYKMKGDYMR Y L A E F A T G S D  R K D A A E N S L 1
1 5 1  A Y K A A S D IA M  H D L P P T H P I R  L G L A L N F S V F  Y Y E IL N S P D R  ACRLA KA AFD
2 0 1  D A IA E L D T L S  E E S Y K D S T L I  M Q L L R D N L T L  W TSDMQAEGD G E P K E Q IQ D V
2 5 1  E D Q D V S
S t a r t - E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
1 - 1 0 1 2 9 9 . 6 1 1 2 9 8 . 6 0 1 2 9 8 . 5 9 0 . 0 1 1 M TERENHVYK O x i d a t i o n  (H )
1 - 1 2 1 5 2 4 . 7 1 1 5 2 3 . 7 0 1 5 2 3 . 7 4 - 0 . 0 4 2 M TERENHVYKAK N - A c e t y l  ( P r o t e i n )
2 - 1 0 1 1 9 4 . 5 6 1 1 9 3 . 5 6 1 1 9 3 . 5 7 - 0 . 0 1 1 TEREHHVYK N - A c e t y l  ( P r o t e i n )
1 3 - 1 9 8 1 6 . 4 2 8 1 5 . 4 1 8 1 5 . 4 1 0 . 0 0 0 LA EQ A ER
1 3 - 2 9 2 0 7 2 . 9 3 2 0 7 1 . 9 2 2 0 7 1 . 9 6 - 0 . 0 4 2 LAEQAERYDEMVEAMKK 2 O x i d a t i o n  (H)
3 0 - 4 2 1 4 7 7 . 7 4 1 4 7 6 . 7 3 1 4 7 6 . 7 1 0 . 0 2 0 V A SM D V ELTV EER
4 3 - 5 0 9 0 7 . 5 2 9 0 6 . 5 1 9 0 6 . 5 2 - 0 . 0 1 0 N LLSVA YK
5 1 - 5 6 6 2 9 . 3 5 6 2 8 . 3 4 6 2 8 . 3 7 - 0 . 0 2 0 X V I  GAR
6 2 - 6 9 9 3 1 . 5 1 9 3 0 . 5 1 9 3 0 . 5 4 - 0 . 0 3 0 I I T S I E Q K
6 2 - 7 3 1 4 3 1 . 7 5 1 4 3 0 . 7 4 1 4 3 0 . 7 6 - 0 . 0 2 1 I IT S IE Q K E E N K
6 2 - 7 8 1 9 4 6 . 0 0 1 9 4 4 . 9 9 1 9 4 5 . 0 0 - 0 . 0 1 2 IIT S IE Q K E E N K G A E E K
1 2 4 - 1 4 1 2 1 1 6 . 9 1 2 1 1 5 . 9 1 2 1 1 5 . 9 8 - 0 . 0 7 2 M KGDYHRYLAEFATGSDR
1 3 1 - 1 5 3 2 5 3 3 . 1 8 2 5 3 2 . 1 7 2 5 3 2 . 2 5 - 0 . 0 8 2 Y L A EFA TG SD R K D A A EN SLIA Y K
1 4 2 - 1 5 3 1 3 2 2 . 6 5 1 3 2 1 . 6 4 1 3 2 1 . 6 9 - 0 . 0 5 1 KDAAENS L IA Y X
1 5 4 - 1 7 0 1 8 1 8 . 8 8 1 8 1 7 . 8 7 1 8 1 7 . 9 1 - 0 . 0 4 0 A A S D IA M N D L P P T H P IR
1 9 7 - 2 1 5 2 0 8 7 . 9 7 2 0 8 6 . 9 6 2 0 8 6 . 9 6 0 . 0 0 0 A A FD D A IA E L D T L S E E S Y K
2 1 6 - 2 2 5 1 1 8 9 . 6 4 1 1 8 8 . 6 3 1 1 8 8 . 6 5 - 0 . 0 2 0 D S T L D fQ L L R
2 2 6 - 2 4 4 2 1 2 2 . 9 4 2 1 2 1 . 9 4 2 1 2 1 . 9 2 0 . 0 2 0 DNLTLW TSDM QAEGDGEPK O x i d a t i o n  (H)
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S p o t  No. 1768 P ro te o s o m e  a7  su b u n i t
P r o b a b i l i t y  B ased  Mouse S c o re
1 .  a i l  7 3 0 3 8 4 3  M a s s : 2 7 7 7 2  S c o r e :  1 6 2  E x p e c t :  2 . 7 e - 0 1 2  Q u e r i e s  m a t c h e d :  1 7
C G 1 5 1 9 - P A ,  i s o f o r m  1  [ D r o s o p h i l a  o i e l a n o g a s t e r ]
1  H S T IG T G Y D L  S A S Q F S P D G R  V F Q ID Y A S K A  V E K S G T V IG I  R  G K D A W L A V  
5 1  E K I I T S K L Y E  P D A G G R I F T I  EK H IG M A V A G  LV A D GHFVAD IA R Q E A A H Y R  
1 0 1  Q Q F E Q A IP L K  H LCH R V A G Y V  H A Y T L Y SA V R  P F G L S I I L A S  U D EV E G PQ LY  
1 5 1  K I E P S G S S F G  Y F A C A S G K A K  Q L A K T E K E K L  K H D M RTDELV E S A G E IIY K V  
2 0 1  H D E L K D K D F R  FE M G L V G R V T G G L H L IH P S E  L T E K A R K A G D  AANK DED SDN 
2 5 1  E T H
S t a r t -  E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2 -  2 0 2 0 0 0 . 9 3 1 9 9 9 . 9 2 1 9 9 9 . 9 1 0 . 0 1 0 S T IG T G Y D L SA SQ F SPD G R  N - A c e t y l  ( P r o t e i n )
2 1 -  2 9 1 0 7 0 . 5 3 1 0 6 9 . 5 2 1 0 6 9 . 5 4 - 0 . 0 2 0 V FQ ID Y A S K
3 4 -  4 1 8 0 2 . 4 7 8 0 1 . 4 7 6 0 1 . 4 7 - 0 . 0 0 0 S G T V IG IR
4 2 -  5 2 1 1 2 8 . 6 2 1 1 2 7 . 6 1 1 1 2 7 . 6 5 - 0 . 0 4 1 GKDAW LAVEK
5 8 -  6 6 9 7 7 . 4 7 9 7 6 . 4 6 9 7 6 . 4 6 - 0 . 0 0 0 LYEPDAGGR
6 7 -  7 2 7 5 0 . 4 4 7 4 9 . 4 3 7 4 9 . 4 3 - 0 . 0 0 0 I F T I E K
7 3 -  9 3 2 0 7 4 . 0 4 2 0 7 3 . 0 4 2 0 7 3 . 0 7 - 0 . 0 3 0 NIGMAVAGLVAD GNFVADIAR
7 3 -  9 3 2 0 9 0 . 0 2 2 0 8 9 . 0 2 2 0 8 9 . 0 6 - 0 . 0 5 0 H I  GMAVAGLVAD GNFVADLAR O x i d a t i o n  (H)
9 4 -  1 0 0 8 3 4 . 4 1 8 3 3 . 4 0 8 3 3 . 3 7 0 . 0 3 0 QEAAHYR P y r o - g l u  ( N - t e r m  Q)
9 4 -  1 0 0 8 5 1 . 4 1 8 5 0 . 4 1 8 5 0 . 3 9 0 . 0 1 0 QEAANYR
1 0 1 -  1 1 0 1 1 8 4 . 6 1 1 1 8 3 . 6 0 1 1 8 3 . 6 2 - 0 . 0 2 0 Q Q F E Q A IP L K  P y r o - g l u  ( N - t e r m  Q)
1 5 2 -  1 6 8 1 7 6 4 . 7 8 1 7 6 3 . 7 7 1 7 6 3 . 7 8 - 0 . 0 1 0 IE P S G SS F G Y F A C A S G K
1 8 6 -  1 9 9 1 5 6 6 . 7 7 1 5 6 5 . 7 6 1 5 6 5 . 7 8 - 0 . 0 2 0 TDELVE SA G E11Y K
2 0 0 -  2 1 0 1 4 0 1 . 7 0 1 4 0 0 . 6 9 1 4 0 0 . 7 0 - 0 . 0 2 2 VHDELKDKDFR
2 1 1 -  2 1 8 9 0 8 . 4 7 9 0 7 . 4 7 9 0 7 . 4 6 0 . 0 1 0 FEMGLVGR
2 1 1 -  2 1 8 9 2 4 . 4 5 9 2 3 . 4 4 9 2 3 . 4 5 - 0 . 0 1 0 FEMGLVGR O x i d a t i o n  (H)
2 1 9 -  2 3 4 1 7 0 7 . 9 1 1 7 0 6 . 9 1 1 7 0 6 . 9 2 - 0 . 0 1 0 V T G G L H L IH P S E L T E K
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S p o t No. 1782 EG:EG0003.7
P r o b a b i l i t y  B ased  Mowse S c o re
1 .  q i 1 3 7 5 7 5 6 4  M a s s :  2 4 2 8 9  S c o r e :  1 0 4  E x p e c t :  1 . 7 e - 0 0 6  Q u e r i e s  m a t c h e d :  12
E G : E G 0 0 0 3 . 7  [ D r o s o p h i l a  t n e l a n o g a s t e r ]
1  H A FG D V T T P Q  G L K E L N A F L A  D H S Y IS G Y T P  S K A D L S V F D A  L G K A PSA D N V
5 1  H V A R W Y RH IA  S F E A A E R A A U  S G T P L P Q L A G  G K PTV A A A A K  PAADDDDDVD
1 0 1  L F G S D D E E D E  E A E R IK Q E R V  AA YAAKKSKK P A L IA K S S V L  LD V K PW D D ET
1 5 1  DMKEMENNVR TIEM D G LLW G  A S K L V P V G Y G  I H K L Q I H C V I  E D D K V S ID L L
2 0 1  Q E K IE E F E D F  V Q S V D IA A F H  K I
S t a r t - E n d O b s e r v e d M r  < e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2 - 1 3 1 2 3 3 . 6 3 1 2 3 2 . 6 3 1 2 3 2 . 6 4 - 0 . 0 1 0 A F G D V T T PQ G L K
2 - 1 3 1 2 7 5 . 6 4 1 2 7 4 . 6 3 1 2 7 4 . 6 5 - 0 . 0 2 0 A F G D V T T P Q G L K  N - A c e t y l  ( P r o t e i n )
1 4 - 3 2 2 0 9 0 . 0 1 2 0 8 9 . 0 0 2 0 8 9 . 0 0 0 . 0 0 0 E L M A F L A D N S Y IS G Y T P S K
3 3 - 4 3 1 1 3 5 . 5 7 1 1 3 4 . 5 7 1 1 3 4 . 5 9 - 0 . 0 3 0 A D L S V F D A L G K
3 3 - 5 4 2 2 3 0 . 2 2 2 2 2 9 . 2 1 2 2 2 9 . 1 4 0 . 0 7 1 A D L  S V FD A L  GKAP SA DHVHVAR
5 8 - 6 7 1 1 3 0 . 5 5 1 1 2 9 . 5 4 1 1 2 9 . 5 5 - 0 . 0 1 0 H IA S F E A A E R
1 3 0 - 1 3 6 7 4 0 . 5 0 7 3 9 . 4 9 7 3 9 . 5 0 - 0 . 0 0 0 K P A L IA K
1 6 1 - 1 7 3 1 4 3 6 . 6 9 1 4 3 5 . 6 8 1 4 3 5 . 7 0 - 0 . 0 2 0 TIE M D G LL W G A SK  O x i d a t i o n  (H )
1 7 4 - 1 8 3 1 0 5 9 . 6 0 1 0 5 8 . 5 9 1 0 5 8 . 6 1 - 0 . 0 2 0 L V P V G Y G IH K
1 9 5 - 2 0 3 1 0 4 4 . 5 5 1 0 4 3 . 5 4 1 0 4 3 . 5 9 - 0 . 0 5 0 V S ID L L Q E K
2 0 4 - 2 2 1 2 1 0 1 . 1 6 2 1 0 0 . 1 5 2 1 0 0 . 0 1 0 . 1 5 0 IE E F E D F V Q  S V D IA A F H K
2 0 4 - 2 2 2 2 2 1 4 . 1 1 2 2 1 3 . 1 0 2 2 1 3 . 0 9 0 . 0 1 1 IE E F E D F V Q S V D IA A F H K I
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S p o t  No. 1811 CG5224
P r o b a b i l i t y  B ased  Mowse S c o re
1 .  q i l  2 1 4 2 8 4 6 2  H a n :  2 5 3 6 3  S c o r e :  7 4  E x p e c t :  0 . 0 0 1 8  Q u e r i e s  m a t c h e d :  7
L D 1 8 6 9 2 p  [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  M S A K P IL Y Y A  P R S P P C R A V L  L T A A A L G L E L  D LRLV N V K A G  E H K S A E F L K L
5 1  N A Q H T IP V L D  D N G T IV S D S H  I IC S Y L A D K Y  A P E G D D S L Y P  K D PEK R R L V D
1 0 1  AR LY Y D C G H L F P R I R F I V E P  V IY F G A G E V P  SD RV A Y LQ K A  Y D G L EH C LA E
1 5 1  G D Y L V G D K LT  IA D L S C I A S V  S T A E A F A P IE  PD Q FPR L V Q W  V K R IQ A L P Y Y
2 0 1  QKHKQEGLDM  L V G L V K G L L A  ER QQK
S t a r t  -  E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2 - 1 2 1 3 2 0 . 6 8 1 3 1 9 . 6 8 1 3 1 9 . 7 2 - 0 . 0 5 0 S A K P IL Y Y A P R  N - A c e t y l  ( P r o t e i n )
1 8  -  3 3 1 6 3 8 . 9 1 1 6 3 7 . 9 0 1 6 3 7 . 9 7 - 0 . 0 7 0 A V L L  T A A A L G L E L D L R
1 0 3  -  1 1 3 1 4 4 0 . 6 0 1 4 3 9 . 5 9 1 4 3 9 . 6 7 - 0 . 0 8 0 L Y Y D C G K L F P R
1 4 0  -  1 5 8 2 1 2 4 . 8 1 2 1 2 3 . 8 1 2 1 2 3 . 9 5 - 0 . 1 4 0 AYD G L E H C LA E GD YL V  GDK
1 8 7  -  1 9 2 7 7 2 . 4 6 7 7 1 . 4 5 7 7 1 . 4 6 - 0 . 0 1 0 L V Q W K
1 9 4  -  2 0 2 1 1 2 3 . 5 4 1 1 2 2 . 5 3 1 1 2 2 . 6 1 - 0 . 0 7 0 IQ A L P Y Y Q K
2 0 3  -  2 1 6 1 5 4 5 . 6 6 1 5 4 4 . 6 5 1 5 4 4 . 7 9 - 0 . 1 3 0 HKQEGLD M LVGLVK O x i d a t i o n  (H )
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Appendix 2
S p o t  No. 1824 GTP-binding n u c lea r  pro te in
P r o b a b i l i t y  B ased  Moose S c o re
1 .  a i l  2 8 3 1 7 1 1 9  M a s s :  2 4 9 2 1  S c o r e :  2 0 3  E x p e c t :  1 . 3 e - 0 1 6  Q u e r i e s  m a t c h e d :  1 8
L D 4 0 8 5 2 o  r D r o s o o h i l a  m e l a n o c r a s t e r l
1  M A Q E G Q D IP T  F K C V L V G D G G  T G K T T F V K R H  M T G E F E K K Y V  A T L G V E V H P L
5 1  I F H T H R G A I R  FN VW DTAGQ E K FG G LRD G Y Y  IQ G Q C A V IM F  D V T S R V T Y K H
1 0 1  V P W H R D L V R  V C E M IP IV L C  G N K V D IK D R K  V K A K S IV F H R  K K N L Q Y Y D IS
1 5 1  A K S H Y H F E K P  FL W L A R K L V G  D P N L E F V A M P  A L L P P E V K M D  KD W Q A Q IERD
2 0 1  L Q E A Q A T A L P  D E D E E L
S t a r t - E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2 - 1 2 1 2 7 5 . 6 1 1 2 7 4 . 6 1 1 2 7 4 . 6 1 - 0 . 0 1 0 A Q E G Q D IP T F K  N - A c e t y l  ( P r o t e i n )
3 0 - 3 7 9 7 8 . 4 2 9 7 7 . 4 1 9 7 7 . 4 3 - 0 . 0 2 0 HMTGEFEK
3 0 - 3 7 9 9 4 . 4 1 9 9 3 . 4 0 9 9 3 . 4 2 - 0 . 0 2 0 HM TGEFEK O x i d a t i o n  (H)
3 0 - 3 8 1 1 2 2 . 5 0 1 1 2 1 . 5 0 1 1 2 1 . 5 2 - 0 . 0 2 1 HMTGEFEKK O x i d a t i o n  (H)
3 9 - 5 6 2 0 6 6 . 0 6 2 0 6 5 . 0 5 2 0 6 5 . 1 1 - 0 . 0 6 0 YV AT LG V EV H PLIFH TH R
6 1 - 7 1 1 2 9 4 . 6 0 1 2 9 3 . 5 9 1 2 9 3 . 6 0 - 0 . 0 0 0 FNVWDTAGQEK
7 7 - 9 5 2 2 3 9 . 0 8 2 2 3 8 . 0 7 2 2 3 8 . 0 1 0 . 0 7 0 DGYYIQ GQ CA VIM FDVTSR O x i d a t i o n  (H)
1 0 0 - 1 0 6 9 2 2 . 4 7 9 2 1 . 4 6 9 2 1 . 4 6 0 . 0 1 0 M VPM fHR
1 1 1 - 1 2 3 1 3 1 5 . 7 6 1 5 1 4 . 7 6 1 5 1 4 . 7 6 - 0 . 0 0 0 V C E N IP IV L C G N K
1 1 1 - 1 2 7 1 9 7 0 . 9 9 1 9 6 9 . 9 8 1 9 7 0 . 0 3 - 0 . 0 5 1 V C E H IPIV L C G M K V D IK
1 1 1 - 1 2 9 2 2 4 2 . 0 2 2 2 4 1 . 0 1 2 2 4 1 . 1 6 - 0 . 1 5 2 V C E K IP1V LC G H K V D IK D R
1 3 5 - 1 4 0 7 5 8 . 4 2 7 5 7 . 4 1 7 5 7 . 4 2 - 0 . 0 1 0 s r v r H R
1 4 3 - 1 3 2 1 2 1 4 . 5 9 1 2 1 3 . 5 8 1 2 1 3 . 6 0 - 0 . 0 2 0 M LQYYDISAK
1 5 3 - 1 6 6 1 7 8 4 . 9 5 1 7 8 3 . 9 4 1 7 8 3 . 9 0 0 . 0 3 0 SHYHFEKPFLVfLAR
1 6 7 - 1 8 8 2 3 9 3 . 1 9 2 3 9 2 . 1 8 2 3 9 2 . 3 1 - 0 . 1 3 1 K LVG DPH LEFVAM PALLPPEVK O x i d a t i o n  (H)
1 6 8 - 1 8 8 2 2 6 5 . 1 1 2 2 6 4 . 1 1 2 2 6 4 . 2 1 - 0 . 1 1 0 LVGDPM LEFVAM PALLPPEVK O x i d a t i o n  (H)
1 8 9 - 1 9 9 1 4 1 9 . 6 7 1 4 1 8 . 6 6 1 4 1 8 . 6 6 0 . 0 0 1 MDKDWQAQIER
1 8 9 - 1 9 9 1 4 3 3 . 6 7 1 4 3 4 . 6 6 1 4 3 4 . 6 6 0 . 0 0 1 MDKDWQAQIER O x i d a t i o n  (H)
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Appendix 2
Spot No. 1832 Glutathione S-transferase E2
2 5  5 0  7 5
P r o b a b i l i t y  B ased  Mouse S c o re
1 .  q i l  1 9 9 2 2 5 2 8  M a s s :  2 5 4 4 0  S c o r e :  8 0  E x p e c t :  0 . 0 0 0 4  Q u e r i e s  m a t c h e d :  9
C G 1 7 5 2 3 - P A  [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  M SDKLVLYGM  D IS P P V R A C K  L T L R A L N L D Y  EY K EM D LLA G  D H FK D A FL K K
5 1  N P Q H T V P L L E  D N G A L IU D S H  A IV C Y L V D K Y  A N S D E L Y P R D  L V LRA Q V D Q R
1 0 1  L F F D A S I L F H  S L R M V S IP Y F  L R Q V S L V P K E  K V D N IK D A Y G  H L E N F L G D N P
1 5 1  Y L T G 3 Q L T IA  D L C C G A T A S S  LA A V L D L D E L  KY PKVAAW FE R L 3 K L P H Y E E
2 0 1  D M L R G L K K Y I H L L K P V L H L E  Q
S t a r t - E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
5 - 1 7 1 4 5 9 . 8 5 1 4 5 8 . 8 4 1 4 5 8 . 7 9 0 . 0 5 0 L V L Y G M D IS P P V R
5 - 1 7 1 4 7 5 . 8 1 1 4 7 4 . 8 0 1 4 7 4 . 7 9 0 . 0 1 0 L V L Y G M D IS P P V R
2 5 - 3 3 1 1 2 8 . 5 6 1 1 2 7 . 5 6 1 1 2 7 . 5 5 0 . 0 1 0 A L H LD Y E Y K
9 0 - 9 4 6 1 5 . 4 1 6 1 4 . 4 1 6 1 4 . 3 8 0 . 0 3 0 D L V L R
1 1 4 - 1 2 2 1 1 0 8 . 6 2 1 1 0 7 . 6 1 1 1 0 7 . 6 1 0 . 0 0 0 N V S IP Y F L R
1 2 3 - 1 2 9 7 7 0 . 4 8 7 6 9 . 4 7 7 6 9 . 4 7 0 . 0 0 0 Q V S L V P K
1 8 5 - 1 9 1 8 7 8 . 4 4 8 7 7 . 4 3 8 7 7 . 4 4 - 0 . 0 1 0 VA AW FER
1 9 5 - 2 0 4 1 2 8 5 . 6 3 1 2 8 4 . 6 2 1 2 8 4 . 6 1 0 . 0 1 0 L P H Y E E D N 1 R
2 0 9 - 2 2 1 1 5 5 6 . 8 9 1 5 5 5 . 8 8 1 5 5 5 . 9 0 - 0 . 0 1 0 Y IN L L K P V L N L E Q
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Spot No. 1841 Cytosolic thioredoxin peroxidase variant 2
P r o b a b i l i t y  B ased  H ouse S c o re
1 .  a i l  1 2 7 4 4 7 9 1  H a s s :  2 1 9 5 2  S c o r e :  1 0 1  E x p e c t :  3 . 4 e - 0 0 6  Q u e r i e s  m a t c h e d :  1 0
c y t o s o l i c  t h i o r e d o x i n  p e r o x i d a s e  v a r i a n t  2 [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  H P Q L Q K P A P A  F A G T A W N G V  F K D IK L S D Y K  G K Y L V L F F Y P  L D F T F V C P T E
5 1  I I A F S E S A A E  F R K I N C E V I G  C S T D S Q F T H L  A U IN T P R K Q G  G L G S M D IP L L
1 0 1  A D K S H K V A R D  Y G V U D E E T G I P F R G L F I I D D  K Q N L R Q IT V H  D L P V G R S V E E
1 5 1  T L R L V Q A F Q Y  T D K Y G E V C P A  N W K PG Q K TH V  A D P T K S K E Y F  E T T S
S t a r t  - E n d O b s e r v e d M r < e x p t ) M r <c a l c ) D e l t a M i s s S e q u e n c e
8 8  - 1 0 3 1 6 5 8 . 7 8 1 6 5 7 . 7 7 1 6 5 7 . 8 7 - 0 . 1 0 1 KQG GLGSM DIPLLADK O x i d a t i o n  (H)
8 9  - 1 0 3 1 5 3 0 . 6 7 1 5 2 9 . 6 6 1 5 2 9 . 7 8 - 0 . 1 1 0 QGGLGSM DIPLLADK O x i d a t i o n  (H)
1 1 0  - 1 2 3 1 6 1 0 . 7 7 1 6 0 9 . 7 6 1 6 0 9 . 7 6 - 0 . 0 0 0 DY G V LD EETG IPFR
1 2 4  - 1 3 1 9 2 0 . 4 6 9 1 9 . 4 5 9 1 9 . 5 0 - 0 . 0 5 0 G L F IID D K
1 2 4  - 1 3 5 1 4 3 1 . 7 7 1 4 3 0 . 7 6 1 4 3 0 . 7 9 - 0 . 0 2 1 G L FIID D K Q K L R
1 3 6  - 1 4 6 1 1 9 4 . 6 2 1 1 9 3 . 6 1 1 1 9 3 . 6 4 - 0 . 0 3 0 QITVHDLPVGR P y r o - g l u  ( N - t e r m  Q)
1 3 6  - 1 4 6 1 2 1 1 . 6 0 1 2 1 0 . 6 0 1 2 1 0 . 6 7 - 0 . 0 7 0 QITVNDLPVGR
1 5 4  - 1 6 3 1 2 1 2 . 6 2 1 2 1 1 . 6 1 1 2 1 1 . 6 2 - 0 . 0 0 0 LVQAFQYTDK
1 6 4  - 1 7 7 1 6 3 3 . 7 1 1 6 3 2 . 7 0 1 6 3 2 . 7 7 - 0 . 0 7 0 YGEVCPAHWKPGQK
1 8 6  - 1 9 4 1 0 9 1 . 4 2 1 0 9 0 . 4 1 1 0 9 0 . 4 8 - 0 . 0 7 1 SK E Y FE TTS
255
Appendix 2
Spot No. 1857 Similar to CG3644
P r o b a b i l i t y  B ased  Mouse S c o re
1 .  g l 1 3 8 0 4 8 3 3 9  M a s s :  1 6 3 9 2  S c o r e :  7 6  E x p e c t :  0 . 0 0 1 1  Q u e r i e s  m a t c h e d :  6
s i m i l a r  t o  D r o s o p h i l a  m e l a n o g a s t e r  b i c  [ D r o s o p h i l a  y a k u b a ]
1  M N PE K L K K LQ  A Q V R IG G K G T  P R R K K K IV H S  T P A TD D K K L Q  S S L K K L S V H T
5 1  I P G I E E V M I I  K K D G T V IH F M  H P K A Q A S L P T  N T F A IT G H G E  M K T IT E M V P G
1 0 1  IL T Q L G P Q D 1  H Q L K K L A T E I  ANKTGAGGAA G SSAA DA GDD D V P D L V E N F E
1 5 1  E V A IA
S t a r t  -  E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2 7  -  3 8 1 3 1 1 . 7 2 1 3 1 0 . 7 1 1 3 1 0 . 6 8 0 . 0 3 1 IV H S  TPATDDKK
4 5  -  6 1 1 8 6 7 . 0 5 1 8 6 6 . 0 5 1 8 6 6 . 0 8 - 0 . 0 4 1 K L S V H T IP G IE E V H IIK
4 6  -  6 1 1 7 3 8 . 9 8 1 7 3 7 . 9 8 1 7 3 7 . 9 9 - 0 . 0 1 0 L S V N T IP G IE E V N IIK
6 2  -  7 3 1 3 5 5 . 6 4 1 3 5 4 . 6 3 1 3 5 4 . 6 6 - 0 . 0 3 0 NDGTVIHENHPK
7 4  -  9 2 1 9 5 6 . 9 6 1 9 5 5 . 9 5 1 9 5 5 . 9 7 - 0 . 0 2 0 A Q ASLP T N T FA IT  GHGEHK
9 3  -  1 1 4 2 4 2 5 . 3 3 2 4 2 4 . 3 2 2 4 2 4 . 2 9 0 . 0 3 0 TITEM V PG ILTQ LG PQ D IH Q LK
Spot No. 1875 elF-5A, translational initiation
P r o b a b i l i t y  B ased  Mouse S c o re
1 .  a i l  2 1 6 2 6 7 1 6  M a s s :  1 7 9 2 2  S c o r e :  6 4  E x p e c t :  0 . 0 1 7  Q u e r i e s  m a t c h e d :  8
C G 3 1 8 6 - P B ,  i s o f o r m  B [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  H A E L D D Q F E T  T D S G A S T T Y P  H Q C SA LR K H G  F V M L K S R P C K  IV Q C S T S K T G
5 1  KHGHAKVHMV G ID IF S H K K Y  E D IC P S T H M C  D V PN V K R ED L Q L IA IS D D S F
1 0 1  L T L H T E S G D L  R E D L K V P E G E  L G E Q L R L D F D  S G K D L L C T V L  K A C G E E C V IA
1 5 1  IK T N T A L D K
S t a r t - E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2 9 - 3 5 8 2 4 . 4 3 8 2 3 . 4 2 8 2 3 . 4 3 - 0 . 0 1 0 MGEVMLK O x i d a t i o n  (M)
4 1 - 4 8 9 1 0 . 3 8 9 0 9 . 3 7 9 0 9 . 4 5 - 0 . 0 8 0 IV E M S T S K  O x i d a t i o n  (K )
5 7 - 6 8 1 3 7 5 . 6 8 1 3 7 4 . 6 7 1 3 7 4 . 7 0 - 0 . 0 3 0 V H M V G ID IF S H K  O x i d a t i o n  (H )
6 9 - 8 6 2 1 6 2 . 7 9 2 1 6 1 . 7 8 2 1 6 1 . 9 8 - 0 . 1 9 1 K Y E D IC PSTH N M D V PN V K  O x i d a t i o n
1 1 2 - 1 2 6 1 7 1 1 . 8 9 1 7 1 0 . 8 9 1 7 1 0 . 8 8 0 . 0 1 1 E D L K V P E G E L C E Q L R
1 1 6 • 1 2 6 1 2 2 6 . 6 1 1 2 2 5 . 6 0 1 2 2 5 . 6 3 - 0 . 0 3 0 V P  E  GEL G EQLR
1 2 7 - 1 3 3 7 8 1 . 3 3 7 8 0 . 3 2 7 8 0 . 3 7 - 0 . 0 4 0 L D F D SG K
1 4 2 - 1 5 2 1 2 4 9 . 5 1 1 2 4 8 . 5 0 1 2 4 8 . 5 8 - 0 . 0 8 0 A C  GEE C V IA I K
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Spot No. 1874Cofilin
P r o b a b i l i t y  B ased  dow se S c o re
1 .  a i l  1 7 1 3 6 9 8 6  H a s s :  1 7 4 2 8  S c o r e :  9 6  E x p e c t :  0 . 0 0 0 4 9  Q u e r i e s  m a t c h e d :  1 8
C G 4 2 S 4 - P A  [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  M A SG V TV SD V  C K T T Y E E IK K  D K K H R Y V IF Y  IR D E K Q ID V E  TVADRHAEYD
5 1  Q F L E D IQ K C G  P G E C R Y G L F D  FEY M H Q C Q G T S E S S K K Q K L F  LM SH C PD T A K
1 0 1  V K K K M L Y S S S  F D A L K K S L V G  V Q K Y IQ A T D L  S E A S R E A V E E  K L R A T D R Q
S t a r t - E n d O b s e r v e d H r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2 - 1 2 1 1 2 2 . 5 9 1 1 2 1 . 5 8 1 1 2 1 . 5 4 0 . 0 4 0 A SG VTVSD VCK
2 - 1 9 1 9 8 7 . 0 2 1 9 8 6 . 0 2 1 9 8 5 . 9 6 0 . 0 5 1 A S G V T V S D V C K T T Y E E IK
1 3 - 2 0 1 0 1 1 . 5 3 1 0 1 0 . 5 3 1 0 1 0 . 5 3 - 0 . 0 0 1 T T Y E E IK K
2 6 - 3 2 9 7 3 . 5 5 9 7 2 . 5 4 9 7 2 . 5 4 - 0 . 0 0 0 Y V IF Y IR
3 6 - 4 5 1 1 2 8 . 5 6 1 1 2 7 . 5 6 1 1 2 7 . 5 5 0 . 0 1 0 Q ID V ETV A D R  P y r o - g l u  ( N - t e r m  Q)
3 6 - 4 5 1 1 4 5 . 5 8 1 1 4 4 . 5 7 1 1 4 4 . 5 7 - 0 . 0 0 0 Q ID V ETV A D R
4 6 - 5 8 1 6 1 2 . 7 5 1 6 1 1 . 7 4 1 6 1 1 . 7 4 - 0 . 0 0 0 N A E Y D Q F LE D IQ K
5 9 - 6 5 8 3 5 . 3 3 8 3 4 . 3 3 8 3 4 . 3 1 0 . 0 2 0 CG PG ECR
6 6 - 8 5 2 4 1 3 . 9 3 2 4 1 2 . 9 3 2 4 1 3 . 0 0 - 0 . 0 7 0 Y G LFD FEY M H Q C Q G TSESSK
6 6 - 8 5 2 4 2 9 . 9 8 2 4 2 8 . 9 7 2 4 2 8 . 9 9 - 0 . 0 2 0 YG LFD FEY M H Q C Q G TSESSK  O x i d a t i o n  (H )
8 7 - 1 0 0 1 7 0 7 . 7 9 1 7 0 6 . 7 9 1 7 0 6 . 8 2 - 0 . 0 3 1 QKLFLM SW CPDTAK P y r o - g l u  ( N - t e r r a  Q)
8 9 - 1 0 0 1 4 6 8 . 6 9 1 4 6 7 . 6 8 1 4 6 7 . 6 9 - 0 . 0 1 0 LFLM SW CPDTAK
8 9 - 1 0 0 1 4 8 4 . 6 8 1 4 8 3 . 6 7 1 4 8 3 . 6 8 - 0 . 0 1 0 L FL M S V C P D T A K  O x i d a t i o n  (M)
1 0 5 - 1 1 5 1 2 6 1 . 6 2 1 2 6 0 . 6 1 1 2 6 0 . 6 1 0 . 0 1 0 M LY S S SF D A L K
1 0 5 - 1 1 5 1 2 7 7 . 6 8 1 2 7 6 . 6 7 1 2 7 6 . 6 0 0 . 0 7 0 H L Y S S S F D A L K  O x i d a t i o n  (H)
1 0 5 - 1 1 6 1 4 0 5 . 7 1 1 4 0 4 . 7 0 1 4 0 4 . 7 0 0 . 0 0 1 M L Y S SSFD A L K K  O x i d a t i o n  (H)
1 1 7 - 1 2 3 7 3 0 . 4 2 7 2 9 . 4 2 7 2 9 . 4 4 - 0 . 0 2 0 SLVGVQK
1 2 4 - 1 3 5 1 3 5 3 . 6 7 1 3 5 2 . 6 6 1 3 5 2 . 6 6 0 . 0 1 0 Y IQ A T D L S E A S R
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Spot No. 1882 Cofilin
40 50 60 70 80
P r o b a b i l i t y  B ased  tlow se S c o re
1 .  a i l  7 2 9 1 7 2 4  M a s s :  1 7 4 2 8  S c o r e :  7 8  E x p e c t :  0 . 0 0 0 7 6  Q u e r i e s  m a t c h e d :  1 9
C G 4 2 5 4 -P A .  [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  M A SG V TV SD V  C K T T Y E E IK K  D K K H R Y V IF Y  IR D E K Q ID V E  TVADRNAEYD
5 1  Q F L E D IQ K C G  P G E C R Y G L F D  FE Y M H Q C Q G T S E S S K K Q K L F  LM SH C PD TA K
1 0 1  V K K K M L Y S S S  F D A L K K S L V G  V Q K Y IQ A T D L  S E A S R E A V E E  K LRA TD RQ
S t a r t _ E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2 - 1 2 1 1 6 4 . 5 7 1 1 6 3 . 5 6 1 1 6 3 . 5 5 0 . 0 2 0 A S G V T V S D V C K  N - A c e t y l  ( P r o t e i n )
1 3 - 1 9 8 8 3 . 4 6 8 8 2 . 4 5 8 8 2 . 4 3 0 . 0 2 0 T T Y E E IK
1 3 - 2 0 1 0 1 1 . 5 2 1 0 1 0 . 5 2 1 0 1 0 . 5 3 - 0 . 0 1 1 T T Y E E IK K
2 6 - 3 2 9 7 3 . 5 6 9 7 2 . 5 5 9 7 2 . 5 4 0 . 0 1 0 Y V I F Y I R
2 6 - 3 5 1 3 4 5 . 7 3 1 3 4 4 . 7 2 1 3 4 4 . 7 1 0 . 0 1 1 Y V IF Y IR D E K
2 6 - 4 5 2 4 7 2 . 0 7 2 4 7 1 . 0 6 2 4 7 1 . 2 7 - 0 . 2 1 2 Y V IF Y IR D E K Q ID V E T V A D R
3 6 - 4 5 1 1 2 8 . 5 7 1 1 2 7 . 5 7 1 1 2 7 . 5 5 0 . 0 2 0 Q ID V E T V A D R  P y r o - g l u  ( N - t e r m  Q)
3 6 - 4 5 1 1 4 5 . 5 8 1 1 4 4 . 5 7 1 1 4 4 . 5 7 - 0 . 0 0 0 Q ID V E T V A D R
4 6 - 5 8 1 6 1 2 . 6 9 1 6 1 1 . 6 9 1 6 1 1 . 7 4 - 0 . 0 6 0 N A E Y D Q F L E D IQ K
5 9 - 6 5 8 1 8 . 2 9 8 1 7 . 2 9 8 1 7 . 2 8 0 . 0 0 0 C G P G E C R  P y r o - g l u  ( N - t e r »  Q )
5 9 - 6 5 8 3 5 . 3 2 8 3 4 . 3 1 8 3 4 . 3 1 - 0 . 0 0 0 C G P G E C R
8 9 - 1 0 0 1 4 6 8 . 6 8 1 4 6 7 . 6 8 1 4 6 7 . 6 9 - 0 . 0 1 0 LFL M S W C PD  TAK
8 9 - 1 0 0 1 4 8 4 . 6 6 1 4 8 3 . 6 5 1 4 8 3 . 6 8 - 0 . 0 3 0 L FL M S W C PD T A K  O x i d a t i o n  (M)
1 0 5 - 1 1 5 1 2 6 1 . 6 1 1 2 6 0 . 6 0 1 2 6 0 . 6 1 - 0 . 0 0 0 M L Y S  S  S F D A L K
1 0 5 - 1 1 5 1 2 7 7 . 5 9 1 2 7 6 . 5 8 1 2 7 6 . 6 0 - 0 . 0 2 0 M L Y S S S F D A L K  O x i d a t i o n  (M)
1 0 5 - 1 1 6 1 3 8 9 . 6 8 1 3 8 8 . 6 7 1 3 8 8 . 7 0 - 0 . 0 3 1 M L Y S  S  S FD A L K K
1 0 5 - 1 1 6 1 4 0 5 . 6 8 1 4 0 4 . 6 8 1 4 0 4 . 7 0 - 0 . 0 2 1 M L Y S S S F D A L K K  O x i d a t i o n  (M)
1 2 4 - 1 3 5 1 3 5 3 . 6 5 1 3 5 2 . 6 4 1 3 5 2 . 6 6 - 0 . 0 2 0 Y IQ A T D L S E A S R
1 4 2 - 1 4 7 7 3 1 . 3 7 7 3 0 . 3 6 7 3 0 . 4 1 - 0 . 0 5 1 L R A T D R
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i—i—i—i—i—f —i—i
75 
P r o b a b i l i t y  B ased  H ouse S c o re
Slow superoxide dismutaseSpot No. 1885
1 .  o i l  4 5 7 2 5 7 3  M a s s :  1 5 2 0 0  S c o r e :  8 6  E x p e c t :  0 . 0 0 0 1 1  Q u e r i e s  m a t c h e d :  7
s l o w  s u p e r o x i d e  d i s m u t a s e  [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  V IN G D A K G T V  F F E Q E S S G T P  V K V S G E V C G L  A K G L H G F H V H  EFG D N T N G C H
5 1  S S G P H F N P Y G  K E H G A FV D E H  R H L G D L G N IE  A T G D C P T K V K  I T D S K I T L F G
1 0 1  A D S I I G R T W  VHAJDADDLGQ G G H E L S K S T G  N A G A R IG C G V  IG IA K V
S t a r t  -  E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
8 - 2 2 1 6 1 2 . 7 5 1 6 1 1 . 7 4 1 6 1 1 . 7 8 l o o 0 G T V F F E Q E S S G T P V K
2 3  -  3 2 1 0 1 9 . 5 0 1 0 1 8 . 4 9 1 0 1 8 . 5 1 - 0 . 0 2 0 V S G E V C G L A K
6 2  -  7 1 1 1 2 3 . 5 2 1 1 2 2 . 5 1 1 1 2 2 . 5 1 0 . 0 0 0 EH G A PV D EN R
7 2  -  8 8 1 7 9 7 . 8 2 1 7 9 6 . 8 1 1 7 9 6 . 8 4 - 0 . 0 3 0 H L G D L G H IE A T G D C P T K
9 6  -  1 0 7 1 2 6 2 . 7 0 1 2 6 1 . 6 9 1 2 6 1 . 7 0
HO01 0 I T L F G A D S I I G R
1 0 8  -  1 2 7 2 0 4 7 . 9 5 2 0 4 6 . 9 4 2 0 4 7 . 0 0 - 0 . 0 5 0 T V W H A D A D D L  GQ GG HEL SK
1 3 6  -  1 4 5 9 8 7 . 5 3 9 8 6 . 5 2 9 8 6 . 5 6 1 o o lb 0 IG C G V IG IA K
Spot No. 1892 40S ribosomal protein S12
T I I I I I I ^  I
100 150
P r o b a b i l i t y  B ased  H ouse S c o re
1 .  q i 1 3 8 0 4 8 2 3 3  M a s s :  1 5 5 0 1  S c o r e :  1 4 7  E x p e c t :  8 . 5 e - 0 1 1  Q u e r i e s  m a t c h e d :  1 0
s i m i l a r  t o  D r o s o p h i l a  m e l a n o g a s t e r  R p S 1 2  [ D r o s o p h i l a  y a k u b a ]
g i l 9 0 2  6 2 2  M a s s :  1 6 9 7 0  S c o r e :  1 3 8  E x p e c t :  6 . 7 e - 0 1 0  Q u e r i e s  m a t c h e d :  1 0
4 0 3  r i b o s o m a l  p r o t e i n  3 1 2  [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  L S K V Q C IL N R  RT HAD VD VD V P S A A P V L D G A  H D IN T A L Q E V  L K K S L IA D G L
5 1  V H G IH Q A C K A  L D K R Q A V L C I L A E S F D E P N Y  K K LV TA LC M E H Q I P L I R V D S
1 0 1  HK KLGEW SG L C K ID K E G K P R  K V C G C S V W I K D F G E E T P A L  D W K D H L R Q N
1 5 1  S
S t a r t  -  E n d O b s e r v e d M r < e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
4 4  -  3 9 1 7 1 8 . 8 7 1 7 1 7 . 8 6 1 7 1 7 . 8 9 - 0 . 0 3 0 SLIADGLVHGIHQACK
6 3  -  8 1 1 9 9 6 . 9 2 1 9 9 5 . 9 1 1 9 9 5 . 9 6 - 0 . 0 5 0 QAVLCILAE SFD EPHYK
6 3  -  8 2 2 1 0 7 . 9 4 2 1 0 6 . 9 4 2 1 0 7 . 0 3 - 0 . 0 9 1 QAVLCILAESFDEPUYKK P y r o - g l u  ( N - t e r m  Q)
6 3  -  8 2 2 1 2 3 . 0 3 2 1 2 4 . 0 2 2 1 2 4 . 0 6 - 0 . 0 3 1 QAVL CILA ESFD EPHY KK
8 3  -  9 7 1 7 7 6 . 9 7 1 7 7 5 . 9 6 1 7 7 5 . 9 7 - 0 . 0 1 0 LV TA LC N E H Q IPLIR
1 0 3  -  1 1 2 1 1 7 7 . 6 1 1 1 7 6 . 6 0 1 1 7 6 . 6 0 0 . 0 0 1 KLGEVSGLCK
1 1 3  -  1 2 0 9 4 2 . 3 4 9 4 1 . 5 4 9 4 1 . 5 3 0 . 0 1 1 IDKEGKPR
1 2 1  -  1 3 1 1 2 4 8 . 6 9 1 2 4 7 . 6 8 1 2 4 7 . 6 7 0 . 0 1 1 K V C G C SV W IK
1 3 2  -  1 4 4 1 4 1 9 . 6 7 1 4 1 8 . 6 6 1 4 1 8 . 6 9 - 0 . 0 3 0 DF GEE TPA LD W K
1 3 2  -  1 4 8 1 9 4 0 . 9 9 1 9 3 9 . 9 8 1 9 3 9 . 9 6 0 . 0 2 1 DF GEE TPA LDW KDHLR
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Appendix 2
Spot No.1894 Cyclophilin 1
%10
5  -
I i r
1 0 0  150
P r o b a b i l i t y  B ased  Mouse S c o re
1 .  a i l  3 3 5 8 9 2 9 6  M a s s :  1 8 0 6 7  S c o r e :  1 7 5
S D 0 1 7 9 3 p  [ D r o s o p h i l a  m e l a n o g a s t e r ]
E x p e c t :  1 . 3 e - 0 1 3  Q u e r i e s  m a t c h e d :  1 6
1  H S T L P R V F F D  M T A D N E P L G R  IV M E L R S D W  P K T A E H F R A L  C T G EK G FG Y K
5 1  G S IF H P W IP M  F M C Q G G D FT H  H N G T G G K S IY  G H K F P D E N F E  L K H T G S G IL S
1 0 1  M AH AG AHTNG S Q F F IC T V K T  A W L D N K M W F  G E W E G L D W  K K IE S Y G S Q S
1 5 1  G K T S K K IIV A  N S G S L
S t a r t - End O b s e r v e d M r (e x p t ) M r ( c a lc ) D e l t a M is s S e q u e n c e
2 - 6 6 1 5 .3 8 6 1 4 .3 7 6 1 4 .3 4 0 .0 4 0 STLPR N - l c e t y l  ( P r o t e i n )
7 - 2 0 1 6 1 1 .8 1 1 6 1 0 .8 0 1 6 1 0 .7 4 0 .0 6 0 VFFDMTADKEPLGR
7 - 2 0 1 6 2 7 .7 5 1 6 2 6 .7 4 1 6 2 6 .7 3 0 .0 1 0 VFFDM TADNEP LGR O x i d a t i o n  (H)
21 - 2 6 7 6 0 .4 2 7 5 9 .4 1 7 5 9 .4 3 - 0 . 0 2 0 IVMELR
2 1 - 26 7 7 6 .4 2 7 7 5 .4 1 7 7 5 .4 3 - 0 . 0 1 0 IVMELR O x i d a t i o n  (H)
21 - 3 2 1 4 0 1 .6 7 1 4 0 0 .6 6 1 4 0 0 .7 7 - 0 . 1 1 1 IVMELRSDVVPK O x i d a t i o n  (H)
33 - 38 7 3 7 .3 1 7 3 6 .3 0 7 3 6 .3 5 - 0 . 0 5 0 TAEKFR
57 - 7 7 2 2 5 1 .0 3 2 2 5 0 .0 2 2 2 4 9 .9 9 0 .0 2 0 VIPHFMCQGGDFTHHNGTGGK
78 - 9 2 1 8 0 0 .8 7 1 7 9 9 .8 6 1 7 9 9 .8 7 - 0 . 0 2 1 SIYGHKFPDEHFELK
84 - 9 2 1 1 3 8 .5 1 1 1 3 7 .5 0 1 1 3 7 .5 3 - 0 . 0 3 0 FPDEHFELK
93 - 1 1 9 2 7 9 9 .3 3 2 7 9 8 .3 2 2 7 9 8 .3 1 0 .0 1 0 HTGSGILSMAHAGANTNGSQFFICTVK O x i d a t i o n
1 2 0 - 1 2 6 8 4 7 .3 8 8 4 6 .3 7 8 4 6 .4 2 - 0 . 0 5 0 TAWLDNK
1 2 7 - 1 4 1 1 6 2 5 .8 7 1 6 2 4 .8 6 1 6 2 4 .8 8 - 0 . 0 2 0 HWF GEWE GLDWK
1 2 7 - 14 2 1 7 5 3 .9 7 1 7 5 2 .9 7 1 7 5 2 .9 8 - 0 . 0 1 1 HWFGEWEGLDWKK
1 4 2 - 1 5 2 1 1 8 3 .6 7 1 1 8 2 .6 6 1 1 8 2 .5 9 0 .0 7 1 KIESYGSQSGK
1 5 6 - 1 6 5 1 0 0 1 .6 1 1 0 0 0 .6 0 1 0 0 0 .5 9 0 .0 1 1 KIIVAHSGSL
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Spot No.1902 RH27794p
P r o b a b i l i t y  B ased  Mouse S c o re
1 .  q i 1 2 1 0 6 4 7 0 3  M a s s :  1 7 2 1 6  S c o r e :  6 1  E x p e c t :  0 . 0 3 4  Q u e r i e s  m a t c h e d :  1 3
R H 2 7 7 9 4 p  [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  H A A N K E R T F I M VK PDG VQ RG L V G K II E R F E  Q K G FK L V A L K  FT W A S K E L L E
5 1  K H Y A D L S A R P  F FP G L V N Y M N  S G P W P M V U E  G L N W K T G R Q  M LG A TK PA D S
1 0 1  L P G T IR G D F C  I Q V G R H II H G  SD A V E SA E K E  IA L W F H E K E L  VTW TPAA KD U
1 5 1  I Y E
S t a r t -  E nd O b s e r v e d M r( e x p t) M r ( c a l c ) D e l t a M is s
-  19 1 3 9 0 .7 7 1 3 8 9 .7 7 1 3 8 9 .7 4 0 .0 2 0
-  19 1 4 0 6 .7 7 1 4 0 5 .7 6 1 4 0 5 .7 4 0 .0 2 0
23 -  35 1 3 9 4 .8 9 1 3 9 3 .8 8 1 3 9 3 .7 7 0 .1 1 2
29 -  35 8 8 3 .4 6 8 8 2 .4 6 8 8 2 .4 6 - 0 .0 0 1
41 -  46 7 3 9 .3 7 7 3 8 .3 7 7 3 8 .3 7 - 0 .0 0 0
47 -  31 6 3 1 .3 2 6 3 0 .3 1 6 3 0 .3 6 - 0 .0 4 0
90 -  1 0 6 1 7 2 4 .9 8 1 7 2 3 . 97 1 7 2 3 .8 6 0 .1 2 0
90 -  1 0 6 1 7 4 0 .9 3 1 7 3 9 .9 2 1 7 3 9 .8 5 0 .0 7 0
-  1 0 6 1 7 5 7 .9 2 1 7 3 6 .9 2 1 7 5 6 .8 8 0 .0 4 0
107 -  1 1 3 1 0 5 1 .5 0 1 0 5 0 .5 0 1 0 3 0 .4 9 0 .0 1 0
116 -  129 1 4 6 9 .7 3 1 4 6 8 .7 3 1 4 6 8 .7 2 0 .0 1 0
130 -  1 3 8 1 1 4 9 .6 0 1 1 4 8 .6 0 1 1 4 8 .5 9 0 .0 1 0
S e q u e n c e
TFIMVKPDGVQR
TFIMVXPDGVQR O x i d a t i o n  (H)
IIERTEQKGFK 
FEQKGFK 
FTWASK 
Fi i me
QMLGATNPADSLPGTIR P y r o - g l u  ( N - t e r a  Q) 
OMLGATHPADSLPGTIR O x i d a t i o n  (H) ; P y r o - g l u  ( N - t e r n  Q) 
OMLGATHPADSLPGTIR O x i d a t i o n  (H)
GDFCIQVGR
HIIHGSIXAVESAEK
EIALWFNEK
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APPENDIX 3
MOWSE Score, matched peptides and sequence coverage of identified proteins 
(Table 5.3)
Spot No. 717 Ubiquitin
i.
Q u e r y  O b s e r v e d  H r ( e x p t )  M r ( c a l c )  D e l t a  H i s s  S c o r e  E x p e c t  R a n k  P e p t i d e
P  1 6  5 3 4 . 3 1  1 0 6 6 . 6 1  1 0 6 6 . 6 1  - 0 . 0 0  0  1 7  2 . 1  1  E S T L H L V L R
W  4 7  8 9 4 . 4 6  1 7 8 6 . 9 0  1 7 8 6 . 9 2  - 0 . 0 2  0  3 3  0 . 0 4 2  1  T I T L E V E P S D T I E H V K
1  M Q IF V K T L T G  K T I T L E V E P S  D T IE H V K A K I  Q D K E G X P P D Q  Q R L IF A G K X L  
5 1  E D G R T L S D Y N  I Q K E S T L H L V  L R L R G G
2i( i / ,11 
1000
u b b~ bO b«~ i—s *q y r* 7* 7* u
1 130.03 6553 |l 12.04 j 5652 E j 9
2 21708 10904 199.07 100.04 S 938581469.79 92155 46128 92057 460 79 8
3 31813 15957 3M.12 H50.56 T 85155 426.28 83452 417.76 833.54 41727 7
4 43121 216.11 41320'207.11 L 75050 375.75 733.47 36724 1 6
5 56827 284.64 550261275.63 H 637.41 31921 62039 310.70 5
6 68136 341.18 oc3 35 332 IS L 500.36 250.68 48333 242.17 4
7 780 43 390 72 762 41 331 71 V 30727 194.14 370 24 185.63 3
8 893.51 44726 875.50 43825 L 28820 144.61 271.18 136.09 2
9 | k 175.12 88.06 158.09 7955 1
*  k k~ k* k— k* k»” W 7 1 " r* y*~ 7« J*" *
11 10203 5153 I 8404 4253 T 16
2 215.14 108.07 | 19713 99 07 I 1686 88 843 94 1669 85 835 4311668 87 8 : 4 ,4  15
3 310.13 158 60 2*8.I*|14959 [~Tj 1573 80 7*7.41 1356.771778 8911533 71 778 40 14
4 <2927 215.14 41L2* 206.13] L 1472.75 736.88 1455.72 j72836l 1454.74 72787 53
5 53031 27944 5403*127066 E 1359 66 680 34 1142.64 671 8: 1141.61 67130 52
6 457.31 329 19' 63*57 32019: V ] 123042 61581 121359 607 30 121261 606 81 11
7 7*042:393 72 76041 38471 r i l 113155;56628 U1453!557.T7 111354 557 27 11
t  1(3.41 44224 r 863 47 433 24 r 16*251 301.76 9*5 48 493 25 98450 492 73 »
9 97051 485 76 95250 476 75 s 90546 45323 888 43 44472 887 45 44423 1
1* 1083 34 54327 106753 53427 T 1 81843 409 72' 801 40 401 20 800 41 '400.71 7
11 1186 58 593.80 116857 584 79 ~ T | 703 40 352201 68637] 343 69 685 39 34320 6
12 129967 650 34 128166 64133 i 60235 30168 | 585 32 293 17 584 34 29267|9j
13 142071 71486 1410.70[70585|~i~1 4*027 [245.141 472 24:236 62 <7120 23613 4
14 1542 75 77188 1525.73 j7d337 i1324.741762 88 34*221180.62 34320 372.101 1*
13 164182 82141 16248081290 162381 '81241 V 246.1«|12359 229.15 115081 1 *1
w K 147.11! 7406 1X09! 6555 j 1 >1
q i l 1 5 8 7 6 7  
u b i q u i t i n
M a s s :  8 5 4 0  S c o r e :  5 0  Q u e r i e s  m a t c h e d :  2
30 4 0  5 0
P r o b a b i l i t y  B a s e d  M ouse S c o r e
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Appendix 3
Spot No. 1780 CG10424-PA
P r o b a b i l i t y  B a se d  M ouse S c o r e
1 .  g i 1 7 2 9 3 8 2 3  M a s s :  3 2 5 3 2  S c o r e :  7 2  E x p e c t :  0 . 0 0 2 8  Q u e r i e s  m a t c h e d :  7
C G 1 0 4 2 4 - P A  [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  M A A V S D IF V H  L P K L L A L F K T  W P K L V N N K H  K G Q Y G R IG V I G G S L E Y T G A P
5 1  Y F A A I S S I R V  GAJDLAM VFCH S H A S A I I K S Y  S P D L I V H P V L  D C V D A V E R IA
1 0 1  P W L E R L H V W  IG P G L G R E P G  IL K T A S N V L K  L C H D T K K P W  ID A D G L F L L N
1 5 1  D N L N L IC G Q P  N V IL T P N V H E  F Q R L F G E D D Q  A A R Q K H S L L G  A G V T V L E K G A
2 0 1  N D K IY L P H C N  E V H S H P S G G S  G R R C G G Q G D L L S G S L A T F F S  W S L Q S G E P N P
2 5 1  A L V A A C A S S Y  F V K K L N A A A F  Q K F G R S L L A S  D H V N Q IP S V F  Q T E F E N S D P Q
3 0 1
S t a r t  -  E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2 - 1 3 1 2 8 8 . 7 0 1 2 8 7 . 7 0 1 2 8 7 . 7 2 - 0 . 0 2 0 A A V S D IP V H L P K  N - A c e t y l  ( P r o t e i n )
1 4  -  1 9 7 0 4 . 4 0 7 0 3 . 4 0 7 0 3 . 4 6 - 0 . 0 7 0 L L A L F K
3 7  -  5 9 2 3 4 2 . 2 1 2 3 4 1 . 2 0 2 3 4 1 . 2 3 - 0 . 0 3 0 IG V IG G S L E Y T  G A P Y F A A IS S IR
6 0  -  7 8 2 0 0 9 . 9 8 2 0 0 8 . 9 8 2 0 0 9 . 0 2 - 0 . 0 4 0 V G A D L A H V F C H S N A S A IIK
7 9  -  9 8 2 2 8 4 . 0 3 2 2 8 3 . 0 2 2 2 8 3 . 1 2 - 0 . 1 0 0 S Y S P D L IV H P V L D  CV DA VER
9 9  -  1 0 5 8 8 4 . 4 9 8 8 3 . 4 8 8 8 3 . 4 9 - 0 . 0 1 0 IA F W L E R
1 0 6  -  1 1 7 1 2 1 6 . 7 5 1 2 1 5 . 7 5 1 2 1 5 . 7 5 0 . 0 0 0 L H V W IG P G L G R
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£  40
Spot No. 1786 CG10160
m
i i i i i r  
100
i i i i i i i i i i
200 300
P r o b a b i l i t y  B a se d  M ouse S c o r e
1 . q i 1 7 2 9 5 3 4 8  M a s s :  3 S 8 0 0  S c o r e :  3 2 6
C G 1 0 1 6 0 - P A  [ D r o s o p h i l a  m e l a n o g a s t e r ]
Q u e r i e s  m a t c h e d :  9
1  M A A IK D S L L A  
5 1  ID V C A D K L Q G  
1 0 1  K E G E S R L S L V  
1 5 1  S G L P K N K V IG  
2 0 1  U S G V N IA G V R  
2 5 1  A I G L S T A S L A  
3 0 1  T S W K Q I L T P
Q V A E V L P S S G  
E L H D L Q H G S N  
Q R N T D I L K N I  
S G T N L D S S R F
L R E L N P I L G T
S A I L R N T S S V
T E V E Q L Q K S A
H K V T IV G IG Q  
F L K N P Q IT A S  
IP K L V E Y S P D  
R F L M S Q R L G V  
G E D P E K U N E L  
A A V S T S V L G E
N IM S D V Q A G L
V G M A S A F S IL  
T D F A A S A N S R  
T IL L M V S N P V  
A P T S C H G W I I
H K Q W D S A Y E
H G ID K D V F L S  
K F
A Q N V S K E V C L
L C IV T A G V R Q  
D IH T Y V A U K L  
G E H G D S S V P V  
V IK L K G Y T S U  
L P C V L N A H G V
Query O b serv ed Mr ( e x p t ) Mr ( c a l c ) D e lt a M iss S co re Ejqpect Sank P e p t id e
17 1 4 9 4 . 71 9 9 7 .5 2 9 9 7 .5 5 - 4 .  44 0 54 0 .0 0 1 4 1 LCIVTJbGV*
17 AS 4 4 3 .2 9 1 2 9 4 .5 4 1 2 4 4 .4 4 - 4 .0 4 0 41 le - 0 0 4 1 VIGSGTNLDSSX
17 22 < 1 1 .3 9 1 2 3 2 .5 9 1 2 3 2 .4 3 - 0 .  04 0 51 0 . 0011 1 QWDSAYEVIK ♦ P y r o - g lu  (N -term  Q)
17 22 < 2 5 .9 2 1 2 4 9 .4 4 1 2 4 9 .4 4 - 9 .0 2 9 (4 2 ) 0 .0 4 7 1 1 QWDSAYEVIK
17 22 M l .  29 1 3 2 4 .5 7 1 3 2 4 .4 1 - 9 .0 4 0 33 4. 054 1 EVCLIDVCJVDK
17 1 1 7 5 5 .3 9 1 5 4 4 .7 7 1 5 0 4 .4 1 - 0 .0 4 0 44 0 .0 0 1 4 1 QILTPTBYXQLQK ♦ P y r o -g lu  (N -term  Q)
17 IS 7 5 < . 3< 1 5 1 4 .7 1 1 5 1 4 .7 5 - 9 .0 4 0 40 0 .0 0 9 4 1 ELNPILGTGEDPEK
17 IS K 3 .9 9 1 5 2 5 .1 4 1 5 2 5 .4 4 - 9 .9 5 0 (2 3 ) 0 .4 7 1 QILTPTEVEQLQK
17 22 1 4 M .5 4 2 1 3 1 .4 7 2 1 3 1 .1 3 - 4 .0 7 0 25 0 .1 4 1 DVEL SLPCVLNANGVT SWK
§
9.
M  
* ? 
k i
* b 1 bi b * ~ s * *  y y* y * ~ 1  ? * I  y *** #
1 11409 [ 5755 L 1 * 1
2 274.11 137 56 C 075.40 438.24 858 .45 429.73 057.47 i42924 0
3 307.21 194.11 I '15.45 358^3 698.42 349 71 *97.44 349 22 7
4 404.27 243.64 V 402.34 301.68 (58534 29317 58435 292 68 6
5 587 32 294.16 56931 285.16 T 503.25 252.15 404J7 243.64 48528 24315 5
6 658 36 32968 64035 320.68 A 402^5 201.63 38522 193.11 4
7 715.30 358.19 « 7 J 7 349.19 G 33L21 166.111314.10 15759 3
t 814 45 407.73 796 44 398 72 V 27419 13760 257.14 129.08 2
»
; R 175.12 8806 15809 79.55 1
§i -  §  e  cl 
■' S -ULL-L
1 k f k* k* k*”  S«* E 5 b  l y  | r *jT1 10008 3034 nr 12
[7 11 118634 55171 1889.52 54526 H86J3 54477 11
i rm .ia 135^9 Q •93.46 497.21 976 43 488 72 975 45 48621 18
4 ■ * 7 2 1  j 179.11] 33920 170 10 S •16.44 468 72 91941 46021 918 43 439 72| •
5 41423)20762 396 22 62 C •49.41 425 21 83238j4166p[ O U I '416201 •
74 515 2S 25814 4T7J87 |34P.14| T | 792J8 396 70 77536 38818 77437 387 69
1? 629JI 31327 61220 30665 | 61131130616 N 69 L M 346 17 67431 23766 67333 337.17 4
a 742L41 {371.71 j 72538 36320 724.401362 70; L r r u t :  289.15 56027 28064 55928 280.15 5
» 857 44 42922 84041 420.71 83943 42022 D 46421 232 61 44718 22410 44620 22360 r
11 944 47 472 74 927 44 46422 926 46 46373 f M 8.lt 1176.18 j33216 16658 331.17 166091 3
11 1031 50 516.25 1014 47 5C7 74 1013 4P 507 25 S 262.15 13158 245.12 123J07 344.14 122.57 | 2
I 175.12 8806115809 7935 I 1
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Appendix 3
s I
* k k ^ k* k*~ k* k** ‘ % 7 y~ y* y*~ J* y*~ *
_I [ 112.04Txia] 9301 '4 8 0 1 ' Q jii
* [ 21111106.06 19408 9734 V 1122 60 561 81 1105 58 353 29 110439 55280 19
; y 31A.II |l55Jp[ 29315 147J* V 182334 51127 1006 31 503 76 1303 33 503 27 »
1 4 425.* 213 11140818 20439 407 19 2041C D 924.47 462 74 *•7.44)45421 906 Je 453 '3  1
5 5 0 2 4  236.62 4P321 24811 49422 24762 S 189.44 40522 792 41) 3*6.711 791 43 39622 7
i 9*127,29214 M125 28363 545.24 283 13 A i 72141 {361.71 j 70538; 353 19 70440:35270 ' 6
7 '* .3 4  373 67 72931 36516 72832 36447 Y 69L37 326 19 634.34 31768 63336 31718 5
1 87538 <3* 19 85835 42968 85737 42919 E 488.11 24466 <71X  [236.14 i-CJC 235 61 4
9 974.45 487 73 95742 47921 956.44;478.72[ ▼ | 35927 180.141 3 ^ 3 4  17162 j 1
11 108733 34437 107030 533 76 1069 32 535 26 I 248.28 130 601 30.17 12209 j 2
11 _ ______I ....... - 1*1 147.11 7406 130 09 6555’ j~Tj
s * * - 
2 *
i
« § * i
*  s  • a:
# k k*» k* k * ~  k* k*~  W y y ~  r  r*** j*  *
[A
. I  
1
1 12907 6504 
226. U [11457] 
127 26 lr,4 13
i u 5 * n « S [  1 T < n
311.11 [10606 I V
n a .l i  15559 1 y  |
112260 [561*1 
1*2334 512*7
11
11055* 553 29 110459 55280 1* 
100651 503 76 100553,50327 *
4
*
442 23 221 62 
53926 265.13
4 S X 21311 4: 4 .’.’ 21161 D *24.47 463 74 M7X6 45422 906461453 7 3 |T |
51224 25662 51125 256.1 3 | * ] *•*.44 40522 792.41 [39671 j 79143 [396221 7
6 600.30 [300.65 5*327)29214 5(229 29165 A 722.41 361 71 7053* 353 19 70440 352 70 4
7 76336)3*21* 74634 37367 745 35 3731* Y 65L37 326 19 634 34 3176* 63336 317 1* 5
i *92 40 446 71 I78X  438 19 1-4.19 437 70 £ 4*4.31 24466 47128)236 14 470 X  23565 ' 4
•  | 991 47 {496241 •7445)4*773 *73.44 4*7 23 V 359.27 180 14 342 24 171 62 I ] |
16 110456,552 7* 1*4733 54427 144435 543 78 1 24*** 13060 34317 12209 2
u [ I I  r l « 1 147.11 7406 1X09 6555 1
U k k ~  k* k*”  W r y~ y* y*~ y° y*~ #
1 130 05 65531 112fl4| 5652 [ E ] 11
2 229 12 11506 211.11 10606 V 119357 596.79 117554 58828 117456 587 78 19
3 389 15 19508 37L14 18607 C 1H364 54725 1076.48 538 74 1075.49 53825 *
4 50223 251.62 4*02 242.61 L *33.47 46724 916.44 458 73 ’ 915 .46 458 23 (
S 615 32 308.16 59731 299 16 I •3L3* 410.70 80336 40218 80238 401 691 7
( 739.34 365.68 71233 35667 D 7*7.39 354.16 69028 345.64 68929 345 151 i
‘ ’ 829 41 41521 81140 406.X V 5*22* 296 64 57525 28813 57427 287 64 5
1 9*944 49523 97143 486 22 C 4*3.21 247.lT 476.18 23859 475X 238.10 , 4
1 1060 48)530.74 104247 521.74 A 33318 16709 316.15 158581 31517 15809 ! 3
11 117551 58836 115750 57925 D 262.14 13157 245.11 123.06 244.13 12257) 2
11 K 14711 7406 1X09 6555) ) | 1
• k k” k* k ~  k* k»”  S*%1 > 1 r* r* 7 -  7* •
1; 11204 5652 | 9501) 4*01 [ [ 1 Q 13
2 225.12 113 07 30S1C 10455 | ! 139*7* 699X  1X176 691X  13*0.77 690*9 12
3 33*21 16961 321.18 16109 1 t 12*5X 64135 1268 67 634*4 1X769 63435 11
4 u * :* 2X13 42223 21162 42134|211.13 T 117262 5*461 115559 5 X X  115461 ' s n j i  1*
5 53*21 268 66 5192* 26014 518X 25963 P 1*7 LS7 51*29 105454 527 77 105356 527 X  *
• 63736 3191* 6X33 31067 61935:3101* T f7462 4*7 76 957 49 47925 956X 478 76 •
76643 383 70 74937)37519 74*39)374.70 E 8T3.47 43724 856 44 4X  72 85546 4X23 7
i *65 47 43334 848 44 42472 84746 42423 V 744.43 372 72 727 41 364 X  726 41 36371 «
* 99451 497 76 977 48 489 24 97650 « 8  75 E *462* 3231* 6X  33 31467 62735 31418 6
« 112257)56179lll0554|553 27 110456)532.7*| Q 51631 25(66 * 9 2 9  2X15 4
11 123*6* 61*33 121*63 609(2 121764 60932 L 38826 194.63 3 7 1 X ,1(6.12 M
12 136371 6*2 36 13466* 673*3 1345TO 67335 Q ' 275.17)1x 0 9 ' 25*14I1 » X *
U 1 * 1147.ll] 7406 1X09 6555 | i |
• k k ~  k* k— k* k » "  S«*. y y~ y* y~ j*
T | 1X 051 6553 j | 11204) 5 6 5 2 ) E [w
2 243. U 12207 226.12111307) L ) 13*2 72)691 *6 1365 69 6*335 136471 6*2*6 13
1 957.11 17909 340 15 170X 339.17 1 70 09 N 12*9.6) 6X 32 125261 626 81 125162 62631 12)
4 45423 22762 437X 219.11 4)822:21*61 P 11*85* 5763* 11X56 569 X  I137J* 56929 11
5 56731 284 16 55*29 [27565 ) 548X 27516 1 E si 1 [5X.77 1*
• 4*841 340 70 66337 33219 *623* 1331 X  L •46.45 47323 9X  43 464 72 927.44. 46422 *
T | 73742 36921 7X39 360 70 719.41 (36021. C (3237 41669 81534 40817 I14M 40768 *
• *3847 419 74 821.44 411 22 8X 46 410 73 T 778X 3X 1* 7X 32 37966 75734: 379.17 ) 7[
9 895 41 44825 87*46 <39 73 877X 43924 C 674X 33765 65727 329.14 ) 656 29 3X65 6
1* 1024 53 512 77 1007 X  504X 100652 503 76 E 617 X  30914 60025 30063 59927 300.14 *1
11 1139 56 570X 1122 53 561 77 1121 55 56! X  D C J ilo * * * * !  <3121 23611 <1022 23562 4
12 12X 61 61881 121958 610X 121860 609 80 P n n |l * 7 .1 l |  3562* 1X 39| 355 X 1781* 3
13 1X565 68333 134863 67482 134764 674 22 E 276 16 138 5! 259 13ilX 07 2X  14 12958 2
14 K 14711 7406 1X09 6555) r * i
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Appendix 3
# k »”  k* k—  k» k»” » r * r* r ~ J* *
1 12907 6504 11204' 5652 lu l
M ll* j lJ l  J»~22S 12 113 07 , 139878 69990 1381 76 69138 1380 77 69089 12
» S ^J  178 12 338 21 169 61 L 1285.78 64335 126867 63484 1267 69 63435 11
4 43628 22864 <1*J t  22013 43827 21964 T 117162 584JI 115559 578X  115461 57781 18
>1 S33-a[2m?i 53i.ll 268 66 5333J 36S:7 7 l*TU7 536.29 1C5454 527 77 105356 527 28 9
« 654 38 327 69 637 36 319 18 636 37 318 69 T 97452 487 76 95749 47925 956 50 478 76 I
B 783 42 392 22 766 40 383 70 765 41 38321 E 873.47 43724 856 44 428 72 85546 42823 7
. 882 49 441 73 865 47 433 24 86448 43274 V 74443 372 72 72740 364201 72641 363 71 «
* 101154 30627 99451 497 76 M M ] 49727 E 64536 32318 62833 31467 62735| 31418 5
i i 113959 570X  1122 37 561 79 1121 58 561 » « | 51631 25866 49929 250 15 | 4 |
u 125268 626 84) 123565{61833 123467 61784 L 38826 19463 37123 186121 1
12 1380 74 69087 1363 71 682 36 1362 73)68187 Q 275.17 1X09) 25814 129 58 M
11 1 K 14711 7406 1X09 6555
2
•  t  k -  b- b ~ k* v » - Se, 1 F  l | r * r y~* j* 7*~ *
1 l |  116011 38-52, 98 02 4932! 0 m
: 215.18 10103 19709 9905 V X17 12 100906 200C09 100055 199910 1000.06 19
Ml j M t n  I f i x j 34416 172-58 F 191805 95953 1X102 95101 190004 9X52 18
' 4, 47526 238.13 ! 45734 22913 L 1177058 88599 175395 877 48 175297 87659 17
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j 18 114461157211 112660 56380 L 111 ID 55132 1084.60 54280 101362 54231 11
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17 178750 85445 177087 81594 1769 19 815 45 S 4)228 21664 41526 208.13 41427 20764 4
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267
Appendix 3
Spot No. 1902 Cysteine proteinase-1
500 100
P r n h a h ilitu  R»«erl
1 .  0 1 1 2 4 6 5 3 5 1 4  Mass: 4 1 9 7 4  Score: 1 2 9  Queries matched: 5
C y s t e i n e  p r o t e i n a s e - 1  C C 6 6 9 2 - P C ,  i s o f o r a  C [ D r o s o p h i l a  m e l a n o g a s t e r ]
Query Observed Mr (expt > Mr(calc) Delta Miss Score Expect Rank Peptide
w 1 5 7 6 . 2 5 1 1 5 8 . 4 8 1 1 5 8 . 5 0 - 8 . 9 2 0 4 4 0 . 4 4 1 K . NSWGTTVJGDK. G
w £ 6 0 3 . 7 8 1 2 9 5 . 5 4 1 2 9 5 . 5 6 - 9 . 0 2 0 3 5 3 . 9 1 R.GFTDIPQGDEK K
w is 7 9 8 . 3 5 1 5 9 4 . 6 8 1 5 9 4 . 7 3 - 9 . 9 5 0 7 3 . 3 e + 0 0 3 1 K.ENQCGIftSftSSYPLV -
w A£ 9 1 9 . 4 2 1 8 3 6 . 8 3 1 8 3 6 . 8 7 - 0 . 0 4 1 2 0 1 .  8 e  + 0 0 2 1 R NKENQCGIASftSSYPLV
w 1 2 9 2 3 . 3 6 1 8 4 4 . 7 8 1 8 4 4 . 7 7 - 8 . 8 7 9 2 3 6 8 1 K .SYPYERIDDSCHENK.G
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Appendix 3
Spot No. 1929 Fragile X-related protein 1
30 40 50 60
P r o b a b il i ty  Based Mouse S core
1 .  c r i  12 3 1 7 0 8 7 3  M a s s :  S 9 8 9 9  S c o r e :  6 5  E x p e c t :  0 . 0 1 3  Q u e r i e s  m a t c h e d :  1 3
C G 6 2 Q 3 - P B ,  i s o  f o r m .  B [ D r o s o p h i l a  m e l a n o g a s t e r ]
o i l  4 0 2 1 6 0 0 2  M a s s :  6 4 2 4 1  S c o r e :  6 1  E x p e c t :  0 . 0 4  Q u e r i e s  m a t c h e d :  1 3
G H 2 2 8 3 9 p  [ D r o s o p h i l a  m e l a n o g a s t e r ]
a i 11 0 7 1 7 1 6 1  M a s s :  7 5 9 6 7  S c o r e :  6 0  E x p e c t :  0 . 0 4 8  Q u e r i e s  m a t c h e d :  1 3
KH d o m a i n  c o n t a i n i n g  R N A - b i n d i n g  p r o t e i n  FM R1 [ D r o s o p h i l a  m e l a n o g a s t e r ]  
a i 12 3 1 7 0 8 7 0  M a s s :  7 6 0 0 1  S c o r e :  6 0  E x p e c t :  0 . 0 4 8  Q u e r i e s  m a t c h e d :  1 3
C G 6 2 0 3 - P D ,  i s o f o r m  D [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  H E D L L V E V R L  DN GA YY KG QV T A V A D D G IF V  D V D G V PE SM K  Y P F V K V R L P P
5 1  E E T V E V A A P I  FE B G M E V E V F T R T H D R E T C G  U O T G IIK H R K  A B IY A V A Y IG
1 0 1  F E T S Y T B IC E  L G R L R A K N S N  P P IT A K T F Y Q  F T L P V P E E L R  E E A Q K D G IK K
1 5 1  E F Q R T ID A G V  C H Y SR D L D A L  I V I S K F E H T Q  K R A S M L O M H  F R N L SQKVML
2 0 1  L K R T E E A A R Q  L E T T K L M S R G  N Y V E E F R V R D  D L H G L A IG S H  C S N IQ A A R T V
2 5 1  D G V T N IE L E E  K S C T F K IS G E  T E E S V Q R A R A  M L E Y A E E F F Q  V P R E L V G K V I
3 0 1  G K N G R I IQ E I  V D K S G V F R IK  D Q N IP R E L A H  V P F V F IG T V E  S IA N A K V L L E
3 5 1  Y H L S H L K E V E  Q L R Q E K M E ID  Q Q L R A 1 Q E S S  M G S T Q S F P V T  R R S E R C Y S S D
4 0 1  IE S V R S M R G G  G G GQ RG RVRG RG G G G PG G G N  G LNQ RYH NN R R D E D D Y N SR G
4 5 1  DK QR D Q Q RG Y  n d r g g g d n t g  s y r g g g g g a g  g p g n n r r g g i  n r r p p p j j d q q
5 0 1  NGRDYQHHM H T T E E V R E T R E  M S S V E R D T N
S t a r t - E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
1 4 1 - 1 5 4 1 7 1 4 . 7 5 1 7 1 3 . 7 4 1 7 1 3 . 8 4 - 0 . 1 0 2 E E A Q K D G IH K E F Q R
1 0 3 - 1 9 2 1 2 3 5 . 5 8 1 2 3 4 . 5 7 1 2 3 4 . 6 0 - 0 . 0 3 1 ASMLKDM HFR
1 8 3 - 1 9 2 1 2 5 1 . 6 4 1 2 5 0 . 6 4 1 2 5 0 . 5 9 0 . 0 5 1 ASMLKDM HFR O x i d a t i o n  <M)
1 8 8 - 1 9 7 1 2 9 1 . 6 5 1 2 9 0 . 6 4 1 2 9 0 . 6 1 0 . 0 3 1 DM X FRN LSQK O x i d a t i o n  (H )
2 1 8 - 2 1 9 1 2 0 6 . 5 6 1 2 0 5 . 5 5 1 2 0 5 . 6 4 - 0 . 0 9 1 q l b t t k l m s r
2 1 8 - 2 2 7 2 2 8 1 . 0 1 2 2 0 0 . 8 1 2 2 0 0 . 0 9 - 0 . 0 9 2 Q L E T T K L M SR G N Y V E E F R
3 6 7 - 3 7 4 1 0 3 2 . 5 5 1 8 3 1 . 5 4 1 0 3 1 . 5 1 0 . 0 4 0 M E ID Q Q L R
3 7 5 - 3 9 2 1 9 9 7 . 9 4 1 9 9 6 . 9 3 1 9 9 6 . 9 6 - 0 . 0 3 1 A IQ E S S M G S T Q S F P V T R R  O x i d a t i o n  (M)
3 9 3 - 4 0 8 1 8 7 4 . 8 7 1 8 7 3 . 8 6 1 8 7 3 . 8 6 0 . 0 0 2 S E R G Y S S D IE S V R S M R  O x i d a t i o n  (H )
4 4 1 - 4 5 4 1 7 6 2 . 7 2 1 7 6 1 . 7 1 1 7 6 1 . 7 4 - 0 . 0 3 2 RD EDDYNSRGDHQR
4 5 5 - 4 6 3 1 1 5 1 . 4 9 1 1 5 0 . 4 8 1 1 5 0 . 5 1 - 0 . 0 3 1 DQQRGYNDR
4 5 9 - 4 8 6 2 5 9 7 . 0 0 2 5 9 5 . 9 9 2 5 9 6 . 1 1 - 8 . 1 2 2 GYNDAGGGDNTGSYAGGGGGAGGPGKNR
5 1 7 — 5 2 6 1 2 2 3 . 6 1 1 2 2 2 . 6 0 1 2 2 2 . 5 6 0 . 0 4 1 E T R E M S S V E R
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Appendix 3
S p o t No. 1930 1-cys perox iredox in  2540
P ro b a b il i ty  Based Mouse Score
1. Cfi 112044363 Hass: 24926 Score: 327 Queries matched: 7
1 - c y s  p e r o x i r e d o x i n  D P x - 2 5 4 0 - 1  [ D r o s o p h i l a  m e l a n o g a s t e r ]
Q u ery O b se r v e d Mr ( e x p t ) M r (c a lc ) D e l t a M iss S c o r e E x p e c t Dank P e p t id e
R 11 5 7 0 .3 0 1 1 3 0 .5 9 1 1 3 0 .< 1 - 0 .0 2 0 23 0 . 54 1 IDVMQPEFAK
R 11 5 7 0 .0 2 1 1 3 9 . <2 1 1 3 9 .< 3 - 0 .0 2 0 55 0 .0 0 0 3 1 1 ALFIISPDHX
R 12 5 0 1 .2 9 1160 54 1 K 0 .  <0 - 0 .0 4 0 53 0 . 00062 1 TIDSLQLTDX
R 21 < 1 2 .7 9 1 2 2 3 .5 7 1 2 2 3 .< 0 - 0 .0 3 0 54 0 .0 0 0 4 1 VSMPSGVNYVX ♦ O x id a t io n  (M)
R 32 < 7 1 .3 5 1 3 4 0 .< 0 1 3 4 0 .7 1 - 0 .0 3 0 53 0 .0 0 0 5 4 1 WDTPANWTPGTK
R 11 7 M . « 1 5 1 9 .7 0 1 5 1 9 .7 5 - 0 .0 < 0 10 1 .3 1 LGQTVPNVEADTTK
R 11 7 0 2 . 3< 1 5 < 2 .7 1 1 5 < 2 .7 5 - 0 .0 4 0 7 1 7 - 3 e -0 0 < 1 DLJkVSLGMLDEEQK ♦ O x id a t io n  <M>
1  M R L G Q T V P N F  E A D T T K G P IK  F H E U Q G N S U V  V L F S H P A D F T  P V C T T E L G R I
5 1  A V H Q P E F A K R  N T K C L A H S V D  A L N S H V D U V N  D I K S Y C L D I P  G D F P Y P I I A D
1 0 1  P T R D L A V S L G  M L D E E Q K K D P  E V G K T IB A L F  I I S P D H K V R L  S H F Y P H S T G R
1 5 1  N V D E I L R T I D  S L Q L T D R L K V  V A T P A H W T P G  T K V M IL P T V T  D E E A H K L F P K
2 0 1  G F D K V S M P S G  V H Y V R T T E N Y
» 1 k” k* k~* k» k»” w 7 r  f* [ f "  *
1 114.09 57.55 1 I Ti*
2 185.13 93 07 I A 1026 54 513 77 1009 51 505 26 100»53|504.77 9|
3 28420 14260 V 955.5# 478 25 938 47 469 74 93’ 49 4c9 25 >
4 42L2C 211.13 H #54.43 428 72 4C 42.';: 838 42 419 71 7
5 549.31 275.16 53229 26665 Q 1 719.37 360191 702J5 35168 7(134 351.181 6
t 64637,323.69 62934 31517 P 1 59L31 29616 57429 28765 573 30 287.16 | 5
1775 41 38821 75838 S 75740 37920 E 49426 24763 477 23 239 12 47625 23863 4
I 922.41 461 74 905 45 45323 904 47 452 74 F | 3022 18311 348 19 17460
993J2 49736 97649 488 75 975JO 48826 A 21115 109 JS 201.12 10107 : 2
u I I I ! K | W7.ll 74.06' 130091 6555 1
| « |  h  | fc** V* k 0 ~ Se,. y 1 r* 1 f* I f* **! f* 1*•** #
j 1 72.04 3653
r
10
I 2 IIS. 13 9307 L 1069.60 53531 105258 526 79 105159 52630 *
i 3332.21 166.60 F f 956.52 478 76 939 49 470 25 93851 469 76 1
4 445 28 223 14 I 809.45 405.23 792.43 396 72 791 44 39622 7
5 55836 27969 I 6*4.37 348 69 67934 340 17 678.36 339.68 *
645 40 32320 627539 31420 s 583.28 292 15 566 26 283 63 56527 283.14 *
1 7 742.45 371.73 j 724.44 362.72 P 496.25 248 63 479.22 240 12 47824 239.62 4
1 857.48 429 2  4 839 47 420.24 D 39920 200 10 382.17 19159 381.19 191.10 3
»
“
994.54 [497.77 97653 488 77 H 2*4.17 142 59 267.15 13408 2
K j 147.11 7406 130.09 6555 1zoo <00 800 1000
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Appendix 3
Spot No. 1984 Glutathione S transferase E9
I
50 75
P ro b a b il i ty  Based Mouse Score
1. gj 17302612 Mass: 2S094 Score: 66
CG17534-PA [Drosophila aelanogaster]
Queries matched: 2
Query
£ 
AS
Observed Mr(expt) Mr (calc) Delta Miss Score Ej^ect Ranh Peptide
5 3 9 .D 1  1 0 7 7 .6 0  1 0 7 7 .6 2  - 0 . 0 2  0 2 1  0 .0 0  1  NIAIPLFYK
7 0 0 .3 0  1 3 3 0 .7 6  1 3 9 8 .7 9  - 0 . 0 3  0 4 5  0 .0 0 2 9  1  LVLYGVEASPPVR
1  M G K L V L Y G V E A S P P V R A C K L  T L D JLL G L Q Y E Y R L V N L L A G E  H K T K E F S L K N
5 1  P Q H T V P V L E D  D G K F IU E S H A  IC A Y L V R R Y A  K S D D L Y P K D Y  F K R A L V D Q R L
1 0 1  H F E S G V L F Q G  C I R H I A I P L F  Y K N I T E V P R S  Q ID A IY E A Y D  F L E A F IG N Q A
1 5 1  Y L C G P V I T I A  D Y S W S S V S S  L V G L A A ID A K  R Y PK L N G U L D  R H A A Q P N Y Q S
2 0 1  L N G N G A Q M L I D M F S S K I T K I  V
200 400 600 800 1000 1200
—
b \>*+ h* b * ~ Seq. y r * y* | r * ~ n
1 115.05 58.03 98.02 1 4932 n | 9
1* 228.13 114.57 211.11 106.06 i j 196439 482.80 947.56 474.28 8
3 239.17 150.09 282 14 14158 A 051.50 42625 834.48 [417.74 7
< 41226 206.63 395 23 198.12 I 710.47 390.74 763.44(38222 6
5 50931 255.16 49228 246.64 P 667.30 334.19 650.351325.68 5
{6 62239 311.70 60537 303.19 L 57033 285.67 553.30 277.15 4
b 769 46 385 23 376.72 F 457.24 229.13 440.22 220.61 3i—
t 93251 466.77 915J0 468.25 Y 310.18 155 39 293.15 147.08 2
K 147.11 74.06 130.09 6535 1
* 1 k " b* 1»“ i  y ~  t* T*~ J* 7*~ *
I t 114X19' 57731 r r
i 2 213.14 107.08 [ Y 
L
1286.71 643.86 1269.68 63535 1268.70 634.85 
11I-.64 594 32 1170 62 585 81 1149.4 ) 58532
12
11
10
}_3 126.24 163.63
4 48931 [34516 V 107434 537 78 105753 52937 1056 55 528 78
S 54633 27367 c OILS 456 25 894.47 447 74 893 4  44735
h
6 445.40 32330 V 86447 427.74 07.45 41933 836.46 418.73 8
7 774.44 387 72 | 79443 378.72 n r 755.48 37831 73833 369.69 73739 36930
7
0
145.41 423 34 827.47 41424 4 42436 31368 609 34 305 17 608 35 304 68 4
9 932.51 [466 76 914381"45775 S 555JI 278 17 538 30 269 65 537 31 269 16 1 *
18 102956 51578 :c: 1 55 50638 r 44839 234 65 ’ 45137:22614 4
11 112641 34381 110860 554 81 p 37134 :18612; 354.21 177 61 1
12 1227.68 61334 1307.67 60434 v 274.19; 137.60 257.16 129 38 2
f»l I | » | 17»J3| 88J6 | 15809 79551 [7
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Appendix 3
Spot No. 2011 Glutatione S transferase D5
P r o b a b i l i ty  Based dowse Score
1 .  g i 1 4 5 4 4 6 4 6 4  H a s s :  2 4 7 S S  S c o r e :  6 9  E x p e c t :  0 . 0 0 6 1  Q u e r i e s  m a t c h e d :  9
C G 1 2 2 4 2 - P A  T D r o s o p h i l a  m e l a n o g a s t e r l
1  M D F Y Y S P R G S  G C R T V IH V A K  A L G V K L N H K L  L N T L E K D Q L K  P E F V K L N P Q H
5 1  T I P T L V D N G F  S I U E S R A I A V  Y LV EK Y G K D D  T L F P K D P K K Q  A L V N Q R L Y F D
1 0 1  M G T L Y D S F A K  Y Y Y P L F H T G K  P G S D E D F K K I  E S S F E Y L N I F  LE G Q N Y V A G D
1 5 1  H L T V A D I A I L  S T V S T F E I F D  F D L N K Y P N V A  RW Y AHAKKVT P G U E E N U K G A
2 0 1  V E L K G V F D A R  Q A AA KQ
Start - End Observed Hr(expt) Mr(calc) Delta Hiss Sequence
1 - 8 1120.48 1119.47 1119.47 0.00 0 MDFYYSPR N-Acetyl (Protein)
1 - 8 1136.45 1135.44 1135.46 -0.03 0 MDFYYSPR N-Acetyl (Protein); Oxidation (H)
67 - 73 1005.56 1004.55 1004.59 -0.04 0 AIAVYLVEX
76 - 85 1183.58 1182.57 1182.59 -0.02 1 YGKDDTLFPK
90 - 96 828.44 827.43 827.46 -0.03 0 QALVNQR
97 - 110 1670.74 1669.73 1669.77 -0.04 0 LYFDMGTLYDSFAK
97 - 110 1686.72 1685.71 1683.76 -0.06 0 LYFDMGTLYDSFAK Oxidation (H)
182 - 187 752.33 751.33 751.37 -0.04 0 WYAMAK
205 - 210 664.28 663.27 663.33 -0.06 0 GVFDAR
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Appendix 3
S p o t No. 326 CG5706
3 25
u
10
5
0
0 40 80 120 160 200 240
P r o b a b il i ty  Based Mouse Score
1 .  a i l 2 1 3 5 5 2 1 1  M a s s :  6 6 4 7 7  S c o r e :  2 1 0  E x p e c t :  3 . 5 e - 0 1 7  Q u e r i e s  m a t c h e d :  1 9
C G 5 7 0 6 - P A  [ D r o s o p h i l a  m e l a n o g a s c e r ]
1  M P T IG V K R D L  L F E A 1 G K T Y T  D D E F Q D L C F A  F G L E L D E V T T  EK QM LTK EQG
5 1  D V AA AA NA SE E I I Y R I D I P A  N R Y D L L C L E G  LV T G L L V F Q G  K L K P P K F Q F V
1 0 1  E L A K R Q V L K I D P S T A Q IR P Y  AVAA VLRNV T F T Q A S Y N S F I  D L Q D K L H Q N I
1 5 1  C R K R T L V A IG  T H D L D T L Q G P  F S Y E A L A P D Q  IK F K P L N Q T K  EM TG SELM D F
2 0 1  Y S TH A Q L K Q Y  L P I I R E S P V Y  P V T Y D A N R W  L S L P P I I N G D  H S K IT L K T K N
2 5 1  V F IE C T A T D R  T K A K W L D T I  V C L F S K H C A Q  K F T V E P C D W  Q P D G S V IS Y P
3 0 1  E L E V R E E R I S  V K R A M A Y IG I D E PA EK L A D M  L TR H Y LE A K V  D G D S L V V K IP
3 5 1  PTR H D V TH A C  D IY E D V A IA Y  G Y N N IK K S L P  A F M Q IA K Q F P  L N K L T E Q L R E
4 0 1  QVAjQA GFTEA L T F T L C S R D D  IG R K L N K N ID  A L P A V H IG N P  K T L E F Q W R T
4 5 1  T L L P G L L K T L  V A N R K M PLPL  K L F E I S D W V  A D E S T E V G A R  NBRRVCA VN C
5 0 1  N K T A G F E W H  G LLD R V M Q LL SV PW K SA SG T KG YY LQA TED P S Y F P G R C AN
5 5 1  V M Y D G W IG K  IG V L H P T V L Q  A F B L T T P C S A  V B F T I E P F V
S t a r t - E n d O b s e r v e d M r ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
9 - 1 7 1 0 0 5 . 5 5 1 0 0 4 . 5 4 1 0 0 4 . 5 5 - 0 . 0 1 0 D L L F E A L G K
4 8 - 6 5 1 9 0 6 . 9 2 1 9 0 5 . 9 1 1 9 0 5 . 9 1 0 . 0 1 0 E Q G D V A A A A N A S E E IIY R
9 1 - 1 0 4 9 8 1 . 5 2 9 8 0 . 5 1 9 8 0 . 5 3 - 0 . 0 2 0 F Q F V E L A K
1 1 0 - 1 2 7 1 9 4 1 .  0 4 1 9 4 0 . 0 4 1 9 4 0 . 0 8 - 0 . 0 5 0 ID P S T A Q IR P Y A V A A V L R
1 2 8 - 1 4 5 2 0 9 0 . 9 7 2 0 8 9 . 9 6 2 0 9 0 . 0 0 - 0 .  0 3 0 N V T F T Q A S Y N S F ID L Q D K
1 5 5 - 1 8 2 3 0 1 3 . 5 3 3 0 1 2 . 5 2 3 0 1 2 . 5 4 - 0 . 0 2 0 T L V A IG T  K D L D T L Q G P F S Y E A L A P D Q IK
2 0 9 - 2 1 5 9 0 2 . 5 4 9 0 1 . 5 4 9 0 1 . 5 4 - 0 . 0 0 0 O Y L P I Z K
2 1 6 - 2 2 8 1 5 2 2 . 7 7 1 5 2 1 . 7 6 1 5 2 1 . 7 5 0 . 0 2 0 E S P V Y P V IY D A N R
2 2 9 - 2 4 3 1 5 8 8 . 8 9 1 5 8 7 . 8 8 1 5 8 7 . 9 0 - 0 . 0 2 0 W L S L P P I I N C D H S K
2 5 0 - 2 6 0 1 3 2 5 . 6 3 1 3 2 4 . 6 2 1 3 2 4 . 6 1 0 . 0 1 0 N V F IE C T A T D R
2 8 2 - 3 0 5 2 7 3 5 . 3 3 2 7 3 4 . 3 2 2 7 3 4 . 3 2 0 . 0 1 0 F T  V E P C D  W Q P D G S  V I S Y P E L E V R
3 7 8 - 3 8 7 1 1 2 1 . 5 9 1 1 2 0 . 5 8 1 1 2 0 . 6 0 - 0 . 0 2 0 S L P A F M Q IA K  O x i d a t i o n  <M>
4 0 0 - 4 1 8 2 1 2 9 . 0 5 2 1 2 8 . 0 4 2 1 2 8 . 0 3 0 . 0 2 0 E Q V A Q A G F T E A L T F T L C S R
4 2 8 - 4 4 1 1 4 5 8 . 8 0 1 4 5 7 . 8 0 1 4 5 7 . 8 0 - 0 .  0 0 0 N ID A L P A V X IG N P K
4 4 2 - 4 4 9 9 9 1 . 5 6 9 9 0 . 5 5 9 9 0 . 5 5 0 . 0 0 0 T L E F Q W R
4 6 5 - 4 7 1 8 4 2 . 5 1 8 4 1 . 5 0 8 4 1 . 5 1 - 0 . 0 1 1 K M P L P L K  O x i d a t i o n  <M>
4 7 2 - 4 9 0 2 0 3 6 . 0 1 2 0 3 5 . 0 1 2 0 3 5 . 8 1 - 0 . 0 0 0 L F E IS D V W A D E  S T E V G A R
5 0 3 - 5 1 5 1 4 1 3 . 7 7 1 4 1 2 . 7 6 1 4 1 2 .  7 4 0 . 0 2 0 T A G F E W H G L L D R
5 3 2 - 5 4 7 1 8 6 3 . 8 6 1 8 6 2 . 8 5 1 8 6 2 . 8 5 0 . 0 0 0 G Y Y L Q A T E D P S Y F P G R
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Appendix 3
S p o t No. 362 CG4199
g j I 7 2 9 0 2 5 4  M a s s : € 1 4 8 1  S c o r e :  83 Q u e r i e s  m a tc h e d :  2
CG 4199-PA , i s o  fo rm  A [ D r o s o p h i l a  a e l a n o g a s t e r ]
Q u e r y  O b s e r v e d  M r ( e x p t )
17
17
< 9 3 . 8 2  
8 0 8 . 3 7
1 3 8 5 . < 3  
K 1 4 . 7 2
M r ( c a l c ) D e l t a  M i s s  S c o r e  E x p e c t  R a n k  P e p t i d e
1 3 8 5 . 7 <  - 0 . 1 3  0  4 3  0 . 1 9  1  L P C B L L IL G T G S K
1 6 1 4 .  8 6  - 0 . 1 4  0  4 0  0 . 3 4  1  D P I  V R Q F U L IS Q G K
1
5 1
101
1 5 1
2 0 1
2 5 1
3 0 1
3 5 1
4 0 1
4 5 1
5 0 1
5 5 1
MSTEKSSPDS
LAVGAKCTHY
CYRVKVGNEG
AVAVETIRQE
YKEYDIELUQ
PGVNLENVRT
QSVTWGRKH
GKVSEWLVD
LESMVPDVYV
KKLEAVPFFF
VTAVASCGRD
VR
KYTSAVPVDC 
GAPLQTGALG 
QUMLRAKRSD 
GFTGRLIFVC 
GVAAEKLDTA 
VRELADTKAI 
VPLKAAFGAE 
DTRLPCDLLI 
GGDIANAHIH 
TLIFGKGIRY 
PIVRQFAELI
RVTDLKEHEM
LGRVRCPUHG
LVNNKRLKNM
RKDYLPYDRV
QKELHCSNGY
LASITPESRV
IGQRVLQLFE
LGTGSKLNTQ
GLAHDRVHIG
AGHGSYKDVI
SQGKCLGRGQ
KQVDFDEDTR 
ACFNLENGDI 
VRRKPDDQRV 
KISKAMNLEI 
WKYDKIYLA 
VCLGSSFIAL 
DNKWMRMES 
FLAKSGVKVN 
HYQLAQYHGR 
IDGSHEDFKF 
IEDPATREDXJ
VLLVKQNDRL
EDFPGLDSLP
FIWGGGPSG
EQLRFRDEEF
TGCSAFRPPI
EAAAGLVSKV
GIAEIVGNED
RNGSVDVTDF
VAAINMCGGV
VAYFINEADT
TKKLGQPLPQ
U « k Seq. j 7“ r* n
1 86101 4315 114.091 57351 L IT
1 2 1(3.1$ 92.08 211.14 :0e3S P 127361 437.34 1256.66 628.83 12
[3 343 IS 17209 37L17 186.09 C 117463 588 82 1159.60 58030 11
1 4 45821 229 61 484.20 243 60 D j 111460 508 80 99937150029 10
5 57119 286.15 5*9.29 300.15 L 94137 45129 88435 442 78 9
6 684 37 342 69 71137 356 69 L 7(8.49 394.75 77146 38623 (
7 797.44 39923 125.45 41323 I 475.40 33821 65838 329.69 7
( 91034 455.78 93154 469.77 L 54132 281.66 54529 273.15 4
9 96736 484.29 995 56 49828 G 44924 225.12 43221 216.61 5
111J 1068.61 534.81 1096.61 548.81 T 39121 196.61 375.19 188.10 4
11 1125 63 543.32 1153.63 57732 G 29L17 146.09 27414 13737 3
12 121267 606 84 1240 66 620.83 S 23414 11738 217 12 109.06 2
13 Ll I 147.11 74.06 130.09 6535 _l|
* *
4-alfL
#
1 v
»* ( " •  * k ~ *• 8 " ' y r *  j* *
I
~2 11309 9303 | 21JJ8 10703
i n  m
D
P
1 i
|M |
13X 84 730 92 1483 82 742 41 14
1 Jfn Tft HVI aft : I-XM M iM DO 11j  aj-o .o i ir jy
4 IT J4  199 13
J24.17 10JJ9
42524 211.12
| I
v
1403.79 702 4D 1386 75 093 88 U
12*71 64386 127368 63734 12
5 468 28 23464 4*4.21 24864 I A 1191 64 59632 117461 58781 11
4 596 34 298 67 57931 290 16 *2454 31267 607 31 30416 Q 11X60 560 80 1103 57 352 29 M
' 1 74341 37231 726 38 363 69 T7L4I 386 21 75438 37769 F 9NJ4i«6.77| 97551 !« t2 6 | t
1 *14 45 407 73 797 42 5W:: *4144 421 72 82541 41321 A *45.47 42324 828 45 414 7J *
9 943 «  47213 926 46 463 73 97L4I 486 25 : 934 46 477 73 C | ^7444 387 72 7J741 37921 7
Ml 103657 58.79 j103953 32028 108457 542 79 1067 54 534 27 L 64539 323 X  628 37 31469 4
116966 58333 115MI 3 l l p l » i r J *  399 33 118062 m o l  1 532.31 266 66 51328 258 14 5
u 1236 69 628 85 ;1239 66 6X 33 1284 68 642 83 1267 66 634 33 S 41*22 210 12 402 X X I  60 4
n 1384 75 692.88 1367 72 684J6 1412 74 70687 1395 72 698 36 Q 332 19 166 60 315 17 158 09 1
u 1441 77 721 39 1424 74 712 17 1469 76 735 39 1452 74 726 87 C m i l  10257 18711 94 06 2
15 K 147 11 74 06 110 09 65 55 1
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Appendix 3
i . «il?g?S S 9?
Spot No. 363 HSP60
—r— 
50
U a s s :  6 0 8 8 5
— I—  
100
—1 
150
P r o b a b i l i ty  Based flowse S co re  
S c o r e :  1 3 4  Q u e r i e s  m a t c h e d :  2
C G 1 2 1 0 1 -P B , i s o f o r m  B [ D r o s o p h i l a  u e l a n o g a s t e r ]
Q u e r y  O b s e r v e d  M r ( e x p t )  M r ( c a l c )
17
17
7 5 2 . 8 6
9 5 5 . 4 6
1 5 0 3 . 7 0
1 9 0 8 . 9 0
1 5 0 3 . 8 2
1 9 0 9 . 0 6
D e l t a  M i s s  S c o r e  E x p e c t  R a n h  P e p t i d e
- 0 . 1 2  0  7 7  1 . 9 e - 0 0 6  1  V E F Q D A L L L L S E K
- 0 . 1 7  0  5 8  0 . 0 0 0 1 3  1  I S  SVQ S IIP A L E L A N R Q R
200 400 600 800 1000 1200 16001400
\ * w  ^
k* k* k * - W f a r  | r *  1M l  1 r * *  j 7* I * " #
l j  100.08 5034 V
2 229.12 115 06 f a n .  n  10606 E 14M.76 * t3 J4  1388.T) 69487 1387 75 69438 12
J T J76.1f1l8860 f ; 358.18 j 17959] F 1274.71 6M J6  125969 43435 1258 70 629 86 11
4 >04.2? 252 Ci 48722 244.111 48623 243.62 Q i 8 b B I 111164 55632 I f
5 619^71310.14 60225 30163 601 26 >301.131 D . 141139! 50130 [ 98436; 492 78 98358 49229 »
•  j 69031 34566 67328 33715 67230 33665 A •1434  443 78 86953 435 27 86855 43478 •
7 80339 402 30 78637; 393 69 785 38 I f  324 L •  1532 40827 79830,399.75 79731 39926
•  914.41 458 741 899 45 '43023 898 47 449 74 L I 712341351.721 685 4 1 13<321 68443 34272 6!
* 102936 515.28 101253 506 77 1011 55 506 28 L 599 )4  29518 57233:28667 57134 28618 5
1* 114265 571 83 112562 563 31 112463 562 82 L 474J7 23864 45924 2)1.13 4M 36 22963 4
11 122968 615 34 1212 65 606 83 1211 67 60634 S 343.19 182 10 346 16 17338 34518,17309 3
12 1358 72 679 86 134169 67135 j1340.71167086 E r i . l t  13838 25913 130.07 25814 12958 2
,13 K j 147.11[ 74.06 130X19; 6535 1
*
A4%
S s: 5
*  S.
A
w J1
lit I I
4 * k“  »♦ k — k* S ^ . y r H T f i '
| 1 lUD O j 5735 I 18
2 2> U 2 |10107 | 1*311 9206 S 1796 99 899 0C 1779 96 890 48 1778 98 889 99 17
i ± 7M .lt 144 58 271.14 1353* S 170995 85548 169293 84697 169194 846 41 14
4 t 387 2 21194121 M B  10.11 V 162292 81196 160590 80345 160491 80296 15
5 i f lU f |2 5 8 1 4 :  498.76 24903 49737 249 14 Q 152)^5 76243 1564J3 75392 1505141753 43 14
4 M 7.il M l 66 5*529 [293.15 5*419 29266 S l ) t $ J t 6M.4I 1378.77 68989 1377 78 685 40 13
7 7 i * e 35*20 09137 349 69 09739,34920, I i m 7 4 654.85 129174 64637 1290 75 64588 12
• 1 t e e . 414 74 I1L40 406.23 919.47 « 5  74 I I W M 59834*117865 58983 117767 58934 11
• 91534 ,40327 , 908.51 454.76 90752 454.27 T M Z M 54180 106557 53329 106458 532.80 I t
U 99037 498 79 97935 4902! 97836 4*97! A 9 8 5 5 4 j« 5 3 7 96852 48476 96753 48427 f
n 110906 555 33 1091 63 546*2 1091 65 546 33 L •  14.51 457 76 89748 4 * 2 4  896 49 448 75 •
* 1M .T* 619 85 122107 01134 1220 09 610 85 E 101.42 431 21 78459 39250 783.41 392.21 7
13 1351.78 670 40 133476 667*8 1333 77,06739 L 472J0  336.69 65535 32818 | 6.
14 1422.12 71191 1405 79 703 40 1434*1,70291 A 5S93Sj28Q.15 | 54237 27164 ! *
153010! 76194 1519S4 760 42 151**5,75993’  N 4M.26 24463 47133 23612 4
160790 804 45 J159017 79594 15*9 89 795.451 A | J74J1  18761 35719 179.10
E
>7 173596:80* «  171»93| 85997’171795:159.4* Q » .  I t  15209 28615.14358 ___1 2 .
if I ITS. 12 1 8806 | 15809 7955 | l i
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Appendix 3
S pot No. 415 Misato
P r o b a b i l i ty  Based Mouse Score
1  M D Y T R E I L T F  Q F G T Y A N Y V G  T H F U N Q Q E A N  F R Y G D E S E Q V  A E E Q L P N N D I
5 1  L Y R E G R N D L N  R T T Y T P R L L S  V D L S G T L G H L  P V T G E L Y G N F  V Q R D E E L L P L
1 0 1  S T G E E L E Q V R  K R A E E S G V C S  P E Q L E V Q E Q S  K A S IS E Y Q R D  L L K N A W P E K
1 5 1  N Y Q L A A T A N S  U V D F L Y A R Y H  P R T L H V L P G L  IR D P T A Q A L G  T Y S A G T E M W Q
2 0 1  E V S F N E E F C D  R I R L Y V E E C D  G L Q G F H V L F D  ID D G F G G L A G  K C L E H L N D E Y
2 5 1  S R A S F A L P L H  Y P R I T S Y P Q A  D T R L S H S I R V  V N N V L G Y H Q L  S E Q A L M F T P L
3 0 1  S T L E T I W R N N  N L K S R S L P G L  Q U E T D N L Y Q T  S A L L A A F F D T  A T L S Y R L R Q T
3 5 1  P E S L L R F C E C  V T P A G R K M T A  A G L A L P F G L R  E G Q D L IE F L D  Q S G D H A L L T Q
4 0 1  L T P G C E P G T S  Y W Q S V T A R G  I P A E R L K R P R  E L A G D Q L R M A  A Y S C D S IS H M
4 5 1  L Q L Y Y Q C T Y H  G S V T N A A A T P  L P L K T Q L P F P  Y E M F A A G IS R  D G Y R L P E G A E
5 0 1  R E T G S R V D S A  P M L A A V Q N S T  K L G E H L D N V H  A Q S H R V Q L A K  L Q A Y S N S G L E
5 5 1  R D E Y D T A L D Q  L L E F R D L Y A D  S Q Y L
1. a i l  17737379 Mass: 65256 Score: 63 Expect: 0 .019 Queries matched: 6
CG1424-PA [ D r o s o p h i l a  m e l a n o g a s t e r ]
S t a r t  -  E n d O b s e r v e d M r ( e x p t ) M r  ( c a l c ) D e l t a M i s s S e q u e n c e
9 4  -  1 1 0 1 9 5 7 . 0 7 1 9 5 6 . 0 6 1 9 5 5 . 9 7 0 . 0 9 0 D E E L L P L S T G E E L E Q V R
1 7 3  -  1 8 2 1 0 9 5 . 7 0 1 0 9 4 . 6 9 1 0 9 4 . 6 8 0 . 0 1 0 T L H V L P G L IR
2 5 3  -  2 6 3 1 2 7 1 . 7 0 1 2 7 0 . 7 0 1 2 7 0 . 6 8 0 . 0 1 0 A S F A L P L H Y P R
3 6 8  -  3 8 0 1 3 3 3 . 7 1 1 3 3 2 . 7 1 1 3 3 2 . 7 2 - 0 . 0 2 0 M T A A G L A L P F G L R  O x i d a t i o n  (M)
4 7 5  -  4 9 0 1 8 4 3 . 9 7 1 8 4 2 . 9 7 1 8 4 2 . 9 0 0 . 0 7 0 T Q L P F P Y E M F A A G IS R  O x i d a t i o n
5 5 2  -  5 6 5 1 7 2 7 . 8 8 1 7 2 6 . 8 8 1 7 2 6 . 8 0 0 . 0 7 0 D E Y D T A L D Q L L E F R
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Appendix 3
Spot No. 1184 Capsid polypeptide (Drosophila C virus)
P ro b a b il i ty  Based House Score
1 . q j 1 2 3 8 8 6 7 4  Mass: 1 0043S  Score: 111 Queries matched: 3
c a p s i d  p o l y p r o t e i n  [ D r o s o p h i l a  C v i r u s ]
Query O bserved M r (e x p t> I b ( u l c ) D e lta Miss Score Expect Rank P ep tid e
p 1 5 * 7 .2 * 1 17 2 .5 4 1172. 45 - * .  11 • 49 * . * 8 * 5 4 1 VSLVNSTLQGR
p 1 »1. •< U t l .  71 1 9 * 1 .9 1 -0 .1 9 • 29 * .4 4 1 LML0YYPYWJYMPN3 ♦ 2 O x id a tio n  (M>
p 2 l i t c . 1 4 3 5 5 5 .4 * 3 55 5 .7 3 -5 .3 3 • 13 54 1 EIVMPS SECVTP STT1VP91VSLSTBYL SMTTR * O x ld a t lo jt <M>
1 ANFQTNNNNI ENSDRKITSE QKEIVHFSSE GVTPSTTAVP DIVSLSTDYL
5 1  SMTTREDRIH TIKDELSRPI IIQTGLWSSA TTAETQLYTA NFPEVFISNT
1 0 1  MYQEKLRGFV GLRATLVIKV QVNSQPFQQG RLMLQYYPYA QYMPNRVSLV
1 5 1  NSTLQGRSGC PRTDLDLSVG TEVBMRIPYV SPHVYYNLIT GQGSFGAIYL
2 0 1  WYSQLRDQV TGTGSVEYTV UAHLEDVDVQ YPTGAHIFTG SSPHFASLGQ
2 5 1  KHSDGKFTEK DLRDIWTSKA YKKQPDKIFA QVASEITQLK ESGTISSGIG
3 0 1  QVSEGLSTMS KIPILGNMFT KPAUISAQVS HIFKHLGFSK PTVQGLPCES
3 5 1  KLRGQVPHAH FDGADTSHKL ALSAQNEIET KSGLSGTSPD EMDLSHVLSI
4 0 1  PNFWDRFTWW TTDATSSILU DNYVTPMKIK PYSSTILDRF RCTHHGFVAN
4 5 1  THGYUCGSIV YTFKFVKTQF HSGRLRISFI PFYYNTTISA GVPDVSRTQK
5 0 1  VIVDLRTSTE VSFTIPYVSS RPUMYCIRPB ASWLGTDNAL MYNAVTGIVR
5 5 1  VBVLHQLVAA NNVFQSIDTI VEVSGGPDLT FAAPHAPSYV PYSGGFTLAD
< 0 1  DAAAKKQREE EYDNKIPQTI SNRGKREVED ARIVAQVMGE DLAIQRHDAQ
< 5 1  HGUHPMTIDT HKIDSNUSPE AHCIGEKIHS IRQLIKRFGM ALNSLNLISD
7 0 1  APNTLIAPFS UQHPTPWAP AEPHSLFEYY YFIYGFWRGG MRFKLQAVRT
7 5 1  NSABTSVKTD TTWTVKLUNS VQDSFNSLIN VFSTTDYPIK STGALPACTS
# 0 1  GFCNSMTYID PEVEGFHEFE IPYYNISHIS PATTYVRGTE SPITINSVLR
• 5 1  GHLPPQIVAV APQGTIATTD WHAQFARAP SDDFSFHYLV GVPPLTNVAR
9 0 1  P
*
f t  « • * » * » - * » 1 " 1* I " * w J r* r y*~ f
1 j 7303 3614 110008 1 3054 | V |
2 139.111 8006 1*7.11 94 06 s 1*7439 53780 105756 52929 18
J-3723ojl3Mo! m » 130 60 L 9*7341494.28 97053 485 77 9
4 37127 186 14 399 26 200.13 V *74.47 437 74 857.45 42923 *
J 485 31 343 16 46828 234 64 31330 257 16 496 28 248 64 N T7M1 38821 75838 37969 7
4 372 34 286 67 555 3 : 278 16 6CC 34 300 67 58331 29216 S 64134 331.19 64434 32267 6
1 c ~ ii9  3372C 656 36 328 68 7C; 38 35: 20 68436 34268 T *7433 287 67 55730 27916 S
1 786 47 393 74 769 45 385 23 814 47 407 74 797 44 39922 L 4732* 237.15 456.26 228.63 4
* 914 53 457 77 89750 44926 942.33 471 77 92550 46325 Q 36020 180.60 343 17 17209 3
11 971 35 486 28 954 53 477 77 999 55 300 28 9*252 49176 G 23214 11637 21511 10806 2.
(11 j R 175.121 88 06 158.09 7955 r«i
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Appendix 3
1200 1400 1600
8 a a ~  a* a* "  k k ~  k J r * r 5r*~ »
1 86.101 43531 | | 11409 57 55 [ L | «
: 233.13:117X17; [ 24U3jl31X>?! M 186983 93543 1852X 9X91 14
3 34633 17361' >7431 18741 L 1723 79 8418* 1703.77 |833X 1)
4 47437 33764 43735 33913 3*137 23164 483 34 24313 Q j 14171 80336 1392 68 79683 13
3 *37.34 31* 17 6X31 310 66 446J3  333 17 64831 33466 Y 14*133 74133 146463 73282 11
i X44*;400 X  7833713*2.19 83.4*;414.X| 81137 4*41, Y 131*3* 639 80 1X1X 651X 14
897 45 44933 880 43 440 73 923 45|46333 908 42 454 71 P 115333 57*37 1138 50 369 75 *
8 106033 5X 76 1043 «  333-33 IMLil 34476 107140 3X33 Y 1*38.47 529 74 104143 32123 *
» 113133 366 3* 111433 337.77 113*35 3*0 38 114333 371 76 A r 89341 44821 878 38 439 69 7
11 133*61 6X31 13433*1631-80 13*7.41 64431 13X38 633 79 Q 834J7 41269 [ 807 35 404.18 4
11 142368 71184 140563 70333 j 1450 67:725 84 143364 71733 Y 694.31 348.66 679 29 340.15 3
12 1565 71 785X  155265 776 85 1557 71 799 X  1580 68 790 84 M 33323 X7 13 31623 23862 4
13 1666 76 83385 164* 74 833 37 1654 76 84788 1677 73 83937 P 3(421 19361 369 19 183.10 J
14 1780 81 890 51 1763 78 882 39 180880 90490 1791 78 89639 N 389 14 14508 272 14 1X37 J .
13 K 173.12 8804 13809 195j | *1
# a a** b \+* s e* 7 r * y* y* ~ U
1 102.05 5153 130.05 6553 E 33
2 215.14 108.07 243.13 122.07 I 3427.69 1714.35 3410.67 1705.84 32
3 31421 15761 34220 17160 V 3314.61 1657.81 329758 1649.30 31
4 45127 226.14 47926 240.13 H 321554 1608.27 319851 1599.76 30
5 59833 299.67 62633 313.67 F 3078.48 1539.74 3061 46 153123 29
6 68537 343.19 71336 357.18 S 2931.41 1466.21 291439 1457 70 28
7 772.40 386.70 80039 400.70 1 S 2844.38 1422.69,282736 1414.18 27
8 901.44 45122 929.44 46522 E 275735 1379.18 274032 1370.67 26
9 958.46 479.74 986 46 493 73 G 2628.31 1314.66 261128 1306.14 25
10 105753 52927 108553 54327 V 257129 1286 15 255426 1277.63 24
11 115858 579.79 118657 593.79 T 247222 1236 61 2455.19 1228.10 23
12 1255.63 62832 128363 642 32 P 2371.17 1186 09 2354.14 117758 22
13 1342.66 67184 1370.66 685.83 S 2274.12 113756 225709 1129.05 21
14 1443.71 72236 1471.71 73636 T 2187.08 1094.05 2170.06 108553 20
15 1544.76 77288 1572.75 786.88 T 2086.04 1043.52 2069.01 103501 19
14 161530 808 40 1643 79 822.48 A 198499 993.00 196796 984 49 18
17 1714.86 857.94 1742.86 871.93 1 V 191395 957 48 189693 948.97 17
18 181152 906.46 1839.91 920.46 P 1814.88 907.95 1797 86 899.43 16
19 192654 96358 1954.94 97727 D 1717.83 859 4: 1700.80 85091 15
20 2040.03 102052 2068.02 103452 I 1602.80 801.91 1585 78 79339 14
21 2139.10 1070.05 2167.09 1084.05 V 1489.72 745.36 1472.69 736.85 13
22 222613 111357 2254.12 112757 S 1390.65 695.83 1373 63 637 3: 12
23 233921 1170.11 236721 1184.11 L 1303.62 652.31 1286.59 643.80 11
24 2426.24 1213.63 2454.24 1227 62 S 1198.54 595 77 117351 58726 10
25 252729 1264.15 255529 1278.15 T 110350 552.26 1086.48 543.74 9
24 2642.32 132166 267031 1335.66 D 1002.46 501.73 985 43 493221 •
27 2805.38 140320 283338 1417.19 V 887.43 444.22 870.40 435.70 7
28 2918.47 1459.74 2946.46 1473.73 L 724.37 362.69 70734 354.17 6
29 3005.50 150325 3033.49 151725 S 611.28 306.14 59426 297.63 5
JO 3152-53 1576.77 318053 1590.77 M 524.25 262 63 50722 254.12 4
31 325358 162729 3281.58 1641.29 T 37721 189.11 360.19 180.60 3
\ 3213354.63 1677.82 3382.62 169182 T 276.17 138 59 259.14 130.07 2
N R 175.12 88 06 158.09 7955 1
200 400 600 800 1000 1200 1400 1600 1800
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Appendix 3
S p o t No. 2273 Cofilin
T 1--1--1--1--1--1--1--1----- 1
7 5  1 00
P r o b a b il i ty  Based Mouse Score
1 .  a i l  1 7 1 3 6 9 8 6  M a s s : 1 7 4 2 8  S c o r e :  1 0 7  E x p e c t :  6 . 9 e - 0 0 7  Q u e r i e s  m a t c h e d :  1 7
C G 4 2 S 4 - P A  [ D r o s o p h i l a  m e l a n o g a s t e r ]
1  M A S G V T V SD V  C K T T Y E E IK K  D K K H R Y V IF Y  IR D E K Q ID V E  TV A D RN A EY D
5 1  Q F L E D IQ K C G  P G E C R Y G L F D  FEY M M Q CQ G T S E S S K K Q K L F  LM SW C P D TA K
1 0 1  V K K K M L Y S S S  F D A L K K S L V G  V Q K Y IQ A T D L  S E A S R E A V E E  K L R A T D R Q
S t a r t _ E n d O b s e r v e d M r  ( e x p t ) M r ( c a l c ) D e l t a M i s s S e q u e n c e
2 - 1 2 1 1 2 2 . 5 9 1 1 2 1 . 5 8 1 1 2 1 . 5 4 0 . 0 4 0 ASGVTVSD VCK
2 - 1 9 1 9 8 7 . 0 2 1 9 8 6 . 0 2 1 9 8 5 . 9 6 0 . 0 5 1 A S G V T V S D V C K T T Y E E IK
1 3 - 2 0 1 0 1 1 . 5 3 1 0 1 0 . 5 3 1 0 1 0 . 5 3 - 0 . 0 0 1 T T Y E E IK K
2 6 - 3 2 9 7 3 . 5 5 9 7 2 . 5 4 9 7 2 . 5 4 - 0 . 0 0 0 Y V IF Y IR
3 6 - 4 5 1 1 2 8 . 5 6 1 1 2 7 . 5 6 1 1 2 7 . 5 5 0 . 0 1 0 Q ID V ETV A D R P y r o - g l u  ( N - t e r m  Q)
3 6 - 4 5 1 1 4 5 . 5 8 1 1 4 4 . 5 7 1 1 4 4 . 5 7 - 0 . 0 0 0 QID V ETV A D R
4 6 - 5 8 1 6 1 2 . 7 5 1 6 1 1 . 7 4 1 6 1 1 . 7 4 - 0 . 0 0 0 K A E Y D Q F LED IQ K
5 9 - 6 5 8 3 5 . 3 3 8 3 4 . 3 3 8 3 4 . 3 1 0 . 0 2 0 CG PGECR
6 6 - 8 5 2 4 1 3 . 9 3 2 4 1 2 . 9 3 2 4 1 3 . 0 0 - 0 . 0 7 0 YG LFD FEYM H QC QGTSESSK
6 6 - 8 5 2 4 2 9 . 9 8 2 4 2 8 . 9 7 2 4 2 8 . 9 9 - 0 . 0 2 0 Y G LFD FEYM H QC QGTSESSK O x i d a t i o n  (H)
8 7 - 1 0 0 1 7 0 7 . 7 9 1 7 0 6 . 7 9 1 7 0 6 . 8 2 - 0 . 0 3 1 QKLFLM SW CPDTAK P y r o - g l u  ( N - t e r m  Q)
8 9 - 1 0 0 1 4 6 8 . 6 9 1 4 6 7 . 6 8 1 4 6 7 . 6 9 - 0 . 0 1 0 LFLM SW CPDTAK
8 9 - 1 0 0 1 4 8 4 . 6 8 1 4 8 3 . 6 7 1 4 8 3 . 6 8 - 0 . 0 1 0 LFLM SW CPDTAK O x i d a t i o n  (H)
1 0 5 - 1 1 5 1 2 6 1 . 6 2 1 2 6 0 . 6 1 1 2 6 0 . 6 1 0 . 0 1 0 M L Y S SSFD A LK
1 0 5 - 1 1 6 1 4 0 5 . 7 1 1 4 0 4 . 7 0 1 4 0 4 . 7 0 0 . 0 0 1 M LY SSSFD A LK K  O x i d a t i o n  (H)
1 1 7 - 1 2 3 7 3 0 . 4 2 7 2 9 . 4 2 7 2 9 . 4 4 - 0 . 0 2 0 SLVGVQK
1 2 4 - 1 3 5 1 3 5 3 . 6 7 1 3 5 2 . 6 6 1 3 5 2 . 6 6 0 . 0 1 0 Y IQ A T D L  S E A S R
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Appendix 3
Spot No.370 Albumin
P ro b a b il i ty  Based Mowse Score
1 .  g i  I 3 0 7 9 4 2 8 0  M a s s :  7 1 2 7 4  S c o r e :  2 1 6  E x p e c t :  4 . 4 e - 0 1 6  Q u e r i e s  m a t c h e d :  2
a l b u m i n  [ B o s  t a u r u s ]
1  M K W T F I S L L  L L F S S A Y S R G  V F R R D T H K S E  IA H R F K D L G E  E H F K G L V L IA
5 1  F S Q Y L Q Q C P F  D E H V K L V N E L  T E F A K T C V A D  E S H A G C E K S L  H T L F G D E L C K
1 0 1  V A S L R E T Y G D  H A D C C E K Q E P  E R N E C F L S H K  D D S P D L P K L K  P D P N T L C D E F
1 5 1  K A D E K K F U G K  Y L Y E IA R R H P  Y F Y A P E L L Y Y  A N K Y N G V F Q E  C C Q A E D K G A C
2 0 1  L L P K I E T M R E  K V L T S S A R Q R  L R C A S IQ K F G  E R A L K A U S V A  R L S Q K F P K A E
2 5 1  F V E V T K L V T D  L T K V H K E C C H  G D L L E C A D D R  A D L A K Y IC D N  Q D T IS S K L K E
3 0 1  C C D K P L L E K S  H C IA E V E K D A  I P E H L P P L T A  D F A E D K D V C K  N Y Q E A K D A F L
3 5 1  G S F L Y E Y S R R  H P E Y A V S V L L  R L A K E Y E A T L  E E C C A K D D P H  A C Y S T V F D K L
4 0 1  K H L V D E P Q H L  IK Q N C D Q F E K  L G E Y G F Q H A L  IV R Y T R K V P Q  V S T P T L V E V S
4 5 1  R S L G K V G T R C  C T K P E S E R M P  C T E D Y L S L I L  H R L C V L H E K T  P V S E K V T K C C
5 0 1  T E S L V H R R P C  F S A L T P D E T Y  V P K A F D E K L F  T F H A D IC T L P  D T E K Q IK K Q T
5 5 1  A L V E L L K H K P  K A T E E Q L K T V  M E H F V A F V D K  CC A A D D K EA C  F A V E G P K L W
6 0 1  S T Q T A L A
t a r t - E n d O b s e r v e d M r  ( e x p t ) M r  ( c a l c ) D e l t a M i s s S e q u e n c e
6 6 - 7 5 1 1 6 3 . 6 1 1 1 6 2 . 6 1 1 1 6 2 . 6 2 - 0 . 0 2 0 L V N E L T E F A K
8 9 - 1 0 0 1 4 1 9 . 6 9 1 4 1 8 . 6 8 1 4 1 8 . 6 9 - 0 . 0 1 0 S L H T L F  G D E L  CK
1 6 1 - 1 6 7 9 2 7 . 4 9 9 2 6 . 4 8 9 2 6 . 4 9 - 0 . 0 1 0 Y L Y E IA R
1 6 9 - 1 8 3 1 8 8 8 . 9 4 1 8 8 7 . 9 3 1 8 8 7 . 9 2 0 . 0 1 0 H P Y F Y A P E L L Y Y A N K
1 8 4 - 1 9 7 1 7 4 7 . 7 1 1 7 4 6 . 7 1 1 7 4 6 . 7 0 0 . 0 1 0 Y H G V F Q E C C Q A E D K
2 0 5 - 2 1 1 9 2 2 . 4 7 9 2 1 . 4 6 9 2 1 . 4 6 0 . 0 0 1 IE T M R E K  O x i d a t i o n  (H )
3 1 9 - 3 4 0 2 4 5 8 . 2 6 2 4 5 7 . 2 5 2 4 5 7 . 1 7 0 . 0 8 1 D A I P E N L P P L  T A D F A E D K D V C K
3 4 7 - 3 5 9 1 5 6 7 . 7 7 1 5 6 6 . 7 6 1 5 6 6 . 7 4 0 . 0 3 0 D A F L G S F L Y E Y S R
3 6 0 - 3 7 1 1 4 3 9 . 8 2 1 4 3 8 . 8 2 1 4 3 8 . 8 0 0 . 0 1 1 R H P E Y A V S V L L R
3 6 1 - 3 7 1 1 2 8 3 . 7 0 1 2 8 2 . 6 9 1 2 8 2 . 7 0 - 0 . 0 1 0 H P E Y A V S V L L R
3 8 7 - 3 9 9 1 5 5 4 . 6 6 1 5 5 3 . 6 6 1 5 5 3 . 6 5 0 . 0 1 0 D D P H A C Y S T V F D K
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Summary
During animal cell chemotaxis, signalling at the plasma 
membrane induces actin polymerisation to drive forward 
cell movement Since the cellular pool of actin is limited, 
efficient protrusion formation also requires the 
coordinated disassembly of pre-existing actin filaments. To 
search for proteins that can monitor filamentous and 
globular actin levels to maintain the balance of 
polymerisation and disassembly, we followed changes in 
the proteome induced by RNA interference (RNAi)- 
mediated alterations in actin signalling. This unbiased 
approach revealed an increase in the levels of an inactive, 
phosphorylated form of the actin-severing protein cofilin 
in cells unable to generate acdn-based lamellipodia. 
Conversely, an increase in F-actin levels induced the 
dephosphorylation and activation of cofilin via activation 
of the Ssh phosphatase. Similarly, in the context of acute 
phosphoinositide 3-kinase (PI3K) signalling, dynamic
changes in cofilin phosphorylation were found to depend 
on the Ssh phosphatase and on changes in lamellipodial F- 
actin. These results indicate that changes in the extent of 
cofilin phosphorylation are regulated by Ssh in response 
to changes in the levels and/or organisation of F-actin. 
Together with the recent finding that Ssh phosphatase 
activity is augmented by F-actin binding, these results 
identify Ssh-dependent regulation of phosphorylated 
cofilin levels as an important feedback control mechanism 
that maintains actin filament homeostasis during actin 
signalling.
Supplementary material available online at 
http://jcs.biologists.org/cgi/content/full/120/ll/1888/DCl
Key words: Actin Cytoskeleton, Proteomics, Cofilin, Phospho- 
regulation
Introduction
Animal cells respond to a variety of signalling events at the 
plasma membrane by remodelling their actin cytoskeleton 
(Ridley et al., 2003). This drives changes in cell shape and is 
important for a variety of morphogenetic events, including cell 
migration and axon pathfinding. In many of these systems, 
actin signalling is triggered by ligand-receptor binding at the 
outer leaflet of the plasma membrane. This induces the 
activation of intracellular phosphoinositide 3-kinase (PI3K), 
which leads to the local activation of Rho family GTPases 
(Katso et al., 2001; Vanhaesebroeck et al., 2001). Rho family 
GTPases serve as ‘master regulators’ of the actin cytoskeleton 
(Ridley et al., 2003). Once active and loaded with GTP, Cdc42 
and Rac GTPases bind Arp2/3 activator complexes, WASp and 
SCAR, respectively (Ibarra et al., 2005; Vartiainen and 
Machesky, 2004), triggering the Arp2/3-dependent nucleation 
of actin filaments and the generation of local actin-dependent 
protrusions. Since the burst of actin polymerisation in 
response to signalling is limited by the availability of actin 
monomers, a robust protrusive response also requires the 
coincident disassembly of the existing actin network. This is 
catalysed by the conserved actin-binding protein cofilin 
(Bamburg, 1999; Carlier et al., 1997; Hotulainen et al., 2005; 
Nishita et al., 2005) For a robust chemotactic response, the
turnover of newly formed actin-based protrusions must also 
be tightly regulated, so that a cell can follow dynamic changes 
in the direction of an extracellular gradient. Finally, it has been 
proposed that cofilin aids directional motility by severing 
actin filaments close to the cell front to create new barbed ends 
to promote new local actin polymerisation (Ghosh et al.,
2004).
Although data from the literature suggest that Rho family 
GTPases help to achieve coordinated control of actin filament 
nucleation and disassembly (Arber et al., 1998; Yang et al., 
1998), little is known about the molecular mechanisms that 
monitor changes in actin organisation to ensure that a 
protrusive response to signalling is robust and self-limiting. To 
identify cytoskeletal regulators that function in this way, we 
used 2D difference gel electrophoresis (2D-DIGE) together 
with RNA interference (RNAi) to search for protein isoforms 
that are sensitive to changes in actin filament organisation and 
to actin signalling in Drosophila S2R+ cells. This identified 
Ssh-dependent changes in cofilin phosphorylation that mirror 
changes in actin filament levels. Taken together, our data 
suggest that the dynamic regulation of cofilin activity acts as 
a feedback control mechanism, which monitors the level of 
actin filaments and helps to restore the resting state of the 
cytoskeleton following acute signalling.
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Results
Levels of phosphorylated cofilin change in response to 
changes in actin filament organisation and PI3K 
signalling
The ability of animal cells to control and coordinate cortical 
actin-filament-based protrusive activity, suggests the existence 
of cellular machinery that monitors and regulates actin filament 
levels. To explore this possibility, we took an unbiased 
approach, using 2D-DIGE to search for protein isoforms that 
are sensitive to RNAi-induced changes in actin cytoskeleton 
organisation. We chose Drosophila S2R+ cells, an adherent 
isolate of the commonly used haemocyte-derived S2 cell line 
(Yanagawa et al., 1998), as a model system for this analysis. 
Triplicate cultures were treated with double-stranded RNA 
(dsRNA) to silence genes that affect lamellipodial formation 
(Kunda et al., 2003); 2D-DIGE was performed to identify 
corresponding changes in the S2R+ proteome, taking advantage 
of the fact that cytoskeletal proteins are relatively abundant in 
S2R+ extracts. Protein expression was first assayed in lysates 
from untreated control cells and from cells treated with 
dsRNAs targeting Cdc42, Racl+Rac2 and Arp3 prepared on
A
different days. These treatments all eliminate lamellipodial 
formation (Kunda et al., 2003). This analysis revealed a 
number of proteins whose expression differed between 
untreated control and one or more of the experimental 
conditions (>1.5-fold average up- or downregulation; P<0.05; 
n=3). Each of these protein spots was excised from the gels for 
mass spectrometry (MS)-based protein identification 
(supplementary material Table SI). In this way, a protein 
corresponding to Drosophila Twinstar -  the homologue of the 
actin depolymerising and severing protein cofilin -  was 
identified with high confidence. This cofilin isoform was 
expressed at elevated levels following loss of Cdc42, Rac and 
Arp3 expression (Fig. 1A, B and supplementary material Fig. 
SI).
Cdc42 and Rac have been implicated in the dynamic 
regulation of cofilin activity in several systems (Arber et al., 
1998; Yang et al., 1998) and are thought to act as part of a PI3K 
signalling cascade (Benard et al., 1999; Hawkins et al., 1995; 
Kotani et al., 1995; Reif et al., 1996). These facts led us to use 
RNAi to explore whether PI3K signalling also influences the 
expression of this cofilin isoform in S2R+ cells. To do this, we 
treated cells with dsRNAs targeting Drosophila 
PI3K or the phosphatidylinositol (3,4,5)- 
trisphosphate [PtdIns(3,4,5)/>3] phosphatase 
PTEN to perturb PtdIns(3,4,5)P3 levels in 
opposing directions. In addition, we used RNAi to 
silence two crucial downstream targets of PI3K 
signalling, Akt and Ras. GFP dsRNA was 
included as an irrelevant control for the effects of 
RNAi. A quantitative analysis revealed a 
significant reduction in the level of this cofilin 
spot in PTEN dsRNA-treated cells (-1.57-fold; 
P=0.005) and a moderate upregulation in PI3K 
dsRNA-treated cells, as expected for a genuine 
target of PI3K signalling (Fig. 1 and 
supplementary material Table SI). The decrease in 
the level of this cofilin isoform observed in Akt 
RNAi cells fell below our confidence limit (Fig. 
1B,C). As expected, GFP dsRNA treatment did
Fig. 1. P-cofilin levels change in response to 
alterations in actin filament organisation and PI3K 
signalling. (A) Representative 2D-DIGE gel images 
and 3D-fluorescence profiles of acidic and basic cofilin 
isoforms are shown for untreated (Ctrl) cells and cells 
treated with control dsRNA and dsRNA targeting 
cofilin, PTEN, PI3K pi 10 catalytic subunit (pi 10), 
Cdc42, Racl and Rac2 (Racl/2), and Arp3. (B) The 
relative abundances of P-cofilin (acidic isoform) and 
cofilin (basic isoform) are shown for RNAi-treated 
cells from 2D-DIGE image analysis. Values represent 
the average of three measurements from biological 
replicates. Error bars represent the standard deviation. 
(C) Immunoblots show P-cofilin levels in untreated 
control and dsRNA-treated S2R+ cell lysates 
confirming 2D-DIGE data. Relative abundance is 
shown below the blot as a percentage of the control, 
and is the average calculated from densitometry 
measurements of blots from three independent 
experiments. (D) Immunoblot of P-Akt and total Akt 
levels in control and dsRNA-treated S2R+ cell lysates 
confirms the loss of PI3K, PTEN and Akt expression.
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not affect cofilin expression. Nevertheless, one protein, 
identified as annexin B l l ,  exhibited significant differences in 
its expression between dsRNA-treated cells and the untreated 
control. This suggests that dsRNA treatment or the engagement 
o f the RNAi machinery itself can alter the expression of some 
proteins even in the absence of a target mRNA.
A second more basic isoform of cofilin was identified on 
these 2D gels by matrix-assisted laser desorption/ionization 
time-of-flight (MALDI-TOF)-based peptide mass 
fingerprinting (supplementary material Fig. SI A), and the 
identification of both isoforms was confirmed by the 
concomitant reduction of both the basic and acidic gel features 
in cofilin RNAi-treated cells (supplementary material Table SI 
and Fig. 1C,D). Based on previous 2D studies (de Graauw et 
al., 2005; Hensbergen et al., 2005), we reasoned that the acidic 
isoform of cofilin may be phosphorylated. To test whether this 
was indeed the case, TiC>2 micro-columns were used to enrich 
for tryptic phosphopeptides from the acidic cofilin gel feature, 
which were then subjected to MALDI-TOF analysis. This 
identified a peptide with a mass corresponding to a 
phosphorylated form of the N-terminal tryptic peptide of 
cofilin (Ac-ASGVTVSDVCK+P; 1244.5 Da), with the 
equivalent peptides from the acidic and basic gel features 
exhibiting an 80 Da mass difference, equal to the mass of one 
phosphate group (supplementary material Fig. SIC). Nano­
liquid chromatography-electrospray ionization collision- 
induced dissociation tandem mass spectrometry (LC-MS/MS)- 
based sequencing was used to identify the site of 
phosphorylation as being serine residue 3 (supplementary 
material Fig. S2). Significantly, this modification is known to 
block the activity of cofilin by preventing it from binding to 
and severing actin filaments (Bamburg, 1999). Since 
commercially available antibodies raised against cofilin 
phosphorylated at Ser3 (hereafter referred to as P-cofilin) did 
not recognise the Drosophila protein, a rabbit polyclonal 
antibody was raised against the Drosophila phospho-peptide 
sequence. The affinity-purified antibody specifically 
recognised the acidic isoform of cofilin in 2D immunoblots 
(supplementary material Fig. SID), again confirming the 
identity of this protein. This antibody against P-cofilin was 
then used to validate the results of the proteomic analysis by 
immunoblotting lysates of the dsRNA-treated cells (Fig. 1C). 
Antibodies against Akt phosphorylated at Ser505 (P-Akt) and 
against total Akt were used in a similar way to demonstrate the 
efficacy of the PI3K, PTEN and Akt RNAi treatments (Fig. 
ID). Taken together, these data show that the extent o f cofilin 
phosphorylation is responsive to changes in PtdIns(3,4,5)P3 
levels and is dependent on the activity of Cdc42 and Rac. More 
surprisingly, these results also indicate that cofilin 
phosphorylation is affected by changes in the level o f Arp3, a 
component of the actin nucleation complex that drives 
lamellipodial formation downstream of Cdc42 and Rac (Kunda 
et al., 2003).
Kinetics of cofilin phosphorylation and actin remodelling 
in response to an acute stimulus
Having identified changes in the extent of cofilin 
phosphorylation in cells at steady state, we next examined the 
dynamics of cofilin phosphorylation in cells undergoing acute 
changes in actin cytoskeletal organisation. This required the 
identification of a stimulus able to induce dynamic actin
remodelling. In testing a number of growth factors in S2R+ 
cells [10% foetal calf serum (FCS), 2-day-old conditioned 
medium, bovine insulin, human EGF, murine vascular 
endothelial growth factor (VEGF) and human platelet-derived 
growth factor (PDGF)], only insulin was found to activate 
signalling, as monitored by immunoblotting with specific 
antibodies against P-Akt, S6K phosphorylated at Thr398 (P- 
S6K) and ERK phosphorylated at T hrl98 and Tyr200 (PP- 
ERK) (supplementary material Fig. S3A) and Lizcano et al. 
(Lizcano et al., 2003). Insulin also induced an increase in the 
level of lamellipodial F-actin in these cells within 5 minutes of 
treatment (Fig. 2A). Elevated levels of filamentous actin 
remained at the cell cortex for 30-40 minutes, before moving 
to the cell interior (perhaps as the result of retrograde flow in 
the absence of new polymerisation). Since actin polymerisation 
is known to generate the force for membrane protrusion, we 
used time-lapse microscopy to determine whether this burst of 
actin filament formation is translated into protrusive activity, 
imaging cells every 20 seconds before and after addition of 
insulin, starting 10 minutes before and finishing 30 minutes 
after addition. (Fig. 2B). As can be seen in the corresponding 
kymographs, insulin induced a significant increase in the rate 
of membrane ruffling. Insulin was also found to induce strong 
cortical F-actin staining in more rounded K cl67 cells, which 
do not possess lamellipodia (Fig. 2C). This suggests that the 
induction of actin polymerisation is the primary response, 
which in adherent S2R+ cells is translated into the formation 
of F-actin-based protrusions.
The kinetics of this actin response was mirrored by changes 
in PI3K signalling, as measured using P-Akt. The insulin- 
induced change in Akt phosphorylation reached its maximum 
level within 2 minutes. High levels o f P-Akt were then 
maintained for 10-20 minutes, before declining gradually to 
background levels (Fig. 2E). This kinetic profile was confirmed 
in fixed cells where, in response to insulin, P-Akt was first seen 
to rapidly accumulate at the plasma membrane, the site of 
PtdIns(3,4,5)P3 generation (supplementary material Fig. S3B). 
P-Akt then became localised to the nucleus, before declining 
to barely detectable levels by 120 minutes. We confirmed this 
to be a generic response of fly cells by observing similar P- 
Akt dynamics in Kcl67 cells following insulin stimulation 
(supplementary material Fig. S3C). We then used 
immunoblotting to follow cofilin phosphorylation dynamics 
during the course of this response. P-cofilin levels responded 
to PI3K signalling, but did not peak until -3 0  minutes after 
insulin stimulation (Fig. 2D); long after the initial burst of actin 
and PI3K signalling.
Having established that insulin induces a robust PI3K signal 
together with a striking change in actin organisation and cofilin 
phosphorylation, we used the PI3K inhibitors LY294002 and 
wortmannin to test whether these events are causally linked. 
The addition of LY294002 (100 pJM) or wortmannin (100 nM) 
to resting S2R+ cells (Fig. 3A) and K cl67 cells (supplementary 
material Fig. S4A) led to a profound loss of cortical actin 
filaments. Moreover, both inhibitors blocked normal 
membrane ruffling in cells (Fig. 3B), suggesting a role for 
PtdIns(3,4,5)P3 in the regulation of actin dynamics in cells at 
steady state. In addition, LY294002 and wortmannin induced 
a retraction of the cell edge, leaving a few relatively inactive 
membrane processes attached to the substrate. Similarly, both 
drugs blocked the ruffling response to insulin treatment
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(supplementary material Fig. S4B). The ability of these 
compounds to block insulin-induced PI3K activity was 
confirmed by immunoblotting for P-Akt (Fig. 3C). We were 
then able to use LY294002 to show that insulin-stimulated
cofilin phosphorylation is a consequence of PI3K signalling 
itself, because treatment with this compound led to a 
significant reduction in the ability of insulin to induce cofilin 
phosphorylation (Fig. 3D). Thus, PtdIns(3,4,5)P3 is required
D istance
D E
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P-Akt
Total Akt
0 2 5 10 15 20 30 60 120
Time course (min)
Fig. 2. The kinetics of actin remodelling and cofilin phosphorylation following an acute stimulus. (A) S2R+ cells stained for F-actin 
(Rhodamine-phalloidin) and nuclei (DAPI) are shown at various times after insulin stimulation (10 p.g/ml). Bar, 50 p,m. (B) Images from a 
time-lapse movie of S2R+ cells stimulated with insulin (10 p.g/ml) for the times indicated. Cells were filmed in phase-contrast on a time-lapse 
microscope using a 100X oil-immersion lens; frames were acquired every 20 seconds, 10 minutes prior to insulin addition and for 30 minutes 
after addition. Images are representative of five independent experiments. Bar, 50 p.m. Right panel shows a kymograph of the movie from 
which the presented images were taken, generated from pixel intensities along a line transecting the cell membrane (shown in first image). It 
shows increased protrusion dynamics after insulin stimulation. (C) F-actin immunostaining (Rhodamine-phalloidin) of serum-starved Kcl67 
cells stimulated with insulin (10 p.g/ml) for the indicated times. Bar, 50 p.m. (D) Cofilin is transiently phosphorylated in S2R+ cells in response 
to insulin. S2R+ cells were grown in serum-free medium overnight and stimulated with insulin at 10 p.g/ml for the indicated times. Lysates were 
prepared and immunoblotted with antibody against P-cofilin. Blots were analysed by densitometry. Values represent the mean P-cofilin signal 
from two experiments after normalising with respect to (3-actin levels. Error bars represent the standard deviation. (E) Time course of Akt 
activation in insulin stimulated S2R+ cells. S2R+ cells were maintained in Schneider’s serum-free medium overnight, and then stimulated with 
bovine insulin (10 p-g/ml) for the times indicated. Immunoblotting was used to assess levels of P-Akt and total Akt.
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for the maintenance of an actin-rich cortex, the 
normal ruffling behaviour of resting cells, and for 
the insulin-induced stimulation of actin 
polymerisation and cofilin phosphorylation in S2R+ 
cells.
Functional analysis of cofilin and P-cofilin 
during acute actin signalling
Using RNAi, we were then able to define roles for 
cofilin and phosphorylated cofilin (P-cofilin) in the 
response of S2R+ cells to PI3K signalling. As before, 
insulin was used to stimulate PI3K-dependent 
membrane ruffling (Fig. 4). We first tested the role 
of cofilin in this process. Five days after the 
treatment of cells with cofilin dsRNA, the majority 
of cells (>90%) displayed a rounded morphology, 
with increased F-actin staining (Fig. 4A). These cells 
were unable to re-organise their actin cytoskeleton or 
to ruffle in response to insulin (Fig. 4B), implying a 
role for cofilin in the generation of new actin 
filaments, as previously described (Ghosh et al., 
2004). Second, since the kinase and phosphatase 
responsible for the control of cofilin phosphorylation 
have been previously identified in both Drosophila 
and other systems, as LIMK (Arber et al., 1998; 
Yang et al., 1998) and slingshot (Ssh) (Niwa et al.,
2002), respectively, we were able to use RNAi to 
assess whether the dynamic changes in cofilin 
phosphorylation observed are dependent on these 
proteins and important for the protrusive response to 
PI3K signalling. As expected, RNAi-induced 
silencing of Ssh led to an increase in basal cofilin 
phosphorylation, whereas silencing of LIMK led to 
a decrease (Fig. 5A). Ssh silencing also induced a 
significant reduction in the ability of cells to mount 
a protrusive response to insulin stimulation (Fig. 
4B), even though gross cellular morphology and 
actin organisation were preserved (Fig. 4A). 
Conversely, cells expressing reduced levels of LIMK 
were found to have well-defined cortical lamella 
(Fig. 4A) and to ruffle intensely before and after 
insulin stimulation (Fig. 4B), suggesting that cofilin 
phosphorylation is not required for the formation of 
new protrusions. Finally, we used RNAi to test for 
the role of Rac and the Arp2/3 complex in this 
response. As previously reported (Kunda et al.,
2003), dsRNAs targeting Rac 1+2 or Arp3 gave rise 
to S2R+ cells with a starfish-like phenotype. These 
cells proved unable to mount a morphological 
response to insulin treatment (Fig. 4A,B). Thus, the 
Rac-Arp2/3 pathway is required for the generation 
of new actin filament-based protrusions downstream 
of acute PI3K signalling, as is active cofilin.
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The proteomic analysis showed that cells lacking 
lamellipodia (Rac 1/2, Cdc42 or Arp3 RNAi cells) 
express relatively high levels of P-cofilin (Fig. 1). This suggested 
the possibility that the observed changes in cofilin 
phosphorylation are triggered as a response to the loss of
Fig. 3. PI3K-signalling controls cortical actin organisation. (A) Actin staining of 
S2R+ cells after treatment with DMSO vehicle (Ctrl), LY294002 (100 p.M) and 
wortmannin (100 nM). Cells were treated for 10 minutes and then fixed and 
stained with Rhodamine-phalloidin. Arrowheads indicate regions of cell 
retraction to leave protrusions. Bar, 50 |xm. (B) Images of time-lapse movies of 
S2R+ cells treated with DMSO, LY294002 (100 p.M) and wortmannin (100 
nM). Cells were filmed in phase-contrast on a time-lapse microscope using a 
100X oil-immersion lens. Frames were acquired every 10 seconds for 30 
minutes with inhibitor treatment after 10 minutes of filming (designated 0’ in the 
figure). Snapshots are shown at 0, 5 and 10 minutes. The corresponding 
kymographs show cells from 3 minutes before until 10 minutes after insulin 
stimulation and were constructed from pixel intensities taken along the lines 
depicted in the images on the left. Bar, 50 p.m. (C) Immunoblotting of P-Akt 
and total Akt in untreated S2R+ cells and cells treated with insulin (for 10 
minutes) with and without pre-treatment (for 10 minutes) with LY294002 (100 
p-M) or wortmannin (100 nM). (D) Immunoblotting of P-Akt, (3-actin and P- 
cofilin in S2R+ cells treated for 10 minutes with LY294002 (100 p.M) and 
insulin (10 pg/ml), alone and in combination. Relative abundance is represented 
as a percentage of the control below the blot and is the average calculated from 
densitometry measurements of blots from three independent experiments.
lamellipodial actin. To test whether this correlation also holds 
during an acute response to PI3K signalling, we used Racl + 
Rac2 RNAi to block lamellipodial formation in cells stimulated
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with insulin. This RNAi treatment eliminated dynamic changes 
P-cofilin, supporting the idea that changes in cofilin activity 
follow changes in the levels of actin filaments in this system (Fig. 
5B). Similarly, Ssh RNAi cells, which have an impaired ruffling 
response, do not display the dynamic changes in cofilin 
phosphorylation in response to insulin/PI3K signalling (Fig. 5B). 
To examine the kinetics of this response more directly, we used 
actin inhibitors to induce acute changes in the relative levels of 
F-actin and G-actin, and tracked the resulting changes in P- 
cofilin levels. Both the G-actin-sequestering agent latrunculin B 
and the barbed-end capping toxin cytochalasin D eliminated the 
actin-rich cell cortex within minutes (Kiger et al., 2003) (data
B
not shown). In both cases, this led to a steady increase in the 
level of cofilin phosphorylation over a period of 30-60 minutes 
(Fig. 5C). Conversely, the addition to cells of jasplakinolide, a 
drug that promotes actin filament formation (Bubb et al., 1994), 
induced the rapid loss of P-cofilin (to barely detectable levels 
within 10 minutes). Jasplakinolide was also able to block the 
accumulation of P-cofilin in insulin-treated cells (Fig. 5D). 
These data reveal a direct correlation between the level of 
cortical actin filaments present in cells and the level of cofilin 
phosphorylation.
RNAi-induced silencing of actin was also found to induce a 
robust increase in cofilin phosphorylation (Fig. 6D). This 
confirms the link between actin filaments and P- 
cofilin, and shows that free cofilin can serve as a 
substrate for LIMK. Importantly, it also 
demonstrates that G-actin is not required for a 
change in F-actin or G-actin levels to be 
translated into a change in the extent of cofilin 
phosphorylation. Actin-dependent changes in 
cofilin phosphorylation could be mediated 
through changes in the rate of its 
phosphorylation and/or its dephosphorylation. 
To explore both possibilities, we used LIMK and 
Ssh dsRNA to reduce the rate of both forward 
and back reactions. This analysis revealed first 
that the loss of P-cofilin observed following the 
treatment of cells with jasplakinolide requires 
Ssh (Fig. 6A). This loss of the jasplakinolide 
response was not due to the raised levels of 
phosphorylated Ser3 in Ssh RNAi cells, because 
Ssh dsRNA also blocked the jasplakinolide- 
induced decrease in P-cofilin levels in cells 
lacking both Ssh and LIMK (Fig. 6B). By 
contrast, although RNAi-induced silencing of 
LIMK significantly reduced the overall levels of 
P-cofilin, it was unable to suppress changes in P- 
cofilin levels seen upon treatment of cells with 
latrunculin (Fig. 6C). Significantly, however, the 
addition of Ssh dsRNA to LIMK RNAi cells 
overrode this latrunculin-induced increase in P- 
cofilin levels. These results suggest that the 
downregulation of Ssh phosphatase activity after 
latrunculin treatment plays an important role in 
the regulation of the P-cofilin response, as does 
its upregulation in the presence of jasplakinolide. 
Thus, Ssh is likely to be the key regulator of 
dynamic regulation of cofilin phosphorylation 
this system.
D iscu ssio n
In this study, we have used Drosophila cell lines 
as a model system to explore the molecular 
mechanisms governing the dynamic remodelling 
of the cortical actin cytoskeleton. First, we 
sought to identify mechanisms that enable cells 
to sense and respond to changes in actin filament 
levels. To do this, we took an unbiased approach, 
making use of the relative abundance of 
cytoskeletal regulators to combine proteome 
expression profiling with RNAi-dependent gene 
silencing to identify proteins that are responsive
A a. 10-
D istance
Fig. 4. Functional analysis of cofilin during acute actin signalling. (A) Actin 
staining in dsRNA-treated cells stimulated with insulin. S2R+ cells were incubated 
with dsRNAs targeting LacZ, cofilin, LIMK, Ssh, Rac land Rac2 (Rac 1/2) and 
Arp3 for 5 days. On day 5, cells were treated with insulin for 10 minutes (10’) or 
left untreated (O’). Cells were then fixed and stained for F-actin with Rhodamine- 
phalloidin. Bars, 50 p.m. (B) Visualisation of actin dynamics in dsRNA-treated 
cells using GFP-labelled moesin. Snapshots of time-lapse movies just before the 
addition of insulin are shown on the left. Bars, 50 p.m. The two lines used to 
generate the kymographs (right) are indicated on the cell images. Actin 
reorganisation was filmed for 3 minutes before and for 10 minutes after the addition 
of 10 p.g/ml insulin, the point of insulin addition labelled as O’. Images are 
representative of at least two independent experiments.
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Fig. 5. PI3K-induced changes in cofilin phosphorylation are the 
result of actin cytoskeletal remodelling. (A) LIMK and Ssh are 
regulators of cofilin phosphorylation. S2R+ cells were left untreated 
(Ctrl) or were treated with dsRNA for knockdown of expression of 
LIMK, Ssh and cofilin for 5 days. Cells were lysed and P-cofilin and 
0-actin levels assessed in the lysates by immunoblotting. (B) 
Immunoblotting of P-cofilin, P-Akt and 0-actin in lysates of dsRNA- 
treated cells stimulated with insulin. S2R+ cells were cultured in the 
presence of dsRNA targeting LacZ (control), Rac 1+2 and Ssh and 
then treated with 10 p-g/ml insulin for the indicated times prior to 
lysis and immunoblotting. (C) P-cofilin and 0-actin levels were 
assessed in extracts from S2R+ cells treated with jasplakinolide (1 
p,g/ml), latrunculin B (1 p,g/ml) or cytochalasin D (2 p.g/ml) for the 
times indicated. (D) P-cofilin, P-Akt and 0-actin levels are shown for 
S2R+ cells pre-treated for 10 minutes with latrunculin B (1 p.g/ml) or 
jasplakinolide (1 p.g/ml) followed by 20 minutes of insulin treatment 
(10 p.g/ml) or vehicle alone.
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Fig. 6. Slingshot is the major regulator of actin-dependent cofilin 
phosphorylation. (A) Ssh RNAi blocks jasplakinolide-induced loss of 
cofilin phosphorylation. Control S2R+ cells and cells treated with 
dsRNA targeting Ssh were treated with jasplakinolide (1 p.g/ml) for 
the times indicated and P-cofilin and 0-actin levels assessed in the 
lysates by immunoblotting. (B) LIMK RNAi does not reverse Ssh 
dsRNA blockade of jasplakinolide-induced loss of cofilin 
phosphorylation. Cells treated with dsRNA targeting Ssh (SSH) or 
Ssh and LIMK together (SSH/LIMK) were treated with jasplakinolide 
(1 p.g/ml) for the indicated times, and P-cofilin and 0-actin levels 
assessed in lysates by immunoblotting. (C) The effect of LIMK and 
Ssh on latrunculin B-induced cofilin-phosphorylation. Cells treated 
with control dsRNA and dsRNA targeting LIMK or LIMK and SSH 
together (LIMK/SSH) were treated with latrunculin B (1 p.g/ml) for 
the indicated times, and P-cofilin and 0-actin levels in lysates were 
determined by immunoblotting. (D) Loss of actin expression induces 
cofilin phosphorylation. P-cofilin and 0-actin levels were determined 
by immunoblotting in lysates of control cells (untreated) and cells 
treated with dsRNAs targeting actin, cofilin and LacZ.
to changes in lamellipodial actin organisation. P-cofilin was 
the only protein spot identified whose expression correlated 
with actin filament levels. Significantly, phosphorylation of 
cofilin on the evolutionarily conserved Ser3 prevents the 
binding of cofilin to actin filaments, completely inhibiting its 
ability to promote filament disassembly (Bamburg, 1999). P- 
cofilin levels were also altered in opposing directions in 
response to changes in levels of PtdIns(3,4,5)P3 induced 
following PI3K and PTEN RNAi, but were unaffected by 
RNAi-induced silencing of Ras and Akt. Thus, the level of 
cofilin phosphorylation is responsive to changes in actin 
organisation and is regulated by actin-signalling events 
downstream of PtdIns(3,4,5)P3 (Firtel and Chung, 2000).
Having established a possible link between PI3K-actin
signalling and cofilin phosphorylation, we were then able to 
use RNAi together with live cell imaging to look for a role for 
the active dephosphorylated form of cofilin in actin 
remodelling. The ability of cells to mount a ruffling response 
in this system was found to require cofilin and, to a lesser 
extent, its dedicated phosphatase Ssh, in agreement with 
previous reports (Ghosh et al., 2004; Nishita et al., 2004). 
Moreover, levels of P-cofilin were found to respond to PI3K 
signalling, as has been observed in other systems (Mouneimne 
et al., 2004; Nishita et al., 2004). In S2R+ cells, P-cofilin levels 
peak 30 minutes after insulin stimulation before gradually 
returning to baseline levels. Although this dynamic response 
reveals a link between PI3K signalling and cofilin 
phosphorylation, as suggested by the analysis in steady state
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(Fig. 4), three pieces of evidence indicated that the observed 
changes in cofilin phosphorylation status were unlikely to 
mediate PI3K-induced actin remodelling. First, PI3K 
signalling, cortical actin accumulation and membrane ruffling 
all occur within the first few seconds or minutes of insulin 
addition; before the detection of any significant changes in 
cofilin phosphorylation. Second, the morphogenetic response 
to insulin was unaffected by the loss of LIMK, the kinase 
responsible for cofilin phosphorylation in this and other 
systems (Fig. 4) (Arber et al., 1998; Yang et al., 1998), 
suggesting that an increase in cofilin phosphorylation is not 
required for cytoskeletal remodelling during the initial 
protrusive response. Third, it is clear from the literature that 
the relationship between PI3K-signalling and cofilin 
phosphorylation varies widely across the different systems in 
which it has been analysed (Mouneimne et al., 2004; Nishita 
et al., 2004; Song et al., 2006). These data led us to explore an 
alternative model in which changes in cofilin phosphorylation 
are a downstream effect of PI3K-induced changes in actin 
filament formation. The first indication that this might be the 
case came from the finding that in our 2D-DIGE analysis, P- 
cofilin levels were increased in Arp3 RNAi cells, in which 
lamellipodia and the underlying cortical actin network are lost 
(Biyasheva et al., 2004; Kunda et al., 2003). Second, in Rac 
RNAi cells, which are unable to generate protrusions, P-cofilin 
levels remained at a constant and elevated level following 
insulin stimulation -  as expected by such a model. Third, the 
treatment of cells with latrunculin B or cytochalasin D caused 
the rapid loss of cortical F-actin, and a delayed increase in P- 
cofilin levels. Conversely, the actin toxin jasplakinolide 
induced ectopic actin filament formation and a relatively rapid 
and complete loss of the P-cofilin signal. Moreover, 
jasplakinolide also blocked the ability of insulin to induce 
cofilin phosphorylation in these cells. Taken together these data 
show that actin remodelling is required for dynamic changes 
in the level of cofilin Ser3 phosphorylation, and that acute 
changes in actin filaments levels are sufficient to alter the 
cofilin phosphorylation status.
It is noticeable that the increase in cofilin phosphorylation 
is observed in cells with a paucity of cortical actin filaments, 
where it will limit the rate of filament disassembly. Conversely, 
cofilin is dephosphorylated and activated in cells with excess 
actin filaments, therefore maintaining the monomeric actin 
pool. This suggests a role for the dynamic regulation of cofilin 
phosphorylation in the maintenance of actin filament 
homeostasis and implies the existence of a sensor that can 
measure dynamic changes in actin filament levels. Four recent 
studies have implicated Ssh in this role, by showing that Ssh 
is activated through binding to actin filaments (Nagata-Ohashi 
et al., 2004; Soosairajah et al., 2005; Tanaka et al., 2005; 
Yamamoto et al., 2006). Similarly, our data show that Ssh is 
likely to be the key regulator of P-cofilin levels in S2R+ cells 
because it is required for dynamic changes in P-cofilin levels 
in response to insulin and because the kinetics of loss of cofilin 
phosphorylation following jasplakinolide treatment are more 
rapid than the effects of latrunculin B -  as would be expected 
if the dynamics of P-cofilin were regulated by a constitutively 
active LIMK and a phosphatase whose activity is regulated by 
the level of actin filaments. Furthermore, Ssh RNAi suppresses 
both jasplakinolide- and latrunculin-induced changes in P- 
cofilin whereas, on its own, LIMK RNAi cannot. Because
RNAi-mediated silencing of actin mimics the effects of actin 
depolymerisation by increasing the level o f cofilin 
phosphorylation, it is unlikely that G-actin levels play a 
significant role in driving the change in P-cofilin levels 
following a perturbation of the ratio between F-actin and G- 
actin. Instead, we favour a model in which the binding o f Ssh 
to actin filaments acts as a measure o f relative levels of F 
actin.
How can we reconcile the role of cofilin in the formation of 
actin-dependent protrusions in S2R+ cells with the observed 
changes in P-cofilin following an acute PI3K response? We 
suggest the following scenario: following insulin addition, 
PI3K is activated within 2 minutes, inducing the conversion of 
phosphatidylinositol (4,5)-bisphosphate [PtdIns(4,5)P2] to 
PtdIns(3,4,5)P3 within the inner leaflet of the plasma 
membrane. This activates Rac, possibly through the association 
of an unidentified PH domain-containing Rac-GEF with 
PtdIns(3,4,5)P3, leading to the nucleation of Arp2/3-dependent 
actin filaments at the cell cortex with subsequent filament 
elongation and protrusion formation. In these cells, active non- 
phosphorylated cofilin at the cell front will depolymerise 
existing ADP-actin filaments to replenish the actin monomer 
pool and to generate uncapped barbed actin filament ends for 
new elongation. We propose that Ssh monitors the level of actin 
filaments throughout this morphological response. At early 
stages, before significant levels of new actin filaments have 
been formed, low-level Ssh activity will act in opposition to 
LIMK to maintain a limited pool of active cofilin sufficient to 
remodel the existing actin filament network. Later, as new actin 
filaments accumulate and the PI3K signal declines at between 
30 and 60 minutes after insulin stimulation, Ssh activity will 
come to dominate through its association with actin filaments 
and, perhaps, through inhibition of LIMK (Soosairajah et al.,
2005). This will reduce cofilin phosphorylation increasing the 
level of actin depolymerisation to restore the F-actin:G-actin 
equilibrium. This dynamic regulation, we suggest, helps the 
cell to generate the robust but self-limiting actin filament 
response to acute actin signalling. In the context of a graded 
extracellular signal in the developing embryo (Wood et al.,
2006), a similar system could act over spatially distinct regions 
of the cell to facilitate chemotaxis by coordinating the 
polymerisation of actin filaments at the cell front, with their 
disassembly at the cell rear.
Materials and Methods
C ell culture m eth o d s
S2R* and Kcl67 cells were maintained in Schneider’s Drosophila medium 
(Invitrogen) supplemented with 10% (v/v) heat-inactivated foetal calf serum (FCS) 
(Helena Biosciences) and antibiotics (50 units/ml penicillin and 50 p.g/ml 
streptomycin; both from Sigma) in T25 flasks (Falcon, BD Biosciences) at 24°C. 
For passage of S2R+ cells, cells were removed from culture flasks using trypsin- 
EDTA (Invitrogen). To determine the effect of insulin on PI3K signalling including 
actin reorganisation, cells were grown in serum-free medium overnight and then 
treated with bovine insulin (10 fig/ml; Sigma) for different times. Other growth 
factors used in this study were human EGF at 200 ng/ml (R&D Systems), murine 
VEGF at 50 ng/ml and human PDGF-BB at 125 ng/ml (both from PeproTech Inc.). 
For inhibitor treatments, cells were treated with 100 nM wortmannin (Calbiochem), 
10-100 |xM LY294002 (Calbiochem), 1 pig/ml latrunculin B (Calbiochem), 1 p.g/ml 
jasplakinolide (Invitrogen) or 2 p.g/ml cytochalasin D (Sigma). All inhibitors were 
made up in DMSO, which served as a vehicle-alone control.
d sR N A  production and RNAi
Primer sequences of -21 bp (supplementary material Table S2) flanked with T7 
sites, were chosen to PCR amplify -500-1500 bp of exonic sequences of the genes 
to be silenced. PCR was carried out using HotStarTag DNA polymerase (Qiagen).
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PCR amplification was confirmed by 1% agarose gel electrophoresis using the 
GeneRuler 1-kb marker to assess the size of PCR products. dsRNAs were generated 
from PCR products by in vitro transcription using the MEGAscript™ High Yield 
Transcription Kit (Ambion). Reactions were conducted at 37°C overnight and 
dsRNAs were purified using Multiscreen PCR% purification plates (Millipore) 
attached to a vacuum pump. Purified dsRNAs were re-suspended in TE buffer (10 
mM Tris-HCl pH 8.0, 1 mM EDTA) and annealed at 95°C for 15 minutes followed 
by slow cooling to room temperature (RT). The dsRNA concentration was estimated 
on 1% agarose gels using 500 ng of the GeneRuler 1-kb marker and dsRNAs were 
stored at -20°C until used. For dsRNA treatment, S2R+ cells were typically 
suspended at 2X106 cells/ml in Schneider’s serum-free medium and 300 p.1 of cells 
per well were plated into 6-well tissue culture plates (Falcon, BD Biosciences). 
dsRNA was added directly to the medium to a final concentration of 0.3 p.M, 
followed by gentle agitation. Cells were incubated for 30 minutes at RT followed 
by addition of 1 ml of Schneider’s medium supplemented with 10% FCS. For 
proteomic experiments, each dsRNA treatment was conducted in triplicate on 
separate days. To allow turnover of target proteins cells were incubated for 5 days 
prior to harvesting for analysis.
Sample preparation for 1D and 2D SDS-PAGE
Cells were washed gently with ice-cold PBS and lysed in NP40 lysis buffer (50 
mM HEPES, 150 mM NaCl, 1% N P 4 0 ,1 mM EDTA) or 2D lysis buffer (8 M urea, 
2 M thiourea, 4% CHAPS, 1 mM EDTA, 10 mM Tris-HCl pH 8.3), both 
supplemented with protease inhibitors (17 p-g/ml aprotinin; 1 p-g/ml pepstatin; 1 
H-g/ml leupeptin, 100 p-g/ml AEBSF) and phosphatase inhibitors (2 mM sodium 
orthovanadate, 5 p-g/ml BpVphen, 5 p.M fenvalerate, 1 p-M okadaic acid). For ID 
SDS-PAGE, cells were lysed in NP40 lysis buffer and scraped off on ice. Cells 
lysed in 2D lysis buffer were homogenised by passage (six times) through a 25G 
needle. Insoluble material was removed by centrifugation (13,000 rpm for 10 
minutes at 4°C). Protein concentrations were determined using Coomassie Protein 
Assay Reagent (Pierce) and a bovine serum albumin (BSA) standard curve with 
three replicate assays performed per sample. For ID SDS-PAGE, lysates were 
denatured in Laemmli sample buffer [50 mM Tris-HCl pH 6.8, 10% (v/v) glycerol, 
2% (w/v) SDS, 0.1% (w/v) Bromophenol Blue, 2% (v/v) p-mercaptoethanol] and 
heated at 100°C for 5 minutes. ID SDS-PAGE was performed following standard 
procedures.
Fluorescence 2D-DIGE protein expression profiling
The N-hydroxy-succinimidyl (NHS) ester of Cy2 was purchased from GE 
Healthcare, whereas NHS-Cy3 and Cy5 were synthesized in-house following the 
protocol outlined in Chan et al. (Chan et al., 2005). 2D difference gel 
electrophoresis (2D-DIGE) was carried out in a dedicated clean-room essentially 
as described (Weeks et al., 2006). For this, 120 p-g of protein extract from each 
triplicate sample was labelled with NHS-Cy3 or NHS-Cy5 at 4 pmol dye/p.g 
protein on ice in the dark for 30 minutes. Equal amounts of protein extract from 
each experiment were pooled together and labelled with NHS-Cy2 to create an 
internal standard which was run on all gels against the Cy3- and Cy5-labelled 
samples to aid in spot matching and quantification (Gharbi et al., 2002). Labelling 
reactions were quenched with a 20-fold molar excess of free L-lysine to dye and 
differentially labelled samples mixed appropriately. Final volumes were adjusted 
to 450 p,l with 2D lysis buffer with final concentrations of 65 mM DTT, 2% carrier 
Ampholine/ Pharmalytes (50:50 v/v) pH 3-10 and 0.05% Bromophenol Blue. For 
2D SDS-PAGE, 24-cm, non-linear pH 3-10 IPG strips (GE Healthcare) were 
rehydrated with Cy-labelled samples overnight in the dark at RT prior to isoelectric 
focusing on a Multiphor II apparatus (GE Healthcare) for 80 kVh at 18°C. Strips 
were then incubated for 10 minutes in equilibration buffer (50 mM Tris-HCl pH 
6.8, 6 M (w/v) urea, 30% (v/v) glycerol, 2% (w/v) SDS) containing 65 mM DTT, 
and then for 10 minutes in the same buffer containing 240 mM iodoacetamide. IPG 
strips were transferred onto 1 5-mm thick 24x20  cm 12% polyacrylamide gels cast 
between low-fluorescence glass plates and bonded to the inner surface of one plate 
with bind-silane (PlusOne, GE Healthcare). Strips were overlaid with 0.5% (w/v) 
low-melting point agarose in Tris-glycine-SDS electrophoresis buffer (Severn 
Biotech) with Bromophenol Blue. Gels were run at 2 W per gel at 8°C in an Ettan 
12 apparatus (GE Healthcare) until the dye front had run off and were then scanned 
(between plates) on a Typhoon 9400 multicolour fluorescence imager using 
ImageQuant software (GE Healthcare). Images were imported into DeCyder™ 
image analysis software (GE Healthcare) for comparison of sample feature 
volumes with the corresponding internal standard feature volumes giving a 
standardised abundance for each matched gel feature. Standardised abundances 
were then averaged from the triplicates for each experimental condition and 
features found on all images were selected for MS-based identification if they 
displayed a 3s 1.5-fold average change in abundance versus the untreated control 
with P « 0.05 (Student’s /-test). Proteins were then visualised by staining of gels 
with colloidal Coomassie Brilliant Blue and the gels were imaged and matched to 
the corresponding Cy-dye images using DeCyder software essentially as described 
(Chan et al., 2005). From this, a list of coordinates of spots of interest was 
generated for automated spot excision using an Ettan spot-picking robot (GE 
Healthcare).
Protein identification by mass spectrometry
In-gel tryptic digestion of excised gel pieces was performed as previously 
described (Weeks et al., 2006). For peptide mass fingerprinting, 0.5 p-1 of tryptic 
digest was mixed with 1 p.1 of matrix -  saturated aqueous 2,5-dihydroxybenzoic 
acid (DHB) -  and spotted onto a sample target and dried. Matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) mass spectra were acquired 
using an externally calibrated Ultraflex mass spectrometer (Bruker Daltonics) in 
the reflector mode. After internal calibration using trypsin autolysis peaks, 
prominent peaks in the mass range m/z 500-5000 were used to generate a peptide 
mass fingerprint which was searched against the updated NCBI database using 
Mascot version 2.0.02 (Matrix Sciences). Identifications were accepted when a 
minimum of six peptide masses matched a particular protein (mass error of ±100 
ppm, allowing one missed cleavage), sequence coverage was >25%, MOWSE 
scores were higher than a threshold value of P=0.05, the predicted protein mass 
agreed with the gel-based mass and Drosophila sequences were identified. 
Identifications were also made by peptide sequencing using nano-liquid 
chromatography-electrospray ionization collision-induced dissociation tandem 
mass spectrometry (LC-MS/MS). This was performed on an Ultimate HPLC 
(Dionex) with a PepMap C18 75 p.m inner-diameter column (LC Packings) at a 
flow rate of 300 nl/minutes, coupled to a Quadrupole Time-Of-Flight 1 (QTOF1) 
mass spectrometer (Waters/Micromass, Manchester, UK). Spectra were processed 
using MassLynx software (Waters) and submitted to Mascot database search 
routines. Positive identifications were accepted when at least two peptide 
sequences matched an entry with MOWSE scores above the P=0.05 threshold 
value.
P h o sp h o p e p tid e  a n a ly sis  using T i0 2 m icro-co lu m n s and LC- 
MS/MS
Enrichment of phosphorylated peptides from peptides generated by in-gel digestion 
of selected protein spots was performed using Ti0 2  essentially as described in 
(Larsen et al., 2005). Briefly, ~3-mm-long 1102 micro-columns were packed in 
GELoader tips with a small C8 3M Empore plug. The trypsin digests from the two 
cofilin protein spots were diluted into 5% TFA, 80% acetonitrile (with inclusion of 
50 mg/ml phthalic acid) and loaded onto the 1102 micro-columns. The columns 
were washed with 5% TFA, 80% acetonitrile and bound phosphorylated peptides 
were eluted with 15 p.1 ammonia solution [10 p.1 ammonia (25% solution) in 490 
p.1 water]. Eluates were acidified and analyzed by MALDI-TOF MS and LC- 
MS/MS. MALDI-TOF MS was performed on a Voyager STR mass spectrometer 
(PerSeptive Biosystems, Framingham, MA). All spectra were obtained in the 
positive reflector mode and DHB (20 g/1) in 50% acetonitrile, 1% phosphoric acid 
was used as the matrix. Data analysis was performed using MoverZ software 
(www.proteometrics.com) and peptide assignment was accomplished using 
GPMAW software (welcome.to/gpmaw). LC-MS/MS was performed on a Proxeon 
Biosystem Easy-nLC nanoflow system (Proxeon Biosystems, Odense, Denmark) 
coupled to a QTOF Ultima mass spectrometer (Waters/Micromass, Manchester, 
UK). Peptides were loaded onto a 75 pm inner-diameter fused silica pre-column 
(ReproSil-Pur, Germany) and eluted with a 1.5% gradient (buffer A: 0.5 % acetic 
acid; buffer B: 0.5% acetic acid in 80% acetonitrile) onto a 50 p.m inner-diameter 
fused silica analytical column (ReproSil-Pur) and into the mass spectrometer. The 
mass spectrometer was operated in data-dependent acquisition mode and two of the 
most intense ions were selected for collision-induced dissociation per MS scan. The 
data were processed using MassLynx software and pkl files were searched using an 
in-house version of Mascot.
Immunoblotting and immunofluorescence staining
Extracts separated by ID or 2D SDS-PAGE were blotted onto Immobilon P 
membrane (Millipore) and blocked with 5% (w/v) BSA in TBS-T [50 mM Tris pH 
8.0,150 mM NaCl, 0.1% (v/v) Tween-20]. Membranes were probed with antibodies 
against C-terminal Drosophila Akt, P-Akt (both from S. Leevers, CRUK), P-S6K 
(Cell Signalling Technology), PP-ERK (Sigma), (3-actin (Sigma) or P-cofilin 
(against the peptide acetyl-ApSGVTVSDC, Eurogentec). Membranes were washed 
(three times 10 minutes) in TBS-T, incubated with the appropriate horseradish- 
peroxidase-conjugated secondary antibody (Amersham Pharmacia), washed again 
and developed using enhanced chemiluminescence (PerkinElmer, Inc.). For 
immunostaining, cells were washed with PBS and fixed with 4% (v/v) formaldehyde 
in PBS for 10 minutes. After washing with PBS, cells were permeabilised with 0.1% 
(v/v) Triton X-100 in PBS for 5 minutes, washed again and blocked with 5% (w/v) 
BSA in PBS for 1 hour. For P-Akt staining, cells were incubated with primary 
antibody (1:300 in PBS) overnight at 4°C, followed by incubation with secondary 
anti-rabbit antibody conjugated to Cy5 for 1 hour at RT. For actin, tubulin and DNA 
staining, the fixed and permeabilised cells were incubated for 1 hour at RT with 
Rhodamine-phalloidin (1:1000), FITC-conjugated anti-tubulin antibody (1:1000) 
and DAP1 (1:2000) respectively, all diluted in PBS. Fluorescent images were 
acquired using a Nikon 2000E microscope with 20X and 40X objectives fitted with 
a cooled CCD camera (Cool Snap; Roper) and using MetaMorph software 
(Universal Imaging Inc.). Within each experiment, all images were acquired and 
processed in an identical fashion to enable comparison across the image series.
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T im e-la p se  m icroscop y
Phase-contrast and fluorescence time-lapse movies were taken on a Nikon 2000E 
microscope with a 100X oil immersion lens at 20-second intervals. Actin dynamics 
were analysed in live dsRNA-treated cells by time-lapse fluorescence microscopy 
using GFP-moesin to visualise F-actin. For this, cells were treated for 4 days with 
dsRNAs and then plated onto uncoated glass dishes. Baculovirus harbouring DNA 
driving the expression of the actin-binding region of moesin fused to GFP from the 
actin5c promoter was then added to the cells and incubated overnight. Actin 
reorganisation in the cells was filmed from 3 minutes before until 10 minutes after 
addition of 10 p.g/ml insulin. Kymographs were generated from time-lapse movie 
images using MetaMorph software. For this, five to ten 1-pixel-thick lines were 
drawn across the cell edges of one to three cells in the field and the pixel intensities 
along each line combined to generate the kymographs. Representative cells, lines 
and kymographs are shown for each experiment.
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